assay_strain,assays_ASSTAI,assays_VARII,assays_ASORGA,assays_ASTI,assays_ASCTY,assays_ASSUBCEFRA,assays_CEI,assays_RELT,assays_ASCATE,assays_SASI,assays_Ti,assays_CHI,assays_SI,assays_ASST,assays_Descr,assays_CURAB,assays_ASTETY,assays_TISI,assays_CONSCO,assays_ASSI,assays_BAFOR,assays_DOI
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL618647,1,A,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate,In vivo,2113.0,1,7524,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL618648,1,A,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,Intermediate,In vivo,2113.0,1,7525,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL618649,1,A,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate,In vivo,2113.0,1,7526,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL618650,1,A,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate,In vivo,2107.0,1,7527,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL618651,1,A,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,Intermediate,In vivo,2107.0,1,7528,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL876497,1,A,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate,In vivo,2107.0,1,7529,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL618652,1,A,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate,In vivo,2048.0,1,7530,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL618653,1,A,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,Intermediate,In vivo,2048.0,1,7531,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL618654,1,A,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate,In vivo,2048.0,1,7532,BAO_0000218,9866
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618655,1,A,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,Intermediate,,,1,7533,BAO_0000218,6351
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618656,1,A,Compound was tested for solubility in water,Intermediate,,,1,7534,BAO_0000218,1465
,,,,,,,,U,,,22229,CHEMBL618657,1,P,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),Intermediate,,,0,7535,BAO_0000100,5182
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618658,1,A,Solubility was determined,Intermediate,,,1,7536,BAO_0000218,17847
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618659,1,A,solubility in water (ug/mL) at 37 degree C.,Intermediate,,,1,7537,BAO_0000218,15339
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618660,1,A,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,Intermediate,,,1,7538,BAO_0000218,5202
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618661,1,A,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,Intermediate,,,1,7539,BAO_0000218,1088
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL873807,1,A,Half life in rats,Intermediate,,,1,7540,BAO_0000218,3169
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618662,1,A,Half life in Dawley rat,Intermediate,,,1,7541,BAO_0000218,5353
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618663,1,A,Half life period after 3 mg/kg iv administration,Intermediate,In vivo,,1,7542,BAO_0000218,2864
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618664,1,A,Half life period after 3 mg/kg iv administration in rat,Intermediate,In vivo,,1,7543,BAO_0000218,2864
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618665,1,A,Half life period after 3 mg/kg iv administration in the rat,Intermediate,In vivo,,1,7544,BAO_0000218,2864
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876498,1,A,Half life period in female Sprague-Dawley rats,Intermediate,,,1,7545,BAO_0000218,6362
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618666,1,A,Half life period in rat,Intermediate,,,1,7546,BAO_0000218,6249
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620440,1,A,Half-life in rats was determined,Intermediate,,,1,7547,BAO_0000218,3169
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620441,1,A,Half-life in rats with metabolic oxidation,Intermediate,,,1,7548,BAO_0000218,3169
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620442,1,A,Half-life in rats,Intermediate,,,1,7549,BAO_0000218,3169
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620443,1,A,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate,In vivo,,1,7550,BAO_0000218,17260
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620444,1,A,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate,In vivo,,1,7551,BAO_0000218,17260
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620445,1,A,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate,In vivo,,1,7552,BAO_0000218,17260
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620446,1,A,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate,In vivo,,1,7553,BAO_0000218,17260
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL620447,1,A,Biological half-life measured in plasma of rat,Intermediate,,1969.0,1,7554,BAO_0000218,2879
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL621129,1,A,Biological half-life measured in plasma of rat; 22-25,Intermediate,,1969.0,1,7555,BAO_0000218,2879
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL621130,1,A,Biological half-life measured in plasma of rat; 9-16,Intermediate,,1969.0,1,7556,BAO_0000218,2879
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL873808,1,A,Compound was evaluated for its half life when administered intravenously in rat,Intermediate,In vivo,,1,7557,BAO_0000218,3184
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876598,1,A,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,Intermediate,In vivo,,1,7558,BAO_0000218,4891
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621131,1,A,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,Intermediate,In vivo,,1,7559,BAO_0000218,429
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621132,1,A,Half life (T1/2) after oral administration in rat,Intermediate,In vivo,,1,7560,BAO_0000218,5656
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621133,1,A,Half life of compound after iv administration of 20 mg/kg dose in rat,Intermediate,In vivo,,1,7561,BAO_0000218,4413
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621312,1,A,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,In vivo,,1,7562,BAO_0000218,3598
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621313,1,A,Half life of compound was determined in rat,Intermediate,,,1,7563,BAO_0000218,17267
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL621314,1,A,Half life of compound was determined in rat blood,Intermediate,,178.0,1,7564,BAO_0000218,4727
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621315,1,A,Half life at 1 mg/kg was determined in rat,Intermediate,In vivo,,1,7565,BAO_0000218,17651
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621316,1,A,Half life at 10 mg/kg was determined in rat,Intermediate,In vivo,,1,7566,BAO_0000218,17651
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621317,1,A,Half life in rats,Intermediate,,,1,7567,BAO_0000218,401
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621318,1,A,Half life in rats in hours,Intermediate,,,1,7568,BAO_0000218,4942
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621319,1,A,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Intermediate,In vivo,,1,7569,BAO_0000218,17735
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621377,1,A,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,Intermediate,In vivo,,1,7570,BAO_0000218,6056
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621378,1,A,Half life was determined,Intermediate,,,1,7571,BAO_0000218,5213
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876599,1,A,Half life after i.v. administration,Intermediate,In vivo,,1,7572,BAO_0000218,6616
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621379,1,A,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,Intermediate,In vivo,,1,7573,BAO_0000218,5937
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL621380,1,A,Half life in rat plasma,Intermediate,,1969.0,1,7574,BAO_0000218,5819
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL621381,1,A,Half life in rat plasma; Not detected,Intermediate,,1969.0,1,7575,BAO_0000218,5819
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618515,1,A,Half life in rats,Intermediate,,,1,7576,BAO_0000218,6803
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618516,1,A,Half life period of compound was determined after peroral administration,Intermediate,In vivo,,1,7577,BAO_0000218,17804
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618517,1,A,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,Intermediate,In vivo,,1,7578,BAO_0000218,17804
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618518,1,A,Half life period in rat,Intermediate,,,1,7579,BAO_0000218,5948
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618519,1,A,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Intermediate,In vivo,,1,7580,BAO_0000218,1916
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618698,1,A,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Intermediate,In vivo,,1,7581,BAO_0000218,1916
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618862,1,A,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,Intermediate,In vivo,,1,7582,BAO_0000218,1916
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618863,1,A,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Intermediate,In vivo,,1,7583,BAO_0000218,4890
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618864,1,A,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,Intermediate,In vivo,,1,7584,BAO_0000218,17764
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618865,1,A,Half life time in rat the dose of 2 mg/kg,Intermediate,In vivo,,1,7585,BAO_0000218,4727
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618866,1,A,Half-life 24 hr after 10 mg/kg iv administration in rats,Intermediate,In vivo,,1,7586,BAO_0000218,17509
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618867,1,A,Half-life 24 hr after 2 mg/kg iv administration in rats,Intermediate,In vivo,,1,7587,BAO_0000218,17509
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875828,1,A,Half-life consistent with the observed metabolic steady state in rats,Intermediate,,,1,7588,BAO_0000218,6597
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618868,1,A,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Intermediate,In vivo,,1,7589,BAO_0000218,17735
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618869,1,A,Half-life for oxidative metabolic stability was determined using male human,Intermediate,,,1,7590,BAO_0000218,6597
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618870,1,A,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",Intermediate,In vivo,,1,7591,BAO_0000218,17670
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL618871,1,A,Half-life in rat plasma,Intermediate,,1969.0,1,7592,BAO_0000218,1696
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL618872,1,A,Half-life in rat plasma was determined,Intermediate,,1969.0,1,7593,BAO_0000218,1742
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL873816,1,A,Half-life in rats was determined,Intermediate,,,1,7594,BAO_0000218,17800
,,,,,,,,U,,,22224,CHEMBL618873,1,A,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,Autocuration,,,0,7595,BAO_0000218,12923
,,,,,,,,U,,,22224,CHEMBL621602,1,A,Area under curve after oral dose of 0.1 mg//kg,Autocuration,,,0,7596,BAO_0000019,11954
,,,,,,,,U,,,22224,CHEMBL621603,1,A,Area under curve after oral dose of 0.3 mg/kg,Autocuration,,,0,7597,BAO_0000218,11954
,,,,,,,,U,,,22224,CHEMBL621604,1,A,Area under curve after oral dose of 1 mg/kg,Autocuration,,,0,7598,BAO_0000218,11954
,,,,,,,,U,,,22224,CHEMBL621605,1,A,Area under curve after oral dose of 10 mg/kg,Autocuration,,,0,7599,BAO_0000218,11954
,,,,,,,,U,,,22224,CHEMBL621606,1,A,Area under curve after oral dose of 23.4 mg/kg,Autocuration,,,0,7600,BAO_0000218,11954
,,,,,,,,U,,,22224,CHEMBL621607,1,A,Area under curve after oral dose of 3 mg/kg,Autocuration,,,0,7601,BAO_0000218,11954
,,,,,,,,U,,,22224,CHEMBL621608,1,A,Area under curve after oral dose of 3.87 mg/kg,Autocuration,,,0,7602,BAO_0000218,11954
,,,,,,,,U,,,22224,CHEMBL621609,1,A,Area under curve was determined,Autocuration,,,0,7603,BAO_0000019,5237
,,,,,,,,U,,,22224,CHEMBL621610,1,A,Area under curve at a dose of 10 mg/kg,Autocuration,,,0,7604,BAO_0000218,4026
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621611,1,A,Area under curve was determined; ND=No data,Intermediate,,,1,7605,BAO_0000218,5237
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621612,1,A,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,,,1,7606,BAO_0000218,14793
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622308,1,A,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,Intermediate,,,1,7607,BAO_0000218,14793
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622309,1,A,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,,,1,7608,BAO_0000218,14793
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622310,1,A,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,Intermediate,,,1,7609,BAO_0000218,14793
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622311,1,A,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,Intermediate,,,1,7610,BAO_0000218,14793
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622312,1,A,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,Intermediate,,,1,7611,BAO_0000218,14793
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622931,1,A,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,,,1,7612,BAO_0000218,14793
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622932,1,A,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,Intermediate,,,1,7613,BAO_0000218,14793
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622736,1,A,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,,1969.0,1,7614,BAO_0000218,14793
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622737,1,A,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,Intermediate,,1969.0,1,7615,BAO_0000218,14793
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622738,1,A,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,,1969.0,1,7616,BAO_0000218,14793
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622739,1,A,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,Intermediate,,1969.0,1,7617,BAO_0000218,14793
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622740,1,A,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,Intermediate,,1969.0,1,7618,BAO_0000218,14793
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622741,1,A,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,Intermediate,,1969.0,1,7619,BAO_0000218,14793
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622742,1,A,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,Intermediate,,1969.0,1,7620,BAO_0000218,14793
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622743,1,A,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,Intermediate,,1969.0,1,7621,BAO_0000218,14793
,10090.0,,Mus musculus,Plasma,,,,N,,,50594,CHEMBL622744,1,A,AUC in mice,Intermediate,,1969.0,1,7622,BAO_0000218,11637
,,,,,,,,U,,,22224,CHEMBL624134,1,A,Area under curve was measured from the graph obtained from concentration Vs time,Autocuration,,,0,7623,BAO_0000019,11149
,,,,,,,,U,,,22224,CHEMBL624135,1,A,Area under curve value of compound per hour after oral administration,Autocuration,,,0,7624,BAO_0000019,10016
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624136,1,A,Area under curve was determined after oral administration in rats,Intermediate,,,1,7625,BAO_0000218,17796
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624137,1,A,Area under curve was determined after oral administration in rats; No data,Intermediate,,,1,7626,BAO_0000218,17796
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624320,1,A,Area under curve was determined after oral administration in rats;No data,Intermediate,,,1,7627,BAO_0000218,17796
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624321,1,A,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,Intermediate,,,1,7628,BAO_0000218,12923
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624322,1,A,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,Intermediate,,,1,7629,BAO_0000218,15372
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624323,1,A,Area under curve was determined for the compound after iv dose of 5.06 in rats,Intermediate,,,1,7630,BAO_0000218,15372
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624324,1,A,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,Intermediate,,,1,7631,BAO_0000218,15372
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624325,1,A,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,Intermediate,,,1,7632,BAO_0000218,15372
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624326,1,A,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,Intermediate,,,1,7633,BAO_0000218,15372
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624327,1,A,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,Intermediate,,,1,7634,BAO_0000218,15372
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624328,1,A,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,Intermediate,,,1,7635,BAO_0000218,15372
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL627848,1,A,Area under curve was determined in Dogs after peroral administration,Intermediate,,,1,7636,BAO_0000218,14169
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627849,1,A,Area under curve was determined in Rats after peroral administration,Intermediate,,,1,7637,BAO_0000218,14169
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627850,1,A,Area under curve was determined in carotid blood of rat when administered intradermally,Intermediate,,,1,7638,BAO_0000218,14258
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627851,1,A,Area under curve was determined in portal blood of rat when administered intradermally,Intermediate,,,1,7639,BAO_0000218,14258
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627852,1,A,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,Intermediate,,,1,7640,BAO_0000218,15011
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627853,1,A,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,Intermediate,,,1,7641,BAO_0000218,15011
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627854,1,A,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),Intermediate,,,1,7642,BAO_0000218,15011
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627855,1,A,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,Intermediate,,,1,7643,BAO_0000218,15011
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627856,1,A,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),Intermediate,,,1,7644,BAO_0000218,15011
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL875339,1,A,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,Intermediate,,,1,7645,BAO_0000218,15011
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627857,1,A,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),Intermediate,,,1,7646,BAO_0000218,15011
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL627858,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,Intermediate,In vivo,2106.0,1,7647,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627859,1,A,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,Intermediate,,178.0,1,7648,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL627860,1,A,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,Intermediate,,955.0,1,7649,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL627019,1,A,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,Intermediate,,948.0,1,7650,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627020,1,A,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,Intermediate,,2107.0,1,7651,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627021,1,A,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,Intermediate,,2048.0,1,7652,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL627022,1,A,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,Intermediate,,2385.0,1,7653,BAO_0000218,10130
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627023,1,A,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,Intermediate,,,1,7654,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL627024,1,A,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,Intermediate,,2106.0,1,7655,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL627025,1,A,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,Intermediate,,2046.0,1,7656,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL627026,1,A,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,Intermediate,,2113.0,1,7657,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627027,1,A,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,Intermediate,,178.0,1,7658,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL627028,1,A,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,Intermediate,,955.0,1,7659,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL627029,1,A,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,Intermediate,,948.0,1,7660,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL627030,1,A,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,Intermediate,,2113.0,1,7661,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627031,1,A,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,Intermediate,,2107.0,1,7662,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627032,1,A,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,Intermediate,,2048.0,1,7663,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL627033,1,A,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,Intermediate,,2385.0,1,7664,BAO_0000218,10130
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627034,1,A,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,Intermediate,,,1,7665,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL627035,1,A,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,Intermediate,,2106.0,1,7666,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL627036,1,A,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,Intermediate,,2046.0,1,7667,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL875340,1,A,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,Intermediate,,178.0,1,7668,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL627037,1,A,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,Intermediate,,948.0,1,7669,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL627038,1,A,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,Intermediate,,2113.0,1,7670,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627039,1,A,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,Intermediate,,2107.0,1,7671,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL627040,1,A,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,Intermediate,,2385.0,1,7672,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL624663,1,A,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,Intermediate,,2106.0,1,7673,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL625963,1,A,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,Intermediate,,2046.0,1,7674,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL876799,1,A,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,Intermediate,,955.0,1,7675,BAO_0000218,10130
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626133,1,A,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,Intermediate,,2048.0,1,7676,BAO_0000218,10130
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626134,1,A,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,Intermediate,,,1,7677,BAO_0000218,10130
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626135,1,A,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,Intermediate,,,1,7678,BAO_0000218,6295
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626136,1,A,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,Intermediate,,,1,7679,BAO_0000218,6296
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626137,1,A,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,Intermediate,,,1,7680,BAO_0000218,6296
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626138,1,A,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,Intermediate,,,1,7681,BAO_0000218,6295
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626139,1,A,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,Intermediate,,,1,7682,BAO_0000218,6296
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626140,1,A,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate,In vivo,,1,7683,BAO_0000218,17260
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626141,1,A,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate,In vivo,,1,7684,BAO_0000218,17260
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626142,1,A,C24h in rat p.o. at 20 mg/kg concentration,Intermediate,,,1,7685,BAO_0000218,17686
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL627930,1,A,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate,In vivo,2385.0,1,7686,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL627931,1,A,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,Intermediate,In vivo,2385.0,1,7687,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL627932,1,A,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate,In vivo,2385.0,1,7688,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL627933,1,A,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Intermediate,In vivo,2106.0,1,7689,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL627934,1,A,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,Intermediate,In vivo,2106.0,1,7690,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL627935,1,A,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,Intermediate,In vivo,2106.0,1,7691,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627936,1,A,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,Intermediate,In vivo,178.0,1,7692,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627937,1,A,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,Intermediate,In vivo,178.0,1,7693,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627938,1,A,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,Intermediate,In vivo,178.0,1,7694,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627939,1,A,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,Intermediate,In vivo,178.0,1,7695,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627940,1,A,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,Intermediate,In vivo,178.0,1,7696,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627941,1,A,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,Intermediate,In vivo,178.0,1,7697,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL876800,1,A,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate,In vivo,178.0,1,7698,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627942,1,A,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,Intermediate,In vivo,178.0,1,7699,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627943,1,A,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,Intermediate,In vivo,178.0,1,7700,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627944,1,A,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,Intermediate,In vivo,178.0,1,7701,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627945,1,A,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,Intermediate,In vivo,178.0,1,7702,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL628584,1,A,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,Intermediate,In vivo,178.0,1,7703,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL628585,1,A,Biodistribution in rat blood in the presence of GdDTPA at 15 min,Intermediate,In vivo,178.0,1,7704,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL628586,1,A,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,Intermediate,In vivo,178.0,1,7705,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL628587,1,A,Biodistribution in rat blood in the presence of GdDTPA at 30 min,Intermediate,In vivo,178.0,1,7706,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL628588,1,A,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,Intermediate,In vivo,178.0,1,7707,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL628589,1,A,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,Intermediate,In vivo,178.0,1,7708,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625304,1,A,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,Intermediate,In vivo,178.0,1,7709,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625305,1,A,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,Intermediate,In vivo,178.0,1,7710,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625306,1,A,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,Intermediate,In vivo,178.0,1,7711,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625307,1,A,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,Intermediate,In vivo,178.0,1,7712,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625308,1,A,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,Intermediate,In vivo,178.0,1,7713,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627740,1,A,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,Intermediate,In vivo,178.0,1,7714,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627741,1,A,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,Intermediate,In vivo,178.0,1,7715,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627742,1,A,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate,In vivo,178.0,1,7716,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627743,1,A,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,Intermediate,In vivo,178.0,1,7717,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627744,1,A,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,Intermediate,In vivo,178.0,1,7718,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL627745,1,A,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,Intermediate,In vivo,10000001.0,1,7719,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL627746,1,A,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,Intermediate,In vivo,10000001.0,1,7720,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL627747,1,A,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,Intermediate,In vivo,10000001.0,1,7721,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL876810,1,A,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,Intermediate,In vivo,10000001.0,1,7722,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL627748,1,A,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,Intermediate,In vivo,10000001.0,1,7723,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL627749,1,A,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,Intermediate,In vivo,10000001.0,1,7724,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL627750,1,A,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate,In vivo,10000001.0,1,7725,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL618728,1,A,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,Intermediate,In vivo,10000001.0,1,7726,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL618729,1,A,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,Intermediate,In vivo,10000001.0,1,7727,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL618730,1,A,Biodistribution in rat bone in the presence of GdDTPA at 15 min,Intermediate,In vivo,10000001.0,1,7728,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL618731,1,A,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,Intermediate,In vivo,10000001.0,1,7729,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL618732,1,A,Biodistribution in rat bone in the presence of GdDTPA at 30 min,Intermediate,In vivo,10000001.0,1,7730,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL618733,1,A,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,Intermediate,In vivo,10000001.0,1,7731,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL618734,1,A,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,Intermediate,In vivo,10000001.0,1,7732,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL618735,1,A,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,Intermediate,In vivo,10000001.0,1,7733,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL876602,1,A,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,Intermediate,In vivo,10000001.0,1,7734,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL618736,1,A,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,Intermediate,In vivo,10000001.0,1,7735,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL618737,1,A,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,Intermediate,In vivo,10000001.0,1,7736,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL618738,1,A,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,Intermediate,In vivo,10000001.0,1,7737,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL618739,1,A,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,Intermediate,In vivo,10000001.0,1,7738,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL618740,1,A,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,Intermediate,In vivo,10000001.0,1,7739,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL618741,1,A,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate,In vivo,10000001.0,1,7740,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL618742,1,A,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,Intermediate,In vivo,10000001.0,1,7741,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL618743,1,A,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,Intermediate,In vivo,10000001.0,1,7742,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL618744,1,A,Half-life from rat plasma at a single oral dose of 25 mg/kg,Intermediate,In vivo,1969.0,1,7743,BAO_0000218,17752
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618745,1,A,Half-life in male rat,Intermediate,,,1,7744,BAO_0000218,5610
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620479,1,A,Half-life in rat after peroral administration at 10 mg/kg concentration,Intermediate,In vivo,,1,7745,BAO_0000218,5939
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620480,1,A,Half-life in rat after peroral administration at 5 mg/kg concentration,Intermediate,In vivo,,1,7746,BAO_0000218,5939
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620481,1,A,Half-life in rat at a dose of 3 mg/kg,Intermediate,In vivo,,1,7747,BAO_0000218,17771
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620482,1,A,Half-life was evaluated in rats,Intermediate,,,1,7748,BAO_0000218,1974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876603,1,A,Half-life was measured in rat,Intermediate,,,1,7749,BAO_0000218,4239
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620483,1,A,Half-life period for the compound was determined in rats at 50 mg/kg dose,Intermediate,In vivo,,1,7750,BAO_0000218,6681
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620484,1,A,Half-life period in rats after intravenous administration at 5 mg/kg,Intermediate,In vivo,,1,7751,BAO_0000218,17752
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620485,1,A,Half-life period in rat at 10 mg/kg,Intermediate,In vivo,,1,7752,BAO_0000218,6046
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620486,1,A,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",Intermediate,In vivo,,1,7753,BAO_0000218,6685
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620487,1,A,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",Intermediate,In vivo,,1,7754,BAO_0000218,6685
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620488,1,A,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",Intermediate,In vivo,,1,7755,BAO_0000218,6685
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620489,1,A,Half-life time in rat the dose of 2 mg/kg,Intermediate,In vivo,,1,7756,BAO_0000218,4727
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620490,1,A,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,Intermediate,In vivo,,1,7757,BAO_0000218,1088
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620491,1,A,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,Intermediate,In vivo,,1,7758,BAO_0000218,5610
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL876604,1,A,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Intermediate,In vivo,1969.0,1,7759,BAO_0000218,3032
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620492,1,A,Oral half life was determined,Intermediate,In vivo,,1,7760,BAO_0000218,5199
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620493,1,A,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,In vivo,,1,7761,BAO_0000218,14941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620494,1,A,Pharmacokinetic property (t1/2) in rat,Intermediate,In vivo,,1,7762,BAO_0000218,4408
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL620495,1,A,Plasma elimination half-life was determined,Intermediate,,1969.0,1,7763,BAO_0000218,2552
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL620496,1,A,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Intermediate,In vivo,1969.0,1,7764,BAO_0000218,5199
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL620497,1,A,Plasma half life was observed after intravenous administration in rat,Intermediate,In vivo,1969.0,1,7765,BAO_0000218,15662
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL620498,1,A,Plasma half-life was determined,Intermediate,,1969.0,1,7766,BAO_0000218,1465
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL620499,1,A,Plasma half-life following oral administration in Fisher rats,Intermediate,In vivo,1969.0,1,7767,BAO_0000218,1446
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL620500,1,A,Plasma half-life in rat,Intermediate,,1969.0,1,7768,BAO_0000218,6824
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL873809,1,A,Plasmatic Half-life after intravenous administration to rat,Intermediate,In vivo,1969.0,1,7769,BAO_0000218,17533
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620501,1,A,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,Intermediate,In vivo,,1,7770,BAO_0000218,5979
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620502,1,A,Terminal half life after intravenous administration (1 mg/kg) in rat,Intermediate,In vivo,,1,7771,BAO_0000218,4689
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620503,1,A,Terminal half life in Rat at a oral dose of 5 mg/kg,Intermediate,In vivo,,1,7772,BAO_0000218,4689
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620504,1,A,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,Intermediate,In vivo,,1,7773,BAO_0000218,2463
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876605,1,A,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,Intermediate,In vivo,,1,7774,BAO_0000218,4883
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620505,1,A,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,Intermediate,In vivo,,1,7775,BAO_0000218,4883
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL873811,1,A,plasma half life was observed after intravenous administration in rat,Intermediate,In vivo,1969.0,1,7776,BAO_0000218,15662
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624016,1,A,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,In vivo,,1,7777,BAO_0000218,3598
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624017,1,A,Half life of compound determined in rat,Intermediate,,,1,7778,BAO_0000218,4576
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624018,1,A,Mean residence time determined in rat,Intermediate,,,1,7779,BAO_0000218,4576
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624019,1,A,Plasma half life determined in rat,Intermediate,,,1,7780,BAO_0000218,4576
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL624020,1,A,Compound was evaluated for Tmax in brain after intravenous administration in male rats,Intermediate,In vivo,955.0,1,7781,BAO_0000218,4910
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624201,1,A,Compound was evaluated for pharmacokinetic parameter maximum time period,Intermediate,In vivo,,1,7782,BAO_0000218,4891
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL872528,1,A,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,Intermediate,In vivo,,1,7783,BAO_0000218,429
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624202,1,A,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,In vivo,,1,7784,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624203,1,A,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,In vivo,,1,7785,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624350,1,A,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate,In vivo,,1,7786,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621320,1,A,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,In vivo,,1,7787,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621321,1,A,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,Intermediate,In vivo,,1,7788,BAO_0000218,17582
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621322,1,A,Maximum time (Tmax) required to reach Cmax in rats,Intermediate,,,1,7789,BAO_0000218,4026
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621323,1,A,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Intermediate,In vivo,,1,7790,BAO_0000218,4890
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621324,1,A,Maximum time of clearance of compound in rats after peroral administration,Intermediate,In vivo,,1,7791,BAO_0000218,6571
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621325,1,A,Maximum time at the dose of 2 mg/kg in rat,Intermediate,,,1,7792,BAO_0000218,4727
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL875837,1,A,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,Intermediate,In vivo,1969.0,1,7793,BAO_0000218,17651
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL621326,1,A,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,Intermediate,In vivo,1969.0,1,7794,BAO_0000218,17651
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621327,1,A,Tmax in Guinea pig (PO dose),Intermediate,In vivo,,1,7795,BAO_0000218,14465
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621328,1,A,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,In vivo,,1,7796,BAO_0000218,14941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621329,1,A,Pharmacokinetic parameter (Tmax) in rat,Intermediate,In vivo,,1,7797,BAO_0000218,5960
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621330,1,A,Pharmacokinetic parameter (Tmax) was estimated,Intermediate,In vivo,,1,7798,BAO_0000218,5022
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621331,1,A,Pharmacokinetic property (Tmax) in rat,Intermediate,In vivo,,1,7799,BAO_0000218,4408
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621332,1,A,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,Intermediate,In vivo,,1,7800,BAO_0000218,5983
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621333,1,A,T max in Rat at a oral dose of 5 mg/kg,Intermediate,In vivo,,1,7801,BAO_0000218,4689
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621334,1,A,T max was determined at 10 mg/kg po dose in rats,Intermediate,In vivo,,1,7802,BAO_0000218,2792
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL621335,1,A,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),Intermediate,,,1,7803,BAO_0000218,15011
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL621336,1,A,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,Intermediate,,,1,7804,BAO_0000218,14180
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621337,1,A,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,Intermediate,,,1,7805,BAO_0000218,14180
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL621338,1,A,Area under curve was measured after i.v. administration into Beagle dog.,Intermediate,,,1,7806,BAO_0000218,14599
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL875838,1,A,Area under curve was measured after iv administration into Beagle dog,Intermediate,,,1,7807,BAO_0000218,14599
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL621339,1,A,Area under curve was measured after po administration into Beagle dog,Intermediate,,,1,7808,BAO_0000218,14599
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL621340,1,A,Area under curve was measured after po administration into Beagle dog.,Intermediate,,,1,7809,BAO_0000218,14599
,,,,,,,,U,,,22224,CHEMBL621341,1,A,Area under curve was measured at peroral dose of 3 mg/kg,Autocuration,,,0,7810,BAO_0000218,15675
,,,,,,,,U,,,22224,CHEMBL621342,1,A,Area under curve was measured by using concentration Vs time,Autocuration,,,0,7811,BAO_0000019,12706
,,,,,,,,U,,,22224,CHEMBL621343,1,A,Area under curve was measured by using concentration Vs time; not tested,Autocuration,,,0,7812,BAO_0000019,12706
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL621344,1,A,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),Intermediate,,,1,7813,BAO_0000218,9750
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL621345,1,A,Area under curve(AUC) was measured in mice after oral administration.,Intermediate,,,1,7814,BAO_0000218,9750
,,,,,,,,U,,,22224,CHEMBL621346,1,A,Area under curve(AUC) value of the compound,Autocuration,,,0,7815,BAO_0000019,14691
,,,,,,,,U,,,22224,CHEMBL621347,1,A,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,Autocuration,,,0,7816,BAO_0000218,14691
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL621348,1,A,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,Intermediate,,,1,7817,BAO_0000218,14691
,,,,Blood,,,,U,,,22224,CHEMBL621349,1,A,Area under curve(carotid artery) was determined by the availability in blood,Autocuration,,178.0,0,7818,BAO_0000019,2939
,,,,Blood,,,,U,,,22224,CHEMBL621350,1,A,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,Autocuration,,178.0,0,7819,BAO_0000019,2939
,,,,Blood,,,,U,,,22224,CHEMBL875839,1,A,Area under curve(carotid artery) was determined by the availability in blood; No data,Autocuration,,178.0,0,7820,BAO_0000019,2939
,,,,Blood,,,,U,,,22224,CHEMBL620211,1,A,Area under curve(portal vein) was determined by the availability in blood,Autocuration,,178.0,0,7821,BAO_0000019,2939
,,,,Blood,,,,U,,,22224,CHEMBL620212,1,A,Area under curve(portal vein) was determined by the availability in blood; ND means no data,Autocuration,,178.0,0,7822,BAO_0000019,2939
,,,,Blood,,,,U,,,22224,CHEMBL620213,1,A,Area under curve(portal vein) was determined by the availability in blood; No data,Autocuration,,178.0,0,7823,BAO_0000019,2939
,9544.0,,Macaca mulatta,Plasma,,,,N,,,50797,CHEMBL620214,1,A,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Intermediate,,1969.0,1,7824,BAO_0000218,9552
,9544.0,,Macaca mulatta,Plasma,,,,N,,,50797,CHEMBL620215,1,A,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Intermediate,,1969.0,1,7825,BAO_0000218,9552
,9544.0,,Macaca mulatta,Plasma,,,,N,,,50797,CHEMBL620216,1,A,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,Intermediate,,1969.0,1,7826,BAO_0000218,9552
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL620888,1,A,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",Intermediate,,1969.0,1,7827,BAO_0000218,9552
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL620889,1,A,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",Intermediate,,1969.0,1,7828,BAO_0000218,9552
,,,,Plasma,,,,U,,,22224,CHEMBL620890,1,A,Area under plasma concentration vs time curve observed in rats for 0-3 h,Autocuration,,1969.0,0,7829,BAO_0000019,9552
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL620891,1,A,Area under plasma time curve determined in male rat,Intermediate,,1969.0,1,7830,BAO_0000218,11911
,,,,,,,,U,,,22224,CHEMBL620892,1,A,Area under the MAP curve measured over 5 min.,Autocuration,,,0,7831,BAO_0000019,16618
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL621079,1,A,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,Intermediate,,,1,7832,BAO_0000218,14387
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL621080,1,A,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,Intermediate,,,1,7833,BAO_0000218,14387
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL621081,1,A,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,Intermediate,,,1,7834,BAO_0000218,12836
,10026.0,,Cricetinae,,,,,N,,,100712,CHEMBL621082,1,A,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,Intermediate,,,1,7835,BAO_0000218,12836
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621083,1,A,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,Intermediate,,,1,7836,BAO_0000218,12836
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL621084,1,A,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,Intermediate,,,1,7837,BAO_0000218,14339
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL621085,1,A,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,Intermediate,,,1,7838,BAO_0000218,14339
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL621086,1,A,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,Intermediate,,,1,7839,BAO_0000218,14339
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL621087,1,A,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),Intermediate,,,1,7840,BAO_0000218,10524
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL622607,1,A,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),Intermediate,,,1,7841,BAO_0000218,9994
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL622608,1,A,Serum AUC in marmosets (IV dose),Intermediate,,,1,7842,BAO_0000218,11325
,,,,,,,,U,,,22224,CHEMBL624481,1,A,Area under the curve after intravenous administration at a dose of 10 umol/kg,Autocuration,,,0,7843,BAO_0000019,12536
,,,,,,,,U,,,22224,CHEMBL624482,1,A,Area under the curve after intravenous administration at a dose of 2 umol/kg,Autocuration,,,0,7844,BAO_0000019,12536
,,,,,,,,U,,,22224,CHEMBL624483,1,A,Area under the curve after intravenous administration at a dose of 4 umol/kg,Autocuration,,,0,7845,BAO_0000019,12536
,,,,,,,,U,,,22224,CHEMBL624484,1,A,Area under the curve after intravenous administration at a dose of 40 umol/kg,Autocuration,,,0,7846,BAO_0000019,12536
,,,,,,,,U,,,22224,CHEMBL624485,1,A,Area under the curve after intravenous administration at a dose of 5 umol/kg,Autocuration,,,0,7847,BAO_0000019,12536
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624486,1,A,Area under the curve for fumarate salt was evaluated in F344 Rats.,Intermediate,,,1,7848,BAO_0000218,15556
,,,,,,,,U,,,22224,CHEMBL624487,1,A,Area under the curve for the compound was calculated.,Autocuration,,,0,7849,BAO_0000019,2809
,,,,,,,,U,,,22224,CHEMBL624488,1,A,Area under the curve in concentration/ time,Autocuration,,,0,7850,BAO_0000019,9511
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624489,1,A,Area under the curve administered intraintestinal in rats.,Intermediate,,,1,7851,BAO_0000218,12818
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625184,1,A,Area under the curve administered intravenously in rats.,Intermediate,,,1,7852,BAO_0000218,12818
,,,,,,,,U,,,22224,CHEMBL625185,1,A,Area under the curve during intravenous administration,Autocuration,,,0,7853,BAO_0000019,15118
,,,,,,,,U,,,22224,CHEMBL875954,1,A,Area under the curve during intravenous administration; Not determined,Autocuration,,,0,7854,BAO_0000019,15118
,,,,,,,,U,,,22224,CHEMBL625186,1,A,Area under the curve during systemic administration,Autocuration,,,0,7855,BAO_0000019,15118
,,,,,,,,U,,,22224,CHEMBL625187,1,A,Area under the curve during systemic administration; Not determined,Autocuration,,,0,7856,BAO_0000019,15118
,,,,,,,,U,,,22224,CHEMBL625188,1,A,Area under the curve was calculated for the compound.,Autocuration,,,0,7857,BAO_0000019,2632
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625189,1,A,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,Intermediate,,,1,7858,BAO_0000218,14346
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625190,1,A,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,Intermediate,,,1,7859,BAO_0000218,14346
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621733,1,A,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,Intermediate,,,1,7860,BAO_0000218,14346
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621734,1,A,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,Intermediate,,,1,7861,BAO_0000218,14346
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621735,1,A,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,Intermediate,,,1,7862,BAO_0000218,11149
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL621736,1,A,Clearance of the drug was measured in the plasma of rat; No data,Intermediate,,1969.0,1,7863,BAO_0000218,17796
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL621737,1,A,The pharmacokinetic parameter plasma clearance in vivo in rats,Intermediate,,1969.0,1,7864,BAO_0000218,5247
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621738,1,A,Plasma clearance at the dose of 2 mg/kg in rat,Intermediate,,,1,7865,BAO_0000218,4727
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622806,1,A,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Intermediate,In vivo,,1,7866,BAO_0000218,5654
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623519,1,A,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Intermediate,In vivo,,1,7867,BAO_0000218,5654
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623520,1,A,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate,In vivo,,1,7868,BAO_0000218,17260
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623521,1,A,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate,In vivo,,1,7869,BAO_0000218,17065
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623522,1,A,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate,In vivo,,1,7870,BAO_0000218,17671
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623523,1,A,Clearance rate in rat,Intermediate,In vivo,,1,7871,BAO_0000218,6672
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623690,1,A,Clearance rate in rat,Intermediate,In vivo,,1,7872,BAO_0000218,6673
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623691,1,A,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,7873,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623692,1,A,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,7874,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623693,1,A,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,7875,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623694,1,A,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,7876,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623695,1,A,Clearance of compound after iv administration of 20 mg/kg dose in rat,Intermediate,In vivo,,1,7877,BAO_0000218,4413
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623696,1,A,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,Intermediate,In vivo,,1,7878,BAO_0000218,2661
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623697,1,A,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,Intermediate,In vivo,,1,7879,BAO_0000218,2661
,9544.0,,Macaca mulatta,Plasma,,,,U,,,22224,CHEMBL623698,1,A,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,Intermediate,In vivo,1969.0,0,7880,BAO_0000218,5005
,10116.0,,Rattus norvegicus,Plasma,,,,U,,,22224,CHEMBL623699,1,A,Compound was tested for its plasma clearance rate in Sprague Dawley rats,Intermediate,In vivo,1969.0,0,7881,BAO_0000218,5005
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623700,1,A,Mean (%CV) PK parameters for CL(mL/min/kg).,Intermediate,In vivo,,1,7882,BAO_0000218,15765
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623701,1,A,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,Intermediate,In vivo,,1,7883,BAO_0000218,3747
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623702,1,A,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,Intermediate,In vivo,1969.0,1,7884,BAO_0000218,16366
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623703,1,A,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,Intermediate,In vivo,,1,7885,BAO_0000218,4199
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623704,1,A,Plasma clearance in rat was determined,Intermediate,In vivo,,1,7886,BAO_0000218,17267
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623705,1,A,Plasma clearance in rat after administration of 2 mg/kg iv,Intermediate,In vivo,,1,7887,BAO_0000218,6535
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623706,1,A,Plasma clearance in rat after administration of 2 mg/kg iv,Intermediate,In vivo,,1,7888,BAO_0000218,6535
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623707,1,A,Plasma clearance was determined,Intermediate,In vivo,,1,7889,BAO_0000218,5041
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623708,1,A,Plasma clearance in rat,Intermediate,In vivo,,1,7890,BAO_0000218,5960
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623709,1,A,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,Intermediate,In vivo,,1,7891,BAO_0000218,5937
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623710,1,A,Plasma clearance in rat by iv administration,Intermediate,In vivo,,1,7892,BAO_0000218,5871
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623711,1,A,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,Intermediate,In vivo,,1,7893,BAO_0000218,5874
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623712,1,A,Plasma clearance in rat p.o.,Intermediate,In vivo,,1,7894,BAO_0000218,6504
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623713,1,A,Plasma clearance in rats,Intermediate,In vivo,,1,7895,BAO_0000218,6803
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623714,1,A,Plasma clearance was determined; ND denotes no data,Intermediate,In vivo,,1,7896,BAO_0000218,5041
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623715,1,A,Plasma clearance was determined; ND denotes not determined,Intermediate,In vivo,,1,7897,BAO_0000218,5041
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623716,1,A,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Intermediate,In vivo,,1,7898,BAO_0000218,1916
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622980,1,A,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Intermediate,In vivo,,1,7899,BAO_0000218,5199
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622981,1,A,Plasma administration to rats,Intermediate,In vivo,,1,7900,BAO_0000218,16367
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622982,1,A,Plasma clearance of the compound in female Sprague-Dawley rats,Intermediate,In vivo,,1,7901,BAO_0000218,6362
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622983,1,A,Plasma clearance was observed after intravenous administration in rat,Intermediate,In vivo,,1,7902,BAO_0000218,15662
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622984,1,A,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,Intermediate,In vivo,,1,7903,BAO_0000218,6215
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622985,1,A,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,Intermediate,In vivo,,1,7904,BAO_0000218,1466
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623631,1,A,plasma clearance was observed after intravenous administration in rat,Intermediate,In vivo,1969.0,1,7905,BAO_0000218,15662
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623632,1,A,In vivo CL/F determined,Intermediate,In vivo,,1,7906,BAO_0000218,4723
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623633,1,A,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,Intermediate,In vivo,1969.0,1,7907,BAO_0000218,2792
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623634,1,A,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,Intermediate,In vivo,1969.0,1,7908,BAO_0000218,2792
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623635,1,A,Compound was tested for the lower blood clearance in rat,Intermediate,In vivo,,1,7909,BAO_0000218,5213
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621195,1,A,Evaluated for the low clearance in rat (in vivo),Intermediate,In vivo,,1,7910,BAO_0000218,4687
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621196,1,A,Pharmacokinetic property (CLb)of the compound was determined in rat,Intermediate,In vivo,,1,7911,BAO_0000218,3371
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875287,1,A,Rapid clearance after intravenous administration in rat was determined,Intermediate,In vivo,,1,7912,BAO_0000218,4690
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621197,1,A,Clearance measured in rat,Intermediate,In vivo,,1,7913,BAO_0000218,5702
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL621198,1,A,Compound was evaluated for plasma clearance in rat,Intermediate,In vivo,1969.0,1,7914,BAO_0000218,740
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL621199,1,A,Low plasma clearance was calculated in rat,Intermediate,In vivo,1969.0,1,7915,BAO_0000218,4853
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621200,1,A,Pharmacokinetic property (Clp) in rat,Intermediate,In vivo,,1,7916,BAO_0000218,5789
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621201,1,A,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,Intermediate,In vivo,,1,7917,BAO_0000218,4527
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621202,1,A,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,Intermediate,In vivo,,1,7918,BAO_0000218,4527
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621203,1,A,Plasma clearance after IV dosing at 0.5 mg/kg in rat,Intermediate,In vivo,,1,7919,BAO_0000218,6518
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621204,1,A,Plasma clearance after IV dosing at 1 mg/kg in rat,Intermediate,In vivo,,1,7920,BAO_0000218,6518
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621205,1,A,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,Intermediate,In vivo,948.0,1,7921,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621206,1,A,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,Intermediate,In vivo,948.0,1,7922,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621207,1,A,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,Intermediate,In vivo,948.0,1,7923,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621208,1,A,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,Intermediate,In vivo,948.0,1,7924,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621209,1,A,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,Intermediate,In vivo,948.0,1,7925,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL876484,1,A,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,Intermediate,In vivo,948.0,1,7926,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621210,1,A,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate,In vivo,948.0,1,7927,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621211,1,A,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,Intermediate,In vivo,948.0,1,7928,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621212,1,A,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,Intermediate,In vivo,948.0,1,7929,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621213,1,A,Biodistribution in rat heart in the presence of GdDTPA at 15 min,Intermediate,In vivo,948.0,1,7930,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621214,1,A,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,Intermediate,In vivo,948.0,1,7931,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621215,1,A,Biodistribution in rat heart in the presence of GdDTPA at 30 min,Intermediate,In vivo,948.0,1,7932,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621216,1,A,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,Intermediate,In vivo,948.0,1,7933,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621217,1,A,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,Intermediate,In vivo,948.0,1,7934,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621218,1,A,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,Intermediate,In vivo,948.0,1,7935,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621219,1,A,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,Intermediate,In vivo,948.0,1,7936,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621220,1,A,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,Intermediate,In vivo,948.0,1,7937,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621221,1,A,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,Intermediate,In vivo,948.0,1,7938,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621222,1,A,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,Intermediate,In vivo,948.0,1,7939,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621223,1,A,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,Intermediate,In vivo,948.0,1,7940,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL876485,1,A,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,Intermediate,In vivo,948.0,1,7941,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621224,1,A,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate,In vivo,948.0,1,7942,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621225,1,A,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,Intermediate,In vivo,948.0,1,7943,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621226,1,A,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,Intermediate,In vivo,948.0,1,7944,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL621227,1,A,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,Intermediate,In vivo,2113.0,1,7945,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL621228,1,A,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,Intermediate,In vivo,2113.0,1,7946,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL621229,1,A,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,Intermediate,In vivo,2113.0,1,7947,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL621230,1,A,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,Intermediate,In vivo,2113.0,1,7948,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL621231,1,A,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,Intermediate,In vivo,2113.0,1,7949,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL621232,1,A,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,Intermediate,In vivo,2113.0,1,7950,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL621233,1,A,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate,In vivo,2113.0,1,7951,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL621234,1,A,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,Intermediate,In vivo,2113.0,1,7952,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL621235,1,A,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Intermediate,In vivo,2113.0,1,7953,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL621236,1,A,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate,In vivo,2113.0,1,7954,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL621237,1,A,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,Intermediate,In vivo,2113.0,1,7955,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL876486,1,A,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,Intermediate,In vivo,2113.0,1,7956,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL622436,1,A,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,Intermediate,In vivo,160.0,1,7957,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL622437,1,A,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,Intermediate,In vivo,160.0,1,7958,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL622438,1,A,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,Intermediate,In vivo,160.0,1,7959,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622439,1,A,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,Intermediate,In vivo,2107.0,1,7960,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622440,1,A,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,Intermediate,In vivo,2107.0,1,7961,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622441,1,A,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,Intermediate,In vivo,2107.0,1,7962,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622442,1,A,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,Intermediate,In vivo,2107.0,1,7963,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622443,1,A,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,Intermediate,In vivo,2107.0,1,7964,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622444,1,A,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,Intermediate,In vivo,2107.0,1,7965,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622445,1,A,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,Intermediate,In vivo,2107.0,1,7966,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622446,1,A,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,Intermediate,In vivo,2107.0,1,7967,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622447,1,A,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Intermediate,In vivo,2107.0,1,7968,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622448,1,A,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,Intermediate,In vivo,2107.0,1,7969,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622449,1,A,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Intermediate,In vivo,2107.0,1,7970,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622450,1,A,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,Intermediate,In vivo,2107.0,1,7971,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622451,1,A,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,Intermediate,In vivo,2107.0,1,7972,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622452,1,A,Biodistribution in rat liver in the presence of GdDTPA at 15 min,Intermediate,In vivo,2107.0,1,7973,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622453,1,A,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,Intermediate,In vivo,2107.0,1,7974,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622454,1,A,Biodistribution in rat liver in the presence of GdDTPA at 30 min,Intermediate,In vivo,2107.0,1,7975,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622455,1,A,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,Intermediate,In vivo,2107.0,1,7976,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL876024,1,A,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,Intermediate,In vivo,2107.0,1,7977,BAO_0000218,9866
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622456,1,A,T max was determined at 3 mg/kg po dose in rats,Intermediate,In vivo,,1,7978,BAO_0000218,2792
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622457,1,A,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,In vivo,,1,7979,BAO_0000218,15078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622458,1,A,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,In vivo,,1,7980,BAO_0000218,15078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622459,1,A,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,Intermediate,,,1,7981,BAO_0000218,15022
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL873343,1,A,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,Intermediate,,,1,7982,BAO_0000218,15022
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622460,1,A,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,Intermediate,,,1,7983,BAO_0000218,15022
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622461,1,A,Time for maximum plasma concentration determined in rat,Intermediate,,1969.0,1,7984,BAO_0000218,4576
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622462,1,A,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Intermediate,In vivo,1969.0,1,7985,BAO_0000218,6681
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622463,1,A,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,Intermediate,In vivo,,1,7986,BAO_0000218,16365
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622464,1,A,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,Intermediate,In vivo,,1,7987,BAO_0000218,16365
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622465,1,A,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,Intermediate,In vivo,,1,7988,BAO_0000218,16365
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622466,1,A,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,Intermediate,In vivo,,1,7989,BAO_0000218,16365
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622467,1,A,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,Intermediate,In vivo,,1,7990,BAO_0000218,16365
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622468,1,A,Time of maximum plasma concentration in rat,Intermediate,,1969.0,1,7991,BAO_0000218,6824
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL876025,1,A,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",Intermediate,,1969.0,1,7992,BAO_0000218,6685
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622469,1,A,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",Intermediate,,1969.0,1,7993,BAO_0000218,6685
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622470,1,A,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Intermediate,,1969.0,1,7994,BAO_0000218,6685
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622471,1,A,Time required to reach maximum concentration (Cmax) after oral administration in rat,Intermediate,In vivo,,1,7995,BAO_0000218,15662
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622472,1,A,Time required to reach maximum concentration in rat plasma,Intermediate,,1969.0,1,7996,BAO_0000218,1742
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622473,1,A,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Intermediate,In vivo,1969.0,1,7997,BAO_0000218,2774
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL624282,1,A,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Intermediate,In vivo,1969.0,1,7998,BAO_0000218,5199
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL624283,1,A,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Intermediate,In vivo,1969.0,1,7999,BAO_0000218,12873
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL624284,1,A,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Intermediate,In vivo,1969.0,1,8000,BAO_0000218,12873
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL624285,1,A,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Intermediate,In vivo,1969.0,1,8001,BAO_0000218,1916
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624286,1,A,Time to reach Cmax after oral administration to rats,Intermediate,In vivo,,1,8002,BAO_0000218,16367
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624287,1,A,Time to reach Cmax when a dose of 1 mg/kg is administered orally,Intermediate,In vivo,,1,8003,BAO_0000218,16366
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624288,1,A,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,Intermediate,,,1,8004,BAO_0000218,216
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL624289,1,A,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,Intermediate,In vivo,1969.0,1,8005,BAO_0000218,6410
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL873344,1,A,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,Intermediate,In vivo,1969.0,1,8006,BAO_0000218,6410
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL619623,1,A,Tmax after peroral administration (10 mg/kg) was determined in rat,Intermediate,In vivo,,1,8007,BAO_0000218,6215
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621399,1,A,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,In vivo,,1,8008,BAO_0000218,3598
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621400,1,A,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,Intermediate,In vivo,,1,8009,BAO_0000218,4527
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621401,1,A,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",Intermediate,In vivo,,1,8010,BAO_0000218,17670
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621402,1,A,Tmax was determined,Intermediate,,,1,8011,BAO_0000218,1465
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621403,1,A,Tmax was determined,Intermediate,,,1,8012,BAO_0000218,2552
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621121,1,A,Tmax after oral administration in rat,Intermediate,In vivo,,1,8013,BAO_0000218,5656
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL872525,1,A,Tmax after peroral administration in rats at 2.4 uM/kg,Intermediate,In vivo,,1,8014,BAO_0000218,17764
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621122,1,A,Tmax in male rat,Intermediate,,,1,8015,BAO_0000218,5610
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621123,1,A,Tmax in rat at 10 mg/kg,Intermediate,In vivo,,1,8016,BAO_0000218,6046
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621124,1,A,Tmax in rat by po administration at a dose of 40 mg/kg,Intermediate,In vivo,,1,8017,BAO_0000218,5874
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621125,1,A,Tmax in rats,Intermediate,,,1,8018,BAO_0000218,17596
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621126,1,A,Tmax was measured in rats after peroral administration at 5 mg/kg,Intermediate,In vivo,,1,8019,BAO_0000218,17804
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621127,1,A,Tmax value after oral dose at a dose of 10 mg/kg in rats.,Intermediate,In vivo,,1,8020,BAO_0000218,1908
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621128,1,A,Tmax value after administration of 20 mg/Kg oral dose in rat,Intermediate,In vivo,,1,8021,BAO_0000218,2959
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618263,1,A,Tmax value at a dose of 10 mg/kg in male SD rats,Intermediate,In vivo,,1,8022,BAO_0000218,6757
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618264,1,A,Tmax value at a dose of 100 mg/kg in male SD rats,Intermediate,In vivo,,1,8023,BAO_0000218,6757
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618265,1,A,Tmax value at a dose of 50 mg/kg in male SD rats,Intermediate,In vivo,,1,8024,BAO_0000218,6757
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL618266,1,A,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Intermediate,In vivo,1969.0,1,8025,BAO_0000218,4186
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618267,1,A,time required to reach maximum concentration (Cmax) after oral administration in rat,Intermediate,In vivo,,1,8026,BAO_0000218,15662
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL618450,1,A,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),Intermediate,,1088.0,1,8027,BAO_0000218,429
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL618451,1,A,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),Intermediate,,1088.0,1,8028,BAO_0000218,429
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618452,1,A,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Intermediate,,,1,8029,BAO_0000218,5546
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL618453,1,A,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,Intermediate,,1088.0,1,8030,BAO_0000218,3173
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL618454,1,A,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,Intermediate,,1088.0,1,8031,BAO_0000218,3173
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL618455,1,A,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,Intermediate,,1088.0,1,8032,BAO_0000218,3173
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618456,1,A,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,Intermediate,In vivo,,1,8033,BAO_0000218,4257
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618457,1,A,Compound distribution in rat tissues was determined,Intermediate,In vivo,,1,8034,BAO_0000218,6011
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618458,1,A,Volume of distribution was evaluated in rat,Intermediate,In vivo,,1,8035,BAO_0000218,5472
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618459,1,A,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,Intermediate,,,1,8036,BAO_0000218,14346
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876733,1,A,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,Intermediate,,,1,8037,BAO_0000218,14346
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL618460,1,A,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,Intermediate,,,1,8038,BAO_0000218,14346
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618461,1,A,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,Intermediate,,,1,8039,BAO_0000218,14346
,,,,,,,,U,,,22224,CHEMBL618462,1,A,Area under the curve was determined after oral administration (300 uM/Kg),Autocuration,,,0,8040,BAO_0000019,15469
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618463,1,A,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,Intermediate,,,1,8041,BAO_0000218,14346
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618464,1,A,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,Intermediate,,,1,8042,BAO_0000218,14346
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618465,1,A,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,Intermediate,,,1,8043,BAO_0000218,14346
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618466,1,A,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,Intermediate,,,1,8044,BAO_0000218,14346
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618467,1,A,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,Intermediate,,,1,8045,BAO_0000218,14346
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618468,1,A,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,Intermediate,,,1,8046,BAO_0000218,15372
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL618469,1,A,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,Intermediate,,1969.0,1,8047,BAO_0000218,12935
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL618470,1,A,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,Intermediate,,1969.0,1,8048,BAO_0000218,12935
,,,,,,,,U,,,22224,CHEMBL618471,1,A,Plasma drug AUC in rat (PO dose),Autocuration,,,0,8049,BAO_0000218,14813
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL618472,1,A,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,Intermediate,,,1,8050,BAO_0000218,15792
,,,,,,,,U,,,22224,CHEMBL618473,1,A,Area under was determined at a dose of 30 mg/kg,Autocuration,,,0,8051,BAO_0000218,3579
,9669.0,,Mustela putorius furo,,,,,N,,,50506,CHEMBL621699,1,A,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,Intermediate,,,1,8052,BAO_0000218,12487
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621700,1,A,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,Intermediate,,,1,8053,BAO_0000218,12487
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621701,1,A,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,Intermediate,,,1,8054,BAO_0000218,12487
,9669.0,,Mustela putorius furo,,,,,N,,,50506,CHEMBL621702,1,A,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,Intermediate,,,1,8055,BAO_0000218,12487
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL621703,1,A,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,Intermediate,,,1,8056,BAO_0000218,12487
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL621704,1,A,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,Intermediate,,,1,8057,BAO_0000218,12487
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624259,1,A,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",Intermediate,,,1,8058,BAO_0000218,12902
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624260,1,A,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",Intermediate,,,1,8059,BAO_0000218,12902
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624430,1,A,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",Intermediate,,,1,8060,BAO_0000218,12902
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624431,1,A,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",Intermediate,,,1,8061,BAO_0000218,12902
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624432,1,A,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",Intermediate,,,1,8062,BAO_0000218,12902
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624433,1,A,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",Intermediate,,,1,8063,BAO_0000218,12902
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624434,1,A,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",Intermediate,,,1,8064,BAO_0000218,12902
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624435,1,A,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",Intermediate,,,1,8065,BAO_0000218,12902
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL618570,1,A,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,Intermediate,,,1,8066,BAO_0000218,12745
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL618571,1,A,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Intermediate,,,1,8067,BAO_0000218,12745
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL618572,1,A,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,Intermediate,,,1,8068,BAO_0000218,12745
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL618573,1,A,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Intermediate,,,1,8069,BAO_0000218,12745
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL619267,1,A,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,Intermediate,,,1,8070,BAO_0000218,12745
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL619431,1,A,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Intermediate,,,1,8071,BAO_0000218,12745
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL619432,1,A,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,Intermediate,,,1,8072,BAO_0000218,12745
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL619433,1,A,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Intermediate,,,1,8073,BAO_0000218,12745
,,,,Plasma,,,,U,,,22224,CHEMBL619434,1,A,AUC in mice after oral dose (50 mg/kg),Autocuration,,1969.0,0,8074,BAO_0000218,13298
,10090.0,,Mus musculus,Serum,,,,N,,,50594,CHEMBL619435,1,A,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,Intermediate,,1977.0,1,8075,BAO_0000218,12226
,,,,Plasma,,,,U,,,22224,CHEMBL619436,1,A,AUC (0-4 hr) ug/ml/h,Autocuration,,1969.0,0,8076,BAO_0000019,12634
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL619437,1,A,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,Intermediate,,,1,8077,BAO_0000218,14810
,,,,,,,,U,,,22224,CHEMBL619438,1,A,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,Autocuration,,,0,8078,BAO_0000218,13889
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL619439,1,A,Compound was evaluated for Area under curve in mice,Intermediate,,,1,8079,BAO_0000218,10018
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL619440,1,A,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Intermediate,,,1,8080,BAO_0000218,8758
,,,,,,,,U,,,22224,CHEMBL619441,1,F,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Autocuration,,,0,8081,BAO_0000218,8758
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL619442,1,A,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,Intermediate,,,1,8082,BAO_0000218,8758
,,,,,,,,U,,,22224,CHEMBL875156,1,A,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,Autocuration,,,0,8083,BAO_0000019,2249
,,,,,,,,U,,,22224,CHEMBL619443,1,A,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,Autocuration,,,0,8084,BAO_0000019,2249
,,,,,,,,U,,,22224,CHEMBL619444,1,A,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,Autocuration,,,0,8085,BAO_0000019,2249
,,,,,,,,U,,,22224,CHEMBL623464,1,A,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,Autocuration,,,0,8086,BAO_0000019,2249
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623465,1,A,Compound was evaluated for area under curve when administered through oral route in mouse,Intermediate,,,1,8087,BAO_0000218,15115
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623466,1,A,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,Intermediate,In vivo,,1,8088,BAO_0000218,6518
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623467,1,A,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,Intermediate,In vivo,,1,8089,BAO_0000218,6518
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623468,1,A,Plasma clearance in rat,Intermediate,In vivo,,1,8090,BAO_0000218,6249
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622660,1,A,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,Intermediate,In vivo,,1,8091,BAO_0000218,2463
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622661,1,A,Plasma clearance rate in Sprague-Dawley rats,Intermediate,In vivo,,1,8092,BAO_0000218,4969
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622662,1,F,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,In vivo,,1,8093,BAO_0000218,17720
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622663,1,A,Pharmacokinetic property (total body clearance) in rat,Intermediate,In vivo,,1,8094,BAO_0000218,3457
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622664,1,A,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,Intermediate,In vivo,,1,8095,BAO_0000218,5983
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622665,1,A,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,Intermediate,,,1,8096,BAO_0000218,6295
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622666,1,A,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,Intermediate,,,1,8097,BAO_0000218,6296
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621615,1,A,Cl in rat i.v. at 2 mg/kg concentration,Intermediate,In vivo,,1,8098,BAO_0000218,17686
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621616,1,A,Clearance of compound after intravenous administration in rats at 24 uM/kg,Intermediate,In vivo,,1,8099,BAO_0000218,17764
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621617,1,A,Clearance was determined,Intermediate,In vivo,,1,8100,BAO_0000218,5503
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621618,1,A,Clearance by intravenous administration of 3.4 mg/kg in rat,Intermediate,In vivo,,1,8101,BAO_0000218,4368
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621619,1,A,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Intermediate,In vivo,,1,8102,BAO_0000218,6005
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621620,1,A,Clearance rate after i.v. administration in rats,Intermediate,In vivo,,1,8103,BAO_0000218,5031
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621786,1,A,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Intermediate,In vivo,,1,8104,BAO_0000218,4890
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621787,1,A,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Intermediate,In vivo,,1,8105,BAO_0000218,5182
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621788,1,A,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,Intermediate,In vivo,,1,8106,BAO_0000218,5979
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621789,1,A,Clearance (Cl) after oral administration in rat,Intermediate,In vivo,,1,8107,BAO_0000218,5656
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621790,1,A,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,Intermediate,In vivo,,1,8108,BAO_0000218,17804
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL621791,1,A,Compound was tested for plasma clearance in rat,Intermediate,In vivo,1969.0,1,8109,BAO_0000218,4839
,10116.0,,Rattus norvegicus,,,Microsomes,,N,,,50597,CHEMBL621792,1,A,In vitro microsome metabolism clearance in rat was determined,Intermediate,In vitro,,1,8110,BAO_0000218,5041
,10116.0,,Rattus norvegicus,,,Microsomes,,N,,,50597,CHEMBL621793,1,A,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,Intermediate,In vitro,,1,8111,BAO_0000218,5041
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621794,1,A,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,In vivo,,1,8112,BAO_0000218,5974
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL621795,1,A,In vivo plasma clearance was determined,Intermediate,In vivo,1969.0,1,8113,BAO_0000218,5496
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621796,1,A,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,Intermediate,In vivo,,1,8114,BAO_0000218,5739
,10116.0,,Rattus norvegicus,Liver,Hepatocyte,,401.0,N,,,50597,CHEMBL621797,1,A,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,Intermediate,In vivo,2107.0,1,8115,BAO_0000218,5676
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621798,1,A,Pharmacokinetic property (Plasma clearance) was measured in rat,Intermediate,In vivo,,1,8116,BAO_0000218,4239
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621799,1,A,Pharmacokinetic property (clearance) in rat i.v.,Intermediate,In vivo,,1,8117,BAO_0000218,5676
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621800,1,A,"Plasma Clearance was evaluated in rats, iv",Intermediate,In vivo,,1,8118,BAO_0000218,1918
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621801,1,A,Plasma clearance (in vivo) in rats was determined,Intermediate,In vivo,,1,8119,BAO_0000218,17800
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621802,1,A,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,Intermediate,In vivo,,1,8120,BAO_0000218,6056
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618596,1,A,Plasma clearance was determined,Intermediate,In vivo,,1,8121,BAO_0000218,5496
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618597,1,A,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,Intermediate,In vivo,,1,8122,BAO_0000218,5939
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618598,1,A,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,Intermediate,In vivo,,1,8123,BAO_0000218,5939
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618599,1,A,Plasma clearance in rats,Intermediate,In vivo,,1,8124,BAO_0000218,17752
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618600,1,A,Plasma clearance rate determined in rat,Intermediate,In vivo,,1,8125,BAO_0000218,4576
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618601,1,A,Plasma clearance was determined in rat,Intermediate,In vivo,,1,8126,BAO_0000218,6011
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618602,1,A,Plasma clearance was determined,Intermediate,In vivo,,1,8127,BAO_0000218,5510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618603,1,A,Plasma clearance value in rat,Intermediate,In vivo,,1,8128,BAO_0000218,5948
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL618604,1,A,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Intermediate,Ex vivo,2107.0,1,8129,BAO_0000218,6125
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618605,1,A,Clearance in rat,Intermediate,In vivo,,1,8130,BAO_0000218,4839
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618606,1,A,Total body clearance in rat i.v. at 2 mg/kg concentration,Intermediate,In vivo,,1,8131,BAO_0000218,17686
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618607,1,A,Clearance of compound in rats after intravenous administration,Intermediate,In vivo,,1,8132,BAO_0000218,6571
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618608,1,A,Clearance after iv administration to rats,Intermediate,In vivo,,1,8133,BAO_0000218,3364
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618609,1,A,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,Intermediate,In vivo,,1,8134,BAO_0000218,13569
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618610,1,A,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,Intermediate,In vivo,,1,8135,BAO_0000218,13569
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618611,1,A,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,Intermediate,In vivo,,1,8136,BAO_0000218,13569
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618612,1,A,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,Intermediate,In vivo,,1,8137,BAO_0000218,13569
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618613,1,A,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,Intermediate,In vivo,,1,8138,BAO_0000218,13569
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621076,1,A,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,Intermediate,In vivo,,1,8139,BAO_0000218,13569
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621077,1,A,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,Intermediate,In vivo,,1,8140,BAO_0000218,13569
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621078,1,A,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",Intermediate,In vivo,,1,8141,BAO_0000218,17670
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621251,1,A,Clearance in rat,Intermediate,In vivo,,1,8142,BAO_0000218,5970
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621252,1,A,Clearance in rat after oral administration at 10 mg/kg,Intermediate,In vivo,,1,8143,BAO_0000218,6495
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621253,1,A,Clearance in rat.,Intermediate,In vivo,,1,8144,BAO_0000218,4590
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621254,1,A,Clearance rate following an oral dose of 20 mg/kg in rats,Intermediate,In vivo,,1,8145,BAO_0000218,6193
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621255,1,A,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,Intermediate,In vivo,,1,8146,BAO_0000218,2832
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL621256,1,A,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,Intermediate,In vivo,1969.0,1,8147,BAO_0000218,1052
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL621257,1,A,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,Intermediate,In vivo,2107.0,1,8148,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL621258,1,A,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,Intermediate,In vivo,2107.0,1,8149,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL621259,1,A,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,Intermediate,In vivo,2107.0,1,8150,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL621260,1,A,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,Intermediate,In vivo,2107.0,1,8151,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL876494,1,A,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,Intermediate,In vivo,2107.0,1,8152,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL621261,1,A,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,Intermediate,In vivo,2107.0,1,8153,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL621262,1,A,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,Intermediate,In vivo,2107.0,1,8154,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL621263,1,A,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Intermediate,In vivo,2107.0,1,8155,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL621264,1,A,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,Intermediate,In vivo,2107.0,1,8156,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL621265,1,A,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,Intermediate,In vivo,2385.0,1,8157,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL621266,1,A,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,Intermediate,In vivo,2385.0,1,8158,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL621267,1,A,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,Intermediate,In vivo,2385.0,1,8159,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL621268,1,A,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,Intermediate,In vivo,2385.0,1,8160,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL621269,1,A,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,Intermediate,In vivo,2385.0,1,8161,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL621270,1,A,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,Intermediate,In vivo,2385.0,1,8162,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL621271,1,A,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,Intermediate,In vivo,2385.0,1,8163,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL621272,1,A,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,Intermediate,In vivo,2385.0,1,8164,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL621273,1,A,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,Intermediate,In vivo,2385.0,1,8165,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL621274,1,A,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,Intermediate,In vivo,2385.0,1,8166,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL876495,1,A,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,Intermediate,In vivo,2385.0,1,8167,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL621275,1,A,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,Intermediate,In vivo,2385.0,1,8168,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL621276,1,A,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,Intermediate,In vivo,2385.0,1,8169,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL621277,1,A,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,Intermediate,In vivo,2385.0,1,8170,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL621278,1,A,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,Intermediate,In vivo,160.0,1,8171,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL621279,1,A,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,Intermediate,In vivo,160.0,1,8172,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL621280,1,A,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),Intermediate,In vivo,160.0,1,8173,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621281,1,A,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,Intermediate,In vivo,2106.0,1,8174,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621282,1,A,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,Intermediate,In vivo,2106.0,1,8175,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621283,1,A,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,Intermediate,In vivo,2106.0,1,8176,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621284,1,A,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,Intermediate,In vivo,2106.0,1,8177,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621285,1,A,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,Intermediate,In vivo,2106.0,1,8178,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621286,1,A,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,Intermediate,In vivo,2106.0,1,8179,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL623220,1,A,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,Intermediate,In vivo,2106.0,1,8180,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL623221,1,A,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,Intermediate,In vivo,2106.0,1,8181,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL876029,1,A,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,Intermediate,In vivo,2106.0,1,8182,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Stomach,,,,N,,,50597,CHEMBL623222,1,A,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,Intermediate,In vivo,945.0,1,8183,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Stomach,,,,N,,,50597,CHEMBL623223,1,A,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,Intermediate,In vivo,945.0,1,8184,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Stomach,,,,N,,,50597,CHEMBL621445,1,A,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,Intermediate,In vivo,945.0,1,8185,BAO_0000218,9866
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL621446,1,A,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,178.0,1,8186,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL621447,1,A,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,178.0,1,8187,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL619681,1,A,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,178.0,1,8188,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL619682,1,A,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,178.0,1,8189,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL619683,1,A,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,178.0,1,8190,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL619684,1,A,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,955.0,1,8191,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL619685,1,A,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,955.0,1,8192,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL619686,1,A,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,955.0,1,8193,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL619687,1,A,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,955.0,1,8194,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL619688,1,A,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,955.0,1,8195,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL619689,1,A,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,948.0,1,8196,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL619690,1,A,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,948.0,1,8197,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL619691,1,A,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,948.0,1,8198,BAO_0000218,13950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL619692,1,A,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,Intermediate,In vivo,,1,8199,BAO_0000218,6062
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL619693,1,A,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,,,1,8200,BAO_0000218,3598
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL619694,1,A,Vc value after IV dose at a dose of 5 mg/kg in rats.,Intermediate,In vivo,,1,8201,BAO_0000218,1908
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL619695,1,A,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,Intermediate,In vivo,,1,8202,BAO_0000218,17596
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL619696,1,A,Compound was evaluated for pharmacokinetic parameter volume of distribution,Intermediate,In vivo,,1,8203,BAO_0000218,4891
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL619697,1,A,Compound was evaluated for volume of distribution in rat,Intermediate,In vivo,,1,8204,BAO_0000218,740
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL619698,1,A,Steady state volume distribution was determined; steady state(ss),Intermediate,In vivo,,1,8205,BAO_0000218,16366
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL619699,1,A,Steady state volume of distribution after iv administration to rats,Intermediate,In vivo,,1,8206,BAO_0000218,3364
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL619700,1,A,Steady state volume of distribution dosing at 3 mg/kg iv,Intermediate,In vivo,,1,8207,BAO_0000218,2552
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL619701,1,A,The compound was evaluated for volume of distribution in rat,Intermediate,In vivo,,1,8208,BAO_0000218,406
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL619702,1,A,The compound was tested for volume of distribution in rat,Intermediate,In vivo,,1,8209,BAO_0000218,12500
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620335,1,A,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,Intermediate,In vivo,,1,8210,BAO_0000218,12500
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620336,1,A,Volume distribution (VD) after oral administration in rat,Intermediate,In vivo,,1,8211,BAO_0000218,5656
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620337,1,A,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate,In vivo,,1,8212,BAO_0000218,17671
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620520,1,A,Volume distribution in rat,Intermediate,In vivo,,1,8213,BAO_0000218,1094
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620521,1,A,Volume distribution in rat,Intermediate,In vivo,,1,8214,BAO_0000218,5833
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875825,1,A,Volume distribution in rat after peroral administration at 10 mg/kg,Intermediate,In vivo,,1,8215,BAO_0000218,5939
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620522,1,A,Volume distribution in rat after peroral administration at 5 mg/kg,Intermediate,In vivo,,1,8216,BAO_0000218,5939
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620523,1,A,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Intermediate,In vivo,,1,8217,BAO_0000218,6005
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620524,1,A,Volume of distribution in rat.,Intermediate,In vivo,,1,8218,BAO_0000218,1696
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620525,1,A,Volume of distribution in rat,Intermediate,In vivo,,1,8219,BAO_0000218,6672
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620526,1,A,Volume of distribution in rat,Intermediate,In vivo,,1,8220,BAO_0000218,6673
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620527,1,A,Volume of distribution in rat by iv administration,Intermediate,In vivo,,1,8221,BAO_0000218,5871
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620528,1,A,Volume of distribution in rats,Intermediate,In vivo,,1,8222,BAO_0000218,6803
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620529,1,A,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Intermediate,In vivo,,1,8223,BAO_0000218,5199
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620530,1,A,Volume distribution at the dose of 2 mg/kg in rat,Intermediate,,,1,8224,BAO_0000218,4727
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620531,1,A,Steady state volume of distribution was determined,Intermediate,In vivo,,1,8225,BAO_0000218,16367
,9544.0,,Macaca mulatta,,,,,U,,,22224,CHEMBL620532,1,A,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,Intermediate,In vivo,,0,8226,BAO_0000218,5005
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL620533,1,A,Compound was tested for its plasma volume distribution in Sprague Dawley rats,Intermediate,In vivo,,0,8227,BAO_0000218,5005
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL620534,1,A,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,Intermediate,In vivo,,0,8228,BAO_0000218,5005
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620535,1,A,Mean (%CV) PK parameters for Vdss(mL/kg).,Intermediate,In vivo,,1,8229,BAO_0000218,15765
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875826,1,A,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,Intermediate,In vivo,,1,8230,BAO_0000218,2792
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620536,1,A,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,Intermediate,In vivo,,1,8231,BAO_0000218,2792
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620537,1,A,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Intermediate,In vivo,,1,8232,BAO_0000218,5334
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618526,1,A,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,Intermediate,In vivo,,1,8233,BAO_0000218,5334
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618527,1,A,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,Intermediate,In vivo,,1,8234,BAO_0000218,5739
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618528,1,A,Pharmacokinetic property (Vdss) in rat,Intermediate,In vivo,,1,8235,BAO_0000218,5789
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618529,1,A,Pharmacokinetic property (vdss) was measured in rat,Intermediate,In vivo,,1,8236,BAO_0000218,4239
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618530,1,A,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,Intermediate,In vivo,,1,8237,BAO_0000218,4709
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618531,1,A,Volume of distribution in rat,Intermediate,In vivo,,1,8238,BAO_0000218,6642
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618532,1,A,The pharmacokinetic parameter volume of distribution in vivo in rats,Intermediate,In vivo,,1,8239,BAO_0000218,5247
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618533,1,F,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,In vivo,,1,8240,BAO_0000218,17720
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618534,1,A,Vdss in rat i.v. at 2 mg/kg concentration,Intermediate,In vivo,,1,8241,BAO_0000218,17686
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618535,1,A,Volume distribution after intravenous administration (1 mg/kg) in rat,Intermediate,In vivo,,1,8242,BAO_0000218,4689
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618536,1,A,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Intermediate,In vivo,,1,8243,BAO_0000218,5654
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618537,1,A,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Intermediate,In vivo,,1,8244,BAO_0000218,5654
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618538,1,A,Volume distribution at a dose of 10 uM/kg in rat was determined,Intermediate,In vivo,,1,8245,BAO_0000218,4527
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618539,1,A,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Intermediate,In vivo,,1,8246,BAO_0000218,4521
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618540,1,A,Volume distribution was calculated in rat,Intermediate,In vivo,,1,8247,BAO_0000218,6057
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618541,1,A,Volume distribution was determined,Intermediate,In vivo,,1,8248,BAO_0000218,5510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618542,1,A,Volume of distribution after intravenous administration was evaluated in rat,Intermediate,In vivo,,1,8249,BAO_0000218,2938
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622544,1,A,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Intermediate,In vivo,,1,8250,BAO_0000218,6679
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622545,1,A,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",Intermediate,In vivo,,1,8251,BAO_0000218,6685
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622546,1,A,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Intermediate,In vivo,,1,8252,BAO_0000218,6685
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622547,1,A,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",Intermediate,In vivo,,1,8253,BAO_0000218,6685
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622548,1,A,Volume of distribution in steady state was determined in rat,Intermediate,In vivo,,1,8254,BAO_0000218,5145
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622549,1,A,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,Intermediate,In vivo,,1,8255,BAO_0000218,6467
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622550,1,A,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Intermediate,In vivo,,1,8256,BAO_0000218,6467
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL622551,1,A,Compound was evaluated for area under curve when administered through oral route to mouse,Intermediate,,,1,8257,BAO_0000218,15115
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622552,1,A,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Intermediate,,,1,8258,BAO_0000218,8758
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622553,1,A,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,Intermediate,,,1,8259,BAO_0000218,8758
,,,,,,,,U,,,22224,CHEMBL622554,1,F,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,Autocuration,In vivo,,0,8260,BAO_0000218,8267
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL622555,1,A,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,Intermediate,,,1,8261,BAO_0000218,8267
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL622556,1,A,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,Intermediate,,,1,8262,BAO_0000218,14239
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL622557,1,A,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,Intermediate,,,1,8263,BAO_0000218,14239
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL622558,1,A,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,Intermediate,,178.0,1,8264,BAO_0000218,10754
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL622559,1,A,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,Intermediate,,178.0,1,8265,BAO_0000218,10754
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL622560,1,A,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,Intermediate,,,1,8266,BAO_0000218,10754
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622561,1,A,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,Intermediate,,,1,8267,BAO_0000218,14681
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622562,1,A,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,Intermediate,,,1,8268,BAO_0000218,14681
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622563,1,A,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,Intermediate,,,1,8269,BAO_0000218,14681
,,,,,,,,U,,,22224,CHEMBL622564,1,A,Concentration of compound in Central nervous system,Autocuration,,,0,8270,BAO_0000019,13118
,,,,,,,,U,,,22224,CHEMBL622565,1,A,Concentration of compound in Central nervous system; Not detectable,Autocuration,,,0,8271,BAO_0000019,13118
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL622566,1,A,"Concentration of diester in the blood, following oral administration in mice",Intermediate,,,1,8272,BAO_0000218,13318
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL624515,1,A,"Concentration of monoester in the blood, following oral administration in mice",Intermediate,,,1,8273,BAO_0000218,13318
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL624516,1,A,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,Intermediate,,,1,8274,BAO_0000218,13318
,,,,,,,,U,,,22224,CHEMBL624517,1,A,Evaluated for Pharmacokinetic property: Area under the curve,Autocuration,,,0,8275,BAO_0000019,15692
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL624518,1,A,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,Intermediate,,,1,8276,BAO_0000218,14839
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL624519,1,A,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,Intermediate,,,1,8277,BAO_0000218,14839
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL624520,1,A,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,Intermediate,,,1,8278,BAO_0000218,14839
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL624521,1,A,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,Intermediate,,,1,8279,BAO_0000218,14839
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL624522,1,A,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,Intermediate,,,1,8280,BAO_0000218,14839
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL624523,1,A,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,Intermediate,,,1,8281,BAO_0000218,14839
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL624409,1,A,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Intermediate,,,1,8282,BAO_0000218,14839
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL624410,1,A,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",Intermediate,,,1,8283,BAO_0000218,14839
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL624411,1,A,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Intermediate,,,1,8284,BAO_0000218,14839
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL623531,1,A,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",Intermediate,,,1,8285,BAO_0000218,14839
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL623532,1,A,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",Intermediate,,,1,8286,BAO_0000218,14839
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL623533,1,A,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",Intermediate,,,1,8287,BAO_0000218,14839
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL623534,1,A,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Intermediate,,,1,8288,BAO_0000218,14839
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623535,1,A,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,Intermediate,,,1,8289,BAO_0000218,14839
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623536,1,A,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,Intermediate,,,1,8290,BAO_0000218,14839
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623537,1,A,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,Intermediate,,,1,8291,BAO_0000218,14839
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623538,1,A,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,Intermediate,,,1,8292,BAO_0000218,14839
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623539,1,A,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,Intermediate,,,1,8293,BAO_0000218,14839
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623540,1,A,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,Intermediate,,,1,8294,BAO_0000218,14839
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623541,1,A,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",Intermediate,,,1,8295,BAO_0000218,14839
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623542,1,A,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",Intermediate,,,1,8296,BAO_0000218,14839
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623543,1,A,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",Intermediate,,,1,8297,BAO_0000218,14839
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623544,1,A,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",Intermediate,,,1,8298,BAO_0000218,14839
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623545,1,A,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",Intermediate,,,1,8299,BAO_0000218,14839
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623546,1,A,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",Intermediate,,,1,8300,BAO_0000218,14839
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623547,1,A,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,Intermediate,In vivo,1969.0,1,8301,BAO_0000218,5408
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623548,1,A,High i.v. clearance in Dawley rats,Intermediate,In vivo,,1,8302,BAO_0000218,6827
,10116.0,,Rattus norvegicus,Liver,,Microsomes,,N,,,50597,CHEMBL623549,1,A,In vitro clearance in rat liver microsomes,Intermediate,In vitro,2107.0,1,8303,BAO_0000218,17538
,10116.0,,Rattus norvegicus,Liver,,Microsomes,,N,,,50597,CHEMBL623550,1,A,Intrinsic clearance in rat liver microsomes was determined,Intermediate,In vitro,2107.0,1,8304,BAO_0000218,6331
,10116.0,,Rattus norvegicus,Liver,Hepatocyte,,401.0,N,,,50597,CHEMBL875276,1,A,Intrinsic clearance in rat hepatocytes was determined,Intermediate,In vitro,2107.0,1,8305,BAO_0000218,5948
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621872,1,A,Plasma Clearance was determined,Intermediate,In vivo,,1,8306,BAO_0000218,4026
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621873,1,A,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,Intermediate,In vivo,,1,8307,BAO_0000218,6647
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621874,1,A,Plasma clearance in rat.,Intermediate,In vivo,,1,8308,BAO_0000218,1696
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621875,1,A,Plasma clearance in rats,Intermediate,In vivo,,1,8309,BAO_0000218,6597
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621876,1,A,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,Intermediate,In vivo,,1,8310,BAO_0000218,347
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621877,1,A,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,Intermediate,In vivo,,1,8311,BAO_0000218,16423
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621878,1,A,Plasma clearance was measured in rat,Intermediate,In vivo,,1,8312,BAO_0000218,2879
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621879,1,A,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Intermediate,In vivo,,1,8313,BAO_0000218,4883
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL621880,1,A,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",Intermediate,In vivo,1969.0,1,8314,BAO_0000218,5328
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621881,1,A,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,Intermediate,In vivo,,1,8315,BAO_0000218,5160
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621882,1,A,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Intermediate,In vivo,,1,8316,BAO_0000218,17582
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875283,1,A,Total clearance at 1 mg/kg was determined in rat,Intermediate,In vivo,,1,8317,BAO_0000218,17651
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621883,1,A,Total clearance at 10 mg/kg was determined in rat,Intermediate,In vivo,,1,8318,BAO_0000218,17651
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621884,1,A,Clearance in rat,Intermediate,In vivo,,1,8319,BAO_0000218,6596
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621885,1,A,Plasma clearance rate determined in rats,Intermediate,In vivo,,1,8320,BAO_0000218,4796
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621886,1,A,Clearance of compound in rat was evaluated,Intermediate,In vivo,,1,8321,BAO_0000218,6850
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL621887,1,A,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Intermediate,In vivo,1969.0,1,8322,BAO_0000218,5932
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621888,1,A,Pharmacokinetic property (blood clearance) in rat,Intermediate,In vivo,,1,8323,BAO_0000218,3371
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621889,1,A,Plasma clearance in rat,Intermediate,In vivo,,1,8324,BAO_0000218,2083
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621890,1,A,Plasma clearance in rats,Intermediate,In vivo,,1,8325,BAO_0000218,4942
,10116.0,,Rattus norvegicus,Liver,,Microsomes,,N,,,50597,CHEMBL621891,1,A,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,Intermediate,In vitro,2107.0,1,8326,BAO_0000218,6838
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621892,1,A,Clearance in Dawley rat,Intermediate,In vivo,,1,8327,BAO_0000218,5353
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621893,1,A,Clearance rat,Intermediate,In vivo,,1,8328,BAO_0000218,6641
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621894,1,A,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),Intermediate,In vivo,,1,8329,BAO_0000218,6641
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621895,1,A,Clearance rat; Not determined,Intermediate,In vivo,,1,8330,BAO_0000218,6641
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875284,1,A,Clearance rate was determined in rat at a dose of 1 mpk i.v.,Intermediate,In vivo,,1,8331,BAO_0000218,6444
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618699,1,A,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Intermediate,In vivo,,1,8332,BAO_0000218,6444
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618700,1,A,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Intermediate,In vivo,,1,8333,BAO_0000218,6444
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618701,1,A,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,Intermediate,In vivo,,1,8334,BAO_0000218,6211
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL876600,1,A,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Intermediate,In vivo,1969.0,1,8335,BAO_0000218,12873
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618702,1,A,Clearance of compound in rat after 1 mg/kg i.v. administration,Intermediate,In vivo,,1,8336,BAO_0000218,6570
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618703,1,A,Compound was evaluated for Hepatic clearance in rat,Intermediate,In vivo,,1,8337,BAO_0000218,3341
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618704,1,A,In vivo clearance after 5 mg/kg dose,Intermediate,In vivo,,1,8338,BAO_0000218,4891
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL618705,1,A,Compound was tested for plasma clearance in rats,Intermediate,In vivo,1969.0,1,8339,BAO_0000218,1094
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618706,1,A,Hepatic clearance after intravenous administration was evaluated in rat,Intermediate,In vivo,,1,8340,BAO_0000218,2938
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618707,1,A,Lower clearance in rat (i.v.) at 0.5 mpk,Intermediate,In vivo,,1,8341,BAO_0000218,17853
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL618708,1,A,Pharmacokinetic parameter expressed as plasma clearance in rat,Intermediate,In vivo,1969.0,1,8342,BAO_0000218,6049
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618709,1,A,Pharmacokinetic property (Clp) in rat,Intermediate,In vivo,,1,8343,BAO_0000218,5789
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618710,1,A,Plasma clearance in Sprague-Dawley rats,Intermediate,In vivo,,1,8344,BAO_0000218,4514
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618711,1,A,Plasma clearance (Clp) in rat,Intermediate,In vivo,,1,8345,BAO_0000218,6448
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618712,1,A,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,Intermediate,In vivo,,1,8346,BAO_0000218,6062
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618713,1,A,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,Intermediate,In vivo,,1,8347,BAO_0000218,5710
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618714,1,A,Plasma clearance after intravenous administration of 1 mg/kg in rat,Intermediate,In vivo,,1,8348,BAO_0000218,4709
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618715,1,A,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Intermediate,In vivo,,1,8349,BAO_0000218,4521
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618716,1,A,Plasma clearance in rat was determined,Intermediate,In vivo,,1,8350,BAO_0000218,1742
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876601,1,A,Plasma clearance measured in rat,Intermediate,In vivo,,1,8351,BAO_0000218,6057
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618717,1,A,Plasma clearance was calculated in rat,Intermediate,In vivo,,1,8352,BAO_0000218,6057
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618718,1,A,Plasma clearance in rat,Intermediate,In vivo,,1,8353,BAO_0000218,5145
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618719,1,A,Plasma clearance in rat,Intermediate,In vivo,,1,8354,BAO_0000218,5833
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618720,1,A,Plasma clearance in rat,Intermediate,In vivo,,1,8355,BAO_0000218,6453
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618721,1,A,Plasma clearance in rat,Intermediate,In vivo,,1,8356,BAO_0000218,6640
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621477,1,A,Plasma clearance in rats,Intermediate,In vivo,,1,8357,BAO_0000218,6305
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621478,1,A,Plasma clearance in rat,Intermediate,In vivo,,1,8358,BAO_0000218,6642
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621479,1,A,Plasma clearance was evaluated in rat,Intermediate,In vivo,,1,8359,BAO_0000218,5472
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621480,1,A,Plasma clearance was evaluated in rat; Not tested,Intermediate,In vivo,,1,8360,BAO_0000218,5472
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621481,1,A,Plasma clearance rate was determined for the compound in rat,Intermediate,In vivo,,1,8361,BAO_0000218,5144
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621482,1,A,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",Intermediate,In vivo,,1,8362,BAO_0000218,6685
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621483,1,A,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Intermediate,In vivo,,1,8363,BAO_0000218,6685
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621484,1,A,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",Intermediate,In vivo,,1,8364,BAO_0000218,6685
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621485,1,A,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,948.0,1,8365,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL621486,1,A,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,948.0,1,8366,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL621487,1,A,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,160.0,1,8367,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL621488,1,A,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,160.0,1,8368,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL621489,1,A,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,160.0,1,8369,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL621490,1,A,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,160.0,1,8370,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL621491,1,A,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,160.0,1,8371,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL621492,1,A,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2113.0,1,8372,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL621493,1,A,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2113.0,1,8373,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL621494,1,A,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2113.0,1,8374,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL621495,1,A,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2113.0,1,8375,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL621496,1,A,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2113.0,1,8376,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL621497,1,A,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2107.0,1,8377,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL621498,1,A,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2107.0,1,8378,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL621499,1,A,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2107.0,1,8379,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL618634,1,A,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2107.0,1,8380,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL618635,1,A,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2107.0,1,8381,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL618636,1,A,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2048.0,1,8382,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL619737,1,A,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2048.0,1,8383,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL619738,1,A,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2048.0,1,8384,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624329,1,A,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2048.0,1,8385,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624330,1,A,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2048.0,1,8386,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL624331,1,A,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2385.0,1,8387,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL624332,1,A,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2385.0,1,8388,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL624333,1,A,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2385.0,1,8389,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL624334,1,A,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2385.0,1,8390,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL624335,1,A,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2385.0,1,8391,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL620016,1,A,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2106.0,1,8392,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL620169,1,A,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2106.0,1,8393,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL620170,1,A,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2106.0,1,8394,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL620171,1,A,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2106.0,1,8395,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL620172,1,A,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,2106.0,1,8396,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Stomach,,,,N,,,50597,CHEMBL620173,1,A,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,945.0,1,8397,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Stomach,,,,N,,,50597,CHEMBL620174,1,A,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,945.0,1,8398,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Stomach,,,,N,,,50597,CHEMBL620175,1,A,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,945.0,1,8399,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Stomach,,,,N,,,50597,CHEMBL620176,1,A,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,945.0,1,8400,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Stomach,,,,N,,,50597,CHEMBL620177,1,A,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,Intermediate,In vivo,945.0,1,8401,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL620178,1,A,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,,2037.0,1,8402,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL620179,1,A,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,,2037.0,1,8403,BAO_0000218,13950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620180,1,A,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,,,1,8404,BAO_0000218,13950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620181,1,A,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,Intermediate,In vivo,,1,8405,BAO_0000218,6570
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620182,1,A,Volume of distribution of compound in rats after intravenous administration,Intermediate,In vivo,,1,8406,BAO_0000218,6571
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620183,1,A,Volume of distribution in rat,Intermediate,In vivo,,1,8407,BAO_0000218,6453
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620184,1,A,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,Intermediate,In vivo,,1,8408,BAO_0000218,6444
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620185,1,A,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Intermediate,In vivo,,1,8409,BAO_0000218,6444
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620186,1,A,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Intermediate,In vivo,,1,8410,BAO_0000218,6444
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620187,1,A,Volume of distribution was determined in Dawley rat,Intermediate,In vivo,,1,8411,BAO_0000218,5353
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620188,1,A,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Intermediate,In vivo,,1,8412,BAO_0000218,5334
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620189,1,A,Volume of distribution was reported in Sprague-Dawley rat,Intermediate,In vivo,,1,8413,BAO_0000218,5334
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620190,1,A,Volumes of distribution in rat after peroral administration,Intermediate,In vivo,,1,8414,BAO_0000218,6641
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620191,1,A,Volumes of distribution in rat after po administration,Intermediate,In vivo,,1,8415,BAO_0000218,6641
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620192,1,A,Volumes of distribution in rat after po administration; Not determined,Intermediate,In vivo,,1,8416,BAO_0000218,6641
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620193,1,A,Pharmacokinetic property (Volume) in rat i.v.,Intermediate,In vivo,,1,8417,BAO_0000218,5676
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620194,1,A,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,Intermediate,In vivo,,1,8418,BAO_0000218,6410
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876730,1,A,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",Intermediate,In vivo,,1,8419,BAO_0000218,17670
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620195,1,A,Volume distribution in rat after oral administration at 10 mg/kg,Intermediate,In vivo,,1,8420,BAO_0000218,6495
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620196,1,A,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,Intermediate,In vivo,,1,8421,BAO_0000218,5408
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620197,1,A,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Intermediate,In vivo,,1,8422,BAO_0000218,4883
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620198,1,A,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,Intermediate,In vivo,,1,8423,BAO_0000218,6647
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620199,1,A,Volume of distribution in rats,Intermediate,In vivo,,1,8424,BAO_0000218,6495
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620200,1,A,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,Intermediate,In vivo,,1,8425,BAO_0000218,2661
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620201,1,A,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,Intermediate,In vivo,,1,8426,BAO_0000218,2661
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620202,1,A,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,In vivo,,1,8427,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620203,1,A,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,In vivo,,1,8428,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620204,1,A,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,Intermediate,In vivo,,1,8429,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620205,1,A,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,In vivo,,1,8430,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624664,1,A,Pharmacokinetic parameter (Vss) in rat,Intermediate,In vivo,,1,8431,BAO_0000218,5960
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624665,1,A,Pharmacokinetic property (Volume) in rat i.v.,Intermediate,In vivo,,1,8432,BAO_0000218,5676
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624666,1,A,Pharmacokinetic property (Vss) in rat,Intermediate,,,1,8433,BAO_0000218,5948
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624667,1,A,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,Intermediate,In vivo,,1,8434,BAO_0000218,5979
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624668,1,A,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,8435,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624669,1,A,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,8436,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624670,1,A,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,8437,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624671,1,A,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,8438,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624672,1,A,Steady state volume distribution in rat,Intermediate,In vivo,,1,8439,BAO_0000218,6448
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL624673,1,A,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",Intermediate,In vivo,1969.0,1,8440,BAO_0000218,12873
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624674,1,A,Steady state volume of distribution determined in rat,Intermediate,In vivo,,1,8441,BAO_0000218,4576
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624675,1,A,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Intermediate,In vivo,,1,8442,BAO_0000218,17582
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621728,1,A,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,Intermediate,In vivo,,1,8443,BAO_0000218,1466
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621729,1,A,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,Intermediate,,,1,8444,BAO_0000218,5182
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621730,1,A,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,Intermediate,,,1,8445,BAO_0000218,5182
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621731,1,A,Volume distribution in rat after administration of 2 mg/kg iv,Intermediate,In vivo,,1,8446,BAO_0000218,6535
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621732,1,A,Volume distribution in rat after administration of 2 mg/kg iv,Intermediate,In vivo,,1,8447,BAO_0000218,6535
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621908,1,A,Volume in steady state distribution value was determined,Intermediate,In vivo,,1,8448,BAO_0000218,5041
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875347,1,A,Volume in steady state distribution value was determined; ND denotes no data,Intermediate,In vivo,,1,8449,BAO_0000218,5041
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621909,1,A,Volume in steady state distribution value was determined; ND denotes not determined,Intermediate,In vivo,,1,8450,BAO_0000218,5041
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621910,1,A,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate,In vivo,,1,8451,BAO_0000218,17065
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621911,1,A,Volume of distribution at steady state was evaluated in rats,Intermediate,In vivo,,1,8452,BAO_0000218,6597
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621912,1,A,Volume of distribution at steady state was observed after intravenous administration in rat,Intermediate,In vivo,,1,8453,BAO_0000218,15662
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621913,1,A,Volume of distribution in steady state was determined in rat,Intermediate,In vivo,,1,8454,BAO_0000218,6485
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621914,1,A,Volume of distribution in steady state was determined in rat,Intermediate,In vivo,,1,8455,BAO_0000218,17655
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621915,1,A,Volume of distribution after i.v. administration,Intermediate,In vivo,,1,8456,BAO_0000218,6616
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621916,1,A,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Intermediate,In vivo,,1,8457,BAO_0000218,1916
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL621917,1,A,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Intermediate,In vivo,2107.0,1,8458,BAO_0000218,16438
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL621918,1,A,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Intermediate,In vivo,2107.0,1,8459,BAO_0000218,16438
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL621919,1,A,Biodistribution of compound (oxidized form) in spleen tissue,Intermediate,In vivo,2106.0,1,8460,BAO_0000218,16438
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL621920,1,A,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",Intermediate,In vivo,2106.0,1,8461,BAO_0000218,16438
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL621921,1,A,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",Intermediate,In vivo,2106.0,1,8462,BAO_0000218,16438
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL622401,1,A,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,In vivo,2106.0,1,8463,BAO_0000218,16438
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL875348,1,A,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Intermediate,In vivo,2106.0,1,8464,BAO_0000218,16438
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL622402,1,A,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Intermediate,In vivo,2106.0,1,8465,BAO_0000218,16438
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL622403,1,A,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,Intermediate,In vivo,178.0,1,8466,BAO_0000218,16438
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL622404,1,A,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,In vivo,178.0,1,8467,BAO_0000218,16438
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL622405,1,A,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,Intermediate,In vivo,955.0,1,8468,BAO_0000218,16438
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL622406,1,A,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Intermediate,In vivo,955.0,1,8469,BAO_0000218,16438
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL622407,1,A,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,In vivo,955.0,1,8470,BAO_0000218,16438
,10090.0,,Mus musculus,Heart,,,,N,,,50594,CHEMBL622408,1,A,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,Intermediate,In vivo,948.0,1,8471,BAO_0000218,16438
,10090.0,,Mus musculus,Heart,,,,N,,,50594,CHEMBL622409,1,A,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Intermediate,In vivo,948.0,1,8472,BAO_0000218,16438
,10090.0,,Mus musculus,Heart,,,,N,,,50594,CHEMBL622410,1,A,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,In vivo,948.0,1,8473,BAO_0000218,16438
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL622411,1,A,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,Intermediate,In vivo,2113.0,1,8474,BAO_0000218,16438
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL627864,1,A,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",Intermediate,In vivo,2113.0,1,8475,BAO_0000218,16438
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL627865,1,A,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,In vivo,2113.0,1,8476,BAO_0000218,16438
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL627866,1,A,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,Intermediate,In vivo,2107.0,1,8477,BAO_0000218,16438
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL627751,1,A,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,In vivo,2107.0,1,8478,BAO_0000218,16438
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL627752,1,A,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,Intermediate,In vivo,2106.0,1,8479,BAO_0000218,16438
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL627753,1,A,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",Intermediate,In vivo,2106.0,1,8480,BAO_0000218,16438
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL627754,1,A,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Intermediate,In vivo,2106.0,1,8481,BAO_0000218,16438
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627755,1,A,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,Intermediate,,,1,8482,BAO_0000218,12467
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL627756,1,A,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,955.0,1,8483,BAO_0000218,17208
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL627757,1,A,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,955.0,1,8484,BAO_0000218,17208
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL627758,1,A,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,955.0,1,8485,BAO_0000218,17208
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL627759,1,A,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,955.0,1,8486,BAO_0000218,17208
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL627760,1,A,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,955.0,1,8487,BAO_0000218,17208
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL627761,1,A,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,955.0,1,8488,BAO_0000218,17208
,10090.0,,Mus musculus,Heart,,,,N,,,50594,CHEMBL876811,1,A,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,948.0,1,8489,BAO_0000218,17208
,10090.0,,Mus musculus,Heart,,,,N,,,50594,CHEMBL627762,1,A,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,948.0,1,8490,BAO_0000218,17208
,10090.0,,Mus musculus,Heart,,,,N,,,50594,CHEMBL627763,1,A,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,948.0,1,8491,BAO_0000218,17208
,10090.0,,Mus musculus,Heart,,,,N,,,50594,CHEMBL627764,1,A,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,948.0,1,8492,BAO_0000218,17208
,10090.0,,Mus musculus,Heart,,,,N,,,50594,CHEMBL627765,1,A,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,948.0,1,8493,BAO_0000218,17208
,10090.0,,Mus musculus,Heart,,,,N,,,50594,CHEMBL627766,1,A,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,948.0,1,8494,BAO_0000218,17208
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL627767,1,A,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2113.0,1,8495,BAO_0000218,17208
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL627768,1,A,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2113.0,1,8496,BAO_0000218,17208
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL628422,1,A,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2113.0,1,8497,BAO_0000218,17208
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL628423,1,A,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2113.0,1,8498,BAO_0000218,17208
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628424,1,A,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,Intermediate,In vivo,,1,8499,BAO_0000218,5089
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628425,1,A,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,Intermediate,In vivo,,1,8500,BAO_0000218,5089
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628426,1,A,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,Intermediate,In vivo,,1,8501,BAO_0000218,4257
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628427,1,A,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Intermediate,In vivo,,1,8502,BAO_0000218,6679
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626938,1,A,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Intermediate,In vivo,,1,8503,BAO_0000218,5546
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626939,1,A,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,Intermediate,In vivo,,1,8504,BAO_0000218,6141
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626940,1,A,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Intermediate,In vivo,,1,8505,BAO_0000218,5334
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626941,1,A,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Intermediate,In vivo,,1,8506,BAO_0000218,5334
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626942,1,A,Plasma clearance was reported in Sprague-Dawley rat,Intermediate,In vivo,,1,8507,BAO_0000218,5334
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876812,1,A,Plasma clearance after intravenous administration (1 mg/kg) in rat,Intermediate,In vivo,,1,8508,BAO_0000218,4689
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626943,1,A,Plasma clearance of compound in rats was evaluated,Intermediate,In vivo,,1,8509,BAO_0000218,6848
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626944,1,A,Plasma clearance of compound in rats was evaluated; ND indicates not determined,Intermediate,In vivo,,1,8510,BAO_0000218,6848
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626945,1,A,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,Intermediate,In vivo,,1,8511,BAO_0000218,6467
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626946,1,A,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Intermediate,In vivo,,1,8512,BAO_0000218,6467
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626856,1,A,Plasma clearance rate in Sprague-Dawley rats,Intermediate,In vivo,,1,8513,BAO_0000218,4956
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626857,1,A,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),Intermediate,In vivo,,1,8514,BAO_0000218,5529
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626858,1,A,The compound was evaluated for plasma clearance in rat,Intermediate,In vivo,1969.0,1,8515,BAO_0000218,406
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627018,1,A,Total plasma clearance in rat,Intermediate,In vivo,1969.0,1,8516,BAO_0000218,17655
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625331,1,A,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,Intermediate,In vivo,178.0,1,8517,BAO_0000218,3293
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625332,1,A,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,Intermediate,In vivo,178.0,1,8518,BAO_0000218,4075
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL877590,1,A,C max was determined at 10 mg/kg po dose in rats,Intermediate,In vivo,,1,8519,BAO_0000218,2792
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625333,1,A,C max was determined at 3 mg/kg po dose in rats,Intermediate,In vivo,,1,8520,BAO_0000218,2792
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625334,1,A,Cmax after repeated oral dose of compound at 1 mg/kg in rats,Intermediate,In vivo,,1,8521,BAO_0000218,17594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625335,1,A,Cmax after single intravenous bolus of 1 mg/kg in rats,Intermediate,In vivo,,1,8522,BAO_0000218,17594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625336,1,A,Cmax of compound at 5 mg/kg after po administration was determined in rat,Intermediate,In vivo,,1,8523,BAO_0000218,4762
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625337,1,A,Cmax 24 hr after 10 mg/kg oral administration in rats,Intermediate,In vivo,,1,8524,BAO_0000218,17509
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625338,1,A,Cmax 24 hr after 2 mg/kg oral administration in rats,Intermediate,In vivo,,1,8525,BAO_0000218,17509
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625339,1,A,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,Intermediate,In vivo,1969.0,1,8526,BAO_0000218,1466
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625340,1,A,Cmax in rat after administration of 2 mg/kg iv,Intermediate,In vivo,,1,8527,BAO_0000218,6535
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625341,1,A,Cmax in rat after administration of 2 mg/kg iv,Intermediate,In vivo,,1,8528,BAO_0000218,6535
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622687,1,A,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,Intermediate,In vivo,,1,8529,BAO_0000218,3169
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622688,1,A,Cmax wa determined in rat plasma at 30 mg/kg after po administration,Intermediate,In vivo,1969.0,1,8530,BAO_0000218,6515
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL622689,1,A,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,Intermediate,In vivo,178.0,1,8531,BAO_0000218,11149
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL620295,1,A,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,Intermediate,In vivo,178.0,1,8532,BAO_0000218,11149
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620296,1,A,Cmax after 10 mg/kg oral administration in rat,Intermediate,In vivo,,1,8533,BAO_0000218,17858
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620297,1,A,Cmax after IV dosing at 0.5 mg/kg in rat; no data,Intermediate,In vivo,,1,8534,BAO_0000218,6518
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620298,1,A,Cmax after IV dosing at 1 mg/kg in rat; no data,Intermediate,In vivo,,1,8535,BAO_0000218,6518
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620299,1,A,Cmax after oral administration at 20 mpk in rats,Intermediate,In vivo,,1,8536,BAO_0000218,4426
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620300,1,A,Cmax after oral administration at 20 mpk in rats; Not performed.,Intermediate,In vivo,,1,8537,BAO_0000218,4426
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620301,1,A,Cmax after oral administration at 20 mpk in rats d; Not performed.,Intermediate,In vivo,,1,8538,BAO_0000218,4426
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620302,1,A,Cmax after oral administration in rat,Intermediate,In vivo,,1,8539,BAO_0000218,5656
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620303,1,A,Cmax after oral administration at a dose of 2 mg/kg in rat,Intermediate,In vivo,,1,8540,BAO_0000218,6518
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620304,1,A,Cmax after oral administration at a dose of 4 mg/kg in rat,Intermediate,In vivo,,1,8541,BAO_0000218,6518
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620305,1,A,Cmax in rats after 20 mg/kg oral dose,Intermediate,In vivo,,1,8542,BAO_0000218,6113
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620306,1,A,Cmax after peroral administration in rats at 2.4 uM/kg,Intermediate,In vivo,,1,8543,BAO_0000218,17764
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620307,1,A,Cmax at the dose of 2 mg/Kg administered perorally in rats,Intermediate,In vivo,,1,8544,BAO_0000218,4756
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620308,1,A,Cmax at the dose of 5 mg/Kg administered perorally in rats,Intermediate,In vivo,,1,8545,BAO_0000218,4756
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620309,1,A,Cmax by administering at 20 mg/kg p.o. in rats,Intermediate,In vivo,,1,8546,BAO_0000218,6402
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620310,1,A,Cmax in male rat,Intermediate,In vivo,,1,8547,BAO_0000218,5610
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620311,1,A,Cmax in rat,Intermediate,In vivo,,1,8548,BAO_0000218,5207
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620312,1,A,Cmax in rat,Intermediate,In vivo,,1,8549,BAO_0000218,6011
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620313,1,A,Cmax in rat,Intermediate,In vivo,,1,8550,BAO_0000218,6504
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620314,1,A,Cmax in rat at 10 mg/kg,Intermediate,In vivo,,1,8551,BAO_0000218,6046
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620315,1,A,Cmax in rat at the dose of 1 mg/kg i.v.,Intermediate,In vivo,,1,8552,BAO_0000218,6504
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620316,1,A,Cmax in rat by po administration at a dose of 40 mg/kg,Intermediate,In vivo,,1,8553,BAO_0000218,5874
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620317,1,A,Cmax in rat p.o. at 20 mg/kg concentration,Intermediate,In vivo,,1,8554,BAO_0000218,17686
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620318,1,A,Cmax in rats,Intermediate,In vivo,,1,8555,BAO_0000218,5836
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620319,1,A,Cmax in rats,Intermediate,In vivo,,1,8556,BAO_0000218,17596
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620320,1,A,Cmax was evaluated after 20 uM/kg of peroral administration,Intermediate,In vivo,,1,8557,BAO_0000218,16423
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620321,1,A,Cmax was measured in rats after peroral administration at 3 mg/kg,Intermediate,In vivo,,1,8558,BAO_0000218,17804
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620322,1,A,Cmax value after oral dose at a dose of 10 mg/kg in rats.,Intermediate,In vivo,,1,8559,BAO_0000218,1908
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620323,1,A,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,,,1,8560,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Frontal cortex,,,,N,,,50597,CHEMBL620324,1,A,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,,1870.0,1,8561,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Frontal cortex,,,,N,,,50597,CHEMBL620325,1,A,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,,1870.0,1,8562,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL620326,1,A,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,,10000000.0,1,8563,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL620327,1,A,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,,10000000.0,1,8564,BAO_0000218,13950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620328,1,A,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,,,1,8565,BAO_0000218,13950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620329,1,A,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,,,1,8566,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Midbrain,,,,N,,,50597,CHEMBL620330,1,A,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,,1891.0,1,8567,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Midbrain,,,,N,,,50597,CHEMBL875286,1,A,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,,1891.0,1,8568,BAO_0000218,13950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620331,1,A,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,,,1,8569,BAO_0000218,13950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620332,1,A,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,,,1,8570,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Striatum,,,,N,,,50597,CHEMBL620333,1,A,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Intermediate,,2435.0,1,8571,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Striatum,,,,N,,,50597,CHEMBL620334,1,A,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Intermediate,,2435.0,1,8572,BAO_0000218,13950
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL621015,1,A,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,,178.0,1,8573,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL621016,1,A,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,,178.0,1,8574,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL621191,1,A,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,,178.0,1,8575,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL621192,1,A,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,,178.0,1,8576,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL621193,1,A,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,,178.0,1,8577,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL621194,1,A,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,,178.0,1,8578,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624204,1,A,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,,178.0,1,8579,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624205,1,A,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,,178.0,1,8580,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624206,1,A,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,,178.0,1,8581,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624207,1,A,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,,178.0,1,8582,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624208,1,A,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,,178.0,1,8583,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624209,1,A,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,,178.0,1,8584,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624210,1,A,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,,178.0,1,8585,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624211,1,A,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,,178.0,1,8586,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624212,1,A,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,,178.0,1,8587,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624213,1,A,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,,178.0,1,8588,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL876611,1,A,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,,178.0,1,8589,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624214,1,A,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,,178.0,1,8590,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624215,1,A,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,,178.0,1,8591,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624216,1,A,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,,178.0,1,8592,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624217,1,A,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,,178.0,1,8593,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624218,1,A,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,,178.0,1,8594,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624219,1,A,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,,178.0,1,8595,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624220,1,A,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,,178.0,1,8596,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624221,1,A,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,,178.0,1,8597,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624222,1,A,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,,,1,8598,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624223,1,A,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,,,1,8599,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624224,1,A,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,,,1,8600,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624225,1,A,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,,,1,8601,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622420,1,A,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,Intermediate,In vivo,,1,8602,BAO_0000218,17764
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622421,1,A,Volume of steady state distribution after i.v. administration in rats,Intermediate,In vivo,,1,8603,BAO_0000218,5031
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622422,1,A,Vss after intravenous administration (5.0 mg/kg) was determined in rat,Intermediate,In vivo,,1,8604,BAO_0000218,6215
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622423,1,A,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate,In vivo,,1,8605,BAO_0000218,17671
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622424,1,A,Vss was determined,Intermediate,In vivo,,1,8606,BAO_0000218,17752
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622425,1,A,Vss in rat,Intermediate,In vivo,,1,8607,BAO_0000218,6596
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876612,1,A,Vss was evaluated after 10 uM/kg of intra arterial administration,Intermediate,In vivo,,1,8608,BAO_0000218,16423
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622426,1,A,volume of distribution at steady state was observed after intravenous administration in rat,Intermediate,In vivo,,1,8609,BAO_0000218,15662
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622427,1,A,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,Intermediate,In vivo,,1,8610,BAO_0000218,6062
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622428,1,A,Pharmacokinetic (PK) parameter Vz in rat,Intermediate,In vivo,,1,8611,BAO_0000218,5874
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622429,1,A,Volume distribution in rats,Intermediate,In vivo,,1,8612,BAO_0000218,4942
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622430,1,A,Volume of distribution in rat; No data,Intermediate,In vivo,,1,8613,BAO_0000218,17796
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622431,1,A,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Intermediate,In vivo,,1,8614,BAO_0000218,4890
,10116.0,,Rattus norvegicus,Ileum,,,,N,,,50597,CHEMBL622432,1,A,% absorption predicted from in vitro rat ileum transport studies,Intermediate,,2116.0,1,8615,BAO_0000218,15765
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622433,1,A,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,Intermediate,In vivo,,1,8616,BAO_0000218,13569
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622434,1,A,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,Intermediate,In vivo,,1,8617,BAO_0000218,13569
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622435,1,A,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,Intermediate,In vivo,,1,8618,BAO_0000218,13569
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618748,1,A,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),Intermediate,In vivo,,1,8619,BAO_0000218,13569
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618749,1,A,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,Intermediate,In vivo,,1,8620,BAO_0000218,13569
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618750,1,A,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,Intermediate,In vivo,,1,8621,BAO_0000218,13569
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618751,1,A,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,Intermediate,In vivo,,1,8622,BAO_0000218,13569
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618752,1,A,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,Intermediate,In vivo,,1,8623,BAO_0000218,13569
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618753,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,8624,BAO_0000218,4576
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL618754,1,A,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,Intermediate,In vivo,1969.0,1,8625,BAO_0000218,750
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618755,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,8626,BAO_0000218,750
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618756,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,8627,BAO_0000218,4590
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618757,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,8628,BAO_0000218,1716
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618758,1,A,Bioavailability in rat,Intermediate,In vivo,,1,8629,BAO_0000218,1974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621088,1,A,Oral bioavailability in rat (dose 30 mg/kg),Intermediate,In vivo,,1,8630,BAO_0000218,4502
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621089,1,A,Pharmacokinetic property (cLogP) in rat,Intermediate,,,1,8631,BAO_0000218,3371
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL621090,1,F,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,Intermediate,,178.0,1,8632,BAO_0000218,9099
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL621091,1,F,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,Intermediate,,178.0,1,8633,BAO_0000218,9099
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876731,1,A,Clearance in rat.,Intermediate,In vivo,,1,8634,BAO_0000218,4590
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621092,1,A,Compound was evaluated for its clearance when administered intravenously in rat,Intermediate,In vivo,,1,8635,BAO_0000218,3184
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621093,1,A,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Intermediate,In vivo,,1,8636,BAO_0000218,16456
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621094,1,A,Blood: Brain distribution ratio is determined in rat,Intermediate,,,1,8637,BAO_0000218,4199
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621095,1,A,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,Intermediate,,,1,8638,BAO_0000218,4199
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621096,1,A,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,Intermediate,,,1,8639,BAO_0000218,4199
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL621097,1,A,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,2113.0,1,8640,BAO_0000218,8677
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621098,1,F,Percent dose excreted in 0-48 hours administered ip to male rat,Intermediate,,,1,8641,BAO_0000218,7449
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL621099,1,A,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,,2037.0,1,8642,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL621100,1,A,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,,2037.0,1,8643,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL621101,1,A,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,,2037.0,1,8644,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL621102,1,A,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,,2037.0,1,8645,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL876732,1,A,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,,2037.0,1,8646,BAO_0000218,11977
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621103,1,A,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,,,1,8647,BAO_0000218,11977
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621104,1,A,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,,,1,8648,BAO_0000218,11977
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621105,1,A,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,,,1,8649,BAO_0000218,11977
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621106,1,A,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,,,1,8650,BAO_0000218,11977
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621107,1,A,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,,,1,8651,BAO_0000218,11977
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621108,1,A,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,,,1,8652,BAO_0000218,11977
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621109,1,A,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,,,1,8653,BAO_0000218,11977
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL621110,1,A,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2113.0,1,8654,BAO_0000218,17208
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL621111,1,A,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2113.0,1,8655,BAO_0000218,17208
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL622541,1,A,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2107.0,1,8656,BAO_0000218,17208
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL622542,1,A,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2107.0,1,8657,BAO_0000218,17208
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL622543,1,A,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2107.0,1,8658,BAO_0000218,17208
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL624412,1,A,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2107.0,1,8659,BAO_0000218,17208
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL624413,1,A,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2107.0,1,8660,BAO_0000218,17208
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL624414,1,A,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2107.0,1,8661,BAO_0000218,17208
,10090.0,,Mus musculus,Lung,,,,N,,,50594,CHEMBL624415,1,A,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2048.0,1,8662,BAO_0000218,17208
,10090.0,,Mus musculus,Lung,,,,N,,,50594,CHEMBL624416,1,A,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2048.0,1,8663,BAO_0000218,17208
,10090.0,,Mus musculus,Lung,,,,N,,,50594,CHEMBL624417,1,A,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2048.0,1,8664,BAO_0000218,17208
,10090.0,,Mus musculus,Lung,,,,N,,,50594,CHEMBL624418,1,A,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2048.0,1,8665,BAO_0000218,17208
,10090.0,,Mus musculus,Lung,,,,N,,,50594,CHEMBL624419,1,A,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2048.0,1,8666,BAO_0000218,17208
,10090.0,,Mus musculus,Lung,,,,N,,,50594,CHEMBL624420,1,A,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2048.0,1,8667,BAO_0000218,17208
,10090.0,,Mus musculus,Muscle tissue,,,,N,,,50594,CHEMBL624421,1,A,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2385.0,1,8668,BAO_0000218,17208
,10090.0,,Mus musculus,Muscle tissue,,,,N,,,50594,CHEMBL624422,1,A,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2385.0,1,8669,BAO_0000218,17208
,10090.0,,Mus musculus,Muscle tissue,,,,N,,,50594,CHEMBL624423,1,A,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2385.0,1,8670,BAO_0000218,17208
,10090.0,,Mus musculus,Muscle tissue,,,,N,,,50594,CHEMBL625123,1,A,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2385.0,1,8671,BAO_0000218,17208
,10090.0,,Mus musculus,Muscle tissue,,,,N,,,50594,CHEMBL625124,1,A,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2385.0,1,8672,BAO_0000218,17208
,10090.0,,Mus musculus,Muscle tissue,,,,N,,,50594,CHEMBL625125,1,A,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2385.0,1,8673,BAO_0000218,17208
,10090.0,,Mus musculus,Zone of skin,,,,N,,,50594,CHEMBL625126,1,A,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,14.0,1,8674,BAO_0000218,17208
,10090.0,,Mus musculus,Zone of skin,,,,N,,,50594,CHEMBL626947,1,A,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,14.0,1,8675,BAO_0000218,17208
,10090.0,,Mus musculus,Zone of skin,,,,N,,,50594,CHEMBL626948,1,A,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,14.0,1,8676,BAO_0000218,17208
,10090.0,,Mus musculus,Zone of skin,,,,N,,,50594,CHEMBL626949,1,A,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,14.0,1,8677,BAO_0000218,17208
,10090.0,,Mus musculus,Zone of skin,,,,N,,,50594,CHEMBL626950,1,A,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,14.0,1,8678,BAO_0000218,17208
,10090.0,,Mus musculus,Zone of skin,,,,N,,,50594,CHEMBL626951,1,A,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,14.0,1,8679,BAO_0000218,17208
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL626952,1,A,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2106.0,1,8680,BAO_0000218,17208
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL626953,1,A,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2106.0,1,8681,BAO_0000218,17208
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL626954,1,A,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2106.0,1,8682,BAO_0000218,17208
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL626955,1,A,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2106.0,1,8683,BAO_0000218,17208
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL626956,1,A,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2106.0,1,8684,BAO_0000218,17208
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL626957,1,A,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,2106.0,1,8685,BAO_0000218,17208
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL626958,1,A,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,178.0,1,8686,BAO_0000218,17208
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL626959,1,A,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,178.0,1,8687,BAO_0000218,17208
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL626960,1,A,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,178.0,1,8688,BAO_0000218,17208
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL626961,1,A,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,178.0,1,8689,BAO_0000218,17208
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL627589,1,A,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,178.0,1,8690,BAO_0000218,17208
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL627590,1,A,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),Intermediate,In vivo,178.0,1,8691,BAO_0000218,17208
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627591,1,A,Time taken for EC90 was determined when tested in mouse,Intermediate,,,1,8692,BAO_0000218,3132
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627592,1,A,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,Intermediate,,,1,8693,BAO_0000218,3132
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627593,1,A,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),Intermediate,In vivo,,1,8694,BAO_0000218,16597
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627594,1,A,Half life in mice,Intermediate,,,1,8695,BAO_0000218,5727
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL876813,1,A,Half life period in mouse after 10 mg/Kg dose,Intermediate,In vivo,,1,8696,BAO_0000218,5302
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627595,1,A,Half life period in mouse after 10 mg/kg dose,Intermediate,In vivo,,1,8697,BAO_0000218,5302
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627596,1,A,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,Intermediate,In vivo,,1,8698,BAO_0000218,6348
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627597,1,A,Cmax value at 5 mg/kg po was determined in rat,Intermediate,In vivo,,1,8699,BAO_0000218,5964
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627598,1,A,Cmax value evaluated in rat,Intermediate,In vivo,,1,8700,BAO_0000218,6078
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL627599,1,A,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,Intermediate,In vivo,955.0,1,8701,BAO_0000218,5206
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627600,1,A,Cmax value after administration of 20 mg/Kg oral dose in rat,Intermediate,In vivo,,1,8702,BAO_0000218,2959
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627601,1,A,Cmax value at 1 mg/kg po in rat,Intermediate,In vivo,,1,8703,BAO_0000218,5964
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627776,1,A,Cmax value at 5 mg/kg po in rat,Intermediate,In vivo,,1,8704,BAO_0000218,5964
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627777,1,A,Cmax value at a dose of 10 mg/kg in male SD rats,Intermediate,In vivo,,1,8705,BAO_0000218,6757
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627778,1,A,Cmax value at a dose of 100 mg/kg in male SD rats,Intermediate,In vivo,,1,8706,BAO_0000218,6757
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627779,1,A,Cmax value at a dose of 50 mg/kg in male SD rats,Intermediate,In vivo,,1,8707,BAO_0000218,6757
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876814,1,A,Cmax value in rats at 10 mg/kg,Intermediate,In vivo,,1,8708,BAO_0000218,17617
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627780,1,A,Cmax value was evaluated in rats at a dose of 20 mg/kg,Intermediate,In vivo,,1,8709,BAO_0000218,1445
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627781,1,A,Cmax value was determined after peroral administration of 20 mg/kg in rat,Intermediate,In vivo,,1,8710,BAO_0000218,6082
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627782,1,A,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,Intermediate,In vivo,,1,8711,BAO_0000218,1446
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627783,1,A,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,Intermediate,In vivo,1969.0,1,8712,BAO_0000218,5407
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627784,1,A,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,Intermediate,In vivo,1969.0,1,8713,BAO_0000218,2690
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627785,1,A,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,Intermediate,In vivo,,1,8714,BAO_0000218,2661
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627786,1,A,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,Intermediate,In vivo,,1,8715,BAO_0000218,2661
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627787,1,A,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,Intermediate,In vivo,1969.0,1,8716,BAO_0000218,4891
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627788,1,A,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,Intermediate,In vivo,1969.0,1,8717,BAO_0000218,2807
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626579,1,A,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,Intermediate,In vivo,1969.0,1,8718,BAO_0000218,2807
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626580,1,A,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,Intermediate,In vivo,1969.0,1,8719,BAO_0000218,2807
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876815,1,A,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,Intermediate,In vivo,,1,8720,BAO_0000218,3634
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626581,1,A,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,Intermediate,In vivo,1969.0,1,8721,BAO_0000218,1881
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626582,1,A,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,Intermediate,In vivo,1969.0,1,8722,BAO_0000218,1881
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626583,1,A,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,Intermediate,In vivo,,1,8723,BAO_0000218,429
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626205,1,A,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,In vivo,,1,8724,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626206,1,A,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,In vivo,,1,8725,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626207,1,A,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate,In vivo,,1,8726,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623882,1,A,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,In vivo,,1,8727,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623883,1,A,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,Intermediate,In vivo,,1,8728,BAO_0000218,17582
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623884,1,A,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,Intermediate,In vivo,,1,8729,BAO_0000218,17582
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623885,1,A,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Intermediate,In vivo,1969.0,1,8730,BAO_0000218,3032
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623886,1,A,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,Intermediate,In vivo,1969.0,1,8731,BAO_0000218,6295
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623887,1,A,Maximal concentration in rat was determined,Intermediate,In vivo,,1,8732,BAO_0000218,6619
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623888,1,A,Maximal concentration after i.v. administration,Intermediate,In vivo,,1,8733,BAO_0000218,6616
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623889,1,A,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,Intermediate,In vivo,1969.0,1,8734,BAO_0000218,3249
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623890,1,A,Maximal plasma concentration in rat after oral administration at 50 mg/kg,Intermediate,In vivo,1969.0,1,8735,BAO_0000218,17791
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623891,1,A,Cmax in rat plasma after oral dose (50 mg/Kg),Intermediate,In vivo,1969.0,1,8736,BAO_0000218,17791
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623892,1,A,Maximal plasma concentration was determined.,Intermediate,In vivo,1969.0,1,8737,BAO_0000218,1360
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623893,1,A,Maximal plasma drug concentration was determined,Intermediate,In vivo,1969.0,1,8738,BAO_0000218,2552
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL877616,1,A,Maximal concentration in rats after peroral administration,Intermediate,In vivo,,1,8739,BAO_0000218,6571
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623894,1,A,Maximum concentration in rat after 2 mg/kg peroral administration,Intermediate,In vivo,,1,8740,BAO_0000218,6570
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623895,1,A,Maximum concentration in rat plasma after 5 mg/kg oral gavage,Intermediate,In vivo,1969.0,1,8741,BAO_0000218,6567
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623896,1,A,Maximum concentration of compound in rat was evaluated.,Intermediate,In vivo,,1,8742,BAO_0000218,3031
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623897,1,A,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,Intermediate,In vivo,,1,8743,BAO_0000218,3436
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623898,1,A,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,Intermediate,In vivo,,1,8744,BAO_0000218,3436
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623899,1,A,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,Intermediate,In vivo,,1,8745,BAO_0000218,2083
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623900,1,A,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,Intermediate,In vivo,,1,8746,BAO_0000218,3436
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623901,1,A,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,Intermediate,In vivo,,1,8747,BAO_0000218,4527
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623902,1,A,Maximum concentration was evaluated in rats,Intermediate,In vivo,,1,8748,BAO_0000218,1974
,10116.0,,Rattus norvegicus,Cerebrospinal fluid,,,,N,,,50597,CHEMBL623903,1,A,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,Intermediate,In vivo,1359.0,1,8749,BAO_0000218,3307
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623904,1,A,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,Intermediate,In vivo,1969.0,1,8750,BAO_0000218,3307
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL877617,1,A,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Intermediate,In vivo,1969.0,1,8751,BAO_0000218,1916
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623905,1,A,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,Intermediate,In vivo,,1,8752,BAO_0000218,1500
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623906,1,A,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,Intermediate,In vivo,,1,8753,BAO_0000218,1500
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623907,1,A,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Intermediate,In vivo,1969.0,1,8754,BAO_0000218,4186
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623908,1,A,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,,,1,8755,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623909,1,A,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,Intermediate,,,1,8756,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623910,1,A,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,,,1,8757,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623911,1,A,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,,,1,8758,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623912,1,A,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,,,1,8759,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624616,1,A,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,,,1,8760,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624617,1,A,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,,,1,8761,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624618,1,A,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,,,1,8762,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624619,1,A,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,,,1,8763,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624794,1,A,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,,,1,8764,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624795,1,A,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,,,1,8765,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623921,1,A,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,,,1,8766,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623922,1,A,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,,,1,8767,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623923,1,A,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,,,1,8768,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623924,1,A,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,,,1,8769,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623925,1,A,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,,,1,8770,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623926,1,A,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,,,1,8771,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623927,1,A,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,,,1,8772,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623928,1,A,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,,,1,8773,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623929,1,A,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,,,1,8774,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623930,1,A,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,,,1,8775,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL623931,1,A,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,,955.0,1,8776,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL622165,1,A,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,,955.0,1,8777,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL621249,1,A,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,,955.0,1,8778,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL621250,1,A,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,,955.0,1,8779,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL621448,1,A,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,,955.0,1,8780,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL621449,1,A,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,,955.0,1,8781,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL621450,1,A,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,,955.0,1,8782,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL621451,1,A,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,,955.0,1,8783,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL621452,1,A,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,,955.0,1,8784,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL621453,1,A,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,,955.0,1,8785,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL621454,1,A,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,,955.0,1,8786,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL621455,1,A,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,,955.0,1,8787,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL621456,1,A,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,,955.0,1,8788,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL625145,1,A,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,,955.0,1,8789,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL875847,1,A,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,,955.0,1,8790,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL625146,1,A,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,,955.0,1,8791,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL625147,1,A,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,,955.0,1,8792,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL625148,1,A,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,,955.0,1,8793,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL625149,1,A,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,,955.0,1,8794,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL625150,1,A,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,,955.0,1,8795,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL625151,1,A,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,,955.0,1,8796,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL625152,1,A,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,,955.0,1,8797,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL625153,1,A,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,,955.0,1,8798,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL625154,1,A,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,,955.0,1,8799,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL625155,1,A,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,,955.0,1,8800,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625156,1,A,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,,,1,8801,BAO_0000218,11977
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624354,1,A,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,,,1,8802,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL624355,1,A,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,,10000000.0,1,8803,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL624356,1,A,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,,10000000.0,1,8804,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL624357,1,A,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,,10000000.0,1,8805,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL624358,1,A,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,,10000000.0,1,8806,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Striatum,,,,N,,,50597,CHEMBL624359,1,A,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,,2435.0,1,8807,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Striatum,,,,N,,,50597,CHEMBL624360,1,A,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,,2435.0,1,8808,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Striatum,,,,N,,,50597,CHEMBL624361,1,A,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,,2435.0,1,8809,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Striatum,,,,N,,,50597,CHEMBL624362,1,A,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,,2435.0,1,8810,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Striatum,,,,N,,,50597,CHEMBL624363,1,A,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,,2435.0,1,8811,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624364,1,A,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,178.0,1,8812,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624365,1,A,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,178.0,1,8813,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624366,1,A,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,178.0,1,8814,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624367,1,A,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,178.0,1,8815,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL624368,1,A,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,955.0,1,8816,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL624369,1,A,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,955.0,1,8817,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL624370,1,A,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,In vivo,955.0,1,8818,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL625069,1,A,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,955.0,1,8819,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL625070,1,A,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,955.0,1,8820,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL626051,1,A,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,948.0,1,8821,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL626052,1,A,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,948.0,1,8822,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL626053,1,A,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,In vivo,948.0,1,8823,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL626054,1,A,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,948.0,1,8824,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL626055,1,A,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,948.0,1,8825,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626056,1,A,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2113.0,1,8826,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626057,1,A,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2113.0,1,8827,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL625193,1,A,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2113.0,1,8828,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL625194,1,A,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2113.0,1,8829,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625195,1,A,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2107.0,1,8830,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625196,1,A,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2107.0,1,8831,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625197,1,A,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,In vivo,2107.0,1,8832,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625198,1,A,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2107.0,1,8833,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627929,1,A,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2107.0,1,8834,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627074,1,A,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2048.0,1,8835,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627075,1,A,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2048.0,1,8836,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627076,1,A,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,In vivo,2048.0,1,8837,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627077,1,A,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2048.0,1,8838,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627078,1,A,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2048.0,1,8839,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL627079,1,A,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),Intermediate,In vivo,2385.0,1,8840,BAO_0000218,11977
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL873824,1,A,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,Intermediate,In vivo,,1,8841,BAO_0000218,4573
,10090.0,,Mus musculus,Plasma,,,,N,,,50594,CHEMBL627080,1,A,Half life in mouse plasma was determined at dose 25 mg/kg,Intermediate,In vivo,1969.0,1,8842,BAO_0000218,3132
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627081,1,A,Half life was determined,Intermediate,,,1,8843,BAO_0000218,17718
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627082,1,A,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,Intermediate,In vivo,,1,8844,BAO_0000218,17728
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627083,1,A,Half-life in male mice after 1 mg/kg intravenous dose,Intermediate,In vivo,,1,8845,BAO_0000218,5961
,10090.0,,Mus musculus,Plasma,,,,N,,,50594,CHEMBL627085,1,A,Half life in mice plasma,Intermediate,,1969.0,1,8847,BAO_0000218,17731
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627086,1,A,Half life in mouse,Intermediate,,,1,8848,BAO_0000218,17592
,10090.0,,Mus musculus,Plasma,,,,N,,,50594,CHEMBL627087,1,A,Half life in mouse plasma at dose 25 mg/kg,Intermediate,In vivo,1969.0,1,8849,BAO_0000218,3132
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627088,1,A,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,Intermediate,In vivo,,1,8850,BAO_0000218,17729
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627089,1,A,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,Intermediate,In vivo,,1,8851,BAO_0000218,17729
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627090,1,A,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,Intermediate,In vivo,,1,8852,BAO_0000218,17729
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627091,1,A,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),Intermediate,In vivo,,1,8853,BAO_0000218,3277
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627092,1,A,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",Intermediate,In vivo,,1,8854,BAO_0000218,3760
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL876785,1,A,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",Intermediate,In vivo,,1,8855,BAO_0000218,3760
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627093,1,A,Half-life by iv administration in mouse,Intermediate,In vivo,,1,8856,BAO_0000218,2862
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627094,1,A,Half-life by oral administration in mouse,Intermediate,In vivo,,1,8857,BAO_0000218,2862
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627095,1,A,Half-life in mice,Intermediate,,,1,8858,BAO_0000218,5980
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL627096,1,A,Half-life using mouse brain homogenate,Intermediate,,955.0,1,8859,BAO_0000218,6159
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627097,1,A,Half-life was measured in mice,Intermediate,,,1,8860,BAO_0000218,6254
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627098,1,A,Half-life was measured in mouse after an iv dose of 1 mg/kg,Intermediate,In vivo,,1,8861,BAO_0000218,6062
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL627099,1,A,Half-life period was determined in mouse blood,Intermediate,,178.0,1,8862,BAO_0000218,1574
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL627100,1,A,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",Intermediate,,955.0,1,8863,BAO_0000218,56
,10090.0,,Mus musculus,Plasma,,,,N,,,50594,CHEMBL627101,1,A,Plasma half life in mouse,Intermediate,,1969.0,1,8864,BAO_0000218,993
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627102,1,A,Stability of the peptide in the presence of mouse serum,Intermediate,,,1,8865,BAO_0000218,6652
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627103,1,A,Terminal half life of compound was determined in mouse,Intermediate,,,1,8866,BAO_0000218,17852
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627104,1,A,Terminal half life was evaluated in mice after intravenous administration,Intermediate,In vivo,,1,8867,BAO_0000218,2675
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627105,1,A,Terminal half life was evaluated in mice after oral administration,Intermediate,In vivo,,1,8868,BAO_0000218,2675
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL876786,1,A,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,Intermediate,,,1,8869,BAO_0000218,499
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL873825,1,A,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,Intermediate,,,1,8870,BAO_0000218,499
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627106,1,A,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,Intermediate,,,1,8871,BAO_0000218,499
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL626336,1,A,half life period is evaluated by administering intravenously at 25 mg/kg in mice,Intermediate,In vivo,,1,8872,BAO_0000218,14239
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL877462,1,A,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",Intermediate,In vivo,,1,8873,BAO_0000218,5506
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL626337,1,A,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",Intermediate,In vivo,,1,8874,BAO_0000218,5506
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL626338,1,A,Half life after intraperitoneal administration of 100 mg/kg in mice,Intermediate,,,1,8875,BAO_0000218,17734
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL626339,1,A,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,Intermediate,In vivo,,1,8876,BAO_0000218,17728
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL626340,1,A,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,Intermediate,In vivo,,1,8877,BAO_0000218,17728
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625377,1,A,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,Intermediate,In vivo,,1,8878,BAO_0000218,17728
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625378,1,A,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,Intermediate,In vivo,,1,8879,BAO_0000218,17728
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625379,1,A,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,Intermediate,In vivo,,1,8880,BAO_0000218,17728
,9823.0,,Sus scrofa,,,Microsomes,,U,,,22224,CHEMBL625380,1,A,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),Autocuration,,,0,8881,BAO_0000251,14294
,9823.0,,Sus scrofa,,,Microsomes,,U,,,22224,CHEMBL625381,1,A,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),Autocuration,,,0,8882,BAO_0000251,14294
,9823.0,,Sus scrofa,,,,,U,,,22224,CHEMBL625382,1,A,Stability to porcine renal DHP-I,Autocuration,,,0,8883,BAO_0000019,6056
,9823.0,,Sus scrofa,,,,,U,,,22224,CHEMBL873828,1,A,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,Autocuration,In vivo,,0,8884,BAO_0000218,1317
,9823.0,,Sus scrofa,,,,,U,,,22224,CHEMBL625383,1,A,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,Autocuration,In vivo,,0,8885,BAO_0000218,1317
,9823.0,,Sus scrofa,,,,,U,,,22224,CHEMBL625384,1,A,Half-life of the parent prodrug in porcine esterase solution,Autocuration,,,0,8886,BAO_0000019,5229
,9823.0,,Sus scrofa,,,,,U,,,22224,CHEMBL625385,1,A,"First order rate constant, k was determined in in pig liver Esterase",Autocuration,,,0,8887,BAO_0000019,4231
,9823.0,,Sus scrofa,Liver,,,,U,,,22224,CHEMBL625386,1,A,Half life of the in pig liver Esterase,Autocuration,,2107.0,0,8888,BAO_0000221,4231
,9823.0,,Sus scrofa,Liver,,,,U,,,22224,CHEMBL623571,1,A,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,Autocuration,,2107.0,0,8889,BAO_0000221,5318
,9823.0,,Sus scrofa,Liver,,,,U,,,22224,CHEMBL623572,1,A,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,Autocuration,,2107.0,0,8890,BAO_0000221,5318
,9823.0,,Sus scrofa,Liver,,,,U,,,22224,CHEMBL623573,1,A,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,Autocuration,,2107.0,0,8891,BAO_0000221,5318
,9823.0,,Sus scrofa,Liver,,,,U,,,22224,CHEMBL623574,1,A,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,Autocuration,,2107.0,0,8892,BAO_0000221,3305
,9823.0,,Sus scrofa,Liver,,,,U,,,22224,CHEMBL623575,1,A,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,Autocuration,,2107.0,0,8893,BAO_0000221,3305
,9823.0,,Sus scrofa,Liver,,,,U,,,22224,CHEMBL623749,1,A,Half-life in the presence of pig liver esterase(PLE) was evaluated.,Autocuration,,2107.0,0,8894,BAO_0000221,2842
,9823.0,,Sus scrofa,Liver,,,,U,,,22224,CHEMBL623750,1,A,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,Autocuration,,2107.0,0,8895,BAO_0000221,2842
,9823.0,,Sus scrofa,Liver,,,,U,,,22224,CHEMBL623751,1,A,Half-life in vitro in pig liver,Autocuration,In vitro,2107.0,0,8896,BAO_0000221,889
,9823.0,,Sus scrofa,Liver,,,,U,,,22224,CHEMBL623752,1,A,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,Autocuration,,2107.0,0,8897,BAO_0000221,1904
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623753,1,A,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,Intermediate,In vivo,1969.0,1,8898,BAO_0000218,4186
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623754,1,A,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Intermediate,In vivo,1969.0,1,8899,BAO_0000218,2774
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623755,1,A,Maximum concentration in rat plasma was determined,Intermediate,In vivo,1969.0,1,8900,BAO_0000218,1742
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623756,1,A,Maximum concentration in rats,Intermediate,In vivo,,1,8901,BAO_0000218,3169
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623757,1,A,Maximum concentration in rats at 1-2 hours,Intermediate,In vivo,,1,8902,BAO_0000218,3169
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623758,1,A,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,Intermediate,In vivo,,1,8903,BAO_0000218,2081
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL623759,1,A,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,Intermediate,In vivo,955.0,1,8904,BAO_0000218,3307
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623760,1,A,Maximum concentration at the dose of 2 mg/kg in rat,Intermediate,In vivo,,1,8905,BAO_0000218,4727
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623761,1,A,Maximum concentration was evaluated in rats,Intermediate,In vivo,,1,8906,BAO_0000218,6597
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623762,1,A,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,Intermediate,In vivo,1969.0,1,8907,BAO_0000218,16365
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL877594,1,A,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,Intermediate,In vivo,1969.0,1,8908,BAO_0000218,16365
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623763,1,A,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,Intermediate,In vivo,1969.0,1,8909,BAO_0000218,16365
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623764,1,A,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,Intermediate,In vivo,1969.0,1,8910,BAO_0000218,16365
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623765,1,A,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,Intermediate,In vivo,1969.0,1,8911,BAO_0000218,16365
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL623766,1,A,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,Intermediate,In vivo,178.0,1,8912,BAO_0000218,2591
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL623767,1,A,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,Intermediate,In vivo,178.0,1,8913,BAO_0000218,2591
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL623768,1,A,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,Intermediate,In vivo,178.0,1,8914,BAO_0000218,2591
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623769,1,A,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,Intermediate,In vivo,1969.0,1,8915,BAO_0000218,5978
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623770,1,A,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,Intermediate,In vivo,1969.0,1,8916,BAO_0000218,5978
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623771,1,A,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,Intermediate,In vivo,1969.0,1,8917,BAO_0000218,5978
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623772,1,A,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,Intermediate,In vivo,1969.0,1,8918,BAO_0000218,5978
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623773,1,A,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,Intermediate,In vivo,1969.0,1,8919,BAO_0000218,5978
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623774,1,A,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,Intermediate,In vivo,1969.0,1,8920,BAO_0000218,5978
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623775,1,A,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,Intermediate,In vivo,1969.0,1,8921,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623776,1,A,Cmax in rat (PO dose),Intermediate,In vivo,,1,8922,BAO_0000218,14465
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622191,1,A,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,In vivo,1969.0,1,8923,BAO_0000218,4723
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622192,1,A,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,In vivo,1969.0,1,8924,BAO_0000218,4723
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622193,1,A,Maximum plasma concentration determined in rat,Intermediate,In vivo,1969.0,1,8925,BAO_0000218,4576
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622194,1,A,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Intermediate,In vivo,1969.0,1,8926,BAO_0000218,12873
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622195,1,A,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Intermediate,In vivo,1969.0,1,8927,BAO_0000218,12873
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622196,1,A,Maximum plasma concentration in rat,Intermediate,In vivo,1969.0,1,8928,BAO_0000218,6824
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622197,1,A,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate,In vivo,1969.0,1,8929,BAO_0000218,17065
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622198,1,A,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,Intermediate,In vivo,1969.0,1,8930,BAO_0000218,2932
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622199,1,A,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,Intermediate,In vivo,1969.0,1,8931,BAO_0000218,2932
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622200,1,A,Maximum plasma concentration of compound was measured in rat,Intermediate,In vivo,1969.0,1,8932,BAO_0000218,2879
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622201,1,A,Maximum plasma concentration after 20 mg/kg oral administration in rat,Intermediate,In vivo,1969.0,1,8933,BAO_0000218,2864
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623990,1,A,Maximum plasma concentration after oral administration to rats,Intermediate,In vivo,1969.0,1,8934,BAO_0000218,16367
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623991,1,A,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,In vivo,1969.0,1,8935,BAO_0000218,17717
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623992,1,A,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",Intermediate,In vivo,1969.0,1,8936,BAO_0000218,17717
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623993,1,A,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,In vivo,1969.0,1,8937,BAO_0000218,17717
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623994,1,A,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,Intermediate,In vivo,1969.0,1,8938,BAO_0000218,17717
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623995,1,F,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,Intermediate,In vivo,1969.0,1,8939,BAO_0000218,17720
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623996,1,F,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,In vivo,1969.0,1,8940,BAO_0000218,17720
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623997,1,F,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,Intermediate,In vivo,1969.0,1,8941,BAO_0000218,17720
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623998,1,A,Maximum plasma concentration dosed orally in rats,Intermediate,In vivo,1969.0,1,8942,BAO_0000218,4516
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623999,1,A,Maximum plasma concentration dosed orally in rats after 6 hours,Intermediate,In vivo,1969.0,1,8943,BAO_0000218,4516
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL624000,1,A,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,Intermediate,In vivo,1969.0,1,8944,BAO_0000218,4516
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL624001,1,A,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Intermediate,In vivo,1969.0,1,8945,BAO_0000218,5199
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL624002,1,A,Maximum plasma concentration in rat after po administration,Intermediate,In vivo,1969.0,1,8946,BAO_0000218,17538
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL624003,1,A,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",Intermediate,In vivo,1969.0,1,8947,BAO_0000218,6685
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL624004,1,A,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",Intermediate,In vivo,1969.0,1,8948,BAO_0000218,6685
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624005,1,A,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,,948.0,1,8949,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624006,1,A,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,,948.0,1,8950,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624007,1,A,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,,948.0,1,8951,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624008,1,A,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,,948.0,1,8952,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624009,1,A,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,,948.0,1,8953,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL874387,1,A,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,,948.0,1,8954,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624010,1,A,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,,948.0,1,8955,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624011,1,A,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Intermediate,,948.0,1,8956,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624012,1,A,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,,948.0,1,8957,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624013,1,A,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,,948.0,1,8958,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624736,1,A,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,,948.0,1,8959,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624737,1,A,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,,948.0,1,8960,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624738,1,A,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,,948.0,1,8961,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624739,1,A,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,,948.0,1,8962,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624740,1,A,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,,948.0,1,8963,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624896,1,A,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,,948.0,1,8964,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624897,1,A,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,,948.0,1,8965,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624108,1,A,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,,948.0,1,8966,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624109,1,A,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,,948.0,1,8967,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624110,1,A,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,,948.0,1,8968,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624111,1,A,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,,948.0,1,8969,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624112,1,A,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,,948.0,1,8970,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624113,1,A,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,,948.0,1,8971,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL619709,1,A,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,,948.0,1,8972,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL619710,1,A,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,,948.0,1,8973,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL619711,1,A,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,,2113.0,1,8974,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL619712,1,A,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,,2113.0,1,8975,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL619713,1,A,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,,2113.0,1,8976,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL619714,1,A,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,,2113.0,1,8977,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL619715,1,A,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,,2113.0,1,8978,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL619716,1,A,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,,2113.0,1,8979,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL619717,1,A,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,,2113.0,1,8980,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL619718,1,A,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,,2113.0,1,8981,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL619719,1,A,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,,2113.0,1,8982,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL875329,1,A,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,,2113.0,1,8983,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL619720,1,A,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,,2113.0,1,8984,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL619721,1,A,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,,2113.0,1,8985,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL619722,1,A,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,,2113.0,1,8986,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL619723,1,A,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,,2113.0,1,8987,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL619724,1,A,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,,2113.0,1,8988,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL619725,1,A,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,,2113.0,1,8989,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL619726,1,A,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,,2113.0,1,8990,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL619727,1,A,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,,2113.0,1,8991,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL619728,1,A,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,,2113.0,1,8992,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL619729,1,A,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,,2113.0,1,8993,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL619730,1,A,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2385.0,1,8994,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL619731,1,A,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2385.0,1,8995,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL619732,1,A,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,In vivo,2385.0,1,8996,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL619733,1,A,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2385.0,1,8997,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL619734,1,A,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2385.0,1,8998,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Zone of skin,,,,N,,,50597,CHEMBL619735,1,A,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,14.0,1,8999,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Zone of skin,,,,N,,,50597,CHEMBL875330,1,A,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,14.0,1,9000,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Zone of skin,,,,N,,,50597,CHEMBL628465,1,A,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,In vivo,14.0,1,9001,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Zone of skin,,,,N,,,50597,CHEMBL628466,1,A,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,14.0,1,9002,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Zone of skin,,,,N,,,50597,CHEMBL628467,1,A,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,14.0,1,9003,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL628468,1,A,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2106.0,1,9004,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL628469,1,A,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2106.0,1,9005,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL628470,1,A,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,In vivo,2106.0,1,9006,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL628471,1,A,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2106.0,1,9007,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL628472,1,A,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2106.0,1,9008,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL625191,1,A,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2046.0,1,9009,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL625192,1,A,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2046.0,1,9010,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL875337,1,A,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Intermediate,In vivo,2046.0,1,9011,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626341,1,A,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2046.0,1,9012,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626342,1,A,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2046.0,1,9013,BAO_0000218,11977
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL621943,1,A,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Intermediate,In vivo,2107.0,1,9014,BAO_0000218,11977
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621944,1,A,Half life in rats,Intermediate,,,1,9015,BAO_0000218,3748
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621945,1,A,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,Intermediate,,,1,9016,BAO_0000218,15765
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621946,1,A,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),Intermediate,,,1,9017,BAO_0000218,4871
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621947,1,A,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,Intermediate,,,1,9018,BAO_0000218,4871
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621948,1,A,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),Intermediate,,,1,9019,BAO_0000218,4872
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621949,1,A,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,Intermediate,,,1,9020,BAO_0000218,4872
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621950,1,A,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),Intermediate,,,1,9021,BAO_0000218,5413
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621951,1,A,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,Intermediate,,,1,9022,BAO_0000218,5413
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL621952,1,A,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,Intermediate,In vivo,178.0,1,9023,BAO_0000218,15272
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL621953,1,A,Stability (%) in rat liver microsomes,Intermediate,,2107.0,1,9024,BAO_0000218,4689
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621954,1,A,Area under curve was calculated after intravenous administration,Intermediate,,,1,9025,BAO_0000218,6057
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621955,1,A,Area under the curve was calculated after iv administration in rat,Intermediate,,,1,9026,BAO_0000218,6057
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621956,1,A,Area under the curve was calculated in rat after peroral administration,Intermediate,,,1,9027,BAO_0000218,6057
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621957,1,A,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,Intermediate,,,1,9028,BAO_0000218,6211
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621958,1,A,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,Intermediate,,,1,9029,BAO_0000218,5710
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621959,1,A,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,Intermediate,,,1,9030,BAO_0000218,5710
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621960,1,A,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,Intermediate,,,1,9031,BAO_0000218,17853
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621961,1,A,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,Intermediate,,,1,9032,BAO_0000218,17853
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621962,1,A,p value of the compound,Intermediate,,,1,9033,BAO_0000218,15765
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876787,1,F,p value of the compound,Intermediate,,,1,9034,BAO_0000218,15765
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621963,1,A,p value of the compound,Intermediate,,,1,9035,BAO_0000218,15765
,10116.0,,Rattus norvegicus,Stomach,,,,N,,,50597,CHEMBL622637,1,A,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,,945.0,1,9036,BAO_0000218,6175
,10116.0,,Rattus norvegicus,Stomach,,,,N,,,50597,CHEMBL622638,1,A,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,,945.0,1,9037,BAO_0000218,6175
,10116.0,,Rattus norvegicus,Stomach,,,,N,,,50597,CHEMBL626561,1,A,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,,945.0,1,9038,BAO_0000218,6175
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL626562,1,F,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),Autocuration,,,0,9039,BAO_0000019,7991
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL626563,1,A,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),Autocuration,,,0,9040,BAO_0000218,429
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL626564,1,A,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),Autocuration,,,0,9041,BAO_0000218,429
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL626565,1,A,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,Autocuration,In vivo,,0,9042,BAO_0000218,6253
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL626566,1,A,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,Autocuration,In vivo,,0,9043,BAO_0000218,6253
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL626567,1,A,Clearance rate in rabbits,Autocuration,In vivo,,0,9044,BAO_0000218,3615
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL626568,1,A,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,Autocuration,In vivo,,0,9045,BAO_0000218,4059
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL626569,1,A,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Autocuration,In vivo,,0,9046,BAO_0000218,5124
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL626570,1,A,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Autocuration,In vivo,,0,9047,BAO_0000218,5124
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL626571,1,A,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Autocuration,In vivo,,0,9048,BAO_0000218,5124
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL626572,1,A,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,Autocuration,In vivo,,0,9049,BAO_0000218,429
,9986.0,,Oryctolagus cuniculus,Plasma,,,,U,,,22224,CHEMBL626573,1,A,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,Autocuration,In vivo,1969.0,0,9050,BAO_0000218,4059
,9986.0,,Oryctolagus cuniculus,Liver,,Microsomes,,U,,,22224,CHEMBL626574,1,A,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,Autocuration,,2107.0,0,9051,BAO_0000251,9659
,9986.0,,Oryctolagus cuniculus,Liver,,Microsomes,,U,,,22224,CHEMBL626575,1,A,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,Autocuration,,2107.0,0,9052,BAO_0000251,9659
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL626576,1,A,Dose at which bioavailability of intravenously administered compound was tested in rabbit,Autocuration,,,0,9053,BAO_0000218,3639
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL626577,1,A,Dose at which bioavailability of perorally administered compound was tested in rabbit,Autocuration,,,0,9054,BAO_0000218,3639
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL626578,1,A,The compound was tested for its bioavailability in rabbit (by oral dosage).,Autocuration,In vivo,,0,9055,BAO_0000218,3639
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL625263,1,A,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Autocuration,In vivo,,0,9056,BAO_0000218,5124
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL625264,1,A,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Autocuration,In vivo,,0,9057,BAO_0000218,5124
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL625265,1,A,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Autocuration,In vivo,,0,9058,BAO_0000218,5124
,9986.0,,Oryctolagus cuniculus,,,Microsomes,,U,,,22224,CHEMBL625266,1,A,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),Autocuration,,,0,9059,BAO_0000251,14294
,9986.0,,Oryctolagus cuniculus,,,Microsomes,,U,,,22224,CHEMBL876796,1,A,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),Autocuration,,,0,9060,BAO_0000251,14294
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL625267,1,A,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,Autocuration,In vivo,,0,9061,BAO_0000218,429
,9986.0,,Oryctolagus cuniculus,Plasma,,,,U,,,22224,CHEMBL625268,1,A,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Autocuration,In vivo,1969.0,0,9062,BAO_0000218,5124
,9986.0,,Oryctolagus cuniculus,Plasma,,,,U,,,22224,CHEMBL625269,1,A,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Autocuration,In vivo,1969.0,0,9063,BAO_0000218,5124
,9986.0,,Oryctolagus cuniculus,Plasma,,,,U,,,22224,CHEMBL624689,1,A,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Autocuration,In vivo,1969.0,0,9064,BAO_0000218,5124
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL624690,1,A,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,Autocuration,In vivo,,0,9065,BAO_0000218,429
,9986.0,,Oryctolagus cuniculus,Urine,,,,U,,,22224,CHEMBL624691,1,A,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),Autocuration,,1088.0,0,9066,BAO_0000218,429
,9986.0,,Oryctolagus cuniculus,Urine,,,,U,,,22224,CHEMBL624692,1,A,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),Autocuration,,1088.0,0,9067,BAO_0000218,429
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL624693,1,A,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,Autocuration,In vivo,,0,9068,BAO_0000218,4059
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL624694,1,A,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,Autocuration,In vivo,,0,9069,BAO_0000218,4137
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL877596,1,A,In vitro Biological half-life in crude homogenate of rabbit renal cortex,Autocuration,In vitro,,0,9070,BAO_0000221,11672
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL624695,1,A,Time within which only 10% of the drug was degraded,Autocuration,,,0,9071,BAO_0000019,12886
,9986.0,,Oryctolagus cuniculus,Liver,,,,U,,,22224,CHEMBL624696,1,A,Half life period in rabbit liver homogenate,Autocuration,,2107.0,0,9072,BAO_0000221,3853
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL624697,1,A,Half life value in rabbits,Autocuration,,,0,9073,BAO_0000019,3615
,9986.0,,Oryctolagus cuniculus,Blood,,,,U,,,22224,CHEMBL624698,1,A,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,Autocuration,In vivo,178.0,0,9074,BAO_0000218,6253
,9986.0,,Oryctolagus cuniculus,Blood,,,,U,,,22224,CHEMBL624699,1,A,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,Autocuration,In vivo,178.0,0,9075,BAO_0000218,6253
,9986.0,,Oryctolagus cuniculus,,,,,U,,,22224,CHEMBL624700,1,A,Half-life period in rabbits following intravenous administration at 2 mg/kg,Autocuration,In vivo,,0,9076,BAO_0000218,6077
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622903,1,A,AUC 0-8 hr value in rats at 10 mg/kg,Intermediate,,1969.0,1,9077,BAO_0000218,17617
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622904,1,A,AUC after administration at 2000 mg/kg/day in rats,Intermediate,,1969.0,1,9078,BAO_0000218,17594
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622905,1,A,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,Intermediate,,1969.0,1,9079,BAO_0000218,6149
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622906,1,A,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Intermediate,,1969.0,1,9080,BAO_0000218,17260
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622907,1,A,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate,,1969.0,1,9081,BAO_0000218,17260
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622908,1,A,AUC in rat after oral administration at 10.5 mg/kg dose,Intermediate,,1969.0,1,9082,BAO_0000218,6644
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622909,1,A,AUC in rat after oral administration at 11.2 mg/kg dose,Intermediate,,1969.0,1,9083,BAO_0000218,6644
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622910,1,A,AUC in rat after oral administration at 9.7 mg/kg dose,Intermediate,,1969.0,1,9084,BAO_0000218,6644
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL622911,1,A,AUC in rat brain after oral administration at 10 mg/kg,Intermediate,,955.0,1,9085,BAO_0000218,6495
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622912,1,A,AUC in rat p.o.,Intermediate,,1969.0,1,9086,BAO_0000218,6504
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622913,1,A,AUC in rat p.o. at 20 mg/kg concentration,Intermediate,,1969.0,1,9087,BAO_0000218,17686
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622914,1,A,AUC in rat plasma after oral administration at 10 mg/kg,Intermediate,,1969.0,1,9088,BAO_0000218,6495
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622915,1,A,AUC in rats,Intermediate,,1969.0,1,9089,BAO_0000218,216
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622916,1,A,AUC value after IV dose at a dose of 5 mg/kg in rats.,Intermediate,,1969.0,1,9090,BAO_0000218,1908
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622917,1,A,AUC value after oral dose at a dose of 10 mg/kg in rats.,Intermediate,,1969.0,1,9091,BAO_0000218,1908
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622918,1,A,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Intermediate,In vivo,1969.0,1,9092,BAO_0000218,6685
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622919,1,A,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,Intermediate,In vivo,1969.0,1,9093,BAO_0000218,216
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622920,1,A,Maximum plasma concentration was evaluated in rat,Intermediate,In vivo,1969.0,1,9094,BAO_0000218,6049
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622921,1,A,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Intermediate,In vivo,1969.0,1,9095,BAO_0000218,2463
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622922,1,A,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,Intermediate,In vivo,1969.0,1,9096,BAO_0000218,6679
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622923,1,A,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Intermediate,In vivo,1969.0,1,9097,BAO_0000218,6681
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL877604,1,A,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Intermediate,In vivo,1969.0,1,9098,BAO_0000218,4890
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622924,1,A,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,Intermediate,In vivo,1969.0,1,9099,BAO_0000218,6410
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622925,1,A,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,Intermediate,In vivo,1969.0,1,9100,BAO_0000218,6410
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622926,1,A,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,Intermediate,In vivo,1969.0,1,9101,BAO_0000218,16366
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623625,1,A,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,Intermediate,In vivo,1969.0,1,9102,BAO_0000218,6227
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623626,1,A,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,In vivo,1969.0,1,9103,BAO_0000218,3598
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623627,1,A,Maximum plasma drug concentration was determined,Intermediate,In vivo,1969.0,1,9104,BAO_0000218,1465
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623628,1,A,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,Intermediate,In vivo,,1,9105,BAO_0000218,4368
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623629,1,A,Mean peak plasma concentration was observed after intravenous administration in rat,Intermediate,In vivo,1969.0,1,9106,BAO_0000218,15662
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623630,1,A,Mean peak plasma concentration was observed after oral administration in rat,Intermediate,In vivo,1969.0,1,9107,BAO_0000218,15662
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623804,1,A,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,Intermediate,In vivo,,1,9108,BAO_0000218,5355
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623805,1,A,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,Intermediate,In vivo,,1,9109,BAO_0000218,5355
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623806,1,A,Peak oral plasma concentration was determined in rats by oral administration,Intermediate,In vivo,1969.0,1,9110,BAO_0000218,1567
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623807,1,A,Peak plasma concentration (Cmax) was determined,Intermediate,In vivo,1969.0,1,9111,BAO_0000218,4026
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623808,1,A,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,Intermediate,In vivo,1969.0,1,9112,BAO_0000218,6193
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623809,1,A,Peak plasma concentration (Cmax) in rats,Intermediate,In vivo,1969.0,1,9113,BAO_0000218,4026
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623810,1,A,Peak plasma concentration at 1 mg/kg peroral administration,Intermediate,In vivo,1969.0,1,9114,BAO_0000218,6485
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623811,1,A,Peak plasma concentration in rat,Intermediate,In vivo,1969.0,1,9115,BAO_0000218,17655
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623812,1,A,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,In vivo,1969.0,1,9116,BAO_0000218,14941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL877605,1,A,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,Intermediate,In vivo,,1,9117,BAO_0000218,5394
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623813,1,A,Pharmacokinetic property (Cmax) in rat,Intermediate,In vivo,,1,9118,BAO_0000218,4408
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623814,1,A,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,Intermediate,In vivo,,1,9119,BAO_0000218,5983
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623815,1,A,Cmax in rat after 3mg/kg oral dose,Intermediate,In vivo,,1,9120,BAO_0000218,4878
Sprague-Dawley,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623816,1,A,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,Intermediate,In vivo,,1,9121,BAO_0000218,5862
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623145,1,A,Cmax in rats after 20 mg/kg oral dose,Intermediate,In vivo,,1,9122,BAO_0000218,4517
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623146,1,A,Cmax in rat plasma after 30mg/kg oral dose,Intermediate,In vivo,1969.0,1,9123,BAO_0000218,5932
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623147,1,A,Plasma concentration after oral administration of 100 mg/kg to rats,Intermediate,In vivo,1969.0,1,9124,BAO_0000218,5436
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL623042,1,A,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,Intermediate,In vivo,955.0,1,9125,BAO_0000218,4910
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623043,1,A,Tested for the Cmax in rat at 10 mg/kg per orally,Intermediate,In vivo,,1,9126,BAO_0000218,4950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623044,1,A,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,In vivo,,1,9127,BAO_0000218,15078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623045,1,A,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,In vivo,,1,9128,BAO_0000218,15078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623046,1,A,Bioavailability as oral Cmax in rats at 30 mins,Intermediate,In vivo,,1,9129,BAO_0000218,3360
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623226,1,A,Bioavailability as oral Cmax in rats at 6hr,Intermediate,In vivo,,1,9130,BAO_0000218,3360
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623227,1,A,The maximum concentration of compound was measured at the dose of 100 umol/kg,Intermediate,In vivo,,1,9131,BAO_0000218,15022
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623228,1,A,The maximum concentration of compound was measured at the dose of 300 umol/kg,Intermediate,In vivo,,1,9132,BAO_0000218,15022
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623229,1,A,The maximum concentration of compound was measured at the dose of 30 umol/kg,Intermediate,In vivo,,1,9133,BAO_0000218,15022
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623230,1,A,The maximum plasma levels for the compounds were determined by LC-MS.,Intermediate,In vivo,1969.0,1,9134,BAO_0000218,5160
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623231,1,A,mean peak plasma concentration was observed after intravenous administration in rat,Intermediate,In vivo,1969.0,1,9135,BAO_0000218,15662
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623232,1,A,mean peak plasma concentration was observed after oral administration in rat,Intermediate,In vivo,1969.0,1,9136,BAO_0000218,15662
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623233,1,A,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,Intermediate,,,1,9137,BAO_0000218,4709
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623234,1,A,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,Intermediate,,,1,9138,BAO_0000218,3535
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623235,1,A,Concentration in plasma (portal) following oral dose in rats at 1 hr,Intermediate,,,1,9139,BAO_0000218,3535
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623236,1,A,Concentration in plasma (portal) following oral dose in rats at 2 hr,Intermediate,,,1,9140,BAO_0000218,3535
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623237,1,A,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,Intermediate,,,1,9141,BAO_0000218,3535
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623238,1,A,Concentration in plasma (systemic) following oral dose in rats at 1 hr,Intermediate,,,1,9142,BAO_0000218,3535
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623239,1,A,Concentration in plasma (systemic) following oral dose in rats at 2 hr,Intermediate,,,1,9143,BAO_0000218,3535
,10116.0,,Rattus norvegicus,Plasma,,,,U,,,22224,CHEMBL623240,1,A,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,Intermediate,In vivo,1969.0,0,9144,BAO_0000218,5005
,10116.0,,Rattus norvegicus,Hypothalamus,,,,N,,,50597,CHEMBL623241,1,A,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",Intermediate,,1898.0,1,9145,BAO_0000218,6326
,10116.0,,Rattus norvegicus,Hypothalamus,,,,N,,,50597,CHEMBL623242,1,A,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",Intermediate,,1898.0,1,9146,BAO_0000218,6326
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874394,1,A,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",Intermediate,,,1,9147,BAO_0000218,6326
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623243,1,A,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",Intermediate,,,1,9148,BAO_0000218,6326
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623244,1,A,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,,,1,9149,BAO_0000218,17411
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL623245,1,A,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,,2113.0,1,9150,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL623246,1,A,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,,2113.0,1,9151,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL623247,1,A,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,,2113.0,1,9152,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL623248,1,A,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,,2113.0,1,9153,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL623249,1,A,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,,2113.0,1,9154,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625072,1,A,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,,2107.0,1,9155,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625073,1,A,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,,2107.0,1,9156,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625074,1,A,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,,2107.0,1,9157,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625075,1,A,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,,2107.0,1,9158,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625076,1,A,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,Intermediate,,2107.0,1,9159,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625077,1,A,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,,2107.0,1,9160,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625078,1,A,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,,2107.0,1,9161,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL874395,1,A,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,,2107.0,1,9162,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625079,1,A,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,,2107.0,1,9163,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625080,1,A,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,,2107.0,1,9164,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625081,1,A,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,,2107.0,1,9165,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625082,1,A,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,,2107.0,1,9166,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625083,1,A,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,,2107.0,1,9167,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625084,1,A,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,,2107.0,1,9168,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625085,1,A,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,,2107.0,1,9169,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625086,1,A,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,,2107.0,1,9170,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625087,1,A,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,,2107.0,1,9171,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625088,1,A,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,,2107.0,1,9172,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622205,1,A,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,,2107.0,1,9173,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622206,1,A,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,,2107.0,1,9174,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622207,1,A,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,,2107.0,1,9175,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622366,1,A,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,,2107.0,1,9176,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622367,1,A,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,,2107.0,1,9177,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL875331,1,A,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,,2107.0,1,9178,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622368,1,A,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,,2107.0,1,9179,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622369,1,A,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,,2048.0,1,9180,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622370,1,A,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,,2048.0,1,9181,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622371,1,A,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,,2048.0,1,9182,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622372,1,A,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,,2048.0,1,9183,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622373,1,A,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,,2048.0,1,9184,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622374,1,A,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,,2048.0,1,9185,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622375,1,A,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,,2048.0,1,9186,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622376,1,A,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Intermediate,,2048.0,1,9187,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622377,1,A,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,,2048.0,1,9188,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622378,1,A,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,,2048.0,1,9189,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622379,1,A,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,,2048.0,1,9190,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622380,1,A,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,,2048.0,1,9191,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622381,1,A,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,,2048.0,1,9192,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622382,1,A,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,,2048.0,1,9193,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622383,1,A,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,Intermediate,,2048.0,1,9194,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Stomach,,,,N,,,50597,CHEMBL875332,1,A,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,,945.0,1,9195,BAO_0000218,6175
,10116.0,,Rattus norvegicus,Stomach,,,,N,,,50597,CHEMBL622384,1,A,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,,945.0,1,9196,BAO_0000218,6175
,10116.0,,Rattus norvegicus,Stomach,,,,N,,,50597,CHEMBL622385,1,A,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,,945.0,1,9197,BAO_0000218,6175
,10116.0,,Rattus norvegicus,Stomach,,,,N,,,50597,CHEMBL622386,1,A,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Intermediate,,945.0,1,9198,BAO_0000218,6175
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622387,1,A,The compound was tested for the plasma binding in rat,Intermediate,,,1,9199,BAO_0000218,10839
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622388,1,A,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",Intermediate,,,1,9200,BAO_0000218,16459
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622389,1,A,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",Intermediate,,,1,9201,BAO_0000218,16459
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622390,1,A,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",Intermediate,,,1,9202,BAO_0000218,16459
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622391,1,A,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),Intermediate,,,1,9203,BAO_0000218,16459
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622392,1,A,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),Intermediate,,,1,9204,BAO_0000218,16459
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622393,1,A,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),Intermediate,,,1,9205,BAO_0000218,16459
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622394,1,A,Plasma level at 2 hr after administration of the compound,Intermediate,,,1,9206,BAO_0000218,3278
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622395,1,A,plasma level at 2 hr after administration of the compound,Intermediate,,,1,9207,BAO_0000218,3278
,10116.0,,Rattus norvegicus,Serum,,,,N,,,50597,CHEMBL622396,1,A,Stability in rat serum measured as % recovery at 1 min,Intermediate,,1977.0,1,9208,BAO_0000218,4684
,10116.0,,Rattus norvegicus,Serum,,,,N,,,50597,CHEMBL624894,1,A,Stability in rat serum measured as % recovery at 10 min,Intermediate,,1977.0,1,9209,BAO_0000218,4684
,10116.0,,Rattus norvegicus,Serum,,,,N,,,50597,CHEMBL624895,1,A,Stability in rat serum measured as % recovery at 10 mins,Intermediate,,1977.0,1,9210,BAO_0000218,4684
,10116.0,,Rattus norvegicus,Serum,,,,N,,,50597,CHEMBL624058,1,A,Stability in rat serum measured as % recovery at 2 hr,Intermediate,,1977.0,1,9211,BAO_0000218,4684
,10116.0,,Rattus norvegicus,Serum,,,,N,,,50597,CHEMBL624059,1,A,Stability in rat serum measured as % recovery at 3 min,Intermediate,,1977.0,1,9212,BAO_0000218,4684
,10116.0,,Rattus norvegicus,Serum,,,,N,,,50597,CHEMBL624060,1,A,Stability in rat serum measured as % recovery at 3 mins,Intermediate,,1977.0,1,9213,BAO_0000218,4684
,10116.0,,Rattus norvegicus,Serum,,,,N,,,50597,CHEMBL624061,1,A,Stability in rat serum measured as % recovery at 5 min,Intermediate,,1977.0,1,9214,BAO_0000218,4684
,10116.0,,Rattus norvegicus,Serum,,,,N,,,50597,CHEMBL624062,1,A,Stability in rat serum measured as % recovery at 5 mins,Intermediate,,1977.0,1,9215,BAO_0000218,4684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624063,1,A,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Intermediate,In vivo,,1,9216,BAO_0000218,16456
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624064,1,A,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Intermediate,In vivo,,1,9217,BAO_0000218,16456
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL624065,1,A,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,Intermediate,,1969.0,1,9218,BAO_0000218,723
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL624066,1,A,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,Intermediate,,1969.0,1,9219,BAO_0000218,723
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL877490,1,A,Half life tested in mature male rat at a dose of 30 mg/kg,Intermediate,In vivo,,1,9220,BAO_0000218,5160
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874442,1,A,Half life after intravenous administration of 1 mg/kg in rat,Intermediate,In vivo,,1,9221,BAO_0000218,4709
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626890,1,A,Half life period after administration (30 mg/kg) in rat,Intermediate,In vivo,,1,9222,BAO_0000218,5633
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626891,1,A,Half life period in rat after 5 mg/Kg dose,Intermediate,In vivo,,1,9223,BAO_0000218,5302
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626892,1,A,Half life period in rat after 5 mg/kg dose,Intermediate,In vivo,,1,9224,BAO_0000218,5302
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626893,1,A,Half life period was determined,Intermediate,,,1,9225,BAO_0000218,17791
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626894,1,A,Half life period was evaluated in rat,Intermediate,,,1,9226,BAO_0000218,17791
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626895,1,A,Half life period was evaluated in rat; 0.5-1.0,Intermediate,,,1,9227,BAO_0000218,17791
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626896,1,A,Half life period was evaluated in rat; 5.9-7.5,Intermediate,,,1,9228,BAO_0000218,17791
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626897,1,A,Half-life in rat plasma,Intermediate,,1969.0,1,9229,BAO_0000218,14512
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626898,1,A,Half-life time in rat was determined,Intermediate,,,1,9230,BAO_0000218,6230
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626899,1,A,Terminal half-life after iv administration to rats,Intermediate,In vivo,,1,9231,BAO_0000218,3364
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626900,1,A,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,Intermediate,In vivo,,1,9232,BAO_0000218,6874
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626901,1,A,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,Intermediate,,,1,9233,BAO_0000218,857
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626902,1,A,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),Intermediate,In vivo,,1,9234,BAO_0000218,858
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626903,1,A,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),Intermediate,In vivo,,1,9235,BAO_0000218,858
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874443,1,A,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,Intermediate,In vivo,,1,9236,BAO_0000218,5355
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626904,1,A,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,Intermediate,In vivo,,1,9237,BAO_0000218,5355
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626905,1,A,Half life in rats,Intermediate,,,1,9238,BAO_0000218,6305
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL873830,1,A,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,Intermediate,In vivo,1969.0,1,9239,BAO_0000218,13501
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626906,1,A,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,Intermediate,In vivo,,1,9240,BAO_0000218,17594
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL631076,1,A,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Intermediate,In vivo,1969.0,1,9241,BAO_0000218,4186
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL631077,1,A,Biological half-life was measured in plasma of rats,Intermediate,,1969.0,1,9242,BAO_0000218,2932
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631078,1,A,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate,In vivo,,1,9243,BAO_0000218,17065
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631079,1,A,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,Intermediate,In vivo,,1,9244,BAO_0000218,15765
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631080,1,A,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,Intermediate,In vivo,,1,9245,BAO_0000218,2713
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631081,1,A,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,Intermediate,In vivo,,1,9246,BAO_0000218,2661
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631239,1,A,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,Intermediate,In vivo,,1,9247,BAO_0000218,2661
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL631240,1,A,Compound was evaluated for plasma half life in rat,Intermediate,,1969.0,1,9248,BAO_0000218,740
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL631241,1,A,AUC value at a dose of 5 mg/kg (p.o.) in rats,Intermediate,,1969.0,1,9249,BAO_0000218,6597
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL631242,1,A,AUC value after administration of 20 mg/Kg oral dose in rat,Intermediate,,1969.0,1,9250,BAO_0000218,2959
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL631243,1,A,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,Intermediate,,1969.0,1,9251,BAO_0000218,17594
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL874444,1,A,AUC0-96 after administration at 50 mg/kg,Intermediate,,1969.0,1,9252,BAO_0000218,17596
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL631244,1,A,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,Intermediate,,1969.0,1,9253,BAO_0000218,17594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631245,1,A,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",Intermediate,,,1,9254,BAO_0000218,3293
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627162,1,A,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,Intermediate,,,1,9255,BAO_0000218,6757
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627163,1,A,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,Intermediate,,,1,9256,BAO_0000218,6757
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627164,1,A,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,Intermediate,,,1,9257,BAO_0000218,6757
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL627165,1,A,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,Intermediate,,2113.0,1,9258,BAO_0000218,5979
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627166,1,A,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,Intermediate,,,1,9259,BAO_0000218,5979
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627167,1,A,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,Intermediate,,,1,9260,BAO_0000218,5979
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627822,1,A,Area under curve (AUC) at a dose of 30 mg/kg in rats,Intermediate,,,1,9261,BAO_0000218,4026
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627823,1,A,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,Intermediate,,,1,9262,BAO_0000218,5355
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627824,1,A,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,Intermediate,,,1,9263,BAO_0000218,5355
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627825,1,A,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,Intermediate,,,1,9264,BAO_0000218,5355
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627826,1,A,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,Intermediate,,,1,9265,BAO_0000218,5633
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627827,1,A,Area under curve (Pharmacokinetic property) was determined,Intermediate,,,1,9266,BAO_0000218,1716
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627828,1,A,Area under curve (Pharmacokinetic property) of the compound; Not determined,Intermediate,,,1,9267,BAO_0000218,1716
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627829,1,A,Area under curve after intravenous administration (1 mg/kg) in rat,Intermediate,,,1,9268,BAO_0000218,4689
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627830,1,A,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,Intermediate,,,1,9269,BAO_0000218,4527
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627831,1,A,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,Intermediate,,,1,9270,BAO_0000218,4527
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627832,1,A,Area under curve in male SD rats was observed after oral administration in rat,Intermediate,,,1,9271,BAO_0000218,15662
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627833,1,A,Area under curve of compound after iv administration of 20 mg/kg dose in rat,Intermediate,,,1,9272,BAO_0000218,4413
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627834,1,A,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,,,1,9273,BAO_0000218,3598
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628004,1,A,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,Expert,,,1,9274,BAO_0000218,3598
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628005,1,A,Area under curve at 5 mg/kg po was determined in rat,Intermediate,,,1,9275,BAO_0000218,5964
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628006,1,A,Area under curve in Rat at a oral dose of 5 mg/kg,Intermediate,,,1,9276,BAO_0000218,4689
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628007,1,A,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Intermediate,,,1,9277,BAO_0000218,4186
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625676,1,A,Area under curve was determined,Intermediate,,,1,9278,BAO_0000218,5510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631309,1,A,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,Intermediate,,,1,9279,BAO_0000218,17858
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631310,1,A,Area under curve after intravenous administration at 3 mg/kg,Intermediate,,,1,9280,BAO_0000218,17804
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631311,1,A,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,Intermediate,,,1,9281,BAO_0000218,6106
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631312,1,A,Area under curve at 4 hr in rat,Intermediate,,,1,9282,BAO_0000218,5964
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631313,1,A,Area under curve at a dose of 30 mg/kg,Intermediate,,,1,9283,BAO_0000218,4026
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631314,1,A,Area under curve at the dose of 2 mg/Kg administered perorally in rats,Intermediate,,,1,9284,BAO_0000218,4756
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631315,1,A,Area under curve at the dose of 5 mg/Kg administered perorally in rats,Intermediate,,,1,9285,BAO_0000218,4756
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631316,1,A,Area under curve for a 2-mpk po dose in SD rats,Intermediate,,,1,9286,BAO_0000218,5862
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631317,1,A,Area under curve in SD rats,Intermediate,,,1,9287,BAO_0000218,5862
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874471,1,A,Area under curve in rat after oral administration at 13 mg/kg dose,Intermediate,,,1,9288,BAO_0000218,6644
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631318,1,A,Area under curve in rat by po administration at 0-24 hr,Intermediate,,,1,9289,BAO_0000218,5871
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL631319,1,A,Area under curve in rat plasma,Intermediate,,1969.0,1,9290,BAO_0000218,5919
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631320,1,A,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,Intermediate,,,1,9291,BAO_0000218,5939
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631321,1,A,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,Intermediate,,,1,9292,BAO_0000218,5939
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631322,1,A,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,Intermediate,,,1,9293,BAO_0000218,10
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631323,1,A,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,Intermediate,,,1,9294,BAO_0000218,11149
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631324,1,A,Area under curve value in rat at a dose of 5 mg/kg,Intermediate,,,1,9295,BAO_0000218,5302
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631325,1,A,Area under curve was determined after oral administration in rats,Intermediate,,,1,9296,BAO_0000218,17796
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631326,1,A,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Intermediate,,,1,9297,BAO_0000218,4890
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631327,1,A,Area under curve was determined after peroral administration in rat,Intermediate,,,1,9298,BAO_0000218,6011
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631328,1,A,Area under curve was determined at a dose 30 mpk administered orally.,Intermediate,,,1,9299,BAO_0000218,5375
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631329,1,A,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,Intermediate,,,1,9300,BAO_0000218,17764
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627217,1,A,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,Intermediate,,,1,9301,BAO_0000218,4368
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626352,1,A,Area under curve was determined in male rat,Intermediate,,,1,9302,BAO_0000218,5610
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626353,1,A,Area under curve was determined in rat after PO administration,Intermediate,,,1,9303,BAO_0000218,5833
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626354,1,A,Area under curve was determined in rat after a 3 mg/kg of oral dose,Intermediate,,,1,9304,BAO_0000218,4257
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626355,1,A,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,Intermediate,,,1,9305,BAO_0000218,5937
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626356,1,A,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,Intermediate,,,1,9306,BAO_0000218,5932
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626357,1,A,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,Intermediate,,,1,9307,BAO_0000218,5932
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626358,1,A,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,,,1,9308,BAO_0000218,17411
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626359,1,A,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,,,1,9309,BAO_0000218,17411
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626360,1,A,Peak plasma concentration in rat at a dose of 3 mg/kg,Intermediate,,1969.0,1,9310,BAO_0000218,17771
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626361,1,A,Plasma concentration at 2 hr in rats was evaluated.,Intermediate,,,1,9311,BAO_0000218,1628
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626362,1,A,Plasma concentration at 2 hr in rats was evaluated; Not available,Intermediate,,,1,9312,BAO_0000218,1628
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626363,1,A,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,,,1,9313,BAO_0000218,17411
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626970,1,A,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,,,1,9314,BAO_0000218,4910
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626971,1,A,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,,,1,9315,BAO_0000218,4910
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626972,1,A,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,,1969.0,1,9316,BAO_0000218,4910
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626973,1,A,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,,1969.0,1,9317,BAO_0000218,4910
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626974,1,A,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,,1969.0,1,9318,BAO_0000218,4910
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL874592,1,A,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,,1969.0,1,9319,BAO_0000218,4910
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626975,1,A,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,Intermediate,,,1,9320,BAO_0000218,5510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626976,1,A,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,Intermediate,,,1,9321,BAO_0000218,5510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626977,1,A,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,Intermediate,,,1,9322,BAO_0000218,5510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626978,1,A,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,Intermediate,,,1,9323,BAO_0000218,5510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626979,1,A,PK study was carried to determine the relative absorption ranking in rat.,Intermediate,,,1,9324,BAO_0000218,16427
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626980,1,A,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,Intermediate,In vivo,1969.0,1,9325,BAO_0000218,4689
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626981,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",Intermediate,,178.0,1,9326,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626982,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",Intermediate,,178.0,1,9327,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626983,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",Intermediate,,178.0,1,9328,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL622522,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",Intermediate,,178.0,1,9329,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL622523,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",Intermediate,,178.0,1,9330,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL622524,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",Intermediate,,178.0,1,9331,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL622525,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",Intermediate,,955.0,1,9332,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL622526,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",Intermediate,,955.0,1,9333,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL619849,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",Intermediate,,955.0,1,9334,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL619850,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",Intermediate,,955.0,1,9335,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL623864,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",Intermediate,,955.0,1,9336,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL623865,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",Intermediate,,955.0,1,9337,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL623866,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",Intermediate,,948.0,1,9338,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL623867,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",Intermediate,,948.0,1,9339,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL877615,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",Intermediate,,948.0,1,9340,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL623868,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",Intermediate,,948.0,1,9341,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL623869,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",Intermediate,,948.0,1,9342,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL623870,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",Intermediate,,948.0,1,9343,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL623871,1,A,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Intermediate,,2048.0,1,9344,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL623872,1,A,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,,2048.0,1,9345,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622129,1,A,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,,2048.0,1,9346,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622130,1,A,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,,2048.0,1,9347,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622131,1,A,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,,2048.0,1,9348,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622132,1,A,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,,2048.0,1,9349,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622133,1,A,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,,2048.0,1,9350,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622134,1,A,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,,2048.0,1,9351,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622135,1,A,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,,2048.0,1,9352,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622136,1,A,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,,2048.0,1,9353,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL622137,1,A,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,,2385.0,1,9354,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL622138,1,A,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,,2385.0,1,9355,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623017,1,A,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,,2385.0,1,9356,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623018,1,A,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,,2385.0,1,9357,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623019,1,A,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,,2385.0,1,9358,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623020,1,A,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,,2385.0,1,9359,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623021,1,A,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,Intermediate,,2385.0,1,9360,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623022,1,A,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Intermediate,,2385.0,1,9361,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623023,1,A,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,,2385.0,1,9362,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623024,1,A,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,,2385.0,1,9363,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623025,1,A,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,,2385.0,1,9364,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL620545,1,A,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,,2385.0,1,9365,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL620546,1,A,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,,2385.0,1,9366,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL620547,1,A,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,,2385.0,1,9367,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL620548,1,A,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,,2385.0,1,9368,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL620549,1,A,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,,2385.0,1,9369,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL620550,1,A,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,,2385.0,1,9370,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL620551,1,A,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Intermediate,,2385.0,1,9371,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL620552,1,A,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,,2385.0,1,9372,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL620553,1,A,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,,2385.0,1,9373,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL620554,1,A,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,,2385.0,1,9374,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL875845,1,A,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,,2385.0,1,9375,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL620555,1,A,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,,2385.0,1,9376,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL620556,1,A,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,,2385.0,1,9377,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL620557,1,A,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,,2385.0,1,9378,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620558,1,A,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,,,1,9379,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620559,1,A,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,,,1,9380,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622939,1,A,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,,,1,9381,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622940,1,A,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,,,1,9382,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622941,1,A,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,,,1,9383,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622942,1,A,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,,,1,9384,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622943,1,A,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,,,1,9385,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622944,1,A,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,,,1,9386,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622945,1,A,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,,,1,9387,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622946,1,A,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,,,1,9388,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622947,1,A,Compound was evaluated for terminal half life in rat,Intermediate,,,1,9389,BAO_0000218,3341
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622948,1,A,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,Intermediate,In vivo,1969.0,1,9390,BAO_0000218,3634
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622949,1,A,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,Intermediate,In vivo,1969.0,1,9391,BAO_0000218,3634
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622950,1,A,Compound was tested for its half life in rat,Intermediate,,,1,9392,BAO_0000218,4839
,9544.0,,Macaca mulatta,Plasma,,,,U,,,22224,CHEMBL622951,1,A,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,Intermediate,In vivo,1969.0,0,9393,BAO_0000218,5005
,10116.0,,Rattus norvegicus,Plasma,,,,U,,,22224,CHEMBL622952,1,A,Compound was tested for its plasma half life in Sprague Dawley rats,Intermediate,,1969.0,0,9394,BAO_0000366,5005
,10116.0,,Rattus norvegicus,Plasma,,,,U,,,22224,CHEMBL622953,1,A,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,Intermediate,,1969.0,0,9395,BAO_0000366,5005
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL873818,1,A,Compound was tested for plasma half-life period in rat,Intermediate,,1969.0,1,9396,BAO_0000218,1094
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622954,1,A,Elimination half life after i.v. administration of compound in rats,Intermediate,In vivo,,1,9397,BAO_0000218,5031
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622955,1,A,Elimination half-life after IV dosing at 0.5 mg/kg in rat,Intermediate,In vivo,,1,9398,BAO_0000218,6518
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875229,1,A,Elimination half-life after IV dosing at 1 mg/kg in rat,Intermediate,In vivo,,1,9399,BAO_0000218,6518
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622956,1,A,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,Intermediate,In vivo,,1,9400,BAO_0000218,6518
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622957,1,A,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,Intermediate,In vivo,,1,9401,BAO_0000218,6518
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL622958,1,A,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,Intermediate,In vivo,955.0,1,9402,BAO_0000218,5408
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622959,1,A,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,Intermediate,In vivo,1969.0,1,9403,BAO_0000218,5408
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL622960,1,A,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,Intermediate,In vivo,955.0,1,9404,BAO_0000218,5408
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622961,1,A,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,Intermediate,In vivo,1969.0,1,9405,BAO_0000218,5408
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622962,1,A,Evaluated for the half life in rat (in vivo),Intermediate,In vivo,,1,9406,BAO_0000218,4687
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622963,1,A,Hafl life in rat,Intermediate,,,1,9407,BAO_0000218,6640
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622964,1,A,Hafl life rat,Intermediate,,,1,9408,BAO_0000218,6640
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622965,1,A,Hafl life rat,Intermediate,,,1,9409,BAO_0000218,6641
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622966,1,A,Hafl life rat; Not determined,Intermediate,,,1,9410,BAO_0000218,6640
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622967,1,A,Hafl life rat; Not determined,Intermediate,,,1,9411,BAO_0000218,6641
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL622968,1,A,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,In vivo,2113.0,1,9412,BAO_0000218,17411
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622969,1,A,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,In vivo,2107.0,1,9413,BAO_0000218,17411
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL875327,1,A,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,In vivo,2048.0,1,9414,BAO_0000218,17411
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628638,1,A,Half life in rat after 1 mg/kg i.v. administration,Intermediate,In vivo,,1,9415,BAO_0000218,6570
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628639,1,A,Half life in rat after 2 mg/kg peroral administration,Intermediate,In vivo,,1,9416,BAO_0000218,6570
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625840,1,A,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,In vivo,,1,9417,BAO_0000218,17411
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625841,1,A,Half life of 10 mg/kg oral dose determined in rats,Intermediate,In vivo,,1,9418,BAO_0000218,4722
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625842,1,A,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,9419,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625843,1,A,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,9420,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625844,1,A,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,9421,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL873822,1,A,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,9422,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625845,1,A,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,9423,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627059,1,A,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,9424,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627060,1,A,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,9425,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627061,1,A,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,9426,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627709,1,A,Half life of compound at 5 mg/kg after po administration was determined in rat,Intermediate,In vivo,,1,9427,BAO_0000218,4762
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627710,1,A,Half life of compound determined after intravenous administration to rat,Intermediate,In vivo,,1,9428,BAO_0000218,5327
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627711,1,A,Half life of compound was determined in rat,Intermediate,,,1,9429,BAO_0000218,4847
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627712,1,A,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,In vivo,1969.0,1,9430,BAO_0000218,17720
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627713,1,A,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,In vivo,,1,9431,BAO_0000218,4723
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627714,1,A,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,In vivo,,1,9432,BAO_0000218,4723
,9541.0,,Macaca fascicularis,,,,,U,,,22224,CHEMBL627889,1,A,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,Intermediate,In vivo,,0,9433,BAO_0000218,4256
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL627890,1,A,Half life determined in rat by intravenous administration,Intermediate,In vivo,,0,9434,BAO_0000218,4256
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627891,1,A,Half life determined in rats after iv administration,Intermediate,In vivo,,1,9435,BAO_0000218,4722
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627892,1,A,Half life in rat plasma after administration of 2 mg/kg iv,Intermediate,In vivo,1969.0,1,9436,BAO_0000218,6535
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627893,1,A,Half life in rat plasma after administration of 2 mg/kg iv,Intermediate,In vivo,1969.0,1,9437,BAO_0000218,6535
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627894,1,A,Half life in rat plasma was determined,Intermediate,,1969.0,1,9438,BAO_0000218,1435
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627895,1,A,Half life in rat plasma was determined; NA means not applicable,Intermediate,,1969.0,1,9439,BAO_0000218,1435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627896,1,A,Half life in rat was tested,Intermediate,,,1,9440,BAO_0000218,5206
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627897,1,A,Half life measured in rat plasma,Intermediate,,1969.0,1,9441,BAO_0000218,6080
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627898,1,A,Half life recorded in rats,Intermediate,,,1,9442,BAO_0000218,4449
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627899,1,A,Half life was calculated,Intermediate,,,1,9443,BAO_0000218,6057
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL873823,1,A,Half life was calculated in rat,Intermediate,,,1,9444,BAO_0000218,6057
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627900,1,A,Half life was determined,Intermediate,,,1,9445,BAO_0000218,3747
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627901,1,A,Half life after 10 mg/kg oral administration in rat,Intermediate,In vivo,,1,9446,BAO_0000218,17858
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627902,1,A,Half life after administering orally a dose of 10 mg/kg to a fasting rat,Intermediate,In vivo,,1,9447,BAO_0000218,16365
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627903,1,A,Half life after administering orally a dose of 30 mg/kg,Intermediate,In vivo,,1,9448,BAO_0000218,16365
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627904,1,A,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,Intermediate,,,1,9449,BAO_0000218,5031
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627905,1,A,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,Intermediate,,,1,9450,BAO_0000218,4722
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627906,1,A,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,Intermediate,,,1,9451,BAO_0000218,6078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627907,1,A,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,Intermediate,,,1,9452,BAO_0000218,6078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876783,1,A,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,Intermediate,,,1,9453,BAO_0000218,6078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627908,1,A,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,Intermediate,,,1,9454,BAO_0000218,6078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627909,1,A,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,Intermediate,,,1,9455,BAO_0000218,17065
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627910,1,A,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,Intermediate,,,1,9456,BAO_0000218,1353
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627911,1,A,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),Intermediate,,,1,9457,BAO_0000218,1353
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627912,1,A,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),Intermediate,,,1,9458,BAO_0000218,1353
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627913,1,A,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),Intermediate,,,1,9459,BAO_0000218,1353
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627914,1,A,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),Intermediate,,,1,9460,BAO_0000218,1353
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627915,1,A,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,Intermediate,,,1,9461,BAO_0000218,16423
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627916,1,A,Area under the curve was evaluated after 20 uM/kg of peroral administration,Intermediate,,,1,9462,BAO_0000218,16423
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627917,1,A,Area under the curve was measured in rat after an iv dose of 1 mg/kg,Intermediate,,,1,9463,BAO_0000218,6062
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627918,1,A,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,Intermediate,,,1,9464,BAO_0000218,6056
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627919,1,A,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,Intermediate,,,1,9465,BAO_0000218,5182
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627920,1,A,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,Intermediate,,,1,9466,BAO_0000218,6410
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627921,1,A,Area under the curve was evaluated at an oral dose of 30 mg/kg,Intermediate,,,1,9467,BAO_0000218,6410
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627922,1,A,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,,,1,9468,BAO_0000218,4723
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876784,1,A,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,,,1,9469,BAO_0000218,4723
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627923,1,A,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,,,1,9470,BAO_0000218,4723
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626208,1,A,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,,,1,9471,BAO_0000218,4723
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626209,1,A,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,,,1,9472,BAO_0000218,4723
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626210,1,A,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,,,1,9473,BAO_0000218,4723
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627994,1,A,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Intermediate,,1969.0,1,9474,BAO_0000218,2463
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627995,1,A,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,Intermediate,,,1,9475,BAO_0000218,4709
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627996,1,A,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,Intermediate,,,1,9476,BAO_0000218,4075
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627997,1,A,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,Intermediate,,,1,9477,BAO_0000218,5394
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627998,1,A,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,Intermediate,,,1,9478,BAO_0000218,2661
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628640,1,A,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,Intermediate,,,1,9479,BAO_0000218,2661
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628641,1,A,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,Intermediate,,,1,9480,BAO_0000218,2661
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628642,1,A,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,Intermediate,,,1,9481,BAO_0000218,2661
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628643,1,A,Compound was evaluated for area under the curve expressed as (h*ug/ml),Intermediate,,,1,9482,BAO_0000218,17791
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628644,1,A,Compound was tested for area under curve in rat,Intermediate,,,1,9483,BAO_0000218,2591
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628645,1,A,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,Intermediate,,,1,9484,BAO_0000218,6567
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628646,1,A,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,Intermediate,,,1,9485,BAO_0000218,6211
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628647,1,A,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),Intermediate,,,1,9486,BAO_0000218,5529
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628648,1,A,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,Intermediate,,,1,9487,BAO_0000218,5408
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625358,1,A,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,Intermediate,,,1,9488,BAO_0000218,5408
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625359,1,A,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,Intermediate,,,1,9489,BAO_0000218,5408
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625360,1,A,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,Intermediate,,,1,9490,BAO_0000218,5408
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625361,1,A,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),Intermediate,,,1,9491,BAO_0000218,429
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625362,1,A,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),Intermediate,,,1,9492,BAO_0000218,429
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625363,1,A,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),Intermediate,,,1,9493,BAO_0000218,429
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625364,1,A,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,Intermediate,,,1,9494,BAO_0000218,4796
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625365,1,A,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,,,1,9495,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625366,1,A,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,,,1,9496,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625367,1,A,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate,,,1,9497,BAO_0000218,5974
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL625368,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",Intermediate,,2113.0,1,9498,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL625369,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",Intermediate,,2113.0,1,9499,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL625370,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",Intermediate,,2113.0,1,9500,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL625371,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",Intermediate,,2113.0,1,9501,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL625372,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",Intermediate,,2113.0,1,9502,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL625373,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",Intermediate,,2113.0,1,9503,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625374,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",Intermediate,,2107.0,1,9504,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL877593,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",Intermediate,,2107.0,1,9505,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625375,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",Intermediate,,2107.0,1,9506,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625376,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",Intermediate,,2107.0,1,9507,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL621973,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",Intermediate,,2107.0,1,9508,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL621974,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",Intermediate,,2107.0,1,9509,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL621975,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",Intermediate,,2048.0,1,9510,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622166,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",Intermediate,,2048.0,1,9511,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622167,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",Intermediate,,2048.0,1,9512,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622168,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",Intermediate,,2048.0,1,9513,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622169,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",Intermediate,,2048.0,1,9514,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622170,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",Intermediate,,2048.0,1,9515,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL622171,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",Intermediate,,2046.0,1,9516,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL622172,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",Intermediate,,2046.0,1,9517,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL622173,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",Intermediate,,2046.0,1,9518,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL622174,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",Intermediate,,2046.0,1,9519,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL622175,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",Intermediate,,2046.0,1,9520,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL622176,1,A,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",Intermediate,,2046.0,1,9521,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL622177,1,A,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",Intermediate,,2046.0,1,9522,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL622178,1,A,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",Intermediate,,2046.0,1,9523,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL622179,1,A,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",Intermediate,,2046.0,1,9524,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL622180,1,A,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",Intermediate,,2046.0,1,9525,BAO_0000218,11450
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622181,1,A,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,,,1,9526,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622182,1,A,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,,,1,9527,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622183,1,A,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,,,1,9528,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622184,1,A,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,,,1,9529,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622185,1,A,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,,,1,9530,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622186,1,A,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,,,1,9531,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622187,1,A,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,,,1,9532,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625002,1,A,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Intermediate,,,1,9533,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622090,1,A,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,Intermediate,,,1,9534,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622091,1,A,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,,,1,9535,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622092,1,A,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,,,1,9536,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622093,1,A,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,,,1,9537,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622094,1,A,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,,,1,9538,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622095,1,A,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,,,1,9539,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622264,1,A,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,,,1,9540,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL622265,1,A,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,,2106.0,1,9541,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL622266,1,A,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,,2106.0,1,9542,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL622267,1,A,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,,2106.0,1,9543,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL622268,1,A,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,,2106.0,1,9544,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL622269,1,A,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,,2106.0,1,9545,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL625071,1,A,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,,2106.0,1,9546,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621621,1,A,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,,2106.0,1,9547,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621622,1,A,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,,2106.0,1,9548,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621623,1,A,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,,2106.0,1,9549,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621624,1,A,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,,2106.0,1,9550,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621625,1,A,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,,2106.0,1,9551,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621626,1,A,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,,2106.0,1,9552,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621627,1,A,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,,2106.0,1,9553,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621628,1,A,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,,2106.0,1,9554,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL875328,1,A,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,,2106.0,1,9555,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621629,1,A,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,,2106.0,1,9556,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621630,1,A,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,,2106.0,1,9557,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621631,1,A,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,,2106.0,1,9558,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621632,1,A,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,,2106.0,1,9559,BAO_0000218,16434
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621633,1,A,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,,2106.0,1,9560,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621634,1,A,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,,2106.0,1,9561,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621635,1,A,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,,2106.0,1,9562,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621636,1,A,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,,2106.0,1,9563,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621637,1,A,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,,2106.0,1,9564,BAO_0000218,16435
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL621638,1,A,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,,2106.0,1,9565,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618883,1,A,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,,,1,9566,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618884,1,A,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Intermediate,,,1,9567,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628627,1,A,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,,,1,9568,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628628,1,A,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,,,1,9569,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628629,1,A,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Intermediate,,,1,9570,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628630,1,A,Half life after administering orally a dose of 3 mg/kg,Intermediate,In vivo,,1,9571,BAO_0000218,16365
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628631,1,A,Half life after administering orally a dose of 3 mg/kg to a fasting rat,Intermediate,In vivo,,1,9572,BAO_0000218,16365
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628632,1,A,Half life after administering intravenously a dose of 1 mg/kg,Intermediate,In vivo,,1,9573,BAO_0000218,16365
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628633,1,A,Half life after oral dosing in rats,Intermediate,In vivo,,1,9574,BAO_0000218,526
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628634,1,A,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,Intermediate,In vivo,,1,9575,BAO_0000218,16365
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627789,1,A,Half life by intravenous administration of 3.4 mg/kg in rat,Intermediate,In vivo,,1,9576,BAO_0000218,4368
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627790,1,A,Half life in rat,Intermediate,,,1,9577,BAO_0000218,3371
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627791,1,A,Half life in rat,Intermediate,,,1,9578,BAO_0000218,6448
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627792,1,A,Half life in rat,Intermediate,,,1,9579,BAO_0000218,6453
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627793,1,A,Half life in rat after intravenous administration of the compound,Intermediate,In vivo,,1,9580,BAO_0000218,4353
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627794,1,A,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,Intermediate,In vivo,1969.0,1,9581,BAO_0000218,4353
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627795,1,A,Half life in rat after po administration of the compound,Intermediate,In vivo,,1,9582,BAO_0000218,4353
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627796,1,A,Half life in rat after po administration of the compound; ND means Not determined,Intermediate,In vivo,,1,9583,BAO_0000218,4353
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL875335,1,A,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,Intermediate,In vivo,1969.0,1,9584,BAO_0000218,4353
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627797,1,A,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,Intermediate,In vivo,1969.0,1,9585,BAO_0000218,4353
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627798,1,A,Half life in rat i.v.,Intermediate,In vivo,,1,9586,BAO_0000218,5789
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627799,1,A,Half life in rat i.v. at 2 mg/kg concentration,Intermediate,In vivo,,1,9587,BAO_0000218,17686
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627800,1,A,Half life in rats,Intermediate,,,1,9588,BAO_0000218,6495
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627801,1,A,Half life in rats after intravenous administration,Intermediate,In vivo,,1,9589,BAO_0000218,484
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627802,1,A,Half life in rats at the dose of 1.0 mpk by i.v. administration,Intermediate,In vivo,,1,9590,BAO_0000218,6467
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627803,1,A,Half life in rat,Expert,,,1,9591,BAO_0000218,6642
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL873820,1,A,Half life was evaluated after intravenous administration to rats,Intermediate,In vivo,,1,9592,BAO_0000218,16367
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627804,1,A,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),Intermediate,,,1,9593,BAO_0000218,1369
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627805,1,A,Half life was evaluated in rat,Intermediate,,,1,9594,BAO_0000218,5472
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627806,1,A,Half life was evaluated in rat,Intermediate,,,1,9595,BAO_0000218,6049
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627107,1,A,Half life was evaluated in rat; Not tested,Intermediate,,,1,9596,BAO_0000218,5472
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627108,1,A,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,Intermediate,In vivo,,1,9597,BAO_0000218,16366
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627109,1,A,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,Intermediate,In vivo,,1,9598,BAO_0000218,11149
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627110,1,A,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,Intermediate,In vivo,178.0,1,9599,BAO_0000218,11149
,9443.0,,Primates,,,,,U,,,22224,CHEMBL627111,1,A,Half life was measured in monkey at dose of 10 mg/kg by po administration,Intermediate,In vivo,,0,9600,BAO_0000218,2891
,9443.0,,Primates,,,,,U,,,22224,CHEMBL627112,1,A,Half life was measured in monkey at dose of 10 mg/kg by po administration,Intermediate,In vivo,,0,9601,BAO_0000218,2891
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL627113,1,A,Half life was measured in rat at dose of 30 mg/kg by iv administration,Intermediate,In vivo,,0,9602,BAO_0000218,2891
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL627114,1,A,Half life was measured in rat at dose of 30 mg/kg by po administration,Intermediate,In vivo,,0,9603,BAO_0000218,2891
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627115,1,A,Half life (t1/2) was determined,Intermediate,,,1,9604,BAO_0000218,4026
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627116,1,A,Half life period at a dose of 10 uM/kg in rat was determined,Intermediate,,,1,9605,BAO_0000218,4527
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627117,1,A,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,Intermediate,In vivo,,1,9606,BAO_0000218,4527
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627118,1,A,Half life period was determined,Intermediate,,,1,9607,BAO_0000218,5503
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627119,1,A,Half life period after intravenous administration at 20 mpk in rats,Intermediate,In vivo,,1,9608,BAO_0000218,4426
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627120,1,A,Half life period after intravenous administration at 20 mpk in rats; Not performed.,Intermediate,In vivo,,1,9609,BAO_0000218,4426
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626922,1,A,Half life period after intravenous administration in rat,Intermediate,In vivo,,1,9610,BAO_0000218,6109
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626923,1,A,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Intermediate,In vivo,,1,9611,BAO_0000218,5654
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626924,1,A,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Intermediate,In vivo,,1,9612,BAO_0000218,5654
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626925,1,A,Half life period in 80% rat plasma at 37 degree Centigrade,Intermediate,,1969.0,1,9613,BAO_0000218,4755
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626926,1,A,Half life period in SD rats,Intermediate,,,1,9614,BAO_0000218,5862
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626927,1,A,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),Intermediate,,1969.0,1,9615,BAO_0000218,1515
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626928,1,A,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),Intermediate,,1969.0,1,9616,BAO_0000218,1515
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626929,1,A,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Intermediate,,1969.0,1,9617,BAO_0000218,1515
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626930,1,A,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Intermediate,,1969.0,1,9618,BAO_0000218,1515
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626931,1,A,Half life period in rat,Intermediate,,,1,9619,BAO_0000218,5960
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626932,1,A,Half life period in rat,Intermediate,,,1,9620,BAO_0000218,6103
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626933,1,A,Half life period in rat,Intermediate,,,1,9621,BAO_0000218,6317
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL873826,1,A,Half life period in rat after oral administration at 10.5 mg/kg dose,Intermediate,In vivo,,1,9622,BAO_0000218,6644
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626934,1,A,Half life period in rat after oral administration at 11.2 mg/kg dose,Intermediate,In vivo,,1,9623,BAO_0000218,6644
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626935,1,A,Half life period in rat after oral administration at 13 mg/kg dose,Intermediate,In vivo,,1,9624,BAO_0000218,6644
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626936,1,A,Half life period in rat after oral administration at 9.7 mg/kg dose,Intermediate,In vivo,,1,9625,BAO_0000218,6644
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626937,1,A,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,,,1,9626,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625906,1,A,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,Intermediate,,,1,9627,BAO_0000218,6295
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625907,1,A,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,Intermediate,,,1,9628,BAO_0000218,6296
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625908,1,A,PK study was carried to determine AUC (area under curve) value in rat,Intermediate,,,1,9629,BAO_0000218,16427
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625909,1,A,Pharmacokinetic parameter AUC after intravenous administration to rats,Intermediate,,,1,9630,BAO_0000218,16367
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625910,1,A,Pharmacokinetic parameter AUC after oral administration to rats,Intermediate,,,1,9631,BAO_0000218,16367
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625911,1,A,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,Intermediate,,,1,9632,BAO_0000218,16365
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625912,1,A,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,Intermediate,,,1,9633,BAO_0000218,16365
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626538,1,A,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,Intermediate,,,1,9634,BAO_0000218,16365
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876794,1,A,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,Intermediate,,,1,9635,BAO_0000218,16365
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626539,1,A,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,Intermediate,,,1,9636,BAO_0000218,16365
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626540,1,A,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,Intermediate,,,1,9637,BAO_0000218,16365
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626541,1,A,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,Intermediate,,,1,9638,BAO_0000218,5394
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626542,1,A,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,Intermediate,,,1,9639,BAO_0000218,5394
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626543,1,A,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,Intermediate,,,1,9640,BAO_0000218,2792
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626544,1,A,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,Intermediate,,,1,9641,BAO_0000218,2792
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626545,1,A,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,Intermediate,,,1,9642,BAO_0000218,2792
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626546,1,A,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,Intermediate,,,1,9643,BAO_0000218,2792
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626547,1,A,Pharmacokinetic parameter area under curve was reported,Intermediate,,,1,9644,BAO_0000218,5334
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626548,1,A,Pharmacokinetic property (AUC) in rat,Intermediate,,,1,9645,BAO_0000218,4408
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626549,1,A,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,Intermediate,,,1,9646,BAO_0000218,5983
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626550,1,A,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,Intermediate,,,1,9647,BAO_0000218,4397
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626551,1,A,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,Intermediate,,,1,9648,BAO_0000218,4397
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623777,1,A,Pharmacokinetic property was determined,Intermediate,,,1,9649,BAO_0000218,5491
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623778,1,A,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,Intermediate,,,1,9650,BAO_0000218,5491
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623779,1,A,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,Intermediate,,,1,9651,BAO_0000218,5491
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623780,1,A,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,Intermediate,,1969.0,1,9652,BAO_0000218,4199
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622015,1,A,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,Intermediate,,1969.0,1,9653,BAO_0000218,4199
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622016,1,A,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,Intermediate,,1969.0,1,9654,BAO_0000218,4199
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622017,1,A,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",Intermediate,,,1,9655,BAO_0000218,5173
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622018,1,A,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",Intermediate,,,1,9656,BAO_0000218,5173
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622019,1,A,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",Intermediate,,,1,9657,BAO_0000218,5173
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622020,1,A,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",Intermediate,,,1,9658,BAO_0000218,5173
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622021,1,A,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,Intermediate,,,1,9659,BAO_0000218,16366
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622022,1,A,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,Intermediate,,,1,9660,BAO_0000218,16366
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622023,1,A,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,Intermediate,,,1,9661,BAO_0000218,5327
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622024,1,A,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,Intermediate,,,1,9662,BAO_0000218,6681
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622693,1,A,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),Intermediate,,,1,9663,BAO_0000218,12873
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622694,1,A,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),Intermediate,,,1,9664,BAO_0000218,12873
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622695,1,A,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",Intermediate,,,1,9665,BAO_0000218,6685
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622696,1,A,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",Intermediate,,,1,9666,BAO_0000218,6685
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622697,1,A,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",Intermediate,,,1,9667,BAO_0000218,6685
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622874,1,A,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",Intermediate,,,1,9668,BAO_0000218,6619
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622875,1,A,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",Intermediate,,,1,9669,BAO_0000218,6619
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622876,1,A,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,Intermediate,,,1,9670,BAO_0000218,10363
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622877,1,A,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,Intermediate,,,1,9671,BAO_0000218,4796
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622878,1,A,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,Intermediate,,,1,9672,BAO_0000218,4910
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622879,1,A,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,Intermediate,,1969.0,1,9673,BAO_0000218,4910
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL877602,1,A,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,Intermediate,,,1,9674,BAO_0000218,4839
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622880,1,A,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,,,1,9675,BAO_0000218,15078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622881,1,A,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,,,1,9676,BAO_0000218,15078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622882,1,A,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,,,1,9677,BAO_0000218,15078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622883,1,A,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,,,1,9678,BAO_0000218,15078
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL622884,1,A,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",Intermediate,,2046.0,1,9679,BAO_0000218,11450
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL622885,1,A,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",Intermediate,,2046.0,1,9680,BAO_0000218,11450
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622886,1,A,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Intermediate,,,1,9681,BAO_0000218,8151
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622887,1,A,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Intermediate,,,1,9682,BAO_0000218,8151
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL622888,1,A,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Intermediate,,1088.0,1,9683,BAO_0000218,8151
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL622889,1,A,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,178.0,1,9684,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL622890,1,A,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,178.0,1,9685,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL622891,1,A,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,178.0,1,9686,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL877603,1,A,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,178.0,1,9687,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL622892,1,A,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,955.0,1,9688,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL622893,1,A,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,955.0,1,9689,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL622894,1,A,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,955.0,1,9690,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL622895,1,A,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,955.0,1,9691,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL622896,1,A,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,Intermediate,In vivo,955.0,1,9692,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL622897,1,A,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,948.0,1,9693,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL622898,1,A,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,948.0,1,9694,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL622899,1,A,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,948.0,1,9695,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL622900,1,A,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,2113.0,1,9696,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL624114,1,A,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,2113.0,1,9697,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL624115,1,A,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,2113.0,1,9698,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL624116,1,A,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,2113.0,1,9699,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL624117,1,A,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,2107.0,1,9700,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL624118,1,A,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,2107.0,1,9701,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL624119,1,A,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,2107.0,1,9702,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL624120,1,A,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,2107.0,1,9703,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624121,1,A,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,2048.0,1,9704,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624122,1,A,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,2048.0,1,9705,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624123,1,A,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,2048.0,1,9706,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624124,1,A,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,2048.0,1,9707,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL624125,1,A,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,2385.0,1,9708,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL624126,1,A,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,2385.0,1,9709,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL624127,1,A,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,2385.0,1,9710,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL624128,1,A,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,2385.0,1,9711,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Zone of skin,,,,N,,,50597,CHEMBL624129,1,A,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,14.0,1,9712,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Zone of skin,,,,N,,,50597,CHEMBL624130,1,A,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,14.0,1,9713,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Zone of skin,,,,N,,,50597,CHEMBL622340,1,A,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,14.0,1,9714,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Zone of skin,,,,N,,,50597,CHEMBL622341,1,A,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,14.0,1,9715,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL622342,1,A,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,160.0,1,9716,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL622343,1,A,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,160.0,1,9717,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL622344,1,A,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,160.0,1,9718,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL622345,1,A,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,160.0,1,9719,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL622346,1,A,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,2106.0,1,9720,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL622347,1,A,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,2106.0,1,9721,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL622348,1,A,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,2106.0,1,9722,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL622349,1,A,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,2106.0,1,9723,BAO_0000218,8677
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622350,1,A,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Intermediate,,,1,9724,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622351,1,A,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Intermediate,,,1,9725,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622352,1,A,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Intermediate,,,1,9726,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622353,1,A,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Intermediate,,,1,9727,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622354,1,A,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Intermediate,,,1,9728,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622355,1,A,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Intermediate,,,1,9729,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622356,1,A,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Intermediate,,,1,9730,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622357,1,A,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Intermediate,,,1,9731,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622358,1,A,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Intermediate,,,1,9732,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622359,1,A,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Intermediate,,,1,9733,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874393,1,A,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Intermediate,,,1,9734,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622872,1,A,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,,,1,9735,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622873,1,A,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,,,1,9736,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623047,1,A,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,,,1,9737,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623048,1,A,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,,,1,9738,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623049,1,A,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,,,1,9739,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623050,1,A,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,,,1,9740,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623051,1,A,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,,,1,9741,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623052,1,A,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,,,1,9742,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626343,1,A,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,,,1,9743,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626344,1,A,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Intermediate,,,1,9744,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626345,1,A,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Intermediate,,,1,9745,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626346,1,A,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Intermediate,,,1,9746,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626347,1,A,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Intermediate,,,1,9747,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626348,1,A,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Intermediate,,,1,9748,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626349,1,A,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Intermediate,,,1,9749,BAO_0000218,16434
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626350,1,F,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Intermediate,,,1,9750,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626351,1,A,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Intermediate,,,1,9751,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627650,1,A,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Intermediate,,,1,9752,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627651,1,F,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Intermediate,,,1,9753,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627652,1,A,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Intermediate,,,1,9754,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627653,1,A,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Intermediate,,,1,9755,BAO_0000218,16435
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627654,1,A,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,Intermediate,,,1,9756,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627835,1,A,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,Intermediate,,,1,9757,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627836,1,A,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,Intermediate,,,1,9758,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627837,1,A,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,Intermediate,,,1,9759,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627838,1,A,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,Intermediate,,,1,9760,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875338,1,A,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,Intermediate,,,1,9761,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627839,1,A,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,Intermediate,,,1,9762,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627840,1,A,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,Intermediate,,,1,9763,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627841,1,A,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,Intermediate,,,1,9764,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627842,1,A,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,Intermediate,,,1,9765,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627843,1,A,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,Intermediate,,,1,9766,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627844,1,A,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,Intermediate,,,1,9767,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627845,1,A,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,Intermediate,,,1,9768,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627846,1,A,Half life period in rat by iv administration at a dose of 3 mg/kg,Intermediate,In vivo,,1,9769,BAO_0000218,5874
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627847,1,A,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),Intermediate,,1969.0,1,9770,BAO_0000218,1515
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL873821,1,A,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),Intermediate,,1969.0,1,9771,BAO_0000218,1515
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626079,1,A,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Intermediate,,1969.0,1,9772,BAO_0000218,1515
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626080,1,A,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Intermediate,,1969.0,1,9773,BAO_0000218,1515
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626081,1,A,Half life period was evaluated in rat plasma,Intermediate,,1969.0,1,9774,BAO_0000218,5491
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL875344,1,A,Half life period was evaluated in rat plasma; Not tested,Intermediate,,1969.0,1,9775,BAO_0000218,5491
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626082,1,A,Half life period was evaluated in rats,Intermediate,,,1,9776,BAO_0000218,1918
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626250,1,A,"Half life period was evaluated in rats, iv",Intermediate,In vivo,,1,9777,BAO_0000218,1918
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626251,1,A,Half life period after intravenous administration at 5 mg/kg in rat,Intermediate,In vivo,,1,9778,BAO_0000218,6113
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626252,1,A,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Intermediate,In vivo,,1,9779,BAO_0000218,5546
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626253,1,A,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,Intermediate,In vivo,,1,9780,BAO_0000218,5553
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626254,1,A,Half life stability of compound was evaluated in rat plasma,Intermediate,,1969.0,1,9781,BAO_0000218,4188
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626255,1,A,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,Intermediate,In vivo,,1,9782,BAO_0000218,6215
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626256,1,A,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,Intermediate,In vivo,,1,9783,BAO_0000218,6141
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626257,1,A,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Intermediate,In vivo,,1,9784,BAO_0000218,5182
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626258,1,A,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,Intermediate,In vivo,,1,9785,BAO_0000218,5182
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626259,1,A,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,Intermediate,In vivo,,1,9786,BAO_0000218,5710
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626260,1,A,Half in rat i.v.,Intermediate,In vivo,,1,9787,BAO_0000218,5789
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875345,1,A,Half period in rat after intravenous administration,Intermediate,In vivo,,1,9788,BAO_0000218,6011
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626261,1,A,Half-life after repeated oral dose of compound at 1 mg/kg in rats,Intermediate,In vivo,,1,9789,BAO_0000218,17594
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL626262,1,A,Half-life measured in in vitro Cathepsin B assay in rat liver,Intermediate,In vitro,2107.0,1,9790,BAO_0000218,12357
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626263,1,A,Half-life of compound was determined in rats,Intermediate,,,1,9791,BAO_0000218,5210
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625270,1,A,Half-life at 10 mg/kg in rat upon intravenous administration,Intermediate,In vivo,,1,9792,BAO_0000218,17596
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625271,1,A,Half-life determined in rat,Intermediate,,,1,9793,BAO_0000218,6672
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625272,1,A,Half-life determined in rat,Intermediate,,,1,9794,BAO_0000218,6673
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL625273,1,A,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,Intermediate,In vivo,955.0,1,9795,BAO_0000218,4910
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625274,1,A,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",Intermediate,,1969.0,1,9796,BAO_0000218,3741
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625275,1,A,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate,In vivo,,1,9797,BAO_0000218,17671
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625276,1,A,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,Intermediate,In vivo,1969.0,1,9798,BAO_0000218,4910
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625277,1,A,Half-life in rat plasma,Intermediate,,1969.0,1,9799,BAO_0000218,17537
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625278,1,A,Half-life in rat plasma was determined,Intermediate,,1969.0,1,9800,BAO_0000218,4965
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625279,1,A,Half-life in rat plasma; Not tested,Intermediate,,1969.0,1,9801,BAO_0000218,17537
,10116.0,,Rattus norvegicus,Serum,,,,N,,,50597,CHEMBL625280,1,A,Half-life in rat serum,Intermediate,,1977.0,1,9802,BAO_0000218,6124
,10116.0,,Rattus norvegicus,Serum,,,,N,,,50597,CHEMBL876797,1,A,Half-life in rat serum; na is not available,Intermediate,,1977.0,1,9803,BAO_0000218,6124
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625281,1,A,Half-life was calculated in rat,Intermediate,,,1,9804,BAO_0000218,6078
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL873827,1,A,Half-life was calculated in rat plasma,Intermediate,,1969.0,1,9805,BAO_0000218,17668
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625282,1,A,Half-life was determined,Intermediate,,,1,9806,BAO_0000218,3185
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625283,1,A,Half-life was determined,Intermediate,,,1,9807,BAO_0000218,4883
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625284,1,A,Half-life after administration of 20 mg/Kg oral dose in rat,Intermediate,In vivo,,1,9808,BAO_0000218,2959
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625285,1,A,Half-life after administration of 3.2 mg/kg intravenously in male rat,Intermediate,In vivo,,1,9809,BAO_0000218,4029
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625286,1,A,Half-life after intravenous administration in female rat,Intermediate,In vivo,,1,9810,BAO_0000218,4029
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625287,1,A,Half-life after intravenous administration in male rat,Intermediate,In vivo,,1,9811,BAO_0000218,4029
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625288,1,A,Half-life after intravenous dose in rat,Intermediate,In vivo,,1,9812,BAO_0000218,6180
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625289,1,A,Half-life in a rat liver homogenate preparation,Intermediate,,2107.0,1,9813,BAO_0000218,1557
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625290,1,A,Half-life in plasma of rat,Intermediate,,1969.0,1,9814,BAO_0000218,12500
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL876798,1,A,Half-life in plasma of rat at dose of 3-10 mgkg,Intermediate,,1969.0,1,9815,BAO_0000218,12500
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625291,1,A,Half-life in rat,Intermediate,,,1,9816,BAO_0000218,5064
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625292,1,A,Half-life in rat,Intermediate,,,1,9817,BAO_0000218,5145
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625293,1,A,Half-life in rat,Intermediate,,,1,9818,BAO_0000218,5147
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622832,1,A,Half-life in rat,Intermediate,,,1,9819,BAO_0000218,5833
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622833,1,A,Half-life in rat,Intermediate,,,1,9820,BAO_0000218,6596
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622834,1,A,Half-life in rat,Intermediate,,,1,9821,BAO_0000218,17655
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622835,1,A,Half-life in rat after oral administration at 10 mg/kg,Intermediate,In vivo,,1,9822,BAO_0000218,6495
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622836,1,A,Half-life in rat after po administration at a dose of 10 mg/kg,Intermediate,In vivo,,1,9823,BAO_0000218,17538
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622837,1,A,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,Intermediate,In vivo,,1,9824,BAO_0000218,17538
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622838,1,A,Half-life in rat at 3 mg/kg dose administered intravenously,Intermediate,In vivo,,1,9825,BAO_0000218,10
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL622839,1,A,Half-life in rat brain homogenate,Intermediate,,955.0,1,9826,BAO_0000218,17669
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622840,1,A,Half-life in rat plasma,Intermediate,,1969.0,1,9827,BAO_0000218,17065
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622841,1,A,Half-life in rats,Intermediate,,,1,9828,BAO_0000218,4333
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622842,1,A,Half-life in Dawley rats,Intermediate,,,1,9829,BAO_0000218,6827
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622843,1,A,Half-life in vitro in rat plasma,Intermediate,In vitro,1969.0,1,9830,BAO_0000218,889
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622844,1,A,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,Intermediate,In vitro,1969.0,1,9831,BAO_0000218,889
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622845,1,A,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",Intermediate,,,1,9832,BAO_0000218,3747
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622846,1,A,The area under the curve of compound was measured at the dose of 100 umol/kg,Intermediate,,,1,9833,BAO_0000218,15022
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622847,1,A,The area under the curve of compound was measured at the dose of 300 umol/kg,Intermediate,,,1,9834,BAO_0000218,15022
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622848,1,A,The area under the curve of compound was measured at the dose of 30 umol/kg,Intermediate,,,1,9835,BAO_0000218,15022
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622849,1,A,Bioavailability as oral AUC in rats,Intermediate,In vivo,,1,9836,BAO_0000218,3360
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622850,1,A,The plasma concentration versus time curve (AUC) was determined,Intermediate,,1969.0,1,9837,BAO_0000218,5334
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876807,1,A,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,,,1,9838,BAO_0000218,17411
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622851,1,A,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,,,1,9839,BAO_0000218,17411
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622852,1,A,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,,,1,9840,BAO_0000218,17411
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622853,1,A,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,Intermediate,,,1,9841,BAO_0000218,6570
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622854,1,A,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,Intermediate,,,1,9842,BAO_0000218,6570
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622855,1,A,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Intermediate,,,1,9843,BAO_0000218,17411
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622856,1,A,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,,1969.0,1,9844,BAO_0000218,14941
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622857,1,A,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,,1969.0,1,9845,BAO_0000218,14941
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622858,1,A,AUC in rat after po administration at a dose of 10 mg/kg,Intermediate,,1969.0,1,9846,BAO_0000218,17538
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622859,1,A,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,Intermediate,,1969.0,1,9847,BAO_0000218,17752
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622860,1,A,Area under curve value 24 hr after 10 mg/kg iv administration in rats,Intermediate,,,1,9848,BAO_0000218,17509
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622861,1,A,Area under curve value 24 hr after 10 mg/kg oral administration in rats,Intermediate,,,1,9849,BAO_0000218,17509
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622862,1,A,Area under curve value 24 hr after 2 mg/kg iv administration in rats,Intermediate,,,1,9850,BAO_0000218,17509
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622863,1,A,Area under curve value 24 hr after 2 mg/kg oral administration in rats,Intermediate,,,1,9851,BAO_0000218,17509
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623817,1,A,Area under curve value 6 hr after po administration in rat,Intermediate,,,1,9852,BAO_0000218,17509
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623818,1,A,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,,,1,9853,BAO_0000218,17717
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623819,1,A,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",Intermediate,,,1,9854,BAO_0000218,17717
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623820,1,A,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,,,1,9855,BAO_0000218,17717
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623821,1,A,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,Intermediate,,,1,9856,BAO_0000218,17717
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623822,1,A,AUC normalized for dose (AUCN) in rat,Intermediate,,1969.0,1,9857,BAO_0000218,6642
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623823,1,A,Area under curve in rat after p.o. administration,Intermediate,,,1,9858,BAO_0000218,6640
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623824,1,A,Area under curve in rat after p.o. administration,Intermediate,,,1,9859,BAO_0000218,6641
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623825,1,A,Area under curve in rat after p.o. administration; Not determined,Intermediate,,,1,9860,BAO_0000218,6641
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622070,1,A,Area under curve in rat after peroral administration,Intermediate,,,1,9861,BAO_0000218,6641
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622071,1,A,Area under curve (carotid artery) value of the compound,Intermediate,,,1,9862,BAO_0000218,3603
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622072,1,A,Bioavailability expressed as the area under curve of rat carotid artery,Intermediate,,,1,9863,BAO_0000218,3550
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622073,1,A,Area under curve in male SD rats was observed after intravenous administration in rat,Intermediate,,,1,9864,BAO_0000218,15662
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622074,1,A,Area under curve of the compound was determined,Intermediate,,,1,9865,BAO_0000218,17720
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622075,1,A,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,Intermediate,,,1,9866,BAO_0000218,5407
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622076,1,A,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,Intermediate,,1969.0,1,9867,BAO_0000218,17752
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622077,1,A,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,Intermediate,,1969.0,1,9868,BAO_0000218,17752
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622078,1,A,Area under curve (portal vein) value of the compound,Intermediate,,,1,9869,BAO_0000218,3603
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622079,1,A,Bioavailability expressed as the area under curve of rat portal vein,Intermediate,,,1,9870,BAO_0000218,3550
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622080,1,A,Area Under plasma concentration time curve in rat upon peroral administration,Intermediate,,1969.0,1,9871,BAO_0000218,17655
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL877612,1,A,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,Intermediate,,,1,9872,BAO_0000218,17582
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622081,1,A,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,Intermediate,,,1,9873,BAO_0000218,17582
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622082,1,A,Compound was evaluated for oral bioavailability in rats,Intermediate,,,1,9874,BAO_0000218,17791
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622083,1,A,Compound was evaluated for oral bioavailability in rats after iv administration,Intermediate,,,1,9875,BAO_0000218,17791
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622084,1,A,Compound was evaluated for oral bioavailability in rats; 30-80,Intermediate,,,1,9876,BAO_0000218,17791
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622085,1,A,Compound was evaluated for oral bioavailability in rats; 50-60,Intermediate,,,1,9877,BAO_0000218,17791
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622086,1,A,Compound was evaluated for oral bioavailability in rats; no data,Intermediate,,,1,9878,BAO_0000218,17791
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622087,1,A,Compound was evaluated for oral bioavailability in rats; peptide,Intermediate,,,1,9879,BAO_0000218,17791
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL622088,1,A,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",Intermediate,,178.0,1,9880,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL622089,1,A,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",Intermediate,,178.0,1,9881,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL623685,1,A,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",Intermediate,,178.0,1,9882,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL623686,1,A,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",Intermediate,,178.0,1,9883,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Stomach,,,,N,,,50597,CHEMBL623687,1,A,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,945.0,1,9884,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Stomach,,,,N,,,50597,CHEMBL623688,1,A,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,945.0,1,9885,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Stomach,,,,N,,,50597,CHEMBL623689,1,A,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,945.0,1,9886,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Stomach,,,,N,,,50597,CHEMBL622485,1,A,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,945.0,1,9887,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL622486,1,A,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,2046.0,1,9888,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL877613,1,A,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,2046.0,1,9889,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL622487,1,A,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,In vivo,2046.0,1,9890,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL622488,1,A,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,2046.0,1,9891,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL622489,1,A,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Intermediate,In vivo,948.0,1,9892,BAO_0000218,8677
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL622490,1,A,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Intermediate,,1088.0,1,9893,BAO_0000218,6899
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL622491,1,A,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Intermediate,,1088.0,1,9894,BAO_0000218,6899
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622492,1,A,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,Intermediate,,2107.0,1,9895,BAO_0000218,6899
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL622493,1,A,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Intermediate,,1088.0,1,9896,BAO_0000218,6899
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL622494,1,A,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Intermediate,,1088.0,1,9897,BAO_0000218,6899
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL622495,1,A,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Intermediate,,2385.0,1,9898,BAO_0000218,8677
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622496,1,A,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,Intermediate,,,1,9899,BAO_0000218,6899
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL622497,1,A,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Intermediate,,1088.0,1,9900,BAO_0000218,6899
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622498,1,A,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,Intermediate,,,1,9901,BAO_0000218,2189
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL624918,1,A,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,Intermediate,,1088.0,1,9902,BAO_0000218,2189
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL624919,1,A,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,Intermediate,,1088.0,1,9903,BAO_0000218,2189
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624920,1,A,Biodistribution of compound in rat blood after 5 min of administration,Intermediate,In vivo,178.0,1,9904,BAO_0000218,10839
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624921,1,A,Biodistribution of compound in rat blood after 5 min of administration.,Intermediate,In vivo,178.0,1,9905,BAO_0000218,10839
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL624922,1,A,Biodistribution of compound in rat brain after 5 min of administration,Intermediate,In vivo,955.0,1,9906,BAO_0000218,10839
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624923,1,A,Biodistribution of compound in rat heart after 5 min of administration,Intermediate,In vivo,948.0,1,9907,BAO_0000218,10839
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624924,1,A,Biodistribution of compound in rat heart after 5 min of administration.,Intermediate,In vivo,948.0,1,9908,BAO_0000218,10839
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL624925,1,A,Biodistribution of compound in rat kidney after 5 min of administration,Intermediate,In vivo,2113.0,1,9909,BAO_0000218,10839
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL624926,1,A,Biodistribution of compound in rat kidney after 5 min of administration.,Intermediate,In vivo,2113.0,1,9910,BAO_0000218,10839
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL624927,1,A,Biodistribution of compound in rat liver after 5 min of administration,Intermediate,In vivo,2107.0,1,9911,BAO_0000218,10839
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL874402,1,A,Biodistribution of compound in rat liver after 5 min of administration.,Intermediate,In vivo,2107.0,1,9912,BAO_0000218,10839
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624928,1,A,Biodistribution of compound in rat lung after 5 min of administration,Intermediate,In vivo,2048.0,1,9913,BAO_0000218,10839
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624929,1,A,Biodistribution of compound in rat lung after 5 min of administration.,Intermediate,In vivo,2048.0,1,9914,BAO_0000218,10839
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL624930,1,A,Biodistribution of compound in rat muscle after 5 min of administration,Intermediate,In vivo,2385.0,1,9915,BAO_0000218,10839
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL624931,1,A,Biodistribution of compound in rat muscle after 5 min of administration.,Intermediate,In vivo,2385.0,1,9916,BAO_0000218,10839
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624932,1,A,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,,948.0,1,9917,BAO_0000218,4043
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624933,1,A,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,,948.0,1,9918,BAO_0000218,4043
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL624934,1,A,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,,2107.0,1,9919,BAO_0000218,4043
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL624935,1,A,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,,2107.0,1,9920,BAO_0000218,4043
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624936,1,A,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,,,1,9921,BAO_0000218,4043
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624937,1,A,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,,,1,9922,BAO_0000218,4043
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL624938,1,A,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,,2106.0,1,9923,BAO_0000218,4043
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL624939,1,A,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,,2106.0,1,9924,BAO_0000218,4043
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624940,1,A,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,,,1,9925,BAO_0000218,4043
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874403,1,A,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Intermediate,,,1,9926,BAO_0000218,4043
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624941,1,A,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,Intermediate,,,1,9927,BAO_0000218,1446
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL624942,1,A,Dose required to lower urine osmolality to 300 mOsm/kg in rat,Intermediate,,1088.0,1,9928,BAO_0000218,9971
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL624943,1,A,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,Intermediate,,1088.0,1,9929,BAO_0000218,9971
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624944,1,A,% Bioavailability after 1 day of the drug administration in rats,Intermediate,In vivo,,1,9930,BAO_0000218,5765
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624945,1,A,% Bioavailability after 4 day of the drug administration in rats,Intermediate,In vivo,,1,9931,BAO_0000218,5765
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624946,1,A,Absolute bioavailability was evaluated in rat,Intermediate,In vivo,,1,9932,BAO_0000218,4257
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624947,1,A,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,Intermediate,,,1,9933,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624948,1,A,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,Intermediate,,,1,9934,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624949,1,A,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,Intermediate,,,1,9935,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL622025,1,A,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,Intermediate,,2113.0,1,9936,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL622026,1,A,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,Intermediate,,2113.0,1,9937,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL622027,1,A,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,Intermediate,,2113.0,1,9938,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL622028,1,A,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,Intermediate,,2113.0,1,9939,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622029,1,A,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,Intermediate,,2107.0,1,9940,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622208,1,A,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,Intermediate,,2107.0,1,9941,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622209,1,A,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,Intermediate,,2107.0,1,9942,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622210,1,A,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,Intermediate,,2107.0,1,9943,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622211,1,A,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,Intermediate,,,1,9944,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622212,1,A,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,Intermediate,,,1,9945,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622213,1,A,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,Intermediate,,,1,9946,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874404,1,A,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,Intermediate,,,1,9947,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL620452,1,A,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,Intermediate,,2385.0,1,9948,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL620453,1,A,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,Intermediate,,2385.0,1,9949,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL620454,1,A,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,Intermediate,,2385.0,1,9950,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL624067,1,A,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,Intermediate,,2385.0,1,9951,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624068,1,A,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,Intermediate,,,1,9952,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Female gonad,,,,N,,,50597,CHEMBL624069,1,A,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,Intermediate,,992.0,1,9953,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Female gonad,,,,N,,,50597,CHEMBL624070,1,A,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,Intermediate,,992.0,1,9954,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Female gonad,,,,N,,,50597,CHEMBL624071,1,A,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,Intermediate,,992.0,1,9955,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL624072,1,A,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,Intermediate,,995.0,1,9956,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL624073,1,A,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,Intermediate,,995.0,1,9957,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL624788,1,A,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,Intermediate,,995.0,1,9958,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL624789,1,A,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,Intermediate,,995.0,1,9959,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624790,1,A,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,Intermediate,,,1,9960,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624791,1,A,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,Intermediate,,,1,9961,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624792,1,A,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,Intermediate,,,1,9962,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624793,1,A,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,Intermediate,,,1,9963,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL877491,1,A,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,Intermediate,,2385.0,1,9964,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL624957,1,A,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,Intermediate,,2385.0,1,9965,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL624958,1,A,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,Intermediate,,2385.0,1,9966,BAO_0000218,13091
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL624959,1,A,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,Intermediate,,2385.0,1,9967,BAO_0000218,13091
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624960,1,A,Dissociation constant was determined,Intermediate,,,1,9968,BAO_0000218,11977
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624961,1,A,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",Intermediate,,,1,9969,BAO_0000218,14941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624962,1,A,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,,,1,9970,BAO_0000218,15078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624963,1,A,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,,,1,9971,BAO_0000218,15078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624964,1,A,Observed rate constant in 80% rat plasma at 37 degree Centigrade,Intermediate,,,1,9972,BAO_0000218,4755
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624965,1,A,LogP value was evaluated in the in situ rat gut perfusion assay,Intermediate,,,1,9973,BAO_0000218,589
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624966,1,A,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Intermediate,In vivo,,1,9974,BAO_0000218,17582
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624967,1,A,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,Intermediate,In vivo,,1,9975,BAO_0000218,5031
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624968,1,A,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,Intermediate,In vivo,,1,9976,BAO_0000218,17764
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624969,1,A,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,,,1,9977,BAO_0000218,17720
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624970,1,F,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,Expert,,,1,9978,BAO_0000218,2862
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624971,1,A,Half-life was evaluated after 10 uM/kg of intra arterial administration,Intermediate,,,1,9979,BAO_0000218,16423
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624972,1,A,Half-life was evaluated after 20 uM/kg of peroral administration,Intermediate,In vivo,,1,9980,BAO_0000218,16423
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624973,1,A,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Intermediate,In vivo,,1,9981,BAO_0000218,6005
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL624974,1,A,Half-life was evaluated in plasma of rat,Intermediate,,1969.0,1,9982,BAO_0000218,2938
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624975,1,A,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,Intermediate,In vivo,,1,9983,BAO_0000218,6410
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL877492,1,A,Half-life was evaluated in rats at an oral dose of 30 mg/kg,Intermediate,In vivo,,1,9984,BAO_0000218,6410
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624976,1,A,Half-life was measured in rat after an iv dose of 1 mg/kg,Intermediate,In vivo,,1,9985,BAO_0000218,6062
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624977,1,A,Half-life period of compound in rats after peroral administration,Intermediate,In vivo,,1,9986,BAO_0000218,6571
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626848,1,A,Half-life period of compound was measured in rat plasma.,Intermediate,,1969.0,1,9987,BAO_0000218,3136
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626849,1,A,Half-life period of compound was measured in rat plasma; ND is not determined,Intermediate,,1969.0,1,9988,BAO_0000218,3136
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626850,1,A,Half-life period of compound was measured in rat plasma; not determined,Intermediate,,1969.0,1,9989,BAO_0000218,3136
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626851,1,A,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Intermediate,In vivo,,1,9990,BAO_0000218,4521
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626852,1,A,Half-life period in rat by iv administration,Intermediate,In vivo,,1,9991,BAO_0000218,5871
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626853,1,A,Half-life period in rats following intravenous administration at 2 mg/kg,Intermediate,In vivo,,1,9992,BAO_0000218,6077
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626854,1,A,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Intermediate,In vivo,,1,9993,BAO_0000218,6679
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627486,1,A,Half-life period was determined for the compound in rat,Intermediate,,,1,9994,BAO_0000218,5144
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627487,1,A,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",Intermediate,In vivo,,1,9995,BAO_0000218,4498
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627488,1,A,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",Intermediate,In vivo,,1,9996,BAO_0000218,4498
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627489,1,A,Half-life value after IV dose at a dose of 5 mg/kg in rats.,Intermediate,In vivo,,1,9997,BAO_0000218,1908
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627490,1,A,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,Intermediate,In vivo,,1,9998,BAO_0000218,6211
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL873829,1,A,Half-life was determined in rat after intravenous administration (0.5 mg/kg),Intermediate,In vivo,,1,9999,BAO_0000218,5529
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627655,1,A,Half-life was determined in rat at a dose of 1 mpk i.v.,Intermediate,In vivo,,1,10000,BAO_0000218,6444
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625994,1,A,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Intermediate,In vivo,,1,10001,BAO_0000218,6444
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625995,1,A,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Intermediate,In vivo,,1,10002,BAO_0000218,6444
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625996,1,A,Half-life in rat,Intermediate,,,1,10003,BAO_0000218,5207
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625850,1,A,In vitro half life in rat plasma,Intermediate,In vitro,1969.0,1,10004,BAO_0000218,530
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625851,1,A,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",Intermediate,In vitro,1969.0,1,10005,BAO_0000218,1116
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625852,1,A,In vitro half life in rat,Intermediate,In vitro,,1,10006,BAO_0000218,3219
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625853,1,A,In vivo half life period after intravenous administration in rat,Intermediate,In vivo,,1,10007,BAO_0000218,6109
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625854,1,A,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Intermediate,In vivo,,1,10008,BAO_0000218,17582
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874450,1,A,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,Intermediate,In vivo,,1,10009,BAO_0000218,17582
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625855,1,A,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,In vivo,,1,10010,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625856,1,A,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,In vivo,,1,10011,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625857,1,A,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate,In vivo,,1,10012,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL873831,1,A,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,In vivo,,1,10013,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625858,1,A,Longer half-life in rat (i.v.) at 0.5 mpk,Intermediate,In vivo,,1,10014,BAO_0000218,17853
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625859,1,A,Longer half-life in rat (p.o.) at 2.0 mpk,Intermediate,In vivo,,1,10015,BAO_0000218,17853
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625860,1,A,Pharmacokinetic property (half life) in rat,Intermediate,,,1,10016,BAO_0000218,3457
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625861,1,A,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,Intermediate,In vivo,,1,10017,BAO_0000218,2792
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625862,1,A,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,Intermediate,In vivo,,1,10018,BAO_0000218,2792
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625863,1,A,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,Intermediate,In vivo,,1,10019,BAO_0000218,2792
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625864,1,A,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,Intermediate,In vivo,,1,10020,BAO_0000218,2792
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625865,1,A,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,Intermediate,In vivo,,1,10021,BAO_0000218,5739
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625866,1,A,Pharmacokinetic half time was determined intravenously in rats.,Intermediate,In vivo,,1,10022,BAO_0000218,15765
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625867,1,A,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,Intermediate,In vivo,1969.0,1,10023,BAO_0000218,6567
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625868,1,A,Plasma half life of hydrolysis of the compound,Intermediate,,1969.0,1,10024,BAO_0000218,2448
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625869,1,A,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,Intermediate,In vivo,1969.0,1,10025,BAO_0000218,5423
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL874451,1,A,Plasma half life period was calculated in rat,Intermediate,,1969.0,1,10026,BAO_0000218,4853
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625870,1,A,Plasma half-life in Sprague-Dawley rats,Intermediate,,1969.0,1,10027,BAO_0000218,4514
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625871,1,A,Plasma half-life in Sprague-Dawley rats; Not determined,Intermediate,,1969.0,1,10028,BAO_0000218,4514
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625872,1,A,Plasma half-life in rats,Intermediate,,1969.0,1,10029,BAO_0000218,1500
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625873,1,A,Plasma half-life in rats; <MQL,Intermediate,,1969.0,1,10030,BAO_0000218,1500
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625874,1,A,Plasma half-life period (0-8 h) was determined,Intermediate,,1969.0,1,10031,BAO_0000218,5334
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625875,1,A,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,Intermediate,,1969.0,1,10032,BAO_0000218,5334
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625876,1,A,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Intermediate,In vivo,1969.0,1,10033,BAO_0000218,5334
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL631258,1,A,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Intermediate,In vivo,1969.0,1,10034,BAO_0000218,5334
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL631259,1,A,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,Intermediate,,1969.0,1,10035,BAO_0000218,4956
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL631260,1,A,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,Intermediate,,1969.0,1,10036,BAO_0000218,4956
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631261,1,A,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",Intermediate,,178.0,1,10037,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631262,1,A,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",Intermediate,,178.0,1,10038,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631263,1,A,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",Intermediate,,178.0,1,10039,BAO_0000218,7768
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631264,1,A,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",Intermediate,,,1,10040,BAO_0000218,7768
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631265,1,A,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",Intermediate,,,1,10041,BAO_0000218,7768
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631266,1,A,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",Intermediate,,,1,10042,BAO_0000218,7768
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631267,1,A,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",Intermediate,,,1,10043,BAO_0000218,7768
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631268,1,A,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",Intermediate,,,1,10044,BAO_0000218,7768
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631269,1,A,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",Intermediate,,,1,10045,BAO_0000218,7768
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631270,1,A,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",Intermediate,,,1,10046,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL631271,1,A,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Intermediate,,948.0,1,10047,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL631272,1,A,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",Intermediate,,948.0,1,10048,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL631273,1,A,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",Intermediate,,948.0,1,10049,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL631274,1,A,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",Intermediate,,948.0,1,10050,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL631275,1,A,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",Intermediate,,948.0,1,10051,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL626984,1,A,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",Intermediate,,948.0,1,10052,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL626985,1,A,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",Intermediate,,948.0,1,10053,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL626986,1,A,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Intermediate,,2107.0,1,10054,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL626987,1,A,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",Intermediate,,2107.0,1,10055,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL626988,1,A,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",Intermediate,,2107.0,1,10056,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL626989,1,A,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",Intermediate,,2107.0,1,10057,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL626990,1,A,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",Intermediate,,2107.0,1,10058,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL626991,1,A,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",Intermediate,,2107.0,1,10059,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL626992,1,A,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",Intermediate,,2107.0,1,10060,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626993,1,A,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",Intermediate,,2048.0,1,10061,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL874593,1,A,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",Intermediate,,2048.0,1,10062,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626994,1,A,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",Intermediate,,2048.0,1,10063,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626995,1,A,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",Intermediate,,2048.0,1,10064,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626190,1,A,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",Intermediate,,2048.0,1,10065,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626191,1,A,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",Intermediate,,2048.0,1,10066,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626364,1,A,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",Intermediate,,2048.0,1,10067,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626365,1,A,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",Intermediate,,2046.0,1,10068,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626366,1,A,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",Intermediate,,2046.0,1,10069,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626367,1,A,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",Intermediate,,2046.0,1,10070,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626368,1,A,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",Intermediate,,2046.0,1,10071,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626369,1,A,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",Intermediate,,2046.0,1,10072,BAO_0000218,7768
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626370,1,A,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",Intermediate,,2046.0,1,10073,BAO_0000218,7768
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626371,1,A,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",Intermediate,In vivo,,1,10074,BAO_0000218,4498
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626372,1,A,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",Intermediate,In vivo,,1,10075,BAO_0000218,4498
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626373,1,A,Bioavailability after a dose of 10 mg/kg p.o.,Intermediate,In vivo,,1,10076,BAO_0000218,3603
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626374,1,A,Bioavailability after peroral administration (10 mg/kg) was determined in rat,Intermediate,In vivo,,1,10077,BAO_0000218,6215
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626375,1,A,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,Intermediate,In vivo,,1,10078,BAO_0000218,5710
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626376,1,A,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),Intermediate,In vivo,,1,10079,BAO_0000218,5710
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626377,1,A,Bioavailability in rat po was determined,Intermediate,In vivo,,1,10080,BAO_0000218,5676
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626378,1,A,Bioavailability of compound at 10 mg/kg in rat after oral administration,Intermediate,In vivo,,1,10081,BAO_0000218,17667
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626379,1,A,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,Intermediate,In vivo,,1,10082,BAO_0000218,17667
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626380,1,A,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Intermediate,In vivo,,1,10083,BAO_0000218,6848
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626381,1,A,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Intermediate,In vivo,,1,10084,BAO_0000218,6848
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626382,1,A,Bioavailability in rat,Intermediate,In vivo,,1,10085,BAO_0000218,17267
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626383,1,A,Bioavailability in rat (Sprague-Dawley) (female),Intermediate,In vivo,,1,10086,BAO_0000218,6362
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874652,1,A,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Intermediate,In vivo,,1,10087,BAO_0000218,17671
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626384,1,A,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),Intermediate,In vivo,,1,10088,BAO_0000218,17671
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626385,1,A,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,Intermediate,In vivo,,1,10089,BAO_0000218,4333
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626386,1,A,Bioavailability in rat at an oral dose of 2 mg/kg,Intermediate,In vivo,,1,10090,BAO_0000218,6077
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626387,1,A,Bioavailability in rat,Intermediate,In vivo,,1,10091,BAO_0000218,3278
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626388,1,A,Bioavailability in rat,Intermediate,In vivo,,1,10092,BAO_0000218,5964
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626389,1,A,Bioavailability in rat,Intermediate,In vivo,,1,10093,BAO_0000218,4884
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626390,1,A,Bioavailability in rat,Intermediate,In vivo,,1,10094,BAO_0000218,4905
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626391,1,A,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,Intermediate,In vivo,,1,10095,BAO_0000218,4884
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626392,1,A,Bioavailability in rat,Intermediate,In vivo,,1,10096,BAO_0000218,6850
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626393,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10097,BAO_0000218,2864
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623026,1,A,Bioavailability was determined in rat,Intermediate,In vivo,,1,10098,BAO_0000218,5780
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623027,1,A,Bioavailability,Intermediate,In vivo,,1,10099,BAO_0000218,1465
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623028,1,A,Bioavailability,Intermediate,In vivo,,1,10100,BAO_0000218,5199
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623029,1,A,Bioavailability in rat after 1 day dosing,Intermediate,In vivo,,1,10101,BAO_0000218,5765
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623030,1,A,Bioavailability in rat after 4 day dosing,Intermediate,In vivo,,1,10102,BAO_0000218,5765
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623031,1,A,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,Intermediate,In vivo,,1,10103,BAO_0000218,6518
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623032,1,A,Bioavailability after IV dosing at 1 mg/kg in rat; no data,Intermediate,In vivo,,1,10104,BAO_0000218,6518
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623033,1,A,Bioavailability after oral administration at a dose of 2 mg/kg in rat,Intermediate,In vivo,,1,10105,BAO_0000218,6518
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623034,1,A,Bioavailability after oral administration at a dose of 4 mg/kg in rat,Intermediate,In vivo,,1,10106,BAO_0000218,6518
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623035,1,A,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,Intermediate,In vivo,,1,10107,BAO_0000218,2083
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623036,1,A,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Intermediate,In vivo,,1,10108,BAO_0000218,17260
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623037,1,A,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Intermediate,In vivo,,1,10109,BAO_0000218,4956
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623038,1,A,Bioavailability by intravenous administration of 3.4 mg/kg in rat,Intermediate,In vivo,,1,10110,BAO_0000218,4368
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL874385,1,A,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,Intermediate,In vivo,1969.0,1,10111,BAO_0000218,17752
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623039,1,A,Bioavailability in rat (Fisher) (fasted),Intermediate,In vivo,,1,10112,BAO_0000218,1446
,9443.0,,Primates,,,,,U,,,22224,CHEMBL623040,1,A,Bioavailability in monkey after po administration of 10 mg/kg dose,Intermediate,In vivo,,0,10113,BAO_0000218,2891
,9443.0,,Primates,,,,,U,,,22224,CHEMBL623041,1,A,Oral bioavailability in monkey (dose 10 mg/kg),Intermediate,In vivo,,0,10114,BAO_0000218,2891
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623741,1,A,Bioavailability in rat,Intermediate,In vivo,,1,10115,BAO_0000218,6672
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623742,1,A,Bioavailability in rat,Intermediate,In vivo,,1,10116,BAO_0000218,6673
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623743,1,A,Bioavailability in rat,Intermediate,In vivo,,1,10117,BAO_0000218,17655
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623744,1,A,Bioavailability in rat,Intermediate,In vivo,,1,10118,BAO_0000218,17796
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623745,1,A,Bioavailability in rat (dose 2.0 mg/kg p.o.),Intermediate,In vivo,,1,10119,BAO_0000218,17853
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623746,1,A,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),Intermediate,In vivo,,1,10120,BAO_0000218,4521
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623747,1,A,Oral bioavailability in rat (dose 5 mg/kg p.o.),Intermediate,In vivo,,1,10121,BAO_0000218,4940
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL623748,1,A,Bioavailability in rat after po administration of 30 mg/kg dose,Intermediate,In vivo,,0,10122,BAO_0000218,2891
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL623916,1,A,Bioavailability in rat after po administration of 30 mg/kg dose,Intermediate,In vivo,,0,10123,BAO_0000218,2891
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623917,1,A,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Intermediate,In vivo,,1,10124,BAO_0000218,4521
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623918,1,A,Bioavailability in rat (dose 2 mg/kg i.v.),Intermediate,In vivo,,1,10125,BAO_0000218,17686
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874386,1,A,Bioavailability in rat,Intermediate,In vivo,,1,10126,BAO_0000218,17796
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623919,1,A,Bioavailability in rat; Only traces detected in rat plasma,Intermediate,In vivo,1969.0,1,10127,BAO_0000218,17796
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623920,1,A,Bioavailability in rat,Intermediate,In vivo,,1,10128,BAO_0000218,5064
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623148,1,A,Bioavailability upon oral administration of compound,Intermediate,In vivo,,1,10129,BAO_0000218,5147
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623149,1,A,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),Intermediate,In vivo,,1,10130,BAO_0000218,1916
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623150,1,A,Bioavailability in rat,Intermediate,In vivo,,1,10131,BAO_0000218,6049
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623151,1,A,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",Intermediate,In vivo,,1,10132,BAO_0000218,1445
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623152,1,A,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",Intermediate,In vivo,,1,10133,BAO_0000218,1445
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623153,1,F,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,Expert,,,1,10134,BAO_0000218,2862
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623154,1,F,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,Expert,,,1,10135,BAO_0000218,2862
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623155,1,A,In vitro and metabolic stability was determined,Intermediate,,,1,10136,BAO_0000218,4194
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623156,1,A,In vitro metabolic stability in rat hepatocytes,Intermediate,,,1,10137,BAO_0000218,4194
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623157,1,A,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,Intermediate,,,1,10138,BAO_0000218,5486
,10116.0,,Rattus norvegicus,Liver,Hepatocyte,,401.0,N,,,50597,CHEMBL623158,1,A,Metabolic rate for compound was observed in rat hepatocytes,Intermediate,In vitro,2107.0,1,10139,BAO_0000218,17582
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623159,1,A,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,Intermediate,,,1,10140,BAO_0000218,5600
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874390,1,A,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),Intermediate,,,1,10141,BAO_0000218,14294
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623160,1,A,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),Intermediate,,,1,10142,BAO_0000218,14294
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623161,1,A,Metabolism of compound in rat S9 microsomes; Trace,Intermediate,,,1,10143,BAO_0000218,14294
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623162,1,A,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,Intermediate,,,1,10144,BAO_0000218,17847
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623163,1,A,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,Intermediate,,,1,10145,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623164,1,A,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,Intermediate,,,1,10146,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623165,1,A,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,Intermediate,,,1,10147,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623166,1,A,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,Intermediate,,,1,10148,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624983,1,A,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,Intermediate,,,1,10149,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624984,1,A,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,Intermediate,,,1,10150,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624985,1,A,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,Intermediate,,,1,10151,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622970,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,Intermediate,,,1,10152,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622971,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,Intermediate,,,1,10153,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622972,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,Intermediate,,,1,10154,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622973,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,Intermediate,,,1,10155,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622974,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,Intermediate,,,1,10156,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622975,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,Intermediate,,,1,10157,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622976,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,Intermediate,,,1,10158,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622977,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,Intermediate,,,1,10159,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624351,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,Intermediate,,,1,10160,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624352,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,Intermediate,,,1,10161,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624353,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,Intermediate,,,1,10162,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622397,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,Intermediate,,,1,10163,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622398,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,Intermediate,,,1,10164,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622399,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,Intermediate,,,1,10165,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622400,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,Intermediate,,,1,10166,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628428,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,Intermediate,,,1,10167,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628590,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,Intermediate,,,1,10168,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628591,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,Intermediate,,,1,10169,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628592,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,Intermediate,,,1,10170,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628593,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,Intermediate,,,1,10171,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875333,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,Intermediate,,,1,10172,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628594,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,Intermediate,,,1,10173,BAO_0000218,11020
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL628595,1,A,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,Intermediate,,1969.0,1,10174,BAO_0000218,4969
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL628596,1,A,Stability in rat plasma was determined,Intermediate,,1969.0,1,10175,BAO_0000218,6737
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL628597,1,A,Stability in rat plasma was determined; ND= no data,Intermediate,,1969.0,1,10176,BAO_0000218,6737
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL628598,1,A,Tested for plasma half life period in rat (0-8 hr),Intermediate,,1969.0,1,10177,BAO_0000218,5089
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL628599,1,A,Tested for plasma half life period in rat (0-8 hr); Not determined,Intermediate,,1969.0,1,10178,BAO_0000218,5089
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628600,1,A,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,Intermediate,In vivo,,1,10179,BAO_0000218,1466
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628601,1,A,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,Intermediate,In vivo,,1,10180,BAO_0000218,1466
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628602,1,A,Tested for the half life in rat,Intermediate,,,1,10181,BAO_0000218,4950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628603,1,A,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,Intermediate,In vitro,,1,10182,BAO_0000218,2412
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628604,1,A,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,Intermediate,In vitro,,1,10183,BAO_0000218,2412
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628605,1,A,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,Intermediate,In vitro,,1,10184,BAO_0000218,2412
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628606,1,A,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,Intermediate,In vitro,,1,10185,BAO_0000218,2412
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628607,1,A,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,Intermediate,In vitro,,1,10186,BAO_0000218,2412
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628608,1,A,The biological half life the compound was measured at the dose of 100 umol/kg,Intermediate,,,1,10187,BAO_0000218,15022
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628609,1,A,The biological half life the compound was measured at the dose of 30 umol/kg,Intermediate,,,1,10188,BAO_0000218,15022
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL628610,1,A,The compound was evaluated for plasma half life period in rat,Intermediate,,1969.0,1,10189,BAO_0000218,406
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL873819,1,A,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,In vivo,,1,10190,BAO_0000218,15078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628611,1,A,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",Intermediate,In vivo,,1,10191,BAO_0000218,15078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628612,1,A,The pharmacokinetic parameter half-life period in vivo in rats,Intermediate,In vivo,,1,10192,BAO_0000218,5247
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628613,1,A,"The pharmacokinetic property, Half-life was determined",Intermediate,In vivo,,1,10193,BAO_0000218,5041
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628614,1,A,"The pharmacokinetic property, Half-life in rat in vivo",Intermediate,In vivo,,1,10194,BAO_0000218,5041
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628615,1,A,"The pharmacokinetic property, Half-life was determined; ND denotes no data",Intermediate,In vivo,,1,10195,BAO_0000218,5041
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628616,1,A,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",Intermediate,In vivo,,1,10196,BAO_0000218,5041
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627924,1,A,The plasma half life period in rats,Intermediate,,1969.0,1,10197,BAO_0000218,3918
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627925,1,A,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,Intermediate,,2107.0,1,10198,BAO_0000218,2906
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627926,1,A,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Intermediate,In vivo,,1,10199,BAO_0000218,6467
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627927,1,A,t1/2 (apparent elimination)of the compound was determined,Intermediate,,,1,10200,BAO_0000218,5510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627928,1,A,t1/2 value in rat,Intermediate,,,1,10201,BAO_0000218,3788
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627539,1,A,Half life in rat,Intermediate,,,1,10202,BAO_0000218,17796
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL876790,1,A,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Intermediate,In vivo,1969.0,1,10203,BAO_0000218,12873
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL858186,1,A,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,Intermediate,In vivo,,1,10204,BAO_0000218,5983
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627540,1,A,Half-life period in fasted rats,Intermediate,,,1,10205,BAO_0000218,15765
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627541,1,A,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,Intermediate,In vivo,,1,10206,BAO_0000218,2661
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627715,1,A,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,Intermediate,In vivo,,1,10207,BAO_0000218,2661
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627716,1,A,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,Intermediate,In vivo,,1,10208,BAO_0000218,429
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627717,1,A,Maximum time required to achieve Cmax was determined in rat,Intermediate,,,1,10209,BAO_0000218,17655
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627718,1,A,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,In vivo,,1,10210,BAO_0000218,17717
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627719,1,A,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Intermediate,In vivo,,1,10211,BAO_0000218,17717
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627720,1,A,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,Intermediate,In vivo,,1,10212,BAO_0000218,17717
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627721,1,A,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,Intermediate,In vivo,,1,10213,BAO_0000218,6570
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627722,1,A,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,Intermediate,In vivo,,1,10214,BAO_0000218,6570
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627723,1,A,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,10215,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626058,1,A,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,10216,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626059,1,A,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,10217,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626060,1,A,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,10218,BAO_0000218,5978
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626061,1,A,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,Intermediate,In vivo,1969.0,1,10219,BAO_0000218,17720
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876791,1,A,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,In vivo,,1,10220,BAO_0000218,4723
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626062,1,A,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,Intermediate,In vivo,,1,10221,BAO_0000218,4723
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626063,1,A,Tmax at the dose of 2 mg/Kg administered perorally in rats,Intermediate,In vivo,,1,10222,BAO_0000218,4756
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626064,1,A,Tmax at the dose of 5 mg/Kg administered perorally in rats,Intermediate,In vivo,,1,10223,BAO_0000218,4756
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626065,1,A,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,Intermediate,In vivo,1969.0,1,10224,BAO_0000218,17720
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626066,1,A,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,Intermediate,In vivo,1969.0,1,10225,BAO_0000218,17720
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626067,1,A,tmax upon peroral administration of 10.0 mg/Kg dose in rat,Intermediate,In vivo,,1,10226,BAO_0000218,1466
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626068,1,F,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,Intermediate,,,1,10227,BAO_0000218,7449
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626069,1,F,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,Intermediate,,,1,10228,BAO_0000218,7449
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626070,1,F,Percent total excretion of 3-methoxyacetaminophen glucuronide,Intermediate,,,1,10229,BAO_0000218,7449
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626071,1,F,Percent total excretion of N-methoxyacetaminophen glucuronide,Intermediate,,,1,10230,BAO_0000218,7449
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626072,1,F,Percent total excretion of N-methoxyacetaminophen sulfate,Intermediate,,,1,10231,BAO_0000218,7449
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626073,1,F,Percent total excretion of acetaminophen,Intermediate,,,1,10232,BAO_0000218,7449
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626741,1,A,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",Intermediate,,2046.0,1,10233,BAO_0000218,7768
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626742,1,A,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",Intermediate,,,1,10234,BAO_0000218,17655
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626743,1,A,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,Intermediate,,,1,10235,BAO_0000218,17735
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876792,1,A,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,Intermediate,,,1,10236,BAO_0000218,5960
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626744,1,A,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Intermediate,,,1,10237,BAO_0000218,17735
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626745,1,A,Compound was tested for antidiuretic activity in rats,Intermediate,,,1,10238,BAO_0000218,7116
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626746,1,A,AUC in rat after 3mg/kg oral dose,Intermediate,In vivo,1969.0,1,10239,BAO_0000218,4878
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626747,1,A,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,Intermediate,,,1,10240,BAO_0000218,5939
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626748,1,A,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,Intermediate,,,1,10241,BAO_0000218,5939
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626749,1,A,Bioavailability administered orally at a dose of 10 mg/kg to rats,Intermediate,,,1,10242,BAO_0000218,16367
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626750,1,A,Oral Bioavailability was determined,Intermediate,,,1,10243,BAO_0000218,16366
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626751,1,A,Oral bioavailability in rat,Intermediate,,,1,10244,BAO_0000218,4426
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626913,1,A,Oral bioavailability in rat; Not performed.,Intermediate,,,1,10245,BAO_0000218,4426
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626914,1,A,Bioavailability,Intermediate,,,1,10246,BAO_0000218,5041
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626915,1,A,Bioavailability was determined; ND denotes no data,Intermediate,,,1,10247,BAO_0000218,5041
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626916,1,A,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,Intermediate,,,1,10248,BAO_0000218,1500
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626917,1,A,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,Intermediate,,,1,10249,BAO_0000218,1500
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626918,1,A,Binding towards rat plasma protein at 10 uM,Intermediate,,,1,10250,BAO_0000218,17409
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626919,1,A,Binding towards rat plasma protein at 100 uM,Intermediate,,,1,10251,BAO_0000218,17409
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626920,1,A,Bioavailability in rat (dose 20 mg/kg p.o.),Intermediate,In vivo,,1,10252,BAO_0000218,2959
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621976,1,A,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,Intermediate,In vivo,,1,10253,BAO_0000218,13501
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL877599,1,A,Bioavailability in rat after 5 mg/kg oral gavage,Intermediate,In vivo,,1,10254,BAO_0000218,6567
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621977,1,A,Bioavailability in rat,Intermediate,In vivo,,1,10255,BAO_0000218,6571
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621978,1,A,Bioavailability in rat (dose 1 mg/kg i.v.),Intermediate,In vivo,,1,10256,BAO_0000218,6715
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621979,1,A,Bioavailability in rat (dose 3 mg/kg p.o.),Intermediate,In vivo,,1,10257,BAO_0000218,6715
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621980,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10258,BAO_0000218,2932
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621981,1,A,Bioavailability of the compound in rats after administration of 30 mg/kg,Intermediate,In vivo,,1,10259,BAO_0000218,4171
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621982,1,A,Bioavailability after administration of 10 mg/kg in rats,Intermediate,In vivo,,1,10260,BAO_0000218,17509
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL882953,1,A,Bioavailability after administration of 2 mg/kg in rats,Intermediate,In vivo,,1,10261,BAO_0000218,17509
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621983,1,A,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,Intermediate,In vivo,,1,10262,BAO_0000218,4527
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621984,1,A,Bioavailability in dogs was determined; high,Intermediate,In vivo,,1,10263,BAO_0000218,4026
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621985,1,A,Bioavailability in monkey after intravenous administration at 1 mpk,Intermediate,In vivo,,1,10264,BAO_0000218,6659
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621986,1,A,Bioavailability in monkey after peroral administration at 10 mpk,Intermediate,In vivo,,1,10265,BAO_0000218,6659
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621987,1,A,Bioavailability in rat after intravenous administration at 1 mpk,Intermediate,In vivo,,1,10266,BAO_0000218,6659
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL877600,1,F,Bioavailability in rat after intravenous administration at 2 mpk,Intermediate,In vivo,,1,10267,BAO_0000218,6659
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621988,1,A,Bioavailability in rat after peroral administration at 30 mpk,Intermediate,In vivo,,1,10268,BAO_0000218,6659
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621989,1,F,Bioavailability in rat after peroral administration at at 100 mpk,Intermediate,In vivo,,1,10269,BAO_0000218,6659
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621990,1,A,Bioavailability in rats was evaluated,Intermediate,In vivo,,1,10270,BAO_0000218,6597
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621991,1,A,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,Intermediate,In vivo,,1,10271,BAO_0000218,1202
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621992,1,A,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,Intermediate,In vivo,,1,10272,BAO_0000218,1202
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621993,1,A,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,Intermediate,In vivo,,1,10273,BAO_0000218,1202
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621994,1,A,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,Intermediate,In vivo,,1,10274,BAO_0000218,1202
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621995,1,A,Bioavailability in rat,Intermediate,In vivo,,1,10275,BAO_0000218,5207
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621996,1,A,Bioavailability in rat,Intermediate,In vivo,,1,10276,BAO_0000218,5970
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621997,1,A,Oral bioavailability in rat (dose 10 mg/kg),Intermediate,In vivo,,1,10277,BAO_0000218,17538
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621998,1,A,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,Intermediate,In vivo,,1,10278,BAO_0000218,17538
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621999,1,A,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,Intermediate,In vivo,,1,10279,BAO_0000218,1466
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622000,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10280,BAO_0000218,2879
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622001,1,A,Bioavailability was measured in rat after oral administration; 2-4,Intermediate,In vivo,,1,10281,BAO_0000218,2879
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622002,1,A,Bioavailability was measured in rat after oral administration; 3-7,Intermediate,In vivo,,1,10282,BAO_0000218,2879
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622003,1,A,Bioavailability in rat (intraduodenal administration),Intermediate,In vivo,,1,10283,BAO_0000218,3777
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL877601,1,A,Bioavailability in rat (intraduodenal administration),Intermediate,In vivo,,1,10284,BAO_0000218,3777
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624871,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10285,BAO_0000218,3777
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622004,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10286,BAO_0000218,3777
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL882954,1,A,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),Intermediate,In vivo,,1,10287,BAO_0000218,5423
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622005,1,A,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,Intermediate,In vivo,,1,10288,BAO_0000218,16365
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622006,1,A,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,Intermediate,In vivo,,1,10289,BAO_0000218,16365
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622007,1,A,Bioavailability was measured in rat,Intermediate,In vivo,,1,10290,BAO_0000218,4239
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622008,1,A,Bioavailability was reported,Intermediate,In vivo,,1,10291,BAO_0000218,5438
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622009,1,A,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate,In vivo,,1,10292,BAO_0000218,5334
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622010,1,A,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Intermediate,In vivo,,1,10293,BAO_0000218,5334
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622011,1,A,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,Intermediate,In vivo,,1,10294,BAO_0000218,4199
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622012,1,A,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),Intermediate,In vivo,,1,10295,BAO_0000218,4199
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622013,1,A,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),Intermediate,In vivo,,1,10296,BAO_0000218,4199
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622014,1,A,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Intermediate,In vivo,,1,10297,BAO_0000218,4890
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624749,1,A,Bioavailability was determined at 3 mg/kg po dose in rats,Intermediate,In vivo,,1,10298,BAO_0000218,2792
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624750,1,A,Oral bioavailability in rat (dose 2 mg/kg),Intermediate,In vivo,,1,10299,BAO_0000218,5529
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624751,1,A,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",Intermediate,In vivo,,1,10300,BAO_0000218,6685
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624752,1,A,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Intermediate,In vivo,,1,10301,BAO_0000218,6685
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624753,1,A,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Intermediate,In vivo,,1,10302,BAO_0000218,6685
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624754,1,A,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,Intermediate,In vivo,,1,10303,BAO_0000218,6005
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624755,1,A,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,Intermediate,In vivo,,1,10304,BAO_0000218,6410
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624756,1,A,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,Intermediate,In vivo,,1,10305,BAO_0000218,6410
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624757,1,A,Bioavailability in rat,Intermediate,In vivo,,1,10306,BAO_0000218,6103
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624758,1,A,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,Intermediate,In vivo,,1,10307,BAO_0000218,6410
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622270,1,A,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,Intermediate,In vivo,,1,10308,BAO_0000218,6410
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622271,1,A,Bioavailability in rat (Sprague-Dawley),Intermediate,In vivo,,1,10309,BAO_0000218,5353
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622272,1,A,Bioavailability in rat at the dose of 2 mg/kg,Intermediate,In vivo,,1,10310,BAO_0000218,4727
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622273,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10311,BAO_0000218,17804
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622274,1,A,Bioavailability in rat (cannulated) (dose 2 mg/kg),Intermediate,In vivo,,1,10312,BAO_0000218,5809
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622275,1,A,Bioavailability value of compound in rats was determined after peroral administration,Intermediate,In vivo,,1,10313,BAO_0000218,17804
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622276,1,A,Oral bioavailability in rat (dose 20 mg/kg),Intermediate,In vivo,,1,10314,BAO_0000218,3634
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622277,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10315,BAO_0000218,3341
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622278,1,A,Oral bioavailability in rat (dose 5 mg/kg),Intermediate,In vivo,,1,10316,BAO_0000218,2690
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622279,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10317,BAO_0000218,3184
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622280,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10318,BAO_0000218,740
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624083,1,A,Compound was evaluated for oral bioavailability in rats; 15-27 %,Intermediate,In vivo,,1,10319,BAO_0000218,1806
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624084,1,A,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,Intermediate,In vivo,,1,10320,BAO_0000218,4891
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624085,1,A,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),Intermediate,In vivo,,1,10321,BAO_0000218,3634
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624086,1,A,Compound was tested for bioavailability in rats,Intermediate,In vivo,,1,10322,BAO_0000218,64
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624087,1,A,Bioavailability in rat,Intermediate,In vivo,,1,10323,BAO_0000218,4839
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624088,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10324,BAO_0000218,1094
,9544.0,,Macaca mulatta,,,,,U,,,22224,CHEMBL624089,1,A,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,Intermediate,In vivo,,0,10325,BAO_0000218,5005
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL624090,1,A,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Intermediate,In vivo,,0,10326,BAO_0000218,5005
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624091,1,A,Evaluated for the bioavailability in rat (in vivo),Intermediate,In vivo,,1,10327,BAO_0000218,4687
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624092,1,A,F value of compound in rats was determined after peroral administration,Intermediate,In vivo,,1,10328,BAO_0000218,17804
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624093,1,A,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Intermediate,In vivo,,1,10329,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624094,1,A,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Intermediate,In vivo,,1,10330,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624095,1,A,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Intermediate,In vivo,,1,10331,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624096,1,A,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Intermediate,In vivo,,1,10332,BAO_0000218,5974
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624097,1,A,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",Intermediate,In vivo,,1,10333,BAO_0000218,1088
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624098,1,A,Maximum fall in carotid flow in rat,Intermediate,In vivo,,1,10334,BAO_0000218,1742
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874392,1,A,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,Intermediate,In vivo,,1,10335,BAO_0000218,4689
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624099,1,A,Oral bioavailability in rat (dose 5 mg/kg),Intermediate,In vivo,,1,10336,BAO_0000218,2463
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624100,1,A,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Intermediate,In vivo,,1,10337,BAO_0000218,5654
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624101,1,A,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Intermediate,In vivo,,1,10338,BAO_0000218,5654
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624102,1,A,Oral bioavailability in rat (male Wistar),Intermediate,In vivo,,1,10339,BAO_0000218,6874
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624103,1,A,Oral bioavailability after administration (30 mg/kg) in rat; good,Intermediate,In vivo,,1,10340,BAO_0000218,5633
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624104,1,A,Oral bioavailability at the dose of 2 mg/kg in rat,Intermediate,In vivo,,1,10341,BAO_0000218,5496
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624105,1,A,Oral bioavailability determined in rats,Intermediate,In vivo,,1,10342,BAO_0000218,2358
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624106,1,A,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),Intermediate,In vivo,,1,10343,BAO_0000218,16456
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624107,1,A,Oral bioavailability in rat (dose single 10 mg/kg),Intermediate,In vivo,,1,10344,BAO_0000218,5302
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623943,1,A,Oral bioavailability in rat (dose single 10 mg/kg),Intermediate,In vivo,,1,10345,BAO_0000218,5302
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623944,1,A,Oral bioavailability in rat (dose 5 mg/kg,Intermediate,In vivo,,1,10346,BAO_0000218,5302
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623945,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,Intermediate,,,1,10347,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623946,1,A,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,Intermediate,,,1,10348,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623947,1,A,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,Intermediate,,,1,10349,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623948,1,A,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,Intermediate,,,1,10350,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623949,1,A,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,Intermediate,,,1,10351,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623950,1,A,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,Intermediate,,,1,10352,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874398,1,A,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,Intermediate,,,1,10353,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623951,1,A,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,Intermediate,,,1,10354,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623952,1,A,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,Intermediate,,,1,10355,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623953,1,A,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,Intermediate,,,1,10356,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623954,1,A,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,Intermediate,,,1,10357,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623955,1,A,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,Intermediate,,,1,10358,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623956,1,A,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,Intermediate,,,1,10359,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627807,1,A,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,Intermediate,,,1,10360,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627808,1,A,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,Intermediate,,,1,10361,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627809,1,A,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,Intermediate,,,1,10362,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627810,1,A,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,Intermediate,,,1,10363,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627811,1,A,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",Intermediate,,,1,10364,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627812,1,A,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",Intermediate,,,1,10365,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627813,1,A,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",Intermediate,,,1,10366,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627814,1,A,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",Intermediate,,,1,10367,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875336,1,A,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",Intermediate,,,1,10368,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627815,1,A,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",Intermediate,,,1,10369,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627816,1,A,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",Intermediate,,,1,10370,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627817,1,A,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",Intermediate,,,1,10371,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627818,1,A,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",Intermediate,,,1,10372,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627819,1,A,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",Intermediate,,,1,10373,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627820,1,A,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",Intermediate,,,1,10374,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627821,1,A,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",Intermediate,,,1,10375,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628464,1,A,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,Intermediate,,,1,10376,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626239,1,A,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,Intermediate,,,1,10377,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626240,1,A,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,Intermediate,,,1,10378,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626241,1,A,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,Intermediate,,,1,10379,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626242,1,A,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,Intermediate,,,1,10380,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626243,1,A,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,Intermediate,,,1,10381,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626244,1,A,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,Intermediate,,,1,10382,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626907,1,A,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,Intermediate,,,1,10383,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626908,1,A,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,Intermediate,,,1,10384,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626909,1,A,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,Intermediate,,,1,10385,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626910,1,A,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,Intermediate,,,1,10386,BAO_0000218,11020
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875342,1,F,Percent total excretion of acetaminophen cysteine conjugate,Intermediate,,,1,10387,BAO_0000218,7449
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626911,1,F,Percent total excretion of acetaminophen glucuronide,Intermediate,,,1,10388,BAO_0000218,7449
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626912,1,F,Percent total excretion of acetaminophen sulfate,Intermediate,,,1,10389,BAO_0000218,7449
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627065,1,F,Percent total excretion of acetaminophen-mercapturic acid,Intermediate,,,1,10390,BAO_0000218,7449
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL627066,1,A,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,Intermediate,,1088.0,1,10391,BAO_0000218,3172
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627067,1,A,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Intermediate,In vivo,,1,10392,BAO_0000218,16456
,8656.0,,ratrat,Muscle tissue,,,,U,,,22224,CHEMBL627068,1,A,Biodistribution of compound in rat muscle after 5 min of administration,Autocuration,In vivo,2385.0,0,10393,BAO_0000218,10839
,8656.0,,ratrat,Muscle tissue,,,,U,,,22224,CHEMBL627069,1,A,Biodistribution of compound in rat muscle after 5 min of administration.,Autocuration,In vivo,2385.0,0,10394,BAO_0000218,10839
,9940.0,,Ovis aries,,,,,U,,,22224,CHEMBL627070,1,A,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Autocuration,In vivo,,0,10395,BAO_0000218,5334
,9940.0,,Ovis aries,,,,,U,,,22224,CHEMBL627071,1,A,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Autocuration,In vivo,,0,10396,BAO_0000218,5334
,9940.0,,Ovis aries,,,,,U,,,22224,CHEMBL627072,1,A,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Autocuration,In vivo,,0,10397,BAO_0000218,5334
,9940.0,,Ovis aries,,,,,U,,,22224,CHEMBL627073,1,A,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Autocuration,In vivo,,0,10398,BAO_0000218,5334
,9940.0,,Ovis aries,,,,,U,,,22224,CHEMBL625387,1,A,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Autocuration,In vivo,,0,10399,BAO_0000218,5334
,9940.0,,Ovis aries,,,,,U,,,22224,CHEMBL625388,1,A,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Autocuration,In vivo,,0,10400,BAO_0000218,5334
,9940.0,,Ovis aries,Plasma,,,,U,,,22224,CHEMBL625389,1,A,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Autocuration,In vivo,1969.0,0,10401,BAO_0000218,5334
,9940.0,,Ovis aries,Plasma,,,,U,,,22224,CHEMBL875343,1,A,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Autocuration,In vivo,1969.0,0,10402,BAO_0000218,5334
,8570.0,,Serpentes,,,,,N,,,50497,CHEMBL876795,1,A,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),Intermediate,,,1,10403,BAO_0000218,1735
,8570.0,,Serpentes,,,,,N,,,50497,CHEMBL626552,1,A,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,Intermediate,,,1,10404,BAO_0000218,1469
,8570.0,,Serpentes,,,,,N,,,50497,CHEMBL626553,1,A,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,Intermediate,,,1,10405,BAO_0000218,1336
,9606.0,,Homo sapiens,Plasma,,,,U,,,22224,CHEMBL626554,1,A,The human biological plasma half life of the compound,Autocuration,,1969.0,0,10406,BAO_0000366,12403
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626555,1,A,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Intermediate,,1088.0,1,10407,BAO_0000218,8151
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626556,1,A,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,Intermediate,,,1,10408,BAO_0000218,8004
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626557,1,A,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,Intermediate,,,1,10409,BAO_0000218,8004
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626558,1,A,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,Intermediate,,,1,10410,BAO_0000218,8004
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626559,1,A,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,Intermediate,,,1,10411,BAO_0000218,8004
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626560,1,A,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,Intermediate,,,1,10412,BAO_0000218,8004
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876803,1,A,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,Intermediate,,,1,10413,BAO_0000218,8004
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627964,1,A,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,Intermediate,,,1,10414,BAO_0000218,8004
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627965,1,A,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,Intermediate,,,1,10415,BAO_0000218,8004
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627966,1,A,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,Intermediate,,,1,10416,BAO_0000218,8004
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627967,1,A,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,Intermediate,,,1,10417,BAO_0000218,8004
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627968,1,A,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,Intermediate,,,1,10418,BAO_0000218,8004
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627969,1,A,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,Intermediate,,,1,10419,BAO_0000218,8004
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627970,1,A,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,Intermediate,,,1,10420,BAO_0000218,8004
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627971,1,A,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,Intermediate,,178.0,1,10421,BAO_0000218,8004
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627972,1,A,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,Intermediate,,178.0,1,10422,BAO_0000218,8004
,9606.0,,Homo sapiens,,,,,D,,,180,CHEMBL856029,1,B,Dissociation constant against binding to human cyclophilin A,Expert,,,9,10423,BAO_0000357,15917
,9913.0,,Bos taurus,,,,,H,,,11591,CHEMBL627973,1,B,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,Expert,,,8,10424,BAO_0000019,12396
,,,,,,,,U,,,22224,CHEMBL627974,1,A,-Log C was determined by performing the electroshock minimum test,Autocuration,,,0,10425,BAO_0000019,7065
,,,,,,,,U,,,22224,CHEMBL627975,1,A,-Log C was determined by performing the foot shock test,Autocuration,,,0,10426,BAO_0000019,7065
,,,,,,,,U,,,22224,CHEMBL627976,1,A,-Log C was determined by performing the incl screen test,Autocuration,,,0,10427,BAO_0000019,7065
,,,,,,,,U,,,22224,CHEMBL627977,1,A,-Log C was determined by performing the maximum electroshock test,Autocuration,,,0,10428,BAO_0000019,7065
,,,,,,,,U,,,22224,CHEMBL627978,1,A,-Log C was determined by performing the pentylenetetrazole test,Autocuration,,,0,10429,BAO_0000019,7065
,,,,,,,,U,,,22224,CHEMBL627979,1,A,Tested for experimental arotinoid inhibitory dose,Autocuration,,,0,10430,BAO_0000019,12415
,,,,,,,,U,,,22224,CHEMBL876804,1,A,Negative log transformed activity,Autocuration,,,0,10431,BAO_0000019,10256
,,,,,,,,U,,,22224,CHEMBL627980,1,A,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",Autocuration,,,0,10432,BAO_0000019,7991
,10141.0,,Cavia porcellus,,,,,N,,,50512,CHEMBL627981,1,A,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,Intermediate,,,1,10433,BAO_0000218,14342
,10141.0,,Cavia porcellus,,,,,N,,,50512,CHEMBL627982,1,A,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,Intermediate,,,1,10434,BAO_0000218,14342
,10141.0,,Cavia porcellus,,,,,N,,,50512,CHEMBL627983,1,A,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,Intermediate,,,1,10435,BAO_0000218,14342
,10141.0,,Cavia porcellus,Ileum,,,,N,,,50512,CHEMBL627984,1,A,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,Intermediate,,2116.0,1,10436,BAO_0000218,14342
,,,,,,,,U,,,22229,CHEMBL627985,1,P,Solubility in water was determined; values expressed as -log,Autocuration,,,0,10437,BAO_0000100,6047
,,,,,,,,U,,,22224,CHEMBL627986,1,A,Ratio of Kcat to that of Km was determined,Autocuration,,,0,10438,BAO_0000019,17269
,,,,,,,,U,,,22224,CHEMBL627987,1,A,Observed first order rate constant,Autocuration,,,0,10439,BAO_0000019,10026
,,,,,,,,U,,,22224,CHEMBL627988,1,A,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,Autocuration,,,0,10440,BAO_0000019,14583
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627989,1,A,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,Intermediate,In vivo,,1,10441,BAO_0000218,2661
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627990,1,A,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,Intermediate,In vivo,,1,10442,BAO_0000218,2661
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876805,1,A,Oral Bioavailability after administration of 10 mg/kg in male rat,Intermediate,In vivo,,1,10443,BAO_0000218,4029
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627991,1,A,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),Intermediate,In vivo,,1,10444,BAO_0000218,17735
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627992,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10445,BAO_0000218,4576
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627993,1,A,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,Intermediate,In vivo,,1,10446,BAO_0000218,17582
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622817,1,A,Oral bioavailability at 1 mg/kg was determined in rat,Intermediate,In vivo,,1,10447,BAO_0000218,17651
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622818,1,A,Oral bioavailability at 10 mg/kg was determined in rat,Intermediate,In vivo,,1,10448,BAO_0000218,17651
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622819,1,A,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",Intermediate,In vivo,,1,10449,BAO_0000218,17670
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL872267,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10450,BAO_0000218,5045
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622820,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10451,BAO_0000218,1696
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622821,1,A,Oral bioavailability after intravenous administration in rats at 24 uM/kg,Intermediate,In vivo,,1,10452,BAO_0000218,17764
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622822,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10453,BAO_0000218,6448
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622823,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10454,BAO_0000218,6596
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622824,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10455,BAO_0000218,17547
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622825,1,A,Oral bioavailability in rat at a dose of 3 mg/kg,Intermediate,In vivo,,1,10456,BAO_0000218,17771
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622901,1,A,Oral bioavailability in rat after oral administration at 10 mg/kg,Intermediate,In vivo,,1,10457,BAO_0000218,6495
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622902,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10458,BAO_0000218,4558
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621844,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10459,BAO_0000218,17596
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621845,1,A,Oral bioavailability in Dawley rats,Intermediate,In vivo,,1,10460,BAO_0000218,6827
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621846,1,A,Oral bioavailability,Intermediate,In vivo,,1,10461,BAO_0000218,4026
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621847,1,A,Oral bioavailability in rat (dose 30 mg/kg),Intermediate,In vivo,,1,10462,BAO_0000218,10
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL877609,1,A,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,Intermediate,In vivo,,1,10463,BAO_0000218,17717
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621848,1,A,Bioavailability in rat (dose 3 mg/kg i.v.),Intermediate,In vivo,,1,10464,BAO_0000218,17717
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621849,1,A,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,Intermediate,In vivo,,1,10465,BAO_0000218,17717
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622030,1,A,Oral bioavailability in rat (dose 60 mg/kg p.o.),Intermediate,In vivo,,1,10466,BAO_0000218,17717
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622031,1,A,Percent oral bioavailability determined in rats,Intermediate,In vivo,,1,10467,BAO_0000218,4796
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622032,1,A,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Intermediate,In vivo,,1,10468,BAO_0000218,4883
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622033,1,A,The compound was evaluated for bioavailability in rats; 32-51,Intermediate,In vivo,,1,10469,BAO_0000218,2137
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622034,1,A,Bioavailability in rat (dose 20 mg/kg p.o.),Intermediate,In vivo,,1,10470,BAO_0000218,2959
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622035,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10471,BAO_0000218,1361
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL882966,1,A,Bioavailability percent in rat at the dose of 2 mg/kg,Intermediate,In vivo,,1,10472,BAO_0000218,4727
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622036,1,A,Bioavailability was evaluated after 20 uM/kg of peroral administration,Intermediate,In vivo,,1,10473,BAO_0000218,16423
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622037,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10474,BAO_0000218,5206
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622038,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10475,BAO_0000218,6448
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622039,1,A,Bioavailability in rats,Intermediate,In vivo,,1,10476,BAO_0000218,17723
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL622040,1,A,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,Intermediate,In vivo,178.0,1,10477,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL622041,1,A,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,Intermediate,In vivo,178.0,1,10478,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL622042,1,A,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,Intermediate,In vivo,178.0,1,10479,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL622043,1,A,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,Intermediate,In vivo,178.0,1,10480,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL622044,1,A,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,Intermediate,In vivo,178.0,1,10481,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL622045,1,A,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,Intermediate,In vivo,10000001.0,1,10482,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL622046,1,A,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,Intermediate,In vivo,10000001.0,1,10483,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL622047,1,A,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,Intermediate,In vivo,10000001.0,1,10484,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL877610,1,A,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,Intermediate,In vivo,10000001.0,1,10485,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL622048,1,A,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,Intermediate,In vivo,955.0,1,10486,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL622049,1,A,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,Intermediate,In vivo,955.0,1,10487,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL622050,1,A,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,Intermediate,In vivo,955.0,1,10488,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL622051,1,A,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,Intermediate,In vivo,955.0,1,10489,BAO_0000218,17738
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622052,1,A,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,Intermediate,In vivo,,1,10490,BAO_0000218,17738
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622053,1,A,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,Intermediate,In vivo,,1,10491,BAO_0000218,17738
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622054,1,A,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,Intermediate,In vivo,,1,10492,BAO_0000218,17738
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622055,1,A,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,Intermediate,In vivo,,1,10493,BAO_0000218,17738
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622056,1,A,Oral bioavailability in rats was determined; High,Intermediate,In vivo,,1,10494,BAO_0000218,5237
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622057,1,A,Oral bioavailability in the rat was determined,Intermediate,In vivo,,1,10495,BAO_0000218,5503
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628008,1,A,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,Intermediate,In vivo,,1,10496,BAO_0000218,15765
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622058,1,A,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),Intermediate,In vivo,,1,10497,BAO_0000218,15660
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622059,1,A,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,10498,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622060,1,A,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,10499,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622061,1,A,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,10500,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622062,1,A,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Intermediate,In vivo,,1,10501,BAO_0000218,5978
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622063,1,A,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,Intermediate,In vivo,,1,10502,BAO_0000218,5656
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL877611,1,A,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,Expert,In vivo,,1,10503,BAO_0000218,3598
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622064,1,A,Oral bioavailability of compound in Sprague Dawley rats,Intermediate,In vivo,,1,10504,BAO_0000218,4216
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622065,1,A,Oral bioavailability of compound in rat,Intermediate,In vivo,,1,10505,BAO_0000218,17839
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622066,1,A,Oral bioavailability in rat (dose 2 mg/kg),Intermediate,In vivo,,1,10506,BAO_0000218,6570
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622067,1,A,Oral bioavailability of compound in rat was determined,Intermediate,In vivo,,1,10507,BAO_0000218,5334
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622068,1,A,Oral bioavailability of compound in rats,Intermediate,In vivo,,1,10508,BAO_0000218,6886
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622069,1,A,Oral bioavailability of compound was determined in rats,Intermediate,In vivo,,1,10509,BAO_0000218,5210
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624796,1,A,Oral bioavailability at a dose of 30 mg/kg in rats,Intermediate,In vivo,,1,10510,BAO_0000218,4170
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624797,1,A,Oral bioavailability in rat (dose 10 mg/kg),Intermediate,In vivo,,1,10511,BAO_0000218,6028
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623053,1,A,Oral bioavailability in rat (dose 10 mg/kg),Intermediate,In vivo,,1,10512,BAO_0000218,6028
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623054,1,A,Oral bioavailability evaluated in rat,Intermediate,In vivo,,1,10513,BAO_0000218,6078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623055,1,A,Oral bioavailability in fasted rat,Intermediate,In vivo,,1,10514,BAO_0000218,6168
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623056,1,A,Oral bioavailability in fed rat,Intermediate,In vivo,,1,10515,BAO_0000218,6168
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623057,1,A,Oral bioavailability in rat (mature male) (dose 30 mg/kg),Intermediate,In vivo,,1,10516,BAO_0000218,5160
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623058,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10517,BAO_0000218,6057
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623059,1,A,Oral bioavailability in rat (dose 10 mg/kg p.o.),Intermediate,In vivo,,1,10518,BAO_0000218,6535
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623060,1,A,Oral bioavailability in rat after administration of 10 mg/kg po,Intermediate,In vivo,,1,10519,BAO_0000218,6535
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623061,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10520,BAO_0000218,4194
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623062,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10521,BAO_0000218,6230
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623063,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10522,BAO_0000218,6619
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623064,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10523,BAO_0000218,17607
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623065,1,A,Oral bioavailability in ratrs,Intermediate,In vivo,,1,10524,BAO_0000218,4942
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623066,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10525,BAO_0000218,4942
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623067,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10526,BAO_0000218,6646
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623068,1,A,Oral bioavailability in rats was determined; High,Intermediate,In vivo,,1,10527,BAO_0000218,5237
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623069,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10528,BAO_0000218,6646
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623070,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10529,BAO_0000218,4449
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623071,1,A,Oral bioavailability was calculated in rat,Intermediate,In vivo,,1,10530,BAO_0000218,6057
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623072,1,A,Oral bioavailability,Intermediate,In vivo,,1,10531,BAO_0000218,2552
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623073,1,A,Oral bioavailability,Intermediate,In vivo,,1,10532,BAO_0000218,5496
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623074,1,A,Oral bioavailability,Intermediate,In vivo,,1,10533,BAO_0000218,6484
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623075,1,A,Oral bioavailability,Intermediate,In vivo,,1,10534,BAO_0000218,6485
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623076,1,A,Oral bioavailability after i.v. administration,Intermediate,In vivo,,1,10535,BAO_0000218,6616
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623077,1,A,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate,In vivo,,1,10536,BAO_0000218,4969
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623078,1,A,Oral bioavailability in rat (Sprague-Dawley),Intermediate,In vivo,,1,10537,BAO_0000218,5862
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623079,1,A,Oral bioavailability in Sprague-Dawley rats,Intermediate,In vivo,,1,10538,BAO_0000218,4514
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623080,1,A,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate,In vivo,,1,10539,BAO_0000218,4514
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623081,1,A,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Intermediate,In vivo,,1,10540,BAO_0000218,4514
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623082,1,A,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,Intermediate,In vivo,,1,10541,BAO_0000218,5546
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874400,1,A,Oral bioavailability in fasted rat,Intermediate,In vivo,,1,10542,BAO_0000218,6168
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623083,1,A,Oral bioavailability in fed rat,Intermediate,In vivo,,1,10543,BAO_0000218,6168
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623084,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10544,BAO_0000218,3624
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623085,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10545,BAO_0000218,5213
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623086,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10546,BAO_0000218,5496
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623087,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10547,BAO_0000218,5553
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623088,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10548,BAO_0000218,5833
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623089,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10549,BAO_0000218,5836
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623090,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10550,BAO_0000218,5865
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623091,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10551,BAO_0000218,5960
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623092,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10552,BAO_0000218,6249
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623093,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10553,BAO_0000218,6448
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874401,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10554,BAO_0000218,6453
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623094,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10555,BAO_0000218,6640
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623095,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10556,BAO_0000218,17607
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623096,1,A,Oral bioavailability in rat after peroral administration at 10 mg/kg,Intermediate,In vivo,,1,10557,BAO_0000218,5939
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624913,1,A,Oral bioavailability in rat after peroral administration at 5 mg/kg,Intermediate,In vivo,,1,10558,BAO_0000218,5939
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624914,1,A,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),Intermediate,In vivo,,1,10559,BAO_0000218,6281
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624915,1,A,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,Intermediate,In vivo,,1,10560,BAO_0000218,5874
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624916,1,A,Oral bioavailability in rat; Not measured,Intermediate,In vivo,,1,10561,BAO_0000218,5213
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624917,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10562,BAO_0000218,4964
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625157,1,A,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,Intermediate,,,1,10563,BAO_0000218,11020
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625158,1,A,In vitro metabolic potential in rat liver microsomes,Intermediate,,2107.0,1,10564,BAO_0000218,6251
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625159,1,A,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",Intermediate,In vivo,,1,10565,BAO_0000218,1568
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625160,1,A,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",Intermediate,In vivo,,1,10566,BAO_0000218,3032
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625161,1,A,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,Intermediate,In vivo,,1,10567,BAO_0000218,3748
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625162,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10568,BAO_0000218,401
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625163,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10569,BAO_0000218,6512
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625164,1,A,Oral bioavailability in rats at 10 mg/kg,Intermediate,In vivo,,1,10570,BAO_0000218,17617
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625165,1,A,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Intermediate,In vivo,,1,10571,BAO_0000218,6679
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625166,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10572,BAO_0000218,6742
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625167,1,A,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,Intermediate,,,1,10573,BAO_0000218,589
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625168,1,A,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,Intermediate,,,1,10574,BAO_0000218,589
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625169,1,A,Plasma clearance of the compound,Intermediate,In vivo,,1,10575,BAO_0000218,3185
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626264,1,A,Plasma clearance at 10 mg/kg in rat upon intravenous administration,Intermediate,In vivo,,1,10576,BAO_0000218,17596
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626265,1,A,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,Intermediate,In vivo,,1,10577,BAO_0000218,2713
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626266,1,A,The compound was tested for plasma clearance in rat,Intermediate,In vivo,1969.0,1,10578,BAO_0000218,12500
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626267,1,A,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,Intermediate,In vivo,1969.0,1,10579,BAO_0000218,12500
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626268,1,A,Plasma concentration upon oral administration of 1 mg/Kg in rats,Intermediate,,,1,10580,BAO_0000218,2713
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626269,1,A,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,Intermediate,,,1,10581,BAO_0000218,1446
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626270,1,A,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,Intermediate,,,1,10582,BAO_0000218,6227
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626271,1,A,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,Intermediate,,,1,10583,BAO_0000218,4709
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626272,1,A,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",Intermediate,,,1,10584,BAO_0000218,5510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626273,1,A,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",Intermediate,,,1,10585,BAO_0000218,5510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875346,1,A,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",Intermediate,,,1,10586,BAO_0000218,5510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626274,1,A,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",Intermediate,,,1,10587,BAO_0000218,5510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626275,1,A,Compound was tested for protein binding in rat plasma,Intermediate,,,1,10588,BAO_0000218,4514
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624646,1,A,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,Intermediate,,,1,10589,BAO_0000218,2713
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624647,1,A,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,Intermediate,,,1,10590,BAO_0000218,2713
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL624648,1,A,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,Intermediate,,2107.0,1,10591,BAO_0000218,5340
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624649,1,A,Area under curve ratio was determined (po/iv) in rat,Intermediate,,,1,10592,BAO_0000218,12058
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624650,1,A,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,Intermediate,,,1,10593,BAO_0000218,11195
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624651,1,A,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,Intermediate,,,1,10594,BAO_0000218,11195
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624652,1,A,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,Intermediate,,,1,10595,BAO_0000218,11195
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624653,1,A,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,Intermediate,,,1,10596,BAO_0000218,6495
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624654,1,A,Ratio of AUCbrain to AUCplasma,Intermediate,,,1,10597,BAO_0000218,6078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624655,1,A,Ratio of brain to plasma,Intermediate,,,1,10598,BAO_0000218,5656
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624656,1,A,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,Intermediate,,,1,10599,BAO_0000218,4910
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624657,1,A,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,Intermediate,,,1,10600,BAO_0000218,4910
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624658,1,A,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,Intermediate,,,1,10601,BAO_0000218,4910
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624659,1,A,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,Intermediate,,,1,10602,BAO_0000218,10130
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624660,1,A,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,Intermediate,,,1,10603,BAO_0000218,10130
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624661,1,A,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,Intermediate,,,1,10604,BAO_0000218,10130
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624662,1,A,Steady state brain :blood ratio was determined,Intermediate,,,1,10605,BAO_0000218,5213
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625199,1,A,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,,,1,10606,BAO_0000218,4910
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625200,1,A,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,Intermediate,,,1,10607,BAO_0000218,4910
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625201,1,A,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,Intermediate,,,1,10608,BAO_0000218,4910
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625202,1,A,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,Intermediate,,,1,10609,BAO_0000218,4910
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625203,1,A,Percentage recovery after 3h incubation with rat hapatocytes was determined,Intermediate,,,1,10610,BAO_0000218,2083
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625204,1,A,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,Intermediate,,,1,10611,BAO_0000218,2082
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625205,1,A,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,Intermediate,,,1,10612,BAO_0000218,2082
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625206,1,A,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,Intermediate,,,1,10613,BAO_0000218,6351
,,,,,,,,U,,,22224,CHEMBL625207,1,A,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",Autocuration,,,0,10614,BAO_0000019,14583
,,,,,,,,U,,,22224,CHEMBL625208,1,A,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,Autocuration,,,0,10615,BAO_0000019,14583
,9606.0,,Homo sapiens,,Caco-2,,495.0,N,,,50587,CHEMBL625209,1,A,In vivo absorption in Caco-2 cell line monolayers was determined,Intermediate,,,1,10616,BAO_0000218,4608
,,,,,,,,U,,,22229,CHEMBL625210,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,10617,BAO_0000100,13668
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625211,1,A,Area under curve was determine after peroral administration at 10 mpk in Rat,Intermediate,,,1,10618,BAO_0000218,5669
,9544.0,,Macaca mulatta,,,,,N,,,50797,CHEMBL625212,1,A,Area under curve was determine after peroral administration at 10 mpk in Rhesus,Intermediate,,,1,10619,BAO_0000218,5669
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625213,1,A,Area under curve was determine after peroral administration at 160 mpk in Rat,Intermediate,,,1,10620,BAO_0000218,5669
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625214,1,A,Area under curve was determine after peroral administration at 20 mpk in Rat,Intermediate,,,1,10621,BAO_0000218,5669
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874542,1,A,Area under curve was determine after peroral administration at 50 mpk in Rat,Intermediate,,,1,10622,BAO_0000218,5669
,,,,,,,,U,,,22229,CHEMBL625215,1,P,Calculated partition coefficient (clogP) (AlogP),Autocuration,,,0,10623,BAO_0000100,6472
,,,,,,,,U,,,22224,CHEMBL625216,1,A,Activated partial thromboplastin time measured,Autocuration,,,0,10624,BAO_0000019,15106
,,,,,,,,U,,,22224,CHEMBL625217,1,P,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),Autocuration,,,0,10625,BAO_0000100,15207
,,,,,,,,U,,,22224,CHEMBL625218,1,P,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),Autocuration,,,0,10626,BAO_0000100,15207
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL622864,1,A,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,Intermediate,,1969.0,1,10627,BAO_0000218,13941
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622865,1,A,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,Intermediate,,1969.0,1,10628,BAO_0000218,13941
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622866,1,A,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,Intermediate,,1969.0,1,10629,BAO_0000218,13941
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL622867,1,A,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,Intermediate,,1969.0,1,10630,BAO_0000218,13941
,10141.0,,Cavia porcellus,Plasma,,,,N,,,50512,CHEMBL876808,1,A,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,Intermediate,,1969.0,1,10631,BAO_0000218,15240
,,,,Brain,,,,U,,,22224,CHEMBL627725,1,A,AUC in brain,Autocuration,,955.0,0,10632,BAO_0000019,10655
,,,,Serum,,,,U,,,22224,CHEMBL627726,1,A,AUC in serum,Autocuration,,1977.0,0,10633,BAO_0000019,10655
,,,,Plasma,,,,U,,,22224,CHEMBL627727,1,A,AUC was determined,Autocuration,,1969.0,0,10634,BAO_0000019,6504
,,,,Plasma,,,,U,,,22224,CHEMBL627728,1,A,AUC of the compound.,Autocuration,,1969.0,0,10635,BAO_0000019,10615
,,,,Plasma,,,,U,,,22224,CHEMBL627729,1,A,AUC value (0-4 hr),Autocuration,,1969.0,0,10636,BAO_0000019,10353
,,,,Plasma,,,,U,,,22224,CHEMBL627730,1,A,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",Autocuration,,1969.0,0,10637,BAO_0000019,14907
,,,,Plasma,,,,U,,,22224,CHEMBL627731,1,A,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,Autocuration,,1969.0,0,10638,BAO_0000019,14907
,,,,Plasma,,,,U,,,22224,CHEMBL627732,1,A,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",Autocuration,,1969.0,0,10639,BAO_0000019,14907
,,,,Plasma,,,,U,,,22224,CHEMBL627733,1,A,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",Autocuration,,1969.0,0,10640,BAO_0000019,14907
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627734,1,A,AUC(area under curve) was determined after intravenous administration in rats,Intermediate,,1969.0,1,10641,BAO_0000218,16359
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627735,1,A,AUC(area under curve) was determined after oral administration in rats,Intermediate,,1969.0,1,10642,BAO_0000218,16359
,10141.0,,Cavia porcellus,Plasma,,,,N,,,50512,CHEMBL627736,1,A,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,Intermediate,,1969.0,1,10643,BAO_0000218,15240
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL876809,1,A,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,Intermediate,,1969.0,1,10644,BAO_0000218,15240
,,,,,,,,U,,,22224,CHEMBL627737,1,A,Area Under Curve after oral dosing of 100 uM/Kg,Autocuration,,,0,10645,BAO_0000019,15469
,,,,,,,,U,,,22224,CHEMBL627738,1,A,Area Under Curve after oral dosing of 30 uM/Kg,Autocuration,,,0,10646,BAO_0000019,15469
,,,,,,,,U,,,22224,CHEMBL627739,1,A,Area Under Curve was measured by ploting the graph between concentration verses time,Autocuration,,,0,10647,BAO_0000019,13520
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626143,1,A,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,Intermediate,,,1,10648,BAO_0000218,17025
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL626144,1,A,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,Autocuration,,,0,10649,BAO_0000218,17025
,9986.0,,Oryctolagus cuniculus,,,,,N,,,50592,CHEMBL626145,1,A,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,Intermediate,,,1,10650,BAO_0000218,17025
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626146,1,A,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,Intermediate,,,1,10651,BAO_0000218,17025
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626147,1,A,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,Intermediate,,178.0,1,10652,BAO_0000218,12032
,,,,,,,,U,,,22224,CHEMBL626148,1,A,Area under curve (AUC) was determined,Autocuration,,,0,10653,BAO_0000019,10291
,,,,,,,,U,,,22224,CHEMBL626149,1,A,Area under curve (AUC) following ip administration at 1 mg/kg,Autocuration,,,0,10654,BAO_0000218,5767
,,,,,,,,U,,,22224,CHEMBL626150,1,A,Area under curve (AUC) was determined; ND is Not determined,Autocuration,,,0,10655,BAO_0000019,1434
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626151,1,A,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,Intermediate,,,1,10656,BAO_0000218,14925
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626152,1,A,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,Intermediate,,,1,10657,BAO_0000218,14925
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626153,1,A,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,Intermediate,,,1,10658,BAO_0000218,14925
,,,,,,,,U,,,22224,CHEMBL626154,1,A,Area under curve (AUR) was determined,Autocuration,,,0,10659,BAO_0000019,1434
,,,,,,,,U,,,22224,CHEMBL626155,1,A,Area under curve at 1 uM/dg administered intravenously,Autocuration,,,0,10660,BAO_0000019,11883
,,,,,,,,U,,,22224,CHEMBL626156,1,A,Area under curve at 10 uM/dg administered perorally,Autocuration,,,0,10661,BAO_0000019,11883
,,,,,,,,U,,,22224,CHEMBL626157,1,A,Area under curve at 2 uM/dg administered intravenously,Autocuration,,,0,10662,BAO_0000019,11883
,,,,,,,,U,,,22224,CHEMBL626158,1,A,Area under curve at 20 uM/dg administered perorally,Autocuration,,,0,10663,BAO_0000019,11883
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626159,1,A,Area under curve at a peroral dose of 3 mg/kg in dog,Intermediate,,,1,10664,BAO_0000218,15233
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626160,1,A,Area under curve at a peroral dose of 3 mg/kg in rat,Intermediate,,,1,10665,BAO_0000218,15233
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626161,1,A,Area under curve at an iv dose of 1 mg/kg in dog,Intermediate,,,1,10666,BAO_0000218,15233
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626162,1,A,Area under curve at an iv dose of 1 mg/kg in rat,Intermediate,,,1,10667,BAO_0000218,15233
,,,,,,,,U,,,22224,CHEMBL626163,1,A,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,Autocuration,,,0,10668,BAO_0000019,12978
,,,,,,,,U,,,22224,CHEMBL626164,1,A,Area under curve gives the effective duration for the angiotensin II antagonist effect.,Autocuration,,,0,10669,BAO_0000019,12978
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL626165,1,A,Area under curve measured as conc vs time after intravenous administration to mice.,Intermediate,,,1,10670,BAO_0000218,11355
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL626166,1,A,Area under curve measured as conc vs time after peroral administration to mice.,Intermediate,,,1,10671,BAO_0000218,11355
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626167,1,A,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,Intermediate,,,1,10672,BAO_0000218,12923
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626168,1,A,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,Intermediate,,,1,10673,BAO_0000218,12923
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL877463,1,A,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,Intermediate,,,1,10674,BAO_0000218,12923
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626169,1,A,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,Intermediate,,,1,10675,BAO_0000218,12923
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL626170,1,A,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,Intermediate,In vivo,948.0,1,10676,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL626171,1,A,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,Intermediate,In vivo,948.0,1,10677,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL626172,1,A,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,Intermediate,In vivo,948.0,1,10678,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL626173,1,A,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,Intermediate,In vivo,948.0,1,10679,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626174,1,A,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,Intermediate,In vivo,2113.0,1,10680,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626175,1,A,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,Intermediate,In vivo,2113.0,1,10681,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626176,1,A,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,Intermediate,In vivo,2113.0,1,10682,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626177,1,A,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,Intermediate,In vivo,2113.0,1,10683,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL622499,1,A,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,Intermediate,In vivo,2113.0,1,10684,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622500,1,A,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,Intermediate,In vivo,2107.0,1,10685,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622501,1,A,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,Intermediate,In vivo,2107.0,1,10686,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622502,1,A,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,Intermediate,In vivo,2107.0,1,10687,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622503,1,A,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,Intermediate,In vivo,2107.0,1,10688,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL877614,1,A,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,Intermediate,In vivo,2107.0,1,10689,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624839,1,A,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,Intermediate,In vivo,2048.0,1,10690,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624840,1,A,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,Intermediate,In vivo,2048.0,1,10691,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624841,1,A,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,Intermediate,In vivo,2048.0,1,10692,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624842,1,A,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,Intermediate,In vivo,2048.0,1,10693,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL624843,1,A,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,Intermediate,In vivo,2385.0,1,10694,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL624844,1,A,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,Intermediate,In vivo,2385.0,1,10695,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL624845,1,A,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,Intermediate,In vivo,2385.0,1,10696,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL621904,1,A,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,Intermediate,In vivo,2385.0,1,10697,BAO_0000218,17738
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL621905,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,Intermediate,In vivo,178.0,1,10698,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL874382,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,Intermediate,In vivo,178.0,1,10699,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL621906,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,Intermediate,In vivo,178.0,1,10700,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL621907,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,Intermediate,In vivo,955.0,1,10701,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL622096,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,Intermediate,In vivo,955.0,1,10702,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL622097,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,Intermediate,In vivo,955.0,1,10703,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL622098,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,Intermediate,In vivo,948.0,1,10704,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL622099,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,Intermediate,In vivo,948.0,1,10705,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL622100,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,Intermediate,In vivo,948.0,1,10706,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL622101,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,Intermediate,In vivo,2113.0,1,10707,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL622102,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,Intermediate,In vivo,2113.0,1,10708,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL622103,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,Intermediate,In vivo,2113.0,1,10709,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622104,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,Intermediate,In vivo,2107.0,1,10710,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622105,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,Intermediate,In vivo,2107.0,1,10711,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622106,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,Intermediate,In vivo,2107.0,1,10712,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622107,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,Intermediate,In vivo,2048.0,1,10713,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622108,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,Intermediate,In vivo,2048.0,1,10714,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622109,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,Intermediate,In vivo,2048.0,1,10715,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL622110,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,Intermediate,In vivo,2385.0,1,10716,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL622111,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,Intermediate,In vivo,2385.0,1,10717,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL874383,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,Intermediate,In vivo,2385.0,1,10718,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Zone of skin,,,,N,,,50597,CHEMBL622112,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,Intermediate,In vivo,14.0,1,10719,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Zone of skin,,,,N,,,50597,CHEMBL622113,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,Intermediate,In vivo,14.0,1,10720,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Zone of skin,,,,N,,,50597,CHEMBL622114,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,Intermediate,In vivo,14.0,1,10721,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL622115,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,Intermediate,In vivo,2106.0,1,10722,BAO_0000218,11195
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL622116,1,A,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,Intermediate,In vivo,2106.0,1,10723,BAO_0000218,11195
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622117,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10724,BAO_0000218,6193
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622118,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10725,BAO_0000218,6803
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622119,1,A,Oral bioavailability in rats at 6 mg/kg,Intermediate,In vivo,,1,10726,BAO_0000218,6647
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622120,1,A,Oral bioavailability in rat (dose 6 mg/kg),Intermediate,In vivo,,1,10727,BAO_0000218,6647
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622121,1,A,Oral bioavailability in rats at 6 mg/kg dose; Not tested,Intermediate,In vivo,,1,10728,BAO_0000218,6647
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622122,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10729,BAO_0000218,6640
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622123,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10730,BAO_0000218,6641
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622124,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10731,BAO_0000218,6641
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622125,1,A,Bioavailability in rat,Intermediate,In vivo,,1,10732,BAO_0000218,6642
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622126,1,A,Oral bioavailability,Intermediate,In vivo,,1,10733,BAO_0000218,5472
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620455,1,A,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Intermediate,In vivo,,1,10734,BAO_0000218,6141
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620456,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10735,BAO_0000218,4390
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620457,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10736,BAO_0000218,5472
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620458,1,A,Oral bioavailability was evaluated; Not tested,Intermediate,In vivo,,1,10737,BAO_0000218,5472
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620459,1,A,Oral bioavailability,Intermediate,In vivo,,1,10738,BAO_0000218,5438
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620460,1,A,Oral bioavailability in rat by oral dosing,Intermediate,In vivo,,1,10739,BAO_0000218,4883
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620461,1,A,Oral bioavailability in rat (dose 10 mg/kg p.o.),Intermediate,In vivo,,1,10740,BAO_0000218,1908
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620462,1,A,Oral bioavailability in rat (Sprague-Dawley),Intermediate,In vivo,,1,10741,BAO_0000218,4853
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620463,1,A,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate,In vivo,,1,10742,BAO_0000218,4853
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620464,1,A,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Intermediate,In vivo,,1,10743,BAO_0000218,4853
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620465,1,A,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Intermediate,In vivo,,1,10744,BAO_0000218,4853
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620466,1,A,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),Intermediate,In vivo,,1,10745,BAO_0000218,4853
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620467,1,A,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,Intermediate,In vivo,,1,10746,BAO_0000218,4853
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620468,1,A,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,Intermediate,In vivo,,1,10747,BAO_0000218,4853
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620469,1,A,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,Intermediate,In vivo,,1,10748,BAO_0000218,12873
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620470,1,A,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,Intermediate,In vivo,,1,10749,BAO_0000218,12873
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620471,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10750,BAO_0000218,3169
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620472,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10751,BAO_0000218,6305
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620473,1,A,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,Intermediate,In vivo,,1,10752,BAO_0000218,4762
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620474,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10753,BAO_0000218,17847
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620475,1,A,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),Intermediate,In vivo,,1,10754,BAO_0000218,6211
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620476,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10755,BAO_0000218,6011
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620477,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10756,BAO_0000218,6317
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620478,1,A,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,Intermediate,In vivo,,1,10757,BAO_0000218,6644
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618768,1,A,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,Intermediate,In vivo,,1,10758,BAO_0000218,6644
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618769,1,A,Oral bioavailability in rat after oral administration at 13 mg/kg dose,Intermediate,In vivo,,1,10759,BAO_0000218,6644
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618770,1,A,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,Intermediate,In vivo,,1,10760,BAO_0000218,6644
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618771,1,A,Oral bioavailability (dose 20 mg/kg p.o.),Intermediate,In vivo,,1,10761,BAO_0000218,6113
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618772,1,A,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,Intermediate,In vivo,,1,10762,BAO_0000218,5937
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618773,1,A,Oral bioavailability in rat at 10 mg/kg of the compound,Intermediate,In vivo,,1,10763,BAO_0000218,5711
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875842,1,A,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,Intermediate,In vivo,,1,10764,BAO_0000218,17717
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618774,1,A,Bioavailability in rat (dose 3 mg/kg i.v.),Intermediate,In vivo,,1,10765,BAO_0000218,17717
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618775,1,A,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,Intermediate,In vivo,,1,10766,BAO_0000218,17717
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618776,1,A,Oral bioavailability in rat (dose 60 mg/kg p.o.),Intermediate,In vivo,,1,10767,BAO_0000218,17717
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618777,1,A,Percent bioavailability (F) in rats after iv administration,Intermediate,In vivo,,1,10768,BAO_0000218,4722
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618778,1,A,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,Intermediate,In vivo,,1,10769,BAO_0000218,4722
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618779,1,A,Bioavailability in rat (dose 5 uM/kg p.o.),Intermediate,In vivo,,1,10770,BAO_0000218,4353
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618780,1,A,Oral bioavailability,Intermediate,In vivo,,1,10771,BAO_0000218,15662
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618781,1,A,Bioavailability in rat (dose 2 mg/kg p.o.),Intermediate,In vivo,,1,10772,BAO_0000218,4756
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618782,1,A,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,Intermediate,In vivo,,1,10773,BAO_0000218,4756
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618783,1,A,Oral bioavailability in rat (dose 20 mg/kg),Intermediate,In vivo,,1,10774,BAO_0000218,3436
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618784,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10775,BAO_0000218,17800
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618785,1,A,Percent oral bioavailability evaluated in rat,Intermediate,In vivo,,1,10776,BAO_0000218,15762
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618786,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10777,BAO_0000218,5089
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618787,1,A,Percent oral bioavailability in rat; Not determined,Intermediate,In vivo,,1,10778,BAO_0000218,5089
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618788,1,A,Oral bioavailability in rat,Intermediate,In vivo,,1,10779,BAO_0000218,3185
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618789,1,A,Bioavailability in rat,Intermediate,In vivo,,1,10780,BAO_0000218,5145
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618790,1,A,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),Intermediate,In vivo,,1,10781,BAO_0000218,3457
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618791,1,A,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),Intermediate,In vivo,,1,10782,BAO_0000218,3457
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875843,1,A,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,Intermediate,In vivo,,1,10783,BAO_0000218,5983
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL618792,1,A,Oral bioavailability in rat (dose 20 mg/kg p.o.),Intermediate,In vivo,,1,10784,BAO_0000218,5739
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623395,1,A,Cmax at a dose of 30 mg/kg in rat,Intermediate,In vivo,,1,10785,BAO_0000218,3579
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL623396,1,A,Cmax in monkeys at a dose of 1 mg/kg,Autocuration,In vivo,,0,10786,BAO_0000218,17788
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623397,1,A,Cmax in rat,Intermediate,In vivo,,1,10787,BAO_0000218,14956
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623398,1,A,Cmax in rats at a dose of 1 mg/kg,Intermediate,In vivo,,1,10788,BAO_0000218,17788
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623399,1,A,Cmax was measured in mice after an oral dose of 50 mg/kg.,Intermediate,In vivo,,1,10789,BAO_0000218,9750
,,,,,,,,U,,,22224,CHEMBL623400,1,A,"Cmax value at a dose of 12.7 uM/kg, po",Autocuration,In vivo,,0,10790,BAO_0000218,12767
,,,,,,,,U,,,22224,CHEMBL623401,1,A,"Cmax value at a dose of 6.3 uM/kg, iv",Autocuration,In vivo,,0,10791,BAO_0000218,12767
,,,,,,,,U,,,22224,CHEMBL623402,1,A,"Cmax value at a dose of 7.1 uM/kg, iv",Autocuration,In vivo,,0,10792,BAO_0000218,12767
,,,,,,,,U,,,22224,CHEMBL623403,1,A,Cmax value of compound was determined after 1 hr,Autocuration,In vivo,,0,10793,BAO_0000218,12703
,,,,,,,,U,,,22224,CHEMBL623404,1,A,Cmax value of the compound,Autocuration,In vivo,,0,10794,BAO_0000218,15778
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625997,1,A,Cmax value administered intraintestinal in rats.,Intermediate,In vivo,,1,10795,BAO_0000218,12818
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625998,1,A,Cmax value administered perorally was determined in rat; Not determined,Intermediate,In vivo,,1,10796,BAO_0000218,14964
,,,,,,,,U,,,22224,CHEMBL625999,1,A,Cmax value at the dose of 2.3 mg/kg,Autocuration,In vivo,,0,10797,BAO_0000218,15808
,,,,,,,,U,,,22224,CHEMBL626000,1,A,Cmax value at the dose of 5 mg/kg,Autocuration,In vivo,,0,10798,BAO_0000218,15808
,,,,,,,,U,,,22224,CHEMBL626001,1,A,Cmax value in the period of 8 hr after dosing. ,Autocuration,In vivo,,0,10799,BAO_0000218,15778
,,,,,,,,U,,,22224,CHEMBL626002,1,A,Cmax value at a oral dose of 20 mg/kg; Not tested,Autocuration,In vivo,,0,10800,BAO_0000218,3715
,,,,,,,,U,,,22224,CHEMBL626003,1,A,Cmax value at a oral dose of 20 mg/kg,Autocuration,In vivo,,0,10801,BAO_0000218,3715
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626004,1,A,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,Intermediate,In vivo,,1,10802,BAO_0000218,1446
,10141.0,,Cavia porcellus,,,,,N,,,50512,CHEMBL626005,1,A,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,Intermediate,In vivo,,1,10803,BAO_0000218,15240
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626006,1,A,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,Intermediate,In vivo,,1,10804,BAO_0000218,15240
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626007,1,A,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,Intermediate,In vivo,1969.0,1,10805,BAO_0000218,14810
,10090.0,,Mus musculus,Plasma,,,,N,,,50594,CHEMBL626008,1,A,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,Intermediate,In vivo,1969.0,1,10806,BAO_0000218,14239
,9615.0,,Canis lupus familiaris,Liver,,,,N,,,50588,CHEMBL626009,1,A,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,Intermediate,In vivo,2107.0,1,10807,BAO_0000218,12555
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626010,1,A,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,Intermediate,In vivo,,1,10808,BAO_0000218,10754
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL626011,1,A,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,Intermediate,In vivo,178.0,1,10809,BAO_0000218,10754
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL626012,1,A,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,Intermediate,In vivo,178.0,1,10810,BAO_0000218,10754
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL626013,1,A,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,Intermediate,In vivo,178.0,1,10811,BAO_0000218,10754
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL626014,1,A,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,Intermediate,In vivo,178.0,1,10812,BAO_0000218,10754
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL877496,1,A,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,Intermediate,In vivo,178.0,1,10813,BAO_0000218,10754
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626015,1,F,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,Intermediate,In vivo,,1,10814,BAO_0000218,14600
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626016,1,F,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,Intermediate,In vivo,,1,10815,BAO_0000218,14600
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626017,1,F,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,Intermediate,In vivo,,1,10816,BAO_0000218,14600
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL626018,1,A,Bioavailability as maximal plasma concentration in dogs,Intermediate,In vivo,1969.0,1,10817,BAO_0000218,13543
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL626692,1,A,Bioavailability as maximal plasma concentration in dogs,Intermediate,In vivo,1969.0,1,10818,BAO_0000218,13543
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626693,1,A,Bioavailability as maximal plasma concentration in rats,Intermediate,In vivo,1969.0,1,10819,BAO_0000218,13543
,10116.0,,Rattus norvegicus,Plasma,,,,U,,,22224,CHEMBL626694,1,A,Bioavailability as maximal plasma concentration in rats,Autocuration,In vivo,1969.0,0,10820,BAO_0000218,13543
,9615.0,,Canis lupus familiaris,Blood,,,,N,,,50588,CHEMBL626695,1,A,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate,In vivo,178.0,1,10821,BAO_0000218,14600
,9615.0,,Canis lupus familiaris,Blood,,,,N,,,50588,CHEMBL626696,1,A,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate,In vivo,178.0,1,10822,BAO_0000218,14600
,9615.0,,Canis lupus familiaris,Blood,,,,N,,,50588,CHEMBL626697,1,A,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate,In vivo,178.0,1,10823,BAO_0000218,14600
,9615.0,,Canis lupus familiaris,Blood,,,,N,,,50588,CHEMBL626859,1,A,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,Intermediate,In vivo,178.0,1,10824,BAO_0000218,14600
,9615.0,,Canis lupus familiaris,Blood,,,,N,,,50588,CHEMBL626860,1,A,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate,In vivo,178.0,1,10825,BAO_0000218,14600
,9615.0,,Canis lupus familiaris,Blood,,,,N,,,50588,CHEMBL626861,1,A,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Intermediate,In vivo,178.0,1,10826,BAO_0000218,14600
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626296,1,A,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,Intermediate,In vivo,,1,10827,BAO_0000218,14681
,,,,,,,,U,,,22224,CHEMBL626297,1,A,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,Autocuration,In vivo,,0,10828,BAO_0000218,15905
,,,,Plasma,,,,U,,,22224,CHEMBL626298,1,A,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,Autocuration,In vivo,1969.0,0,10829,BAO_0000218,15905
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626299,1,A,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",Intermediate,In vivo,1969.0,1,10830,BAO_0000218,13304
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626300,1,A,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,Intermediate,In vivo,1969.0,1,10831,BAO_0000218,15137
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626301,1,A,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,Intermediate,In vivo,1969.0,1,10832,BAO_0000218,15137
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626962,1,A,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,Intermediate,In vivo,1969.0,1,10833,BAO_0000218,15137
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626963,1,A,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,Intermediate,In vivo,1969.0,1,10834,BAO_0000218,15137
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626964,1,A,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,Intermediate,In vivo,1969.0,1,10835,BAO_0000218,15137
,9541.0,,Macaca fascicularis,Plasma,,,,N,,,100710,CHEMBL626965,1,A,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,Intermediate,In vivo,1969.0,1,10836,BAO_0000218,14839
,10090.0,,Mus musculus,Plasma,,,,N,,,50594,CHEMBL626966,1,A,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,In vivo,1969.0,1,10837,BAO_0000218,14839
,10090.0,,Mus musculus,Plasma,,,,N,,,50594,CHEMBL626967,1,A,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,In vivo,1969.0,1,10838,BAO_0000218,14839
,9541.0,,Macaca fascicularis,Plasma,,,,N,,,100710,CHEMBL626968,1,A,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,Intermediate,In vivo,1969.0,1,10839,BAO_0000218,14839
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL626969,1,A,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,Intermediate,,948.0,1,10840,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL627126,1,A,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,Intermediate,,948.0,1,10841,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL631276,1,A,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,Intermediate,,948.0,1,10842,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL631277,1,A,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,Intermediate,,948.0,1,10843,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL631278,1,A,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,Intermediate,,948.0,1,10844,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL874457,1,A,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,Intermediate,,948.0,1,10845,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL631279,1,A,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,Intermediate,,948.0,1,10846,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL631280,1,A,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,Intermediate,,948.0,1,10847,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL631281,1,A,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,Intermediate,,948.0,1,10848,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL631968,1,A,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,Intermediate,,948.0,1,10849,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL631969,1,A,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,Intermediate,,948.0,1,10850,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL631970,1,A,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,Intermediate,,948.0,1,10851,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL631971,1,A,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,Intermediate,,948.0,1,10852,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL631972,1,A,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,Intermediate,,948.0,1,10853,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL630435,1,A,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,Intermediate,,948.0,1,10854,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL630436,1,A,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,Intermediate,,948.0,1,10855,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL630437,1,A,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,Intermediate,,948.0,1,10856,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL630438,1,A,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,Intermediate,,948.0,1,10857,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL630439,1,A,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,Intermediate,,948.0,1,10858,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL630440,1,A,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,Intermediate,,2113.0,1,10859,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL630441,1,A,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,Intermediate,,2113.0,1,10860,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL630442,1,A,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,Intermediate,,2113.0,1,10861,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL625234,1,A,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,Intermediate,,2113.0,1,10862,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL625235,1,A,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,Intermediate,,2113.0,1,10863,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL625236,1,A,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,Intermediate,,2113.0,1,10864,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL625237,1,A,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,Intermediate,,2113.0,1,10865,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626125,1,A,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,Intermediate,,2113.0,1,10866,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626126,1,A,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,Intermediate,,2113.0,1,10867,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626127,1,A,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,Intermediate,,2113.0,1,10868,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626128,1,A,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,Intermediate,,2113.0,1,10869,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626129,1,A,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,Intermediate,,2113.0,1,10870,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626130,1,A,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,Intermediate,,2113.0,1,10871,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626131,1,A,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,Intermediate,,2113.0,1,10872,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626132,1,A,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,Intermediate,,2113.0,1,10873,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626752,1,A,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,Intermediate,,2113.0,1,10874,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626753,1,A,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,Intermediate,,2113.0,1,10875,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626754,1,A,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,Intermediate,,2113.0,1,10876,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626755,1,A,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,Intermediate,,2113.0,1,10877,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL626756,1,A,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,Intermediate,,2107.0,1,10878,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL626757,1,A,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,Intermediate,,2107.0,1,10879,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL626758,1,A,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,Intermediate,,2107.0,1,10880,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL626759,1,A,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,Intermediate,,2107.0,1,10881,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL626760,1,A,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,Intermediate,,2107.0,1,10882,BAO_0000218,8418
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626394,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,10883,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626395,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,Intermediate,,,1,10884,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626396,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),Intermediate,,,1,10885,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626397,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Intermediate,,,1,10886,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626398,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Intermediate,,,1,10887,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626399,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,10888,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874653,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,Intermediate,,,1,10889,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626400,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,10890,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626401,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Intermediate,,,1,10891,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626402,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Intermediate,,,1,10892,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626403,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Intermediate,,,1,10893,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626404,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,10894,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626405,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,Intermediate,,,1,10895,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625529,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,10896,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625530,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Intermediate,,,1,10897,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625531,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Intermediate,,,1,10898,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625532,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Intermediate,,,1,10899,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625533,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,10900,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875474,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,Intermediate,,,1,10901,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625534,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,10902,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625535,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Intermediate,,,1,10903,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625536,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),Intermediate,,,1,10904,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625537,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Intermediate,,,1,10905,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625538,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,10906,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625539,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,Intermediate,,,1,10907,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625540,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,10908,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625541,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Intermediate,,,1,10909,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625542,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Intermediate,,,1,10910,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625543,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Intermediate,,,1,10911,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625544,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,10912,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625545,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,Intermediate,,,1,10913,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625546,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Intermediate,,,1,10914,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625547,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,Intermediate,,,1,10915,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625548,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,10916,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625549,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,10917,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625550,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),Intermediate,,,1,10918,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625551,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,10919,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL875475,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,10920,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625552,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,10921,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625553,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),Intermediate,,,1,10922,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625554,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Intermediate,,,1,10923,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625555,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Intermediate,,,1,10924,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625556,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,10925,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624986,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,Intermediate,,,1,10926,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624987,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),Intermediate,,,1,10927,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624988,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Intermediate,,,1,10928,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL624989,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,Intermediate,In vivo,1637.0,1,10929,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL624990,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,Intermediate,In vivo,1637.0,1,10930,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL874391,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,Intermediate,In vivo,1637.0,1,10931,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL624991,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,Intermediate,In vivo,1637.0,1,10932,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL624992,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,Intermediate,In vivo,1637.0,1,10933,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL624993,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,Intermediate,In vivo,1637.0,1,10934,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL624994,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,Intermediate,In vivo,1637.0,1,10935,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL624995,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,Intermediate,In vivo,1637.0,1,10936,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL624996,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,Intermediate,In vivo,1637.0,1,10937,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL624997,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,Intermediate,In vivo,1637.0,1,10938,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL624998,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,Intermediate,In vivo,1637.0,1,10939,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL624999,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,Intermediate,In vivo,1637.0,1,10940,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL882955,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,Intermediate,In vivo,1637.0,1,10941,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL625000,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,Intermediate,In vivo,1637.0,1,10942,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL625001,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,Intermediate,In vivo,1637.0,1,10943,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL625089,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,Intermediate,In vivo,1637.0,1,10944,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL625090,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,Intermediate,In vivo,1637.0,1,10945,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL625091,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,Intermediate,In vivo,1637.0,1,10946,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL625092,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,Intermediate,In vivo,1637.0,1,10947,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL625093,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,Intermediate,In vivo,1637.0,1,10948,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL625094,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,Intermediate,In vivo,1637.0,1,10949,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL625095,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,Intermediate,In vivo,1637.0,1,10950,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625096,1,A,Compound was evaluated for its bioavailability in the dogs,Intermediate,In vivo,,1,10951,BAO_0000218,2249
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625097,1,A,Compound was evaluated for its bioavailability in the rats,Intermediate,In vivo,,1,10952,BAO_0000218,2249
,,,,,,,,U,,,22224,CHEMBL882956,1,A,Compound was evaluated for oral bioavailability,Autocuration,In vivo,,0,10953,BAO_0000218,17515
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625098,1,A,Compound was evaluated for percentage of Oral bioavailability in rats,Intermediate,In vivo,,1,10954,BAO_0000218,14541
,10141.0,,Cavia porcellus,,,,,U,,,22224,CHEMBL625099,1,A,Bioavailability in guinea pig,Autocuration,In vivo,,0,10955,BAO_0000218,12797
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625100,1,A,Compound was evaluated for the oral bioavailability in rat,Intermediate,In vivo,,1,10956,BAO_0000218,12797
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625101,1,A,Compound was evaluated for the oral bioavailability in dog,Intermediate,In vivo,,1,10957,BAO_0000218,12797
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874396,1,A,Compound was evaluated for the oral bioavailability in rat,Intermediate,In vivo,,1,10958,BAO_0000218,12797
,9615.0,,Canis lupus familiaris,,,,,U,,,22224,CHEMBL625102,1,F,Bioavailability in dog (dosed i.v.),Autocuration,In vivo,,0,10959,BAO_0000218,11727
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625103,1,A,Compound was tested for in vivo bioavailability in dog,Intermediate,In vivo,,1,10960,BAO_0000218,13249
,10026.0,,Cricetinae,,,,,N,,,100712,CHEMBL625104,1,A,Compound was tested for in vivo bioavailability in hamsters,Intermediate,In vivo,,1,10961,BAO_0000218,13249
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL625105,1,A,Compound was tested for in vivo bioavailability in monkey,Autocuration,In vivo,,0,10962,BAO_0000218,13249
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625106,1,A,Compound was tested for in vivo bioavailability in rat,Intermediate,In vivo,,1,10963,BAO_0000218,13249
,10090.0,,Mus musculus,,,,,U,,,22224,CHEMBL625107,1,A,Oral bioavailability in mouse,Autocuration,In vivo,,0,10964,BAO_0000218,9552
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625108,1,A,Compound was tested for percent of oral bioavailability in mice; 56-74,Intermediate,In vivo,,1,10965,BAO_0000218,9552
,10090.0,,Mus musculus,,,,,U,,,22224,CHEMBL625109,1,A,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),Autocuration,In vivo,,0,10966,BAO_0000218,14839
,9541.0,,Macaca fascicularis,,,,,U,,,22224,CHEMBL625110,1,A,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),Autocuration,In vivo,,0,10967,BAO_0000218,14839
,9541.0,,Macaca fascicularis,,,,,U,,,22224,CHEMBL625111,1,A,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),Autocuration,In vivo,,0,10968,BAO_0000218,14839
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625112,1,A,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),Intermediate,In vivo,,1,10969,BAO_0000218,14839
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL875334,1,A,Oral bioavailability in nude mice,Intermediate,In vivo,,1,10970,BAO_0000218,14839
,9443.0,,Primates,,,,,U,,,22224,CHEMBL628617,1,A,Bioavailability in monkey (i.d. dosing),Autocuration,In vivo,,0,10971,BAO_0000218,11219
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL628618,1,A,Bioavailability in rat,Autocuration,In vivo,,0,10972,BAO_0000218,9552
,,,,,,,,U,,,22224,CHEMBL628619,1,A,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,Autocuration,In vivo,,0,10973,BAO_0000218,11732
,,,,,,,,U,,,22224,CHEMBL628620,1,A,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,Autocuration,In vivo,,0,10974,BAO_0000218,11732
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL628621,1,A,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Intermediate,In vivo,,1,10975,BAO_0000218,14839
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL628622,1,A,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Intermediate,In vivo,,1,10976,BAO_0000218,14839
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL628623,1,A,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Intermediate,In vivo,,1,10977,BAO_0000218,14839
,9541.0,,Macaca fascicularis,Plasma,,,,N,,,100710,CHEMBL628624,1,A,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,Intermediate,In vivo,1969.0,1,10978,BAO_0000218,14839
,10090.0,,Mus musculus,Plasma,,,,N,,,50594,CHEMBL628625,1,A,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,In vivo,1969.0,1,10979,BAO_0000218,14839
,9541.0,,Macaca fascicularis,Plasma,,,,N,,,100710,CHEMBL628626,1,A,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,Intermediate,In vivo,1969.0,1,10980,BAO_0000218,14839
,10090.0,,Mus musculus,Plasma,,,,N,,,50594,CHEMBL627041,1,A,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,In vivo,1969.0,1,10981,BAO_0000218,14839
,10090.0,,Mus musculus,Plasma,,,,N,,,50594,CHEMBL627042,1,A,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,In vivo,1969.0,1,10982,BAO_0000218,14839
,10090.0,,Mus musculus,Plasma,,,,N,,,50594,CHEMBL627043,1,A,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Intermediate,In vivo,1969.0,1,10983,BAO_0000218,14839
,,,,Plasma,,,,U,,,22224,CHEMBL627044,1,A,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,Autocuration,In vivo,1969.0,0,10984,BAO_0000218,13932
,10090.0,,Mus musculus,Plasma,,,,N,,,50594,CHEMBL627045,1,A,Cmax in mouse plasma,Intermediate,In vivo,1969.0,1,10985,BAO_0000218,11637
,,,,Plasma,,,,U,,,22224,CHEMBL627046,1,A,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,Autocuration,In vivo,1969.0,0,10986,BAO_0000218,11637
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627047,1,A,Maximal plasma concentration in rat,Intermediate,In vivo,1969.0,1,10987,BAO_0000218,13960
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627048,1,A,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,Intermediate,In vivo,1969.0,1,10988,BAO_0000218,15905
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627049,1,A,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,Intermediate,In vivo,,1,10989,BAO_0000218,14062
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627050,1,A,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,Intermediate,In vivo,,1,10990,BAO_0000218,14062
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627051,1,A,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,Intermediate,In vivo,,1,10991,BAO_0000218,14062
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627052,1,A,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,Intermediate,In vivo,,1,10992,BAO_0000218,14062
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627053,1,A,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,Intermediate,In vivo,,1,10993,BAO_0000218,14062
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627054,1,A,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,Intermediate,In vivo,,1,10994,BAO_0000218,14062
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627055,1,A,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,Intermediate,In vivo,,1,10995,BAO_0000218,15011
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627056,1,A,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,Intermediate,In vivo,,1,10996,BAO_0000218,15011
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627057,1,A,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),Intermediate,In vivo,,1,10997,BAO_0000218,15011
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627058,1,A,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,Intermediate,In vivo,,1,10998,BAO_0000218,15011
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL626211,1,A,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,Intermediate,In vivo,,1,10999,BAO_0000218,15011
,,,,,,,,U,,,22224,CHEMBL626212,1,A,Maximum Concentration of the compound.,Autocuration,In vivo,,0,11000,BAO_0000218,10291
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626213,1,A,Maximum Concentration was measured after iv administration into Beagle dog,Intermediate,In vivo,,1,11001,BAO_0000218,14599
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626214,1,A,Maximum Concentration was measured after iv administration into Beagle dog.,Intermediate,In vivo,,1,11002,BAO_0000218,14599
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626215,1,A,Maximum Concentration was measured after po administration into Beagle dog,Intermediate,In vivo,,1,11003,BAO_0000218,14599
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626216,1,A,Maximum Concentration was measured after po administration into Beagle dog.,Intermediate,In vivo,,1,11004,BAO_0000218,14599
,,,,Blood,,,,U,,,22224,CHEMBL626217,1,A,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,Autocuration,In vivo,178.0,0,11005,BAO_0000218,12767
,,,,Blood,,,,U,,,22224,CHEMBL626218,1,A,Maximum blood level reached after an iv dose of 12.2 uM/kg,Autocuration,In vivo,178.0,0,11006,BAO_0000218,12767
,,,,Blood,,,,U,,,22224,CHEMBL626219,1,A,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,Autocuration,In vivo,178.0,0,11007,BAO_0000218,12767
,,,,Blood,,,,U,,,22224,CHEMBL626220,1,A,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,Autocuration,In vivo,178.0,0,11008,BAO_0000218,12767
,,,,Blood,,,,U,,,22224,CHEMBL626221,1,A,Maximum blood level reached after an oral dose of 5.0 mg/kg,Autocuration,In vivo,178.0,0,11009,BAO_0000218,12767
,,,,Blood,,,,U,,,22224,CHEMBL626222,1,A,Maximum blood level reached at dose of 10.6 uM/kg orally,Autocuration,In vivo,178.0,0,11010,BAO_0000218,12767
,10141.0,,Cavia porcellus,,,,,N,,,50512,CHEMBL626223,1,A,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,Intermediate,In vivo,,1,11011,BAO_0000218,14706
,10141.0,,Cavia porcellus,,,,,N,,,50512,CHEMBL626224,1,A,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,Intermediate,In vivo,,1,11012,BAO_0000218,14706
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL626225,1,A,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,Intermediate,In vivo,955.0,1,11013,BAO_0000218,14793
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL626226,1,A,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,Intermediate,In vivo,955.0,1,11014,BAO_0000218,14793
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL626227,1,A,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,Intermediate,In vivo,955.0,1,11015,BAO_0000218,14793
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL626228,1,A,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,Intermediate,In vivo,955.0,1,11016,BAO_0000218,14793
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626229,1,A,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Intermediate,In vivo,,1,11017,BAO_0000218,14793
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626921,1,A,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,Intermediate,In vivo,,1,11018,BAO_0000218,14793
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876793,1,A,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,Intermediate,In vivo,,1,11019,BAO_0000218,14793
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625309,1,A,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,Intermediate,In vivo,,1,11020,BAO_0000218,14793
,1423.0,,Bacillus subtilis,,,,,N,,,50278,CHEMBL625310,1,A,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),Intermediate,In vivo,,1,11021,BAO_0000218,10524
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL625311,1,A,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,Autocuration,In vivo,,0,11022,BAO_0000218,11871
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625312,1,A,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,Intermediate,In vivo,,1,11023,BAO_0000218,11871
,,,,,,,,U,,,22224,CHEMBL625313,1,A,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,Autocuration,In vivo,,0,11024,BAO_0000218,3437
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625314,1,A,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,Intermediate,In vivo,,1,11025,BAO_0000218,12038
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625315,1,A,Maximum concentration in male rats after iv administration of 20 mg/kg,Intermediate,In vivo,,1,11026,BAO_0000218,12038
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625316,1,A,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,Intermediate,,2107.0,1,11027,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625317,1,A,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,Intermediate,,2107.0,1,11028,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625318,1,A,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,Intermediate,,2107.0,1,11029,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625319,1,A,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,Intermediate,,2107.0,1,11030,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625320,1,A,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,Intermediate,,2107.0,1,11031,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625321,1,A,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,Intermediate,,2107.0,1,11032,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625322,1,A,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,Intermediate,,2107.0,1,11033,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL876801,1,A,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,Intermediate,,2107.0,1,11034,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625323,1,A,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,Intermediate,,2107.0,1,11035,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625324,1,A,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,Intermediate,,2107.0,1,11036,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625325,1,A,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,Intermediate,,2107.0,1,11037,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625326,1,A,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,Intermediate,,2107.0,1,11038,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625327,1,A,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,Intermediate,,2107.0,1,11039,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625328,1,A,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,Intermediate,,2107.0,1,11040,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL625329,1,A,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,Intermediate,,2048.0,1,11041,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL625330,1,A,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,Intermediate,,2048.0,1,11042,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627774,1,A,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,Intermediate,,2048.0,1,11043,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627775,1,A,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,Intermediate,,2048.0,1,11044,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627949,1,A,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,Intermediate,,2048.0,1,11045,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627950,1,A,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,Intermediate,,2048.0,1,11046,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627951,1,A,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,Intermediate,,2048.0,1,11047,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627952,1,A,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,Intermediate,,2048.0,1,11048,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627953,1,A,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,Intermediate,,2048.0,1,11049,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627954,1,A,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,Intermediate,,2048.0,1,11050,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627955,1,A,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,Intermediate,,2048.0,1,11051,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627956,1,A,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,Intermediate,,2048.0,1,11052,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL876802,1,A,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,Intermediate,,2048.0,1,11053,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627957,1,A,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,Intermediate,,2048.0,1,11054,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627958,1,A,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,Intermediate,,2048.0,1,11055,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627959,1,A,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,Intermediate,,2048.0,1,11056,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627960,1,A,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,Intermediate,,2048.0,1,11057,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627961,1,A,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,Intermediate,,2048.0,1,11058,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627962,1,A,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,Intermediate,,2048.0,1,11059,BAO_0000218,8418
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627963,1,A,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Intermediate,,,1,11060,BAO_0000218,9796
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624759,1,A,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,,,1,11061,BAO_0000218,9796
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624760,1,A,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Intermediate,,,1,11062,BAO_0000218,9796
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624761,1,A,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,,,1,11063,BAO_0000218,9796
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL877607,1,A,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,,,1,11064,BAO_0000218,9796
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL624762,1,A,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Intermediate,,2107.0,1,11065,BAO_0000218,9796
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL624763,1,A,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,,2107.0,1,11066,BAO_0000218,9796
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL624764,1,A,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Intermediate,,2107.0,1,11067,BAO_0000218,9796
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL624765,1,A,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,,2107.0,1,11068,BAO_0000218,9796
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL624766,1,A,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,,2107.0,1,11069,BAO_0000218,9796
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624767,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,11070,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624768,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,Intermediate,,,1,11071,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624769,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),Intermediate,,,1,11072,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624770,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Intermediate,,,1,11073,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624771,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Intermediate,,,1,11074,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624772,1,A,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,11075,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624773,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,Intermediate,,,1,11076,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624774,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,11077,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624775,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Intermediate,,,1,11078,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624776,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Intermediate,,,1,11079,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624777,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Intermediate,,,1,11080,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624778,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,11081,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624779,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,Intermediate,,,1,11082,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624780,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Intermediate,,,1,11083,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624781,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Intermediate,,,1,11084,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL877608,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,11085,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624782,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Intermediate,,,1,11086,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624783,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,11087,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624784,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,Intermediate,,,1,11088,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624785,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,11089,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624786,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Intermediate,,,1,11090,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624787,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Intermediate,,,1,11091,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628676,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,11092,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621842,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,Intermediate,,,1,11093,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL621843,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,11094,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623873,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Intermediate,,,1,11095,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623874,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Intermediate,,,1,11096,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623875,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Intermediate,,,1,11097,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623876,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,11098,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL623877,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,Intermediate,,,1,11099,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL623878,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Intermediate,,,1,11100,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL623879,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,Intermediate,,,1,11101,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL623880,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,11102,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL623881,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,11103,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL623957,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),Intermediate,,,1,11104,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL623958,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,11105,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL623959,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,11106,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL623960,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,11107,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL623961,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),Intermediate,,,1,11108,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL623962,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Intermediate,,,1,11109,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624676,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Intermediate,,,1,11110,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624677,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,11111,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624678,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,Intermediate,,,1,11112,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624679,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),Intermediate,,,1,11113,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624680,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Intermediate,,,1,11114,BAO_0000218,6996
,,,,,,,,U,,,22224,CHEMBL624849,1,A,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,Autocuration,In vivo,,0,11115,BAO_0000218,11732
,,,,,,,,U,,,22224,CHEMBL624850,1,A,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,Autocuration,In vivo,,0,11116,BAO_0000218,11732
,,,,,,,,U,,,22224,CHEMBL874399,1,A,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,Autocuration,In vivo,,0,11117,BAO_0000218,11732
,,,,,,,,U,,,22224,CHEMBL624851,1,A,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,Autocuration,In vivo,,0,11118,BAO_0000218,11732
,,,,,,,,U,,,22224,CHEMBL624852,1,A,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,Autocuration,In vivo,,0,11119,BAO_0000218,11732
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL624853,1,A,Oral bioavailability in rat (dose 10 mg/kg),Autocuration,In vivo,,0,11120,BAO_0000218,13359
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL624854,1,A,Oral bioavailability in rat (Sprague-Dawley),Autocuration,In vivo,,0,11121,BAO_0000218,16618
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL624855,1,A,Oral bioavailability in rat,Autocuration,In vivo,,0,11122,BAO_0000218,13960
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL624856,1,A,Oral bioavailability in rats was determined in vivo,Autocuration,In vivo,,0,11123,BAO_0000218,13917
,9615.0,,Canis lupus familiaris,,,,,U,,,22224,CHEMBL882957,1,A,Oral bioavailability in dog,Autocuration,In vivo,,0,11124,BAO_0000218,14266
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL624857,1,A,Oral bioavailability of compound in monkey,Autocuration,In vivo,,0,11125,BAO_0000218,12359
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622202,1,A,Oral bioavailability of compound in rat,Intermediate,In vivo,,1,11126,BAO_0000218,12359
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL622203,1,A,Bioavailability in rat of PMEA prodrug,Autocuration,In vivo,,0,11127,BAO_0000218,12359
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625522,1,A,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,Intermediate,In vivo,,1,11128,BAO_0000218,12359
,9544.0,,Macaca mulatta,,,,,U,,,22224,CHEMBL622868,1,A,Serum conc at 3 hours following 25 mg/kg dose,Autocuration,In vivo,,0,11129,BAO_0000218,10791
,9544.0,,Macaca mulatta,Urine,,,,U,,,22224,CHEMBL622869,1,A,Urine conc 0-5 hours following 25 mg/kg dose,Autocuration,In vivo,1088.0,0,11130,BAO_0000218,10791
,9544.0,,Macaca mulatta,Urine,,,,U,,,22224,CHEMBL622870,1,A,Urine conc 0-24 hours following 25 mg/kg dose,Autocuration,In vivo,1088.0,0,11131,BAO_0000218,10791
,9534.0,,Chlorocebus aethiops,,,,,U,,,22224,CHEMBL622871,1,A,Oral bioavailability in African green monkeys; 20-25,Autocuration,In vivo,,0,11132,BAO_0000218,138
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL620560,1,A,Oral bioavailability in cynomolgus monkey.,Intermediate,In vivo,,1,11133,BAO_0000218,14521
,9615.0,,Canis lupus familiaris,,,,,U,,,22224,CHEMBL620561,1,A,Oral bioavailability in dog,Autocuration,In vivo,,0,11134,BAO_0000218,13953
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL620562,1,A,Oral bioavailability in dog at 10 mg/kg oral dose,Intermediate,In vivo,,1,11135,BAO_0000218,12836
,10026.0,,Cricetinae,,,,,N,,,100712,CHEMBL620563,1,A,Oral bioavailability in hamster at 10 mg/kg oral dose,Intermediate,In vivo,,1,11136,BAO_0000218,12836
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL620564,1,A,Oral bioavailability in rat at 10 mg/kg oral dose,Intermediate,In vivo,,1,11137,BAO_0000218,12836
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL872265,1,A,Oral bioavailability in rat,Autocuration,In vivo,,0,11138,BAO_0000218,14521
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL620565,1,A,Oral bioavailability in rat,Autocuration,In vivo,,0,11139,BAO_0000218,13953
,9347.0,,Eutheria,,,,,U,,,22224,CHEMBL620566,1,A,Oral bioavailability,Autocuration,In vivo,,0,11140,BAO_0000218,6799
,,,,,,,,U,,,22224,CHEMBL620567,1,A,Oral bioavailability was determined; range 49-102%,Autocuration,In vivo,,0,11141,BAO_0000218,11311
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL620568,1,A,Oral bioavailability was determined in dogs,Intermediate,In vivo,,1,11142,BAO_0000218,4013
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL620569,1,A,Oral bioavailability in rat,Autocuration,In vivo,,0,11143,BAO_0000218,4013
,9347.0,,Eutheria,,,,,U,,,22224,CHEMBL620570,1,A,Oral bioavailability,Autocuration,In vivo,,0,11144,BAO_0000218,17591
,,,,,,,,U,,,22224,CHEMBL620571,1,A,Oral bioavailability was determined; Not orally available,Autocuration,In vivo,,0,11145,BAO_0000218,17591
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL620572,1,A,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),Intermediate,In vivo,,1,11146,BAO_0000218,15011
,10090.0,,Mus musculus,,,,,U,,,22224,CHEMBL620573,1,A,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),Autocuration,In vivo,,0,11147,BAO_0000218,15011
,10090.0,,Mus musculus,,,,,U,,,22224,CHEMBL620574,1,A,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,Autocuration,In vivo,,0,11148,BAO_0000218,15011
,9544.0,,Macaca mulatta,,,,,U,,,22224,CHEMBL620575,1,A,Oral bioavailability in Rhesus monkey,Autocuration,In vivo,,0,11149,BAO_0000218,9552
,9615.0,,Canis lupus familiaris,,,,,U,,,22224,CHEMBL620576,1,A,Oral bioavailability in dog (female mongrel),Autocuration,In vivo,,0,11150,BAO_0000218,9552
,,,,,,,,U,,,22224,CHEMBL875846,1,A,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,Autocuration,In vivo,,0,11151,BAO_0000218,3639
,9615.0,,Canis lupus familiaris,,,,,U,,,22224,CHEMBL620577,1,A,Oral bioavailability in dog,Autocuration,In vivo,,0,11152,BAO_0000218,13397
,,,,,,,,U,,,22224,CHEMBL620578,1,A,Percentage Bioavailability was evaluated.,Autocuration,In vivo,,0,11153,BAO_0000218,3031
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL620579,1,A,Bioavailability in rat administered i.d.,Autocuration,In vivo,,0,11154,BAO_0000218,12818
,9347.0,,Eutheria,,,,,U,,,22224,CHEMBL621248,1,A,Bioavailability,Autocuration,In vivo,,0,11155,BAO_0000218,4847
,9615.0,,Canis lupus familiaris,,,,,U,,,22224,CHEMBL625390,1,A,Bioavailability in dog (male Beagle) i.v. administration,Autocuration,In vivo,,0,11156,BAO_0000218,12421
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL625391,1,A,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",Autocuration,In vivo,,0,11157,BAO_0000218,11966
,9443.0,,Primates,,,,,U,,,22224,CHEMBL872266,1,A,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),Autocuration,In vivo,,0,11158,BAO_0000218,11218
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL625392,1,A,Oral bioavailability in rat (Sprague-Dawley) (male),Autocuration,In vivo,,0,11159,BAO_0000218,13129
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625393,1,A,The oral bioavailability was measured on rats after oral administration,Intermediate,In vivo,,1,11160,BAO_0000218,12350
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625394,1,A,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,Intermediate,In vivo,,1,11161,BAO_0000218,2231
,9544.0,,Macaca mulatta,,,,,N,,,50797,CHEMBL625395,1,A,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,Intermediate,In vivo,,1,11162,BAO_0000218,2231
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL625396,1,A,Bioavailability in rat (dose 10 mg/kg i.d.),Autocuration,In vivo,,0,11163,BAO_0000218,12187
,9615.0,,Canis lupus familiaris,,,,,U,,,22224,CHEMBL625397,1,A,Bioavailability in dog (male Beagle) i.v. administration,Autocuration,In vivo,,0,11164,BAO_0000218,12421
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625398,1,A,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,,1,11165,BAO_0000218,13256
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL625399,1,A,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,178.0,1,11166,BAO_0000218,13256
,10090.0,,Mus musculus,Cerebellum,,,,N,,,50594,CHEMBL626074,1,A,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,2037.0,1,11167,BAO_0000218,13256
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL626075,1,A,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,,1,11168,BAO_0000218,13256
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626076,1,A,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,Intermediate,In vivo,1969.0,1,11169,BAO_0000218,2231
,9544.0,,Macaca mulatta,Plasma,,,,N,,,50797,CHEMBL626077,1,A,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,Intermediate,In vivo,1969.0,1,11170,BAO_0000218,2231
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626078,1,A,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),Intermediate,In vivo,178.0,1,11171,BAO_0000218,12178
,,,,Blood,,,,U,,,22224,CHEMBL625846,1,A,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),Autocuration,In vivo,178.0,0,11172,BAO_0000218,12178
,,,,Blood,,,,U,,,22224,CHEMBL625847,1,A,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),Autocuration,In vivo,178.0,0,11173,BAO_0000218,12178
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625848,1,A,Maximum concentration observed in rats at an oral dose of 50 mg/kg,Expert,In vivo,,1,11174,BAO_0000218,15633
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625849,1,A,Maximum concentration of compound in plasma administered orally to rats,Intermediate,In vivo,1969.0,1,11175,BAO_0000218,14258
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL626023,1,A,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",Intermediate,In vivo,1969.0,1,11176,BAO_0000218,14224
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL626024,1,A,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",Intermediate,In vivo,1969.0,1,11177,BAO_0000218,14224
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL626025,1,A,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",Intermediate,In vivo,1969.0,1,11178,BAO_0000218,14224
,,,,,,,,U,,,22224,CHEMBL626026,1,A,Maximum concentration after 10 mg/kg by oral administration,Autocuration,In vivo,,0,11179,BAO_0000218,5566
,,,,,,,,U,,,22224,CHEMBL626027,1,A,Maximum concentration at a dose of 1.5 mg/kg,Autocuration,In vivo,,0,11180,BAO_0000218,16935
,,,,,,,,U,,,22224,CHEMBL626028,1,A,Maximum concentration at a dose of 2.0 mg/kg,Autocuration,In vivo,,0,11181,BAO_0000218,16935
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL626029,1,A,Maximum concentration in dog plasma,Intermediate,In vivo,1969.0,1,11182,BAO_0000218,14224
,,,,Plasma,,,,U,,,22224,CHEMBL626030,1,A,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,Autocuration,In vivo,1969.0,0,11183,BAO_0000218,12536
,,,,Plasma,,,,U,,,22224,CHEMBL626031,1,A,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,Autocuration,In vivo,1969.0,0,11184,BAO_0000218,12536
,,,,Plasma,,,,U,,,22224,CHEMBL626032,1,A,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,Autocuration,In vivo,1969.0,0,11185,BAO_0000218,12536
,,,,Plasma,,,,U,,,22224,CHEMBL626033,1,A,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,Autocuration,In vivo,1969.0,0,11186,BAO_0000218,12536
,,,,Plasma,,,,U,,,22224,CHEMBL626034,1,A,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,Autocuration,In vivo,1969.0,0,11187,BAO_0000218,12536
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL626035,1,A,Maximum concentration in plasma after oral administration in dog (25 mg/kg),Intermediate,In vivo,1969.0,1,11188,BAO_0000218,9994
,,,,Plasma,,,,U,,,22224,CHEMBL626036,1,A,Maximum concentration in plasma at Tmax,Autocuration,In vivo,1969.0,0,11189,BAO_0000218,1434
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL626037,1,A,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,Expert,In vivo,1969.0,1,11190,BAO_0000218,12836
,10026.0,,Cricetinae,Plasma,,,,N,,,100712,CHEMBL626038,1,A,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,Intermediate,In vivo,1969.0,1,11191,BAO_0000218,12836
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626039,1,A,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,Intermediate,In vivo,1969.0,1,11192,BAO_0000218,12836
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626040,1,A,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,Intermediate,In vivo,1969.0,1,11193,BAO_0000218,12545
,9986.0,,Oryctolagus cuniculus,Plasma,,,,N,,,50592,CHEMBL626041,1,A,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,Intermediate,In vivo,1969.0,1,11194,BAO_0000218,13856
,,,,,,,,U,,,22224,CHEMBL626042,1,A,Maximum concentration was calculated,Autocuration,In vivo,,0,11195,BAO_0000218,3550
,,,,,,,,U,,,22224,CHEMBL626043,1,A,Maximum concentration was calculated.,Autocuration,In vivo,,0,11196,BAO_0000218,2632
,,,,,,,,U,,,22224,CHEMBL626044,1,A,Maximum concentration at a peroral dose of 10 mg/kg,Autocuration,In vivo,,0,11197,BAO_0000218,5566
,,,,,,,,U,,,22224,CHEMBL626045,1,A,Maximum concentration of the drug at 10 uM/dg administered perorally,Autocuration,In vivo,,0,11198,BAO_0000218,11883
,,,,,,,,U,,,22224,CHEMBL626046,1,A,Maximum concentration of the drug at 2 uM/dg administered intravenously,Autocuration,In vivo,,0,11199,BAO_0000218,11883
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL626047,1,A,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",Intermediate,In vivo,1969.0,1,11200,BAO_0000218,14122
,10026.0,,Cricetinae,Plasma,,,,N,,,100712,CHEMBL626048,1,A,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",Intermediate,In vivo,1969.0,1,11201,BAO_0000218,14122
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626049,1,A,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",Intermediate,In vivo,1969.0,1,11202,BAO_0000218,14122
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626050,1,A,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,Intermediate,In vivo,1969.0,1,11203,BAO_0000218,12542
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL874541,1,A,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,Intermediate,In vivo,1969.0,1,11204,BAO_0000218,12542
,10026.0,,Cricetinae,Plasma,,,,N,,,100712,CHEMBL622826,1,A,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,Intermediate,In vivo,1969.0,1,11205,BAO_0000218,12542
,10026.0,,Cricetinae,Plasma,,,,N,,,100712,CHEMBL622827,1,A,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,Intermediate,In vivo,1969.0,1,11206,BAO_0000218,12542
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622828,1,A,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,Intermediate,In vivo,1969.0,1,11207,BAO_0000218,12542
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622829,1,A,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,Intermediate,In vivo,1969.0,1,11208,BAO_0000218,14080
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876806,1,A,Maximum concentration reached following intravenous administration in male rat,Intermediate,In vivo,,1,11209,BAO_0000218,11911
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL622830,1,A,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,Intermediate,In vivo,,1,11210,BAO_0000218,13204
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622831,1,A,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,Intermediate,In vivo,,1,11211,BAO_0000218,13204
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626794,1,A,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,Intermediate,In vivo,,1,11212,BAO_0000218,14346
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626795,1,A,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,Intermediate,In vivo,,1,11213,BAO_0000218,14346
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626796,1,A,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,Intermediate,In vivo,,1,11214,BAO_0000218,14346
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626797,1,A,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,Intermediate,In vivo,,1,11215,BAO_0000218,14346
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626798,1,A,Maximum drug concentration is determined after oral dosing in rats.,Intermediate,In vivo,,1,11216,BAO_0000218,14127
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626799,1,A,Maximum observed concentration in oral (5 mg/kg) fasted dogs,Intermediate,In vivo,,1,11217,BAO_0000218,14339
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626800,1,A,Maximum observed concentration in oral (5 mg/kg) fed dogs,Intermediate,In vivo,,1,11218,BAO_0000218,14339
,,,,Plasma,,,,U,,,22224,CHEMBL626801,1,A,Maximum plasma concentration,Autocuration,In vivo,1969.0,0,11219,BAO_0000218,13494
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL876816,1,A,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,Intermediate,In vivo,1969.0,1,11220,BAO_0000218,14925
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626802,1,A,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,Intermediate,In vivo,1969.0,1,11221,BAO_0000218,14474
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL626803,1,A,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,Intermediate,In vivo,1969.0,1,11222,BAO_0000218,14474
,,,,Plasma,,,,U,,,22224,CHEMBL626804,1,A,Maximum plasma concentration following oral administration of 30 umol/kg,Autocuration,In vivo,1969.0,0,11223,BAO_0000218,13917
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626805,1,A,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,Intermediate,,1969.0,1,11224,BAO_0000218,9796
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626309,1,A,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Intermediate,,1969.0,1,11225,BAO_0000218,9796
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626310,1,A,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Intermediate,,1969.0,1,11226,BAO_0000218,9796
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626311,1,A,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,,1969.0,1,11227,BAO_0000218,9796
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626312,1,A,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,,1969.0,1,11228,BAO_0000218,9796
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL626313,1,A,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,,995.0,1,11229,BAO_0000218,9796
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL626314,1,A,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Intermediate,,995.0,1,11230,BAO_0000218,9796
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL626315,1,A,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Intermediate,,995.0,1,11231,BAO_0000218,9796
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL626316,1,A,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,,995.0,1,11232,BAO_0000218,9796
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL626317,1,A,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Intermediate,,995.0,1,11233,BAO_0000218,9796
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626318,1,A,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,,,1,11234,BAO_0000218,8363
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626319,1,A,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,,,1,11235,BAO_0000218,8363
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626320,1,A,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,,,1,11236,BAO_0000218,8363
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875053,1,A,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,,,1,11237,BAO_0000218,8363
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626321,1,A,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,,,1,11238,BAO_0000218,8363
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626322,1,A,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,,,1,11239,BAO_0000218,8363
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626323,1,A,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,,,1,11240,BAO_0000218,8363
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626324,1,A,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,,,1,11241,BAO_0000218,8363
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626325,1,A,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,,,1,11242,BAO_0000218,8363
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626326,1,A,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,,,1,11243,BAO_0000218,8363
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626327,1,A,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),Intermediate,,,1,11244,BAO_0000218,8363
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626328,1,A,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),Intermediate,,,1,11245,BAO_0000218,8363
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626329,1,A,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",Intermediate,,178.0,1,11246,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626330,1,A,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",Intermediate,,178.0,1,11247,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626331,1,A,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",Intermediate,,178.0,1,11248,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626332,1,A,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",Intermediate,,178.0,1,11249,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626333,1,A,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",Intermediate,,178.0,1,11250,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626334,1,A,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",Intermediate,,178.0,1,11251,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626335,1,A,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",Intermediate,,178.0,1,11252,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624798,1,A,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",Intermediate,,178.0,1,11253,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL624799,1,A,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",Intermediate,,955.0,1,11254,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL624800,1,A,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",Intermediate,,955.0,1,11255,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL624801,1,A,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",Intermediate,,955.0,1,11256,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL624802,1,A,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",Intermediate,,955.0,1,11257,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL624803,1,A,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",Intermediate,,955.0,1,11258,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL624804,1,A,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",Intermediate,,955.0,1,11259,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL624805,1,A,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",Intermediate,,955.0,1,11260,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL624806,1,A,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",Intermediate,,955.0,1,11261,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624807,1,A,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",Intermediate,,,1,11262,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624808,1,A,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11263,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624809,1,A,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11264,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624810,1,A,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",Intermediate,,,1,11265,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL877618,1,A,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11266,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624811,1,A,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",Intermediate,,,1,11267,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624812,1,A,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11268,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624813,1,A,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11269,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624814,1,A,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",Intermediate,,,1,11270,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624815,1,A,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11271,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624816,1,A,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11272,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624817,1,A,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",Intermediate,,,1,11273,BAO_0000218,8684
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624818,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,11274,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624819,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,Intermediate,,,1,11275,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624820,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),Intermediate,,,1,11276,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624821,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Intermediate,,,1,11277,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624822,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Intermediate,,,1,11278,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624823,1,A,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,11279,BAO_0000218,6996
,562.0,,Escherichia coli,,,,,N,,,50212,CHEMBL624824,1,A,Observed diffusion coefficient in organic solvent for Escherichia coli,Intermediate,,,1,11280,BAO_0000218,15599
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624825,1,A,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,,178.0,1,11281,BAO_0000218,9614
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624826,1,A,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,,178.0,1,11282,BAO_0000218,9614
,10116.0,,Rattus norvegicus,Cardiac atrium,,,,N,,,50597,CHEMBL876817,1,A,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,,2081.0,1,11283,BAO_0000218,9614
,10116.0,,Rattus norvegicus,Cardiac atrium,,,,N,,,50597,CHEMBL624827,1,A,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,,2081.0,1,11284,BAO_0000218,9614
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624828,1,A,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,,,1,11285,BAO_0000218,9614
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624829,1,A,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,,,1,11286,BAO_0000218,9614
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL624830,1,A,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,,2107.0,1,11287,BAO_0000218,9614
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL624831,1,A,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,,2107.0,1,11288,BAO_0000218,9614
,10116.0,,Rattus norvegicus,Cardiac atrium,,,,N,,,50597,CHEMBL624832,1,A,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,,2081.0,1,11289,BAO_0000218,9614
,10116.0,,Rattus norvegicus,Cardiac atrium,,,,N,,,50597,CHEMBL624833,1,A,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,,2081.0,1,11290,BAO_0000218,9614
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624834,1,A,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,,,1,11291,BAO_0000218,9614
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624835,1,A,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,,,1,11292,BAO_0000218,9614
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL624836,1,A,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Intermediate,,2106.0,1,11293,BAO_0000218,9614
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL624837,1,A,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Intermediate,,2106.0,1,11294,BAO_0000218,9614
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624838,1,A,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,Intermediate,,178.0,1,11295,BAO_0000218,9071
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL622188,1,A,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,Intermediate,,178.0,1,11296,BAO_0000218,9071
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL622189,1,A,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,Intermediate,,948.0,1,11297,BAO_0000218,9071
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL622190,1,A,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,Intermediate,,948.0,1,11298,BAO_0000218,9071
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL625170,1,A,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,Intermediate,,948.0,1,11299,BAO_0000218,9071
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL625171,1,A,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Intermediate,,2113.0,1,11300,BAO_0000218,9071
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL625172,1,A,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Intermediate,,2113.0,1,11301,BAO_0000218,9071
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL625173,1,A,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,Intermediate,,2113.0,1,11302,BAO_0000218,9071
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625174,1,A,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,Intermediate,,2107.0,1,11303,BAO_0000218,9071
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625175,1,A,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,Intermediate,,2107.0,1,11304,BAO_0000218,9071
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625176,1,A,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,Intermediate,,2107.0,1,11305,BAO_0000218,9071
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL625177,1,A,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Intermediate,,2048.0,1,11306,BAO_0000218,9071
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL625178,1,A,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,Intermediate,,2048.0,1,11307,BAO_0000218,9071
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL625179,1,A,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,Intermediate,,2048.0,1,11308,BAO_0000218,9071
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL625180,1,A,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Intermediate,,2048.0,1,11309,BAO_0000218,9071
,,,,,,,,U,,,22224,CHEMBL625181,1,A,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",Autocuration,,,0,11310,BAO_0000218,10677
,10090.0,,Mus musculus,Urine,,,,N,,,50594,CHEMBL625182,1,A,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,Intermediate,,1088.0,1,11311,BAO_0000218,9750
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625183,1,A,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Intermediate,,,1,11312,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875848,1,A,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,Intermediate,,,1,11313,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622260,1,A,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Intermediate,,,1,11314,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622261,1,A,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,Intermediate,,,1,11315,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622262,1,A,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Intermediate,,,1,11316,BAO_0000218,8319
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL622263,1,A,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Intermediate,,2113.0,1,11317,BAO_0000218,8319
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL622418,1,A,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Intermediate,,2113.0,1,11318,BAO_0000218,8319
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622419,1,A,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,Intermediate,,2107.0,1,11319,BAO_0000218,8319
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623388,1,A,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,,1,11320,BAO_0000218,13256
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL623389,1,A,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,2107.0,1,11321,BAO_0000218,13256
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623390,1,A,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,,1,11322,BAO_0000218,13256
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623391,1,A,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,,1,11323,BAO_0000218,13256
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL623392,1,A,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,178.0,1,11324,BAO_0000218,13256
,10090.0,,Mus musculus,Cerebellum,,,,N,,,50594,CHEMBL623393,1,A,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,2037.0,1,11325,BAO_0000218,13256
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623394,1,A,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,,1,11326,BAO_0000218,13256
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL618885,1,A,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,,1,11327,BAO_0000218,13256
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL618886,1,A,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,2107.0,1,11328,BAO_0000218,13256
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL618887,1,A,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,,1,11329,BAO_0000218,13256
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL619535,1,A,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,,1,11330,BAO_0000218,13256
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL619536,1,A,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,178.0,1,11331,BAO_0000218,13256
,10090.0,,Mus musculus,Cerebellum,,,,N,,,50594,CHEMBL619537,1,A,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,2037.0,1,11332,BAO_0000218,13256
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL619705,1,A,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,,1,11333,BAO_0000218,13256
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL619706,1,A,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,,1,11334,BAO_0000218,13256
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL619707,1,A,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,2107.0,1,11335,BAO_0000218,13256
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL619708,1,A,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,,1,11336,BAO_0000218,13256
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625219,1,A,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,,1,11337,BAO_0000218,13256
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL625220,1,A,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,178.0,1,11338,BAO_0000218,13256
,10090.0,,Mus musculus,Cerebellum,,,,N,,,50594,CHEMBL625221,1,A,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,2037.0,1,11339,BAO_0000218,13256
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625222,1,A,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,,1,11340,BAO_0000218,13256
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625223,1,A,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,,1,11341,BAO_0000218,13256
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL625224,1,A,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,2107.0,1,11342,BAO_0000218,13256
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625225,1,A,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Intermediate,In vivo,,1,11343,BAO_0000218,13256
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625226,1,A,Biodistribution in Rat blood after 24 hours of iv administration,Intermediate,In vivo,178.0,1,11344,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625227,1,A,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,Intermediate,In vivo,178.0,1,11345,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625228,1,A,Biodistribution in Rat blood after 30 minutes of iv administration,Intermediate,In vivo,178.0,1,11346,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL875354,1,A,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,Intermediate,In vivo,178.0,1,11347,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625229,1,A,Biodistribution in Rat blood after 5 minutes of iv administration,Intermediate,In vivo,178.0,1,11348,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625230,1,A,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,Intermediate,In vivo,178.0,1,11349,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL625231,1,A,Biodistribution in Rat heart after 24 hours of iv administration,Intermediate,In vivo,948.0,1,11350,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL625900,1,A,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,Intermediate,In vivo,948.0,1,11351,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL625901,1,A,Biodistribution in Rat heart after 30 minutes of iv administration,Intermediate,In vivo,948.0,1,11352,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL625902,1,A,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,Intermediate,In vivo,948.0,1,11353,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL625903,1,A,Biodistribution in Rat heart after 5 minutes of iv administration,Intermediate,In vivo,948.0,1,11354,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL625904,1,A,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,Intermediate,In vivo,948.0,1,11355,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625905,1,A,Biodistribution in Rat liver after 24 hours of iv administration,Intermediate,In vivo,2107.0,1,11356,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627861,1,A,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,Intermediate,In vivo,2107.0,1,11357,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627862,1,A,Biodistribution in Rat liver after 30 minutes of iv administration,Intermediate,In vivo,2107.0,1,11358,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627863,1,A,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Intermediate,In vivo,2107.0,1,11359,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627769,1,A,Biodistribution in Rat liver after 30 minutes of iv administration,Intermediate,In vivo,2107.0,1,11360,BAO_0000218,8829
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL627770,1,A,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,Intermediate,In vivo,1969.0,1,11361,BAO_0000218,13249
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL627771,1,A,Cmax in cynomolgus monkey (PO dose),Intermediate,In vivo,,1,11362,BAO_0000218,13622
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627772,1,A,Cmax in rat (PO dose),Intermediate,In vivo,,1,11363,BAO_0000218,13622
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627773,1,A,Cmax in rat (PO dose),Intermediate,In vivo,,1,11364,BAO_0000218,13622
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL621922,1,A,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,Intermediate,In vivo,1969.0,1,11365,BAO_0000218,13494
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL621923,1,A,Cmax in rat plasma after oral dose (10 mg/kg),Intermediate,In vivo,1969.0,1,11366,BAO_0000218,12170
,,,,Plasma,,,,U,,,22224,CHEMBL621924,1,A,Cmax in plasma after oral dose (10 mg/kg),Autocuration,In vivo,1969.0,0,11367,BAO_0000218,12170
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL621925,1,A,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,Intermediate,In vivo,1969.0,1,11368,BAO_0000218,17025
,314293.0,,Simiiformes,Plasma,,,,U,,,22224,CHEMBL621926,1,A,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,Autocuration,In vivo,1969.0,0,11369,BAO_0000218,17025
,9986.0,,Oryctolagus cuniculus,Plasma,,,,N,,,50592,CHEMBL621927,1,A,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,Intermediate,In vivo,1969.0,1,11370,BAO_0000218,17025
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL621928,1,A,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,Intermediate,In vivo,1969.0,1,11371,BAO_0000218,17025
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL621929,1,A,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,Intermediate,In vivo,1969.0,1,11372,BAO_0000218,14187
,10090.0,,Mus musculus,Plasma,,,,N,,,50594,CHEMBL621930,1,A,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,Intermediate,In vivo,1969.0,1,11373,BAO_0000218,14816
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL621931,1,A,Maximum plasma concentration after oral dosing in rat,Intermediate,In vivo,1969.0,1,11374,BAO_0000218,17820
,,,,Plasma,,,,U,,,22224,CHEMBL621932,1,A,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,Autocuration,In vivo,1969.0,0,11375,BAO_0000218,14380
,,,,Plasma,,,,U,,,22224,CHEMBL621933,1,A,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,Autocuration,In vivo,1969.0,0,11376,BAO_0000218,14380
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL621934,1,A,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,Intermediate,In vivo,1969.0,1,11377,BAO_0000218,14691
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL621935,1,A,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,Intermediate,In vivo,1969.0,1,11378,BAO_0000218,14691
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL621936,1,A,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,Intermediate,In vivo,1969.0,1,11379,BAO_0000218,13375
,,,,Plasma,,,,U,,,22224,CHEMBL621937,1,A,Maximum plasma concentration was determined,Autocuration,In vivo,1969.0,0,11380,BAO_0000218,6236
,,,,Plasma,,,,U,,,22224,CHEMBL621938,1,A,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Autocuration,In vivo,1969.0,0,11381,BAO_0000218,14380
,,,,Plasma,,,,U,,,22224,CHEMBL621939,1,A,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Autocuration,In vivo,1969.0,0,11382,BAO_0000218,14380
,,,,Plasma,,,,U,,,22224,CHEMBL621940,1,A,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,Autocuration,In vivo,1969.0,0,11383,BAO_0000218,14380
,,,,Plasma,,,,U,,,22224,CHEMBL621941,1,A,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,Autocuration,In vivo,1969.0,0,11384,BAO_0000218,14380
,,,,Plasma,,,,U,,,22224,CHEMBL621942,1,A,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,Autocuration,In vivo,1969.0,0,11385,BAO_0000218,14380
,,,,Plasma,,,,U,,,22224,CHEMBL626178,1,A,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,Autocuration,In vivo,1969.0,0,11386,BAO_0000218,14380
,,,,Plasma,,,,U,,,22224,CHEMBL626179,1,A,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,Autocuration,In vivo,1969.0,0,11387,BAO_0000218,14380
,,,,Plasma,,,,U,,,22224,CHEMBL626180,1,A,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,Autocuration,In vivo,1969.0,0,11388,BAO_0000218,14380
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626181,1,A,Plasma Cmax in rat (PO dose),Intermediate,In vivo,1969.0,1,11389,BAO_0000218,13622
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626182,1,A,Maximum serum concentration after po dose of 5.22 mg/kg in rats,Intermediate,In vivo,,1,11390,BAO_0000218,15372
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626183,1,A,Maximum serum concentration after po dose of 5.46 mg/kg in rats,Intermediate,In vivo,,1,11391,BAO_0000218,15372
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626184,1,A,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,Intermediate,In vivo,,1,11392,BAO_0000218,15372
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626185,1,A,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,Intermediate,In vivo,,1,11393,BAO_0000218,15372
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL626186,1,A,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,Intermediate,In vivo,1969.0,1,11394,BAO_0000218,14925
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL877589,1,A,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,Intermediate,In vivo,1969.0,1,11395,BAO_0000218,14925
,,,,,,,,U,,,22224,CHEMBL626187,1,A,Maximum concentration of the drug at 1 uM/dg administered intravenously,Autocuration,In vivo,,0,11396,BAO_0000218,11883
,,,,,,,,U,,,22224,CHEMBL626188,1,A,Maximum concentration of the drug at 20 uM/dg administered perorally,Autocuration,In vivo,,0,11397,BAO_0000218,11883
,,,,,,,,U,,,22224,CHEMBL626189,1,A,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,Autocuration,In vivo,,0,11398,BAO_0000218,13391
,,,,Blood,,,,U,,,22224,CHEMBL626855,1,A,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,In vivo,178.0,0,11399,BAO_0000218,13391
,,,,Blood,,,,U,,,22224,CHEMBL623781,1,A,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,In vivo,178.0,0,11400,BAO_0000218,13391
,,,,Blood,,,,U,,,22224,CHEMBL623782,1,A,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,In vivo,178.0,0,11401,BAO_0000218,13391
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623783,1,A,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,Intermediate,In vivo,1969.0,1,11402,BAO_0000218,16360
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL623784,1,A,Cmax in dog plasma after 1mg/kg oral dose,Intermediate,In vivo,1969.0,1,11403,BAO_0000218,3673
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL623785,1,A,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,Intermediate,In vivo,1969.0,1,11404,BAO_0000218,14431
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623786,1,A,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,Intermediate,In vivo,1969.0,1,11405,BAO_0000218,14431
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623787,1,A,Oral maximum concentration in rat,Intermediate,In vivo,,1,11406,BAO_0000218,14964
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623788,1,A,Oral maximum concentration in rat,Intermediate,In vivo,,1,11407,BAO_0000218,14964
,10090.0,,Mus musculus,Plasma,,,,N,,,50594,CHEMBL623789,1,A,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,Intermediate,In vivo,1969.0,1,11408,BAO_0000218,14209
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL623790,1,A,Peak concentration in blood after intravenous administration to mice,Intermediate,In vivo,178.0,1,11409,BAO_0000218,11355
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL623791,1,A,Peak concentration in blood after peroral administration to mice,Intermediate,In vivo,178.0,1,11410,BAO_0000218,11355
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623792,1,A,Peak concentration in rat plasma was determined,Intermediate,In vivo,1969.0,1,11411,BAO_0000218,11966
,314293.0,,Simiiformes,Plasma,,,,U,,,22224,CHEMBL623793,1,A,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,Autocuration,In vivo,1969.0,0,11412,BAO_0000218,8918
,10090.0,,Mus musculus,Plasma,,,,N,,,50594,CHEMBL623794,1,A,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,Intermediate,In vivo,1969.0,1,11413,BAO_0000218,8918
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623795,1,A,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,Intermediate,In vivo,1969.0,1,11414,BAO_0000218,8918
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623796,1,A,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11415,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623797,1,A,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",Intermediate,,,1,11416,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623798,1,A,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11417,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623799,1,A,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11418,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL624490,1,A,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",Intermediate,,160.0,1,11419,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL624491,1,A,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",Intermediate,,160.0,1,11420,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL624492,1,A,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",Intermediate,,160.0,1,11421,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL624493,1,A,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",Intermediate,,160.0,1,11422,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL877595,1,A,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",Intermediate,,160.0,1,11423,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL624494,1,A,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",Intermediate,,160.0,1,11424,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL624495,1,A,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",Intermediate,,160.0,1,11425,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL624681,1,A,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",Intermediate,,160.0,1,11426,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624682,1,A,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",Intermediate,,,1,11427,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624683,1,A,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11428,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624684,1,A,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11429,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624685,1,A,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",Intermediate,,,1,11430,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624686,1,A,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11431,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624687,1,A,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",Intermediate,,,1,11432,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624688,1,A,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11433,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627161,1,A,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11434,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622127,1,A,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",Intermediate,,,1,11435,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622128,1,A,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11436,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874384,1,A,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11437,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624898,1,A,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",Intermediate,,,1,11438,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624899,1,A,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11439,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624900,1,A,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",Intermediate,,,1,11440,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624901,1,A,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11441,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624902,1,A,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11442,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624903,1,A,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",Intermediate,,,1,11443,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624904,1,A,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11444,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624905,1,A,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11445,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624906,1,A,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",Intermediate,,,1,11446,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624907,1,A,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11447,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624908,1,A,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",Intermediate,,,1,11448,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624909,1,A,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11449,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624910,1,A,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11450,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL624911,1,A,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",Intermediate,,2385.0,1,11451,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL874388,1,A,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",Intermediate,,2385.0,1,11452,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL624912,1,A,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",Intermediate,,2385.0,1,11453,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL622930,1,A,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",Intermediate,,2385.0,1,11454,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623121,1,A,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",Intermediate,,2385.0,1,11455,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623122,1,A,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",Intermediate,,2385.0,1,11456,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623123,1,A,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",Intermediate,,2385.0,1,11457,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623124,1,A,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",Intermediate,,2385.0,1,11458,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623125,1,A,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",Intermediate,,,1,11459,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623126,1,A,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11460,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623127,1,A,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11461,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623128,1,A,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",Intermediate,,,1,11462,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623129,1,A,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11463,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623130,1,A,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",Intermediate,,,1,11464,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623131,1,A,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11465,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623132,1,A,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11466,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL623133,1,A,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Intermediate,,2107.0,1,11467,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623134,1,A,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Intermediate,,,1,11468,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874389,1,A,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Intermediate,,,1,11469,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623135,1,A,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,Intermediate,,,1,11470,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623136,1,A,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Intermediate,,,1,11471,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623137,1,A,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,Intermediate,,,1,11472,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623138,1,A,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Intermediate,,,1,11473,BAO_0000218,8319
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL623139,1,A,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Intermediate,,2113.0,1,11474,BAO_0000218,8319
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL623140,1,A,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Intermediate,,2113.0,1,11475,BAO_0000218,8319
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL623141,1,A,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,Intermediate,,2107.0,1,11476,BAO_0000218,8319
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL623142,1,A,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Intermediate,,2107.0,1,11477,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623143,1,A,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Intermediate,,,1,11478,BAO_0000218,8319
,10090.0,,Mus musculus,Urine,,,,N,,,50594,CHEMBL623144,1,A,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,Intermediate,,1088.0,1,11479,BAO_0000218,14571
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623405,1,A,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,Intermediate,,1088.0,1,11480,BAO_0000218,14571
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624074,1,A,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Intermediate,,,1,11481,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624075,1,A,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,Intermediate,,,1,11482,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624076,1,A,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Intermediate,,,1,11483,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624077,1,A,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,Intermediate,,,1,11484,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624078,1,A,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Intermediate,,,1,11485,BAO_0000218,8319
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL624079,1,A,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Intermediate,,2113.0,1,11486,BAO_0000218,8319
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL624261,1,A,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Intermediate,,2113.0,1,11487,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624262,1,A,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,Intermediate,,,1,11488,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624263,1,A,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Intermediate,,,1,11489,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624264,1,A,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Intermediate,,,1,11490,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624265,1,A,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Intermediate,,,1,11491,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624266,1,A,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,Intermediate,,,1,11492,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624267,1,A,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Intermediate,,,1,11493,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624268,1,A,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,Intermediate,,,1,11494,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875227,1,A,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Intermediate,,,1,11495,BAO_0000218,8319
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL624269,1,A,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Intermediate,,2113.0,1,11496,BAO_0000218,8319
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL624270,1,A,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Intermediate,,2113.0,1,11497,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624271,1,A,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,Intermediate,,,1,11498,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624272,1,A,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Intermediate,,,1,11499,BAO_0000218,8319
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624273,1,A,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Intermediate,,,1,11500,BAO_0000218,8319
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL624274,1,A,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,Intermediate,,1088.0,1,11501,BAO_0000218,12064
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL624275,1,A,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,Intermediate,,1088.0,1,11502,BAO_0000218,12064
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL624276,1,A,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,Intermediate,,1088.0,1,11503,BAO_0000218,12064
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL624277,1,A,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,Intermediate,,1088.0,1,11504,BAO_0000218,12038
,,,,,,,,U,,,22224,CHEMBL624278,1,A,% dose converted to 2-amino-5-chlorophenyl sulfate,Autocuration,,,0,11505,BAO_0000019,14314
,,,,,,,,U,,,22224,CHEMBL624279,1,A,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),Autocuration,,,0,11506,BAO_0000019,14314
,10116.0,,Rattus norvegicus,Feces,,,,N,,,50597,CHEMBL624280,1,A,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Intermediate,,1988.0,1,11507,BAO_0000218,11488
,10116.0,,Rattus norvegicus,Feces,,,,N,,,50597,CHEMBL624281,1,A,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Intermediate,,1988.0,1,11508,BAO_0000218,11488
,10116.0,,Rattus norvegicus,Feces,,,,N,,,50597,CHEMBL622933,1,A,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Intermediate,,1988.0,1,11509,BAO_0000218,11488
,10116.0,,Rattus norvegicus,Feces,,,,N,,,50597,CHEMBL622934,1,A,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Intermediate,,1988.0,1,11510,BAO_0000218,11488
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622935,1,A,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Intermediate,In vivo,2107.0,1,11511,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622936,1,A,Biodistribution in Rat liver after 5 minutes of iv administration,Intermediate,In vivo,2107.0,1,11512,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL875228,1,A,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,Intermediate,In vivo,2107.0,1,11513,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622937,1,A,Biodistribution in Rat lung after 24 hours of iv administration,Intermediate,In vivo,2048.0,1,11514,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622938,1,A,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,Intermediate,In vivo,2048.0,1,11515,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL619736,1,A,Biodistribution in Rat lung after 30 minutes of iv administration,Intermediate,In vivo,2048.0,1,11516,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL625117,1,A,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,Intermediate,In vivo,2048.0,1,11517,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL625118,1,A,Biodistribution in Rat lung after 5 minutes of iv administration,Intermediate,In vivo,2048.0,1,11518,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL625119,1,A,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,Intermediate,In vivo,2048.0,1,11519,BAO_0000218,8829
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL625120,1,A,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",Intermediate,In vivo,2037.0,1,11520,BAO_0000218,14972
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625121,1,A,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",Intermediate,In vivo,,1,11521,BAO_0000218,14972
,10116.0,,Rattus norvegicus,Thalamus,,,,N,,,50597,CHEMBL625122,1,A,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",Intermediate,In vivo,10000006.0,1,11522,BAO_0000218,14972
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL622204,1,A,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,In vivo,178.0,1,11523,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL877503,1,A,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,In vivo,178.0,1,11524,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627127,1,A,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,In vivo,178.0,1,11525,BAO_0000218,14608
,,,,Hippocampus,,,,U,,,22224,CHEMBL627128,1,A,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,Autocuration,In vivo,10000000.0,0,11526,BAO_0000218,14608
,,,,Hippocampus,,,,U,,,22224,CHEMBL627129,1,A,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,Autocuration,In vivo,10000000.0,0,11527,BAO_0000218,14608
,,,,Hippocampus,,,,U,,,22224,CHEMBL627130,1,A,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,Autocuration,In vivo,10000000.0,0,11528,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL627131,1,A,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,In vivo,955.0,1,11529,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL627132,1,A,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,In vivo,955.0,1,11530,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL627133,1,A,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,In vivo,955.0,1,11531,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL627134,1,A,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,In vivo,2037.0,1,11532,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL627135,1,A,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,In vivo,2037.0,1,11533,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL627136,1,A,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,In vivo,2037.0,1,11534,BAO_0000218,14608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628435,1,A,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,In vivo,,1,11535,BAO_0000218,14608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628436,1,A,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,In vivo,,1,11536,BAO_0000218,14608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628437,1,A,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,In vivo,,1,11537,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL628438,1,A,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,In vivo,948.0,1,11538,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL628439,1,A,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,In vivo,948.0,1,11539,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL628440,1,A,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,In vivo,948.0,1,11540,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL628441,1,A,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,In vivo,10000000.0,1,11541,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL628442,1,A,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,In vivo,10000000.0,1,11542,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL628443,1,A,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,In vivo,10000000.0,1,11543,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL628444,1,A,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,In vivo,2113.0,1,11544,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL628445,1,A,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,In vivo,2113.0,1,11545,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL877504,1,A,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,In vivo,2113.0,1,11546,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL628446,1,A,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,In vivo,2107.0,1,11547,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL626874,1,A,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,In vivo,2107.0,1,11548,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL626875,1,A,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,In vivo,2107.0,1,11549,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626876,1,A,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,In vivo,2048.0,1,11550,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626877,1,A,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,In vivo,2048.0,1,11551,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626878,1,A,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,In vivo,2048.0,1,11552,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL626879,1,A,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,In vivo,2385.0,1,11553,BAO_0000218,14608
,314293.0,,Simiiformes,Plasma,,,,U,,,22224,CHEMBL626880,1,A,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,Autocuration,In vivo,1969.0,0,11554,BAO_0000218,8918
,10090.0,,Mus musculus,Plasma,,,,N,,,50594,CHEMBL626881,1,A,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,Intermediate,In vivo,1969.0,1,11555,BAO_0000218,8918
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626882,1,A,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,Intermediate,In vivo,1969.0,1,11556,BAO_0000218,8918
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL626883,1,A,Peak plasma concentration was measured in dogs,Intermediate,In vivo,1969.0,1,11557,BAO_0000218,14470
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626884,1,A,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,In vivo,,1,11558,BAO_0000218,14393
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626885,1,A,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,Intermediate,In vivo,,1,11559,BAO_0000218,14886
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626886,1,A,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,Intermediate,In vivo,,1,11560,BAO_0000218,14886
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626887,1,A,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,Intermediate,In vivo,,1,11561,BAO_0000218,14886
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626888,1,A,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,In vivo,,1,11562,BAO_0000218,14393
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626889,1,A,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,Intermediate,In vivo,,1,11563,BAO_0000218,13465
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL626761,1,A,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,Autocuration,In vivo,,0,11564,BAO_0000218,13465
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626762,1,A,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,Intermediate,In vivo,,1,11565,BAO_0000218,13465
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626763,1,A,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,Intermediate,In vivo,,1,11566,BAO_0000218,13465
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626764,1,A,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,Intermediate,In vivo,,1,11567,BAO_0000218,13465
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626765,1,A,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,Intermediate,In vivo,,1,11568,BAO_0000218,13465
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626766,1,A,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,Intermediate,In vivo,,1,11569,BAO_0000218,13465
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626767,1,A,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,Intermediate,In vivo,,1,11570,BAO_0000218,13465
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626768,1,A,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,Intermediate,In vivo,,1,11571,BAO_0000218,13465
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626769,1,A,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,Intermediate,In vivo,,1,11572,BAO_0000218,13465
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL874463,1,A,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,Intermediate,In vivo,,1,11573,BAO_0000218,13465
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL626770,1,A,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,Autocuration,In vivo,,0,11574,BAO_0000218,13465
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL626771,1,A,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,Autocuration,In vivo,,0,11575,BAO_0000218,13465
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626772,1,A,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,Intermediate,In vivo,,1,11576,BAO_0000218,13465
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL626773,1,A,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,Intermediate,In vivo,,1,11577,BAO_0000218,14731
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL626774,1,A,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,Intermediate,In vivo,,1,11578,BAO_0000218,14731
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626775,1,A,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,Intermediate,In vivo,,1,11579,BAO_0000218,13376
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626776,1,A,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,Intermediate,In vivo,,1,11580,BAO_0000218,13376
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626777,1,A,Maximum concentration (Cmax) in rat when administered orally,Intermediate,In vivo,,1,11581,BAO_0000218,14443
,314293.0,,Simiiformes,Plasma,,,,U,,,22224,CHEMBL626778,1,A,Maximal concentration in monkey plasma after 25 mg/kg oral dose,Autocuration,In vivo,1969.0,0,11582,BAO_0000218,13465
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL626779,1,A,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",Autocuration,In vivo,,0,11583,BAO_0000218,16359
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL626780,1,A,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",Autocuration,In vivo,,0,11584,BAO_0000218,16359
,,,,Plasma,,,,U,,,22224,CHEMBL626781,1,A,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,Autocuration,In vivo,1969.0,0,11585,BAO_0000218,15618
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632164,1,A,Pharmacokinetic profile Cmax was evaluated in rats,Intermediate,In vivo,,1,11586,BAO_0000218,14554
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL632165,1,A,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),Intermediate,In vivo,,1,11587,BAO_0000218,11537
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL632166,1,A,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),Intermediate,In vivo,,1,11588,BAO_0000218,11537
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL632167,1,A,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),Intermediate,In vivo,,1,11589,BAO_0000218,11537
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL632168,1,A,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),Intermediate,In vivo,,1,11590,BAO_0000218,11537
,10116.0,,Rattus norvegicus,Plasma,,,,U,,,22224,CHEMBL632169,1,A,Cmax in rat plasma,Autocuration,In vivo,1969.0,0,11591,BAO_0000218,2021
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL632170,1,A,Cmax in dog plasma after 30mg/kg oral dose,Intermediate,In vivo,1969.0,1,11592,BAO_0000218,5932
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL632171,1,A,Cmax in rat plasma after 30mg/kg oral dose,Intermediate,In vivo,1969.0,1,11593,BAO_0000218,5932
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL632172,1,A,Plasma level in rats at 30 mg/kg,Intermediate,In vivo,1969.0,1,11594,BAO_0000218,17320
,10090.0,,Mus musculus,Plasma,,,,N,,,50594,CHEMBL632173,1,A,Tested for maximum plasma concentration in mice,Intermediate,In vivo,1969.0,1,11595,BAO_0000218,15831
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632174,1,A,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,In vivo,,1,11596,BAO_0000218,15078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632175,1,A,The Cmax values in female wistar rats.,Intermediate,In vivo,,1,11597,BAO_0000218,14941
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL632176,1,A,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,Intermediate,In vivo,1969.0,1,11598,BAO_0000218,15343
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL632177,1,A,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,Intermediate,In vivo,1969.0,1,11599,BAO_0000218,15343
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL632178,1,A,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,Intermediate,In vivo,1969.0,1,11600,BAO_0000218,14856
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632179,1,A,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,Intermediate,In vivo,,1,11601,BAO_0000218,13129
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL632180,1,A,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,Intermediate,In vivo,178.0,1,11602,BAO_0000218,13098
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL632181,1,A,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,Intermediate,In vivo,178.0,1,11603,BAO_0000218,13098
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL632182,1,A,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,Intermediate,In vivo,178.0,1,11604,BAO_0000218,13098
,10090.0,,Mus musculus,Blood,,,,U,,,22224,CHEMBL632183,1,A,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,Autocuration,In vivo,178.0,0,11605,BAO_0000218,15478
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL632184,1,A,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,Intermediate,In vivo,,1,11606,BAO_0000218,15341
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874470,1,A,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,Intermediate,In vivo,,1,11607,BAO_0000218,15341
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631302,1,A,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",Intermediate,,,1,11608,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631303,1,A,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11609,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631304,1,A,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11610,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631305,1,A,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",Intermediate,,,1,11611,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631306,1,A,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11612,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631307,1,A,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",Intermediate,,,1,11613,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631308,1,A,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11614,BAO_0000218,8684
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625557,1,A,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",Intermediate,,,1,11615,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL625558,1,A,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",Intermediate,,2106.0,1,11616,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL625559,1,A,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",Intermediate,,2106.0,1,11617,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL625560,1,A,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",Intermediate,,2106.0,1,11618,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL625561,1,A,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",Intermediate,,2106.0,1,11619,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL625562,1,A,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",Intermediate,,2106.0,1,11620,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL875320,1,A,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",Intermediate,,2106.0,1,11621,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL625563,1,A,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",Intermediate,,2106.0,1,11622,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL625564,1,A,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",Intermediate,,2106.0,1,11623,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL625565,1,A,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",Intermediate,,995.0,1,11624,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL625566,1,A,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",Intermediate,,995.0,1,11625,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL625567,1,A,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",Intermediate,,995.0,1,11626,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL625568,1,A,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",Intermediate,,995.0,1,11627,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL628217,1,A,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",Intermediate,,995.0,1,11628,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL628218,1,A,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",Intermediate,,995.0,1,11629,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL628219,1,A,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",Intermediate,,995.0,1,11630,BAO_0000218,8684
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL628220,1,A,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",Intermediate,,995.0,1,11631,BAO_0000218,8684
,,,,,,,,U,,,22224,CHEMBL628221,1,A,Distribution in the blood after 120 min of intravenous administration,Autocuration,,,0,11632,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628222,1,A,Distribution in the blood after 15 min of intravenous administration,Autocuration,,,0,11633,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628223,1,A,Distribution in the blood after 30 min of intravenous administration,Autocuration,,,0,11634,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628224,1,A,Distribution in the blood after 5 min of intravenous administration,Autocuration,,,0,11635,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628225,1,A,Distribution in the blood after 60 min of intravenous administration,Autocuration,,,0,11636,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628226,1,A,Distribution in the blood after 90 min of intravenous administration,Autocuration,,,0,11637,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628227,1,A,Distribution in the bone after 120 min of intravenous administration,Autocuration,,,0,11638,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL875481,1,A,Distribution in the bone after 15 min of intravenous administration,Autocuration,,,0,11639,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628228,1,A,Distribution in the bone after 30 min of intravenous administration,Autocuration,,,0,11640,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628229,1,A,Distribution in the bone after 5 min of intravenous administration,Autocuration,,,0,11641,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628230,1,A,Distribution in the bone after 60 min of intravenous administration,Autocuration,,,0,11642,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628231,1,A,Distribution in the bone after 90 min of intravenous administration,Autocuration,,,0,11643,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628232,1,A,Distribution in the heart after 120 min of intravenous administration,Autocuration,,,0,11644,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628233,1,A,Distribution in the heart after 15 min of intravenous administration,Autocuration,,,0,11645,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628234,1,A,Distribution in the heart after 30 min of intravenous administration,Autocuration,,,0,11646,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628235,1,A,Distribution in the heart after 5 min of intravenous administration,Autocuration,,,0,11647,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628236,1,A,Distribution in the heart after 60 min of intravenous administration,Autocuration,,,0,11648,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628237,1,A,Distribution in the heart after 90 min of intravenous administration,Autocuration,,,0,11649,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628238,1,A,Distribution in the kidneys after 120 min of intravenous administration,Autocuration,,,0,11650,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628239,1,A,Distribution in the kidneys after 15 min of intravenous administration,Autocuration,,,0,11651,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628240,1,A,Distribution in the kidneys after 30 min of intravenous administration,Autocuration,,,0,11652,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628241,1,A,Distribution in the kidneys after 5 min of intravenous administration,Autocuration,,,0,11653,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628242,1,A,Distribution in the kidneys after 60 min of intravenous administration,Autocuration,,,0,11654,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL875482,1,A,Distribution in the kidneys after 90 min of intravenous administration,Autocuration,,,0,11655,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628243,1,A,Distribution in the liver after 120 min of intravenous administration,Autocuration,,,0,11656,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628244,1,A,Distribution in the liver after 15 min of intravenous administration,Autocuration,,,0,11657,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628245,1,A,Distribution in the liver after 30 min of intravenous administration,Autocuration,,,0,11658,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628246,1,A,Distribution in the liver after 5 min of intravenous administration,Autocuration,,,0,11659,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628247,1,A,Distribution in the liver after 60 min of intravenous administration,Autocuration,,,0,11660,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628248,1,A,Distribution in the liver after 90 min of intravenous administration,Autocuration,,,0,11661,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628249,1,A,Distribution in the lung after 120 min of intravenous administration,Autocuration,,,0,11662,BAO_0000019,8926
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625452,1,A,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",Intermediate,,,1,11663,BAO_0000218,14839
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625453,1,A,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",Intermediate,,,1,11664,BAO_0000218,14839
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625454,1,A,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",Intermediate,,,1,11665,BAO_0000218,14839
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623844,1,A,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",Intermediate,,,1,11666,BAO_0000218,14839
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623845,1,A,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,Intermediate,,,1,11667,BAO_0000218,12178
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623846,1,A,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,Intermediate,,,1,11668,BAO_0000218,12178
,,,,,,,,U,,,22224,CHEMBL623847,1,A,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,Autocuration,,,0,11669,BAO_0000218,12178
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL623848,1,A,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,Intermediate,,,1,11670,BAO_0000218,12186
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL623849,1,A,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Intermediate,,,1,11671,BAO_0000218,12186
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL623850,1,A,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,Intermediate,,,1,11672,BAO_0000218,12186
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL623851,1,A,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Intermediate,,,1,11673,BAO_0000218,12186
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL623852,1,A,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,Autocuration,,,0,11674,BAO_0000218,12187
,9669.0,,Mustela putorius furo,,,,,N,,,50506,CHEMBL624551,1,A,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,Intermediate,,,1,11675,BAO_0000218,12187
,9669.0,,Mustela putorius furo,,,,,N,,,50506,CHEMBL624552,1,A,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",Intermediate,,,1,11676,BAO_0000218,12187
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL624553,1,A,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,Autocuration,,,0,11677,BAO_0000218,12187
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL624554,1,A,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,Autocuration,,,0,11678,BAO_0000218,12187
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624555,1,A,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,Intermediate,,,1,11679,BAO_0000218,12187
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624741,1,A,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Intermediate,,,1,11680,BAO_0000218,12187
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624742,1,A,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",Intermediate,,,1,11681,BAO_0000218,14122
,10026.0,,Cricetinae,,,,,N,,,100712,CHEMBL624743,1,A,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",Intermediate,,,1,11682,BAO_0000218,14122
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL877606,1,A,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",Intermediate,,,1,11683,BAO_0000218,14122
,,,,,,,,U,,,22224,CHEMBL624744,1,A,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,Autocuration,,,0,11684,BAO_0000218,13391
,,,,Blood,,,,U,,,22224,CHEMBL624745,1,A,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,,178.0,0,11685,BAO_0000218,13391
,,,,Blood,,,,U,,,22224,CHEMBL624746,1,A,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,,178.0,0,11686,BAO_0000218,13391
,,,,Blood,,,,U,,,22224,CHEMBL624747,1,A,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,Autocuration,,178.0,0,11687,BAO_0000218,13391
,,,,,,,,U,,,22224,CHEMBL624748,1,A,Oral absorption expressed as Area under curve was determined,Autocuration,,,0,11688,BAO_0000019,16360
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL622504,1,A,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,Intermediate,,,1,11689,BAO_0000218,3673
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL622505,1,A,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",Intermediate,,,1,11690,BAO_0000218,14122
,10026.0,,Cricetinae,,,,,N,,,100712,CHEMBL622506,1,A,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",Intermediate,,,1,11691,BAO_0000218,14122
,10026.0,,Cricetinae,,,,,N,,,100712,CHEMBL622507,1,A,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",Intermediate,,,1,11692,BAO_0000218,14122
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622508,1,A,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",Intermediate,,,1,11693,BAO_0000218,14122
,,,,,,,,U,,,22224,CHEMBL622509,1,A,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,Autocuration,,,0,11694,BAO_0000019,13889
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622510,1,A,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,,,1,11695,BAO_0000218,14393
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622511,1,A,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),Intermediate,,,1,11696,BAO_0000218,17279
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL622512,1,A,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,Intermediate,,,1,11697,BAO_0000218,14548
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL622513,1,A,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,Intermediate,,,1,11698,BAO_0000218,14548
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL622514,1,A,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,Intermediate,,,1,11699,BAO_0000218,14548
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL622515,1,A,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,Intermediate,,,1,11700,BAO_0000218,14548
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL622516,1,A,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,Intermediate,,,1,11701,BAO_0000218,14548
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622517,1,A,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,Intermediate,,,1,11702,BAO_0000218,14548
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622518,1,A,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,Intermediate,,,1,11703,BAO_0000218,14548
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622519,1,A,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,Intermediate,,,1,11704,BAO_0000218,14548
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL622520,1,A,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,In vivo,2385.0,1,11705,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL622521,1,A,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,In vivo,2385.0,1,11706,BAO_0000218,14608
,10090.0,,Mus musculus,Zone of skin,,,,N,,,50594,CHEMBL625113,1,A,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,In vivo,14.0,1,11707,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Zone of skin,,,,N,,,50597,CHEMBL625114,1,A,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,In vivo,14.0,1,11708,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Zone of skin,,,,N,,,50597,CHEMBL874397,1,A,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,In vivo,14.0,1,11709,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL625115,1,A,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,In vivo,2106.0,1,11710,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL625116,1,A,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,In vivo,2106.0,1,11711,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL623932,1,A,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,In vivo,2106.0,1,11712,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Striatum,,,,N,,,50597,CHEMBL623933,1,A,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,In vivo,2435.0,1,11713,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Striatum,,,,N,,,50597,CHEMBL623934,1,A,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,In vivo,2435.0,1,11714,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Striatum,,,,N,,,50597,CHEMBL623935,1,A,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,In vivo,2435.0,1,11715,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL623936,1,A,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,Intermediate,In vivo,2046.0,1,11716,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL623937,1,A,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,Intermediate,In vivo,2046.0,1,11717,BAO_0000218,14608
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL623938,1,A,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,Intermediate,In vivo,2046.0,1,11718,BAO_0000218,14608
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623939,1,A,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,,,1,11719,BAO_0000218,15383
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623940,1,A,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Intermediate,,,1,11720,BAO_0000218,15383
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623941,1,A,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate,,,1,11721,BAO_0000218,15383
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627216,1,A,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,,,1,11722,BAO_0000218,15383
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623942,1,A,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,,,1,11723,BAO_0000218,15383
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL618793,1,A,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,,955.0,1,11724,BAO_0000218,15383
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL618794,1,A,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,,955.0,1,11725,BAO_0000218,15383
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL618795,1,A,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,,955.0,1,11726,BAO_0000218,15383
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL618796,1,A,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,,,1,11727,BAO_0000218,15383
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL618797,1,A,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,,,1,11728,BAO_0000218,15383
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL618798,1,A,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Intermediate,,2113.0,1,11729,BAO_0000218,15383
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL618799,1,A,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,,2113.0,1,11730,BAO_0000218,15383
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL618800,1,A,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Intermediate,,2113.0,1,11731,BAO_0000218,15383
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL618801,1,A,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate,,2113.0,1,11732,BAO_0000218,15383
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL618802,1,A,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,,2113.0,1,11733,BAO_0000218,15383
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL618803,1,A,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,,2113.0,1,11734,BAO_0000218,15383
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL618804,1,A,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Intermediate,,2107.0,1,11735,BAO_0000218,15383
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL618805,1,A,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,,2107.0,1,11736,BAO_0000218,15383
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL618806,1,A,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Intermediate,,2107.0,1,11737,BAO_0000218,15383
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL618807,1,A,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate,,2107.0,1,11738,BAO_0000218,15383
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL618808,1,A,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,,2107.0,1,11739,BAO_0000218,15383
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL618809,1,A,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,,2107.0,1,11740,BAO_0000218,15383
,10090.0,,Mus musculus,Muscle tissue,,,,N,,,50594,CHEMBL618810,1,A,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,,2385.0,1,11741,BAO_0000218,15383
,10090.0,,Mus musculus,Muscle tissue,,,,N,,,50594,CHEMBL618811,1,A,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Intermediate,,2385.0,1,11742,BAO_0000218,15383
,10090.0,,Mus musculus,Muscle tissue,,,,N,,,50594,CHEMBL875844,1,A,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate,,2385.0,1,11743,BAO_0000218,15383
,10090.0,,Mus musculus,Muscle tissue,,,,N,,,50594,CHEMBL618812,1,A,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,,2385.0,1,11744,BAO_0000218,15383
,10090.0,,Mus musculus,Muscle tissue,,,,N,,,50594,CHEMBL618813,1,A,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,,2385.0,1,11745,BAO_0000218,15383
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL618814,1,A,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,,,1,11746,BAO_0000218,15383
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL618815,1,A,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,,,1,11747,BAO_0000218,15383
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL618816,1,A,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,,,1,11748,BAO_0000218,15383
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL618817,1,A,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,,,1,11749,BAO_0000218,15383
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL620544,1,A,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,,,1,11750,BAO_0000218,15383
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626230,1,A,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,Intermediate,In vivo,,1,11751,BAO_0000218,15341
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626231,1,A,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,Intermediate,In vivo,,1,11752,BAO_0000218,15341
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626232,1,A,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,Intermediate,In vivo,,1,11753,BAO_0000218,15341
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL626233,1,A,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,Intermediate,In vivo,1969.0,1,11754,BAO_0000218,14906
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626234,1,A,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,Intermediate,In vivo,1969.0,1,11755,BAO_0000218,14906
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL875341,1,A,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,Intermediate,In vivo,1969.0,1,11756,BAO_0000218,14906
,9606.0,,Homo sapiens,Plasma,,,,N,,,50587,CHEMBL626235,1,A,The maximum plasma concentration (100 mg/kg) administered orally in human,Intermediate,In vivo,1969.0,1,11757,BAO_0000218,14215
,9481.0,,Callithrix,Plasma,,,,U,,,22224,CHEMBL626236,1,A,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,Autocuration,In vivo,1969.0,0,11758,BAO_0000218,14215
,314293.0,,Simiiformes,Plasma,,,,U,,,22224,CHEMBL626237,1,A,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,Autocuration,In vivo,1969.0,0,11759,BAO_0000218,14215
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL626238,1,A,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,Intermediate,In vivo,1969.0,1,11760,BAO_0000218,14215
,9606.0,,Homo sapiens,Plasma,,,,N,,,50587,CHEMBL622412,1,A,The maximum plasma concentration (200 mg/kg) administered orally in human,Intermediate,In vivo,1969.0,1,11761,BAO_0000218,14215
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623114,1,A,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,Intermediate,In vivo,1969.0,1,11762,BAO_0000218,14215
,9481.0,,Callithrix,Plasma,,,,U,,,22224,CHEMBL623115,1,A,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,Autocuration,In vivo,1969.0,0,11763,BAO_0000218,14215
,314293.0,,Simiiformes,Plasma,,,,U,,,22224,CHEMBL623116,1,A,The maximum plasma concentration (25 mg/kg) administered orally in monkey,Autocuration,In vivo,1969.0,0,11764,BAO_0000218,14215
,9615.0,,Canis lupus familiaris,Plasma,,,,U,,,22224,CHEMBL623117,1,A,The maximum plasma concentration (30 mg/kg) administered orally in dog,Autocuration,In vivo,1969.0,0,11765,BAO_0000218,14215
,9606.0,,Homo sapiens,Plasma,,,,N,,,50587,CHEMBL623118,1,A,The maximum plasma concentration (400 mg/kg) administered orally in human,Intermediate,In vivo,1969.0,1,11766,BAO_0000218,14215
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623119,1,A,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,Intermediate,In vivo,1969.0,1,11767,BAO_0000218,14215
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623120,1,A,The maximum plasma concentration (50 mg/kg) administered orally in rat,Intermediate,In vivo,1969.0,1,11768,BAO_0000218,14215
,9606.0,,Homo sapiens,Plasma,,,,N,,,50587,CHEMBL623286,1,A,The maximum plasma concentration (800 mg/kg) administered orally in human,Intermediate,In vivo,1969.0,1,11769,BAO_0000218,14215
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623287,1,A,The maximum plasma concentration was measured on rats,Intermediate,In vivo,1969.0,1,11770,BAO_0000218,14067
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623288,1,A,The maximum plasma concentration was measured on rats after oral administration,Intermediate,In vivo,1969.0,1,11771,BAO_0000218,12350
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623289,1,A,Plasma drug Cmax in rat (PO dose),Intermediate,In vivo,1969.0,1,11772,BAO_0000218,14813
,,,,,,,,U,,,22224,CHEMBL623290,1,A,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,Autocuration,In vivo,,0,11773,BAO_0000218,12536
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL623291,1,A,maximum Plasma concentration in Dog was determined after Peroral administration,Intermediate,In vivo,1969.0,1,11774,BAO_0000218,14169
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623292,1,A,maximum Plasma concentration in Rats was determined after Peroral administration,Intermediate,In vivo,1969.0,1,11775,BAO_0000218,14169
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL623293,1,A,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,Intermediate,In vivo,1969.0,1,11776,BAO_0000218,15604
,314293.0,,Simiiformes,Plasma,,,,U,,,22224,CHEMBL623294,1,A,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,Autocuration,In vivo,1969.0,0,11777,BAO_0000218,15604
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623295,1,A,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,Intermediate,In vivo,1969.0,1,11778,BAO_0000218,15604
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623296,1,A,maximum concentration was measured when administered through oral route in mice,Intermediate,In vivo,,1,11779,BAO_0000218,14387
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL875349,1,A,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,Intermediate,,,1,11780,BAO_0000218,15115
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL623297,1,A,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,Autocuration,,,0,11781,BAO_0000019,15115
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL623298,1,A,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,Autocuration,,,0,11782,BAO_0000019,15115
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL623299,1,A,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,Autocuration,,,0,11783,BAO_0000019,15115
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623300,1,A,Pharmacokinetic parameter was evaluated in rats,Intermediate,,,1,11784,BAO_0000218,16359
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623301,1,A,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,Intermediate,,,1,11785,BAO_0000218,12829
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623302,1,A,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,Intermediate,,,1,11786,BAO_0000218,12829
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623303,1,A,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,Intermediate,,,1,11787,BAO_0000218,12829
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623304,1,A,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,Intermediate,,,1,11788,BAO_0000218,12829
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623305,1,A,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,Intermediate,,,1,11789,BAO_0000218,12829
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623306,1,A,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,Intermediate,,1969.0,1,11790,BAO_0000218,15137
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623307,1,A,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,Intermediate,,1969.0,1,11791,BAO_0000218,15137
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL623308,1,A,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,Intermediate,,1969.0,1,11792,BAO_0000218,15137
,10090.0,,Mus musculus,Plasma,,,,N,,,50594,CHEMBL623309,1,A,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,Intermediate,,1969.0,1,11793,BAO_0000218,15137
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623310,1,A,Plasma Concentration after 120 min of oral administration to mice,Intermediate,,,1,11794,BAO_0000218,13509
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623311,1,A,Plasma Concentration after 30 min of oral administration to mice,Intermediate,,,1,11795,BAO_0000218,13509
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL623312,1,A,Plasma Concentration after 60 min of oral administration to mice,Intermediate,,,1,11796,BAO_0000218,13509
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL875350,1,A,Plasma Concentration after 60 min of oral administration to mice; Not determined,Intermediate,,,1,11797,BAO_0000218,13509
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL628635,1,A,Plasma Concentration after 90 min of oral administration to mice,Intermediate,,,1,11798,BAO_0000218,13509
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628636,1,A,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,Intermediate,,,1,11799,BAO_0000218,12064
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628637,1,A,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,Intermediate,,,1,11800,BAO_0000218,12064
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628058,1,A,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,Intermediate,,,1,11801,BAO_0000218,12064
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628059,1,A,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,Intermediate,,,1,11802,BAO_0000218,10677
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628060,1,A,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,Intermediate,,,1,11803,BAO_0000218,10677
,,,,,,,,U,,,22224,CHEMBL628061,1,A,Distribution in the lung after 15 min of intravenous administration,Autocuration,,,0,11804,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628062,1,A,Distribution in the lung after 30 min of intravenous administration,Autocuration,,,0,11805,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628063,1,A,Distribution in the lung after 5 min of intravenous administration,Autocuration,,,0,11806,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628064,1,A,Distribution in the lung after 60 min of intravenous administration,Autocuration,,,0,11807,BAO_0000019,8926
,,,,,,,,U,,,22224,CHEMBL628065,1,A,Distribution in the lung after 90 min of intravenous administration,Autocuration,,,0,11808,BAO_0000019,8926
,,,,Muscle tissue,,,,U,,,22224,CHEMBL628066,1,A,Distribution in the muscle after 120 min of intravenous administration,Autocuration,,2385.0,0,11809,BAO_0000019,8926
,,,,Muscle tissue,,,,U,,,22224,CHEMBL628067,1,A,Distribution in the muscle after 15 min of intravenous administration,Autocuration,,2385.0,0,11810,BAO_0000019,8926
,10090.0,,Mus musculus,Muscle tissue,,,,N,,,50594,CHEMBL874646,1,A,Distribution in the muscle after 30 min of intravenous administration,Intermediate,,2385.0,1,11811,BAO_0000218,8926
,,,,Muscle tissue,,,,U,,,22224,CHEMBL628068,1,A,Distribution in the muscle after 5 min of intravenous administration,Autocuration,,2385.0,0,11812,BAO_0000019,8926
,,,,Muscle tissue,,,,U,,,22224,CHEMBL628069,1,A,Distribution in the muscle after 60 min of intravenous administration,Autocuration,,2385.0,0,11813,BAO_0000019,8926
,,,,Muscle tissue,,,,U,,,22224,CHEMBL628070,1,A,Distribution in the muscle after 90 min of intravenous administration,Autocuration,,2385.0,0,11814,BAO_0000019,8926
,,,,Spleen,,,,U,,,22224,CHEMBL628071,1,A,Distribution in the spleen after 120 min of intravenous administration,Autocuration,,2106.0,0,11815,BAO_0000019,8926
,,,,Spleen,,,,U,,,22224,CHEMBL628072,1,A,Distribution in the spleen after 15 min of intravenous administration,Autocuration,,2106.0,0,11816,BAO_0000019,8926
,,,,Spleen,,,,U,,,22224,CHEMBL628073,1,A,Distribution in the spleen after 30 min of intravenous administration,Autocuration,,2106.0,0,11817,BAO_0000019,8926
,,,,Spleen,,,,U,,,22224,CHEMBL628074,1,A,Distribution in the spleen after 5 min of intravenous administration,Autocuration,,2106.0,0,11818,BAO_0000019,8926
,,,,Spleen,,,,U,,,22224,CHEMBL628075,1,A,Distribution in the spleen after 60 min of intravenous administration,Autocuration,,2106.0,0,11819,BAO_0000019,8926
,,,,Spleen,,,,U,,,22224,CHEMBL628076,1,A,Distribution in the spleen after 90 min of intravenous administration,Autocuration,,2106.0,0,11820,BAO_0000019,8926
,10116.0,,Rattus norvegicus,Adrenal cortex,,,,N,,,50597,CHEMBL628077,1,A,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,Intermediate,,1235.0,1,11821,BAO_0000218,7570
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL628078,1,A,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,Intermediate,,178.0,1,11822,BAO_0000218,7570
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL628079,1,A,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,Intermediate,,2107.0,1,11823,BAO_0000218,7570
,10116.0,,Rattus norvegicus,Female gonad,,,,N,,,50597,CHEMBL628080,1,A,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,Intermediate,,992.0,1,11824,BAO_0000218,7570
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL628081,1,A,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,Intermediate,,2046.0,1,11825,BAO_0000218,7570
,10116.0,,Rattus norvegicus,Adrenal cortex,,,,N,,,50597,CHEMBL628082,1,A,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,Intermediate,,1235.0,1,11826,BAO_0000218,7570
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL874647,1,A,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,Intermediate,,178.0,1,11827,BAO_0000218,7570
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL626406,1,A,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,Intermediate,,2107.0,1,11828,BAO_0000218,7570
,10116.0,,Rattus norvegicus,Female gonad,,,,N,,,50597,CHEMBL626407,1,A,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,Intermediate,,992.0,1,11829,BAO_0000218,7570
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626408,1,A,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,Intermediate,,2046.0,1,11830,BAO_0000218,7570
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626409,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",Intermediate,,178.0,1,11831,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626410,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",Intermediate,,178.0,1,11832,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626411,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",Intermediate,,178.0,1,11833,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626412,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",Intermediate,,178.0,1,11834,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626413,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",Intermediate,,178.0,1,11835,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626414,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",Intermediate,,178.0,1,11836,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626415,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",Intermediate,,178.0,1,11837,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626416,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",Intermediate,,178.0,1,11838,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627062,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",Intermediate,,178.0,1,11839,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627063,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",Intermediate,,178.0,1,11840,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627064,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",Intermediate,,178.0,1,11841,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627227,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",Intermediate,,178.0,1,11842,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627228,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",Intermediate,,178.0,1,11843,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627229,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",Intermediate,,178.0,1,11844,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625792,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",Intermediate,,178.0,1,11845,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625793,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",Intermediate,,178.0,1,11846,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625794,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",Intermediate,,178.0,1,11847,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625795,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",Intermediate,,178.0,1,11848,BAO_0000218,8608
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625796,1,A,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,Intermediate,,,1,11849,BAO_0000218,13792
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625797,1,A,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,Intermediate,,,1,11850,BAO_0000218,13376
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625798,1,A,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,Intermediate,,,1,11851,BAO_0000218,13376
,,,,,,,,U,,,22224,CHEMBL875613,1,A,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Autocuration,,,0,11852,BAO_0000218,14380
,,,,,,,,U,,,22224,CHEMBL625799,1,A,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,Autocuration,,,0,11853,BAO_0000218,14380
,,,,,,,,U,,,22224,CHEMBL625800,1,A,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,Autocuration,,,0,11854,BAO_0000218,14380
,,,,,,,,U,,,22224,CHEMBL625801,1,A,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,Autocuration,,,0,11855,BAO_0000218,14380
,,,,,,,,U,,,22224,CHEMBL625802,1,A,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,Autocuration,,,0,11856,BAO_0000218,14380
,,,,,,,,U,,,22224,CHEMBL625803,1,A,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,Autocuration,,,0,11857,BAO_0000218,14380
,,,,,,,,U,,,22224,CHEMBL625804,1,A,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,Autocuration,,,0,11858,BAO_0000019,14380
,,,,,,,,U,,,22224,CHEMBL622530,1,A,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,Autocuration,,,0,11859,BAO_0000218,14380
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL622531,1,A,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,Intermediate,,,1,11860,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL622532,1,A,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Intermediate,,,1,11861,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623176,1,A,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Intermediate,,,1,11862,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623177,1,A,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),Intermediate,,,1,11863,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623178,1,A,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Intermediate,,,1,11864,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623179,1,A,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,Intermediate,,,1,11865,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623180,1,A,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),Intermediate,,,1,11866,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623181,1,A,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Intermediate,,,1,11867,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL624131,1,A,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Intermediate,,,1,11868,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL624132,1,A,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),Intermediate,,,1,11869,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL624133,1,A,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),Intermediate,,,1,11870,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL624846,1,A,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,Intermediate,,,1,11871,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL624847,1,A,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),Intermediate,,,1,11872,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL624848,1,A,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Intermediate,,,1,11873,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625012,1,A,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Intermediate,,,1,11874,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625013,1,A,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Intermediate,,,1,11875,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625014,1,A,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,Intermediate,,,1,11876,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625015,1,A,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),Intermediate,,,1,11877,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625016,1,A,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),Intermediate,,,1,11878,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625017,1,A,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,Intermediate,,,1,11879,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625018,1,A,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Intermediate,,,1,11880,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625019,1,A,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),Intermediate,,,1,11881,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625020,1,A,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),Intermediate,,,1,11882,BAO_0000218,13701
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625021,1,A,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,Intermediate,,,1,11883,BAO_0000218,13701
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625022,1,A,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,,,1,11884,BAO_0000218,14393
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625023,1,A,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,Intermediate,,,1,11885,BAO_0000218,14731
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL625024,1,A,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,Intermediate,,,1,11886,BAO_0000218,14731
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL627626,1,A,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,Intermediate,,,1,11887,BAO_0000218,14731
,,,,Brain,,,,U,,,22224,CHEMBL627627,1,A,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,Autocuration,,955.0,0,11888,BAO_0000218,13758
,,,,Serum,,,,U,,,22224,CHEMBL627628,1,A,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,Autocuration,,1977.0,0,11889,BAO_0000218,13758
,,,,Brain,,,,U,,,22224,CHEMBL627629,1,A,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,Autocuration,,955.0,0,11890,BAO_0000218,13758
,,,,Serum,,,,U,,,22224,CHEMBL627630,1,A,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,Autocuration,,1977.0,0,11891,BAO_0000218,13758
,,,,,,,,U,,,22224,CHEMBL627631,1,A,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),Autocuration,,,0,11892,BAO_0000019,16359
,,,,,,,,U,,,22224,CHEMBL629515,1,A,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),Autocuration,,,0,11893,BAO_0000218,16359
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL629516,1,A,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,,2106.0,1,11894,BAO_0000218,15383
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL629517,1,A,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,,2106.0,1,11895,BAO_0000218,15383
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL629518,1,A,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,,2106.0,1,11896,BAO_0000218,15383
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL877499,1,A,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Intermediate,,,1,11897,BAO_0000218,15383
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629519,1,A,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Intermediate,,,1,11898,BAO_0000218,15383
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629520,1,A,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Intermediate,,,1,11899,BAO_0000218,15383
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629521,1,A,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Intermediate,,,1,11900,BAO_0000218,15383
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629522,1,A,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),Intermediate,,,1,11901,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629523,1,A,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),Intermediate,,,1,11902,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629524,1,A,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),Intermediate,,,1,11903,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629525,1,A,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),Intermediate,,,1,11904,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629526,1,A,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),Intermediate,,,1,11905,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629527,1,A,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),Intermediate,,,1,11906,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629528,1,A,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),Intermediate,,,1,11907,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629529,1,A,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),Intermediate,,,1,11908,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629530,1,A,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),Intermediate,,,1,11909,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629531,1,A,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),Intermediate,,,1,11910,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL628656,1,A,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),Intermediate,,,1,11911,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL628657,1,A,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),Intermediate,,,1,11912,BAO_0000218,14439
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628658,1,A,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,In vivo,,1,11913,BAO_0000218,13751
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628659,1,A,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,In vivo,,1,11914,BAO_0000218,13751
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL877500,1,A,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,In vivo,,1,11915,BAO_0000218,13751
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628660,1,A,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,In vivo,,1,11916,BAO_0000218,13751
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628661,1,A,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,In vivo,,1,11917,BAO_0000218,13751
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628662,1,A,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,In vivo,,1,11918,BAO_0000218,13751
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628663,1,A,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,In vivo,,1,11919,BAO_0000218,13751
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628664,1,A,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,In vivo,,1,11920,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL628665,1,A,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,In vivo,178.0,1,11921,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL628666,1,A,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,In vivo,178.0,1,11922,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL628667,1,A,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,In vivo,178.0,1,11923,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL628668,1,A,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,In vivo,178.0,1,11924,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL628669,1,A,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,In vivo,178.0,1,11925,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL628670,1,A,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,In vivo,178.0,1,11926,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL628671,1,A,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,In vivo,178.0,1,11927,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL628672,1,A,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,In vivo,10000001.0,1,11928,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL630300,1,A,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,In vivo,10000001.0,1,11929,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL629787,1,A,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,In vivo,10000001.0,1,11930,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL629788,1,A,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,In vivo,10000001.0,1,11931,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL629789,1,A,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,In vivo,955.0,1,11932,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL629790,1,A,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,In vivo,955.0,1,11933,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL629791,1,A,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,In vivo,955.0,1,11934,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL629792,1,A,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,In vivo,955.0,1,11935,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL629793,1,A,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,In vivo,955.0,1,11936,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL629794,1,A,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,In vivo,955.0,1,11937,BAO_0000218,13751
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874459,1,A,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,Intermediate,,,1,11938,BAO_0000218,10677
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629795,1,A,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,Intermediate,,,1,11939,BAO_0000218,10677
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629796,1,A,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,Intermediate,,,1,11940,BAO_0000218,10677
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629797,1,A,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,Intermediate,,,1,11941,BAO_0000218,10677
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629798,1,A,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,Intermediate,,,1,11942,BAO_0000218,10677
,10116.0,,Rattus norvegicus,Adrenal gland,,,,N,,,50597,CHEMBL629799,1,A,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,In vivo,2369.0,1,11943,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Adrenal gland,,,,N,,,50597,CHEMBL629800,1,A,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2369.0,1,11944,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Adrenal gland,,,,N,,,50597,CHEMBL629801,1,A,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2369.0,1,11945,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Adrenal gland,,,,N,,,50597,CHEMBL629802,1,A,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,Intermediate,In vivo,2369.0,1,11946,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Adrenal gland,,,,N,,,50597,CHEMBL629803,1,A,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2369.0,1,11947,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL629804,1,A,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,In vivo,178.0,1,11948,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL629805,1,A,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,178.0,1,11949,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL629806,1,A,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Intermediate,In vivo,178.0,1,11950,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL629807,1,A,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,178.0,1,11951,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL629808,1,A,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,178.0,1,11952,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL629809,1,A,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,In vivo,955.0,1,11953,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL629810,1,A,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,955.0,1,11954,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL629811,1,A,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Intermediate,In vivo,955.0,1,11955,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL629812,1,A,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,955.0,1,11956,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL629813,1,A,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,Intermediate,In vivo,955.0,1,11957,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL874460,1,A,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,955.0,1,11958,BAO_0000218,10911
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629814,1,A,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,In vivo,,1,11959,BAO_0000218,10911
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629815,1,A,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,,1,11960,BAO_0000218,10911
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629816,1,A,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,,1,11961,BAO_0000218,10911
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629817,1,A,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,,1,11962,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626643,1,A,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,In vivo,2113.0,1,11963,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626644,1,A,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2113.0,1,11964,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626806,1,A,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2113.0,1,11965,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626807,1,A,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2113.0,1,11966,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627261,1,A,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,In vivo,2107.0,1,11967,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627262,1,A,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2107.0,1,11968,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627263,1,A,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2107.0,1,11969,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627264,1,A,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2107.0,1,11970,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627265,1,A,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,In vivo,2048.0,1,11971,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627266,1,A,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2048.0,1,11972,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627267,1,A,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2048.0,1,11973,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627268,1,A,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2048.0,1,11974,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL627269,1,A,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,In vivo,2385.0,1,11975,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL627270,1,A,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2385.0,1,11976,BAO_0000218,10911
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627271,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",Intermediate,,,1,11977,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627946,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",Intermediate,,,1,11978,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875472,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",Intermediate,,,1,11979,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627947,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",Intermediate,,,1,11980,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627948,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",Intermediate,,,1,11981,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628113,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",Intermediate,,,1,11982,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628114,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",Intermediate,,,1,11983,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628115,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",Intermediate,,,1,11984,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628116,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",Intermediate,,,1,11985,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628117,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",Intermediate,,,1,11986,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628118,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",Intermediate,,,1,11987,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628119,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",Intermediate,,,1,11988,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628120,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",Intermediate,,,1,11989,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628121,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",Intermediate,,,1,11990,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628122,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",Intermediate,,,1,11991,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627297,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",Intermediate,,,1,11992,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627298,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",Intermediate,,,1,11993,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627299,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",Intermediate,,,1,11994,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627300,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",Intermediate,,,1,11995,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627301,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",Intermediate,,,1,11996,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627302,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",Intermediate,,,1,11997,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627303,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",Intermediate,,,1,11998,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627304,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",Intermediate,,,1,11999,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627305,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",Intermediate,,,1,12000,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627306,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",Intermediate,,,1,12001,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623982,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",Intermediate,,,1,12002,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623983,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",Intermediate,,,1,12003,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623984,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",Intermediate,,,1,12004,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623985,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",Intermediate,,,1,12005,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623986,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",Intermediate,,,1,12006,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623987,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",Intermediate,,,1,12007,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623988,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",Intermediate,,,1,12008,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623989,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",Intermediate,,,1,12009,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622215,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",Intermediate,,,1,12010,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622216,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",Intermediate,,,1,12011,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL877481,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",Intermediate,,,1,12012,BAO_0000218,8608
,,,,,,,,U,,,22224,CHEMBL622217,1,A,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),Autocuration,,,0,12013,BAO_0000218,16359
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL622218,1,A,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),Intermediate,,,1,12014,BAO_0000218,13701
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622219,1,A,Pharmacokinetic profile AUC was evaluated in rats,Intermediate,,,1,12015,BAO_0000218,14554
,,,,,,,,U,,,22224,CHEMBL622220,1,A,Pharmacokinetic property (Area under curve),Autocuration,,,0,12016,BAO_0000019,6241
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL622221,1,A,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",Intermediate,,,1,12017,BAO_0000218,11537
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL622222,1,A,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",Intermediate,,,1,12018,BAO_0000218,11537
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL622223,1,A,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",Intermediate,,,1,12019,BAO_0000218,11537
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL622224,1,A,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",Intermediate,,,1,12020,BAO_0000218,11537
,,,,,,,,U,,,22224,CHEMBL622225,1,A,Plasma concentration (AUC) was determined,Autocuration,,,0,12021,BAO_0000019,13118
,,,,,,,,U,,,22224,CHEMBL622226,1,A,Plasma concentration (AUC) was determined; Not detectable,Autocuration,,,0,12022,BAO_0000019,13118
,10141.0,,Cavia porcellus,,,,,N,,,50512,CHEMBL624154,1,A,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),Intermediate,,,1,12023,BAO_0000218,9562
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624155,1,A,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,Intermediate,,,1,12024,BAO_0000218,10363
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624156,1,A,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,Intermediate,,,1,12025,BAO_0000218,10363
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624157,1,A,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,Intermediate,,,1,12026,BAO_0000218,10363
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624158,1,A,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,Intermediate,,,1,12027,BAO_0000218,10363
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624159,1,A,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,Intermediate,,,1,12028,BAO_0000218,12504
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624160,1,A,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,Intermediate,,,1,12029,BAO_0000218,12504
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624161,1,A,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,Intermediate,,,1,12030,BAO_0000218,12504
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624162,1,A,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,Intermediate,,,1,12031,BAO_0000218,12504
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624163,1,A,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,Intermediate,,,1,12032,BAO_0000218,13317
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624164,1,A,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,,,1,12033,BAO_0000218,15078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624165,1,A,The AUC(0-infinity) values in female wistar rats.,Intermediate,,,1,12034,BAO_0000218,14941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624166,1,A,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,,,1,12035,BAO_0000218,15078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624167,1,A,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",Intermediate,,,1,12036,BAO_0000218,15078
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624168,1,A,The AUC(0-t)values in female wistar rats.,Intermediate,,,1,12037,BAO_0000218,14941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624169,1,A,The Area under the concentration time curve of compound was measured on rats,Intermediate,,,1,12038,BAO_0000218,14067
,9606.0,,Homo sapiens,,,,,N,,,50587,CHEMBL624170,1,A,The area under curve (100 mg/kg) administered orally in humans,Intermediate,,,1,12039,BAO_0000218,14215
,9481.0,,Callithrix,,,,,U,,,22224,CHEMBL624171,1,A,The area under curve (12.5 mg/kg) administered intravenously in marmoset,Autocuration,,,0,12040,BAO_0000218,14215
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL624172,1,A,The area under curve (12.5 mg/kg) administered intravenously in monkey,Autocuration,,,0,12041,BAO_0000218,14215
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624173,1,A,The area under curve (15 mg/kg) administered intravenously in dog,Intermediate,,,1,12042,BAO_0000218,14215
,9606.0,,Homo sapiens,,,,,N,,,50587,CHEMBL877488,1,A,The area under curve (200 mg/kg) administered orally in humans,Intermediate,,,1,12043,BAO_0000218,14215
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624174,1,A,The area under curve (25 mg/kg) administered intravenously in rat,Intermediate,,,1,12044,BAO_0000218,14215
,9481.0,,Callithrix,,,,,U,,,22224,CHEMBL624175,1,A,The area under curve (25 mg/kg) administered orally in marmoset,Autocuration,,,0,12045,BAO_0000218,14215
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL624176,1,A,The area under curve (25 mg/kg) administered orally in monkey,Autocuration,,,0,12046,BAO_0000218,14215
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624177,1,A,The area under curve (30 mg/kg) administered orally in dog,Intermediate,,,1,12047,BAO_0000218,14215
,9606.0,,Homo sapiens,,,,,N,,,50587,CHEMBL624178,1,A,The area under curve (400 mg/kg) administered orally in humans,Intermediate,,,1,12048,BAO_0000218,14215
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624179,1,A,The area under curve (50 mg/kg) administered orally in fasted rat,Intermediate,,,1,12049,BAO_0000218,14215
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627689,1,A,The area under curve (50 mg/kg) administered orally in rat,Intermediate,,,1,12050,BAO_0000218,14215
,9606.0,,Homo sapiens,,,,,N,,,50587,CHEMBL627690,1,A,The area under curve (800 mg/kg) administered orally in humans,Intermediate,,,1,12051,BAO_0000218,14215
,,,,,,,,U,,,22224,CHEMBL627691,1,A,The compound was evaluated for area under the curve,Autocuration,,,0,12052,BAO_0000019,11324
,9481.0,,Callithrix,,,,,U,,,22224,CHEMBL627692,1,A,The compound was evaluated for area under the curve in marmosets,Autocuration,,,0,12053,BAO_0000019,11324
,9481.0,,Callithrix,,,,,U,,,22224,CHEMBL627693,1,A,The compound was evaluated for area under the curve in marmosets,Autocuration,,,0,12054,BAO_0000019,11324
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627694,1,A,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate,,,1,12055,BAO_0000218,13875
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627695,1,A,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate,,,1,12056,BAO_0000218,13875
,,,,,,,,U,,,22224,CHEMBL627696,1,A,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),Autocuration,,,0,12057,BAO_0000218,13875
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627697,1,A,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate,,,1,12058,BAO_0000218,13875
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627698,1,A,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate,,,1,12059,BAO_0000218,13875
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627699,1,A,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,Intermediate,,,1,12060,BAO_0000218,13875
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627700,1,A,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,Intermediate,,,1,12061,BAO_0000218,13807
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627701,1,A,Total drug exposure is determined after oral dosing in rats.,Intermediate,,,1,12062,BAO_0000218,14127
,,,,,,,,U,,,22224,CHEMBL627702,1,A,Total drug exposure (5 mg/kg) when administered intravenously,Autocuration,,,0,12063,BAO_0000218,15116
,,,,,,,,U,,,22224,CHEMBL627703,1,A,Total drug exposure (5 mg/kg) when administered orally,Autocuration,,,0,12064,BAO_0000218,15116
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL626873,1,A,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,Autocuration,,,0,12065,BAO_0000218,15604
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629583,1,A,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,Intermediate,,,1,12066,BAO_0000218,15604
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL629584,1,A,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,Intermediate,,,1,12067,BAO_0000218,15604
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL629585,1,A,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,Intermediate,,,1,12068,BAO_0000218,15604
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL629586,1,A,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,In vivo,955.0,1,12069,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL629587,1,A,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,In vivo,955.0,1,12070,BAO_0000218,13751
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629588,1,A,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,In vivo,,1,12071,BAO_0000218,13751
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629589,1,A,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,In vivo,,1,12072,BAO_0000218,13751
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629590,1,A,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,In vivo,,1,12073,BAO_0000218,13751
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629591,1,A,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,In vivo,,1,12074,BAO_0000218,13751
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629592,1,A,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,In vivo,,1,12075,BAO_0000218,13751
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629593,1,A,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,In vivo,,1,12076,BAO_0000218,13751
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629594,1,A,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,In vivo,,1,12077,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL629595,1,A,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,In vivo,948.0,1,12078,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL630290,1,A,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,In vivo,948.0,1,12079,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL627137,1,A,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,In vivo,948.0,1,12080,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL627138,1,A,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,In vivo,948.0,1,12081,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL627139,1,A,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,In vivo,948.0,1,12082,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL627140,1,A,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,In vivo,948.0,1,12083,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL627141,1,A,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,In vivo,948.0,1,12084,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL627142,1,A,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,In vivo,2113.0,1,12085,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL627143,1,A,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,In vivo,2113.0,1,12086,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL874449,1,A,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,In vivo,2113.0,1,12087,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL627144,1,A,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,In vivo,2113.0,1,12088,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL627145,1,A,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,In vivo,2113.0,1,12089,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL627146,1,A,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,In vivo,2113.0,1,12090,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL627147,1,A,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,In vivo,2113.0,1,12091,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627148,1,A,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,In vivo,2107.0,1,12092,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627149,1,A,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,In vivo,2048.0,1,12093,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL632160,1,A,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,In vivo,2048.0,1,12094,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL632161,1,A,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,In vivo,2048.0,1,12095,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL632162,1,A,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,In vivo,2048.0,1,12096,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL632163,1,A,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,In vivo,2048.0,1,12097,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL874469,1,A,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,In vivo,2048.0,1,12098,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627182,1,A,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,In vivo,2048.0,1,12099,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL627183,1,A,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",Intermediate,In vivo,2385.0,1,12100,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL627184,1,A,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,In vivo,2385.0,1,12101,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL627185,1,A,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,In vivo,2385.0,1,12102,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL627186,1,A,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,In vivo,2385.0,1,12103,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL627187,1,A,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,In vivo,2385.0,1,12104,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL627188,1,A,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,In vivo,2385.0,1,12105,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL627189,1,A,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,In vivo,2385.0,1,12106,BAO_0000218,13751
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627190,1,A,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,In vivo,,1,12107,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627191,1,A,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",Intermediate,In vivo,2107.0,1,12108,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627192,1,A,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Intermediate,In vivo,2107.0,1,12109,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627193,1,A,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",Intermediate,In vivo,2107.0,1,12110,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL874590,1,A,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Intermediate,In vivo,2385.0,1,12111,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL627194,1,A,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2385.0,1,12112,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL627195,1,A,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2385.0,1,12113,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Female gonad,,,,N,,,50597,CHEMBL627196,1,A,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,In vivo,992.0,1,12114,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Female gonad,,,,N,,,50597,CHEMBL627197,1,A,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,992.0,1,12115,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Female gonad,,,,N,,,50597,CHEMBL627198,1,A,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,992.0,1,12116,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Female gonad,,,,N,,,50597,CHEMBL627199,1,A,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,Intermediate,In vivo,992.0,1,12117,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Female gonad,,,,N,,,50597,CHEMBL627200,1,A,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,992.0,1,12118,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627201,1,A,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,In vivo,1969.0,1,12119,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627202,1,A,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,1969.0,1,12120,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627203,1,A,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,1969.0,1,12121,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627204,1,A,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,1969.0,1,12122,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL627205,1,A,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,In vivo,2106.0,1,12123,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL627206,1,A,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2106.0,1,12124,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL627207,1,A,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2106.0,1,12125,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL627208,1,A,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2106.0,1,12126,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL627209,1,A,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,In vivo,2046.0,1,12127,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL627210,1,A,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2046.0,1,12128,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL627211,1,A,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2046.0,1,12129,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL627212,1,A,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,2046.0,1,12130,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL627213,1,A,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Intermediate,In vivo,995.0,1,12131,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL626599,1,A,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,995.0,1,12132,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL626600,1,A,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,995.0,1,12133,BAO_0000218,10911
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL626601,1,A,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Intermediate,In vivo,995.0,1,12134,BAO_0000218,10911
,,,,,,,,U,,,22224,CHEMBL627484,1,A,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,Autocuration,,,0,12135,BAO_0000019,8081
,9541.0,,Macaca fascicularis,Plasma,,,,N,,,100710,CHEMBL627485,1,A,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),Intermediate,,1969.0,1,12136,BAO_0000218,17248
,9541.0,,Macaca fascicularis,Plasma,,,,N,,,100710,CHEMBL628147,1,A,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,Intermediate,,1969.0,1,12137,BAO_0000218,17248
,9541.0,,Macaca fascicularis,Plasma,,,,N,,,100710,CHEMBL628148,1,A,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,Intermediate,,1969.0,1,12138,BAO_0000218,17248
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL628149,1,A,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),Intermediate,,1969.0,1,12139,BAO_0000218,17248
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL628150,1,A,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,Intermediate,,1969.0,1,12140,BAO_0000218,17248
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL628318,1,A,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,Intermediate,,1969.0,1,12141,BAO_0000218,17248
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL628319,1,A,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,Intermediate,,1969.0,1,12142,BAO_0000218,17248
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL875609,1,A,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",Intermediate,,,1,12143,BAO_0000218,15592
,,,,,,,,U,,,22224,CHEMBL628320,1,A,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,Autocuration,,,0,12144,BAO_0000019,7040
,,,,,,,,U,,,22224,CHEMBL628321,1,A,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,Autocuration,,,0,12145,BAO_0000019,7040
,,,,,,,,U,,,22224,CHEMBL628322,1,A,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,Autocuration,,,0,12146,BAO_0000019,7040
,,,,,,,,U,,,22224,CHEMBL628323,1,A,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,Autocuration,,,0,12147,BAO_0000019,7040
,,,,,,,,U,,,22224,CHEMBL628324,1,A,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,Autocuration,,,0,12148,BAO_0000019,7040
,,,,,,,,U,,,22224,CHEMBL628325,1,A,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,Autocuration,,,0,12149,BAO_0000019,7040
,,,,,,,,U,,,22224,CHEMBL628326,1,A,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,Autocuration,,,0,12150,BAO_0000019,7040
,9615.0,,Canis lupus familiaris,Adrenal medulla,,,,N,,,50588,CHEMBL628327,1,A,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",Intermediate,,1236.0,1,12151,BAO_0000218,9614
,9615.0,,Canis lupus familiaris,Adrenal medulla,,,,N,,,50588,CHEMBL628328,1,A,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",Intermediate,,1236.0,1,12152,BAO_0000218,9614
,9615.0,,Canis lupus familiaris,Blood,,,,N,,,50588,CHEMBL628329,1,A,"Concentration of compound in blood of dog 1, after administering intravenously",Intermediate,,178.0,1,12153,BAO_0000218,9614
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL628330,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",Intermediate,,2107.0,1,12154,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL628331,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",Intermediate,,2107.0,1,12155,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL628332,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",Intermediate,,2107.0,1,12156,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL628333,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",Intermediate,,2107.0,1,12157,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL628334,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",Intermediate,,2107.0,1,12158,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL628335,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",Intermediate,,2107.0,1,12159,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL628336,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",Intermediate,,2107.0,1,12160,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL628337,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",Intermediate,,2107.0,1,12161,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL628338,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",Intermediate,,2107.0,1,12162,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL875610,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",Intermediate,,2107.0,1,12163,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL628339,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",Intermediate,,2107.0,1,12164,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL628340,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",Intermediate,,2107.0,1,12165,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL628341,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",Intermediate,,2107.0,1,12166,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622214,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",Intermediate,,2107.0,1,12167,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL623167,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",Intermediate,,2107.0,1,12168,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL623168,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",Intermediate,,2107.0,1,12169,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL623169,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",Intermediate,,2107.0,1,12170,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL623170,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",Intermediate,,2107.0,1,12171,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627224,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",Intermediate,,2048.0,1,12172,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL875634,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",Intermediate,,2048.0,1,12173,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627225,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",Intermediate,,2048.0,1,12174,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627226,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",Intermediate,,2048.0,1,12175,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626083,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",Intermediate,,2048.0,1,12176,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626084,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",Intermediate,,2048.0,1,12177,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626085,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",Intermediate,,2048.0,1,12178,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626086,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",Intermediate,,2048.0,1,12179,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626087,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",Intermediate,,2048.0,1,12180,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626088,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",Intermediate,,2048.0,1,12181,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626089,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",Intermediate,,2048.0,1,12182,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626090,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",Intermediate,,2048.0,1,12183,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626091,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",Intermediate,,2048.0,1,12184,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626092,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",Intermediate,,2048.0,1,12185,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626093,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",Intermediate,,2048.0,1,12186,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626094,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",Intermediate,,2048.0,1,12187,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626095,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",Intermediate,,2048.0,1,12188,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL626096,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",Intermediate,,2048.0,1,12189,BAO_0000218,8608
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL626097,1,A,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,Autocuration,,,0,12190,BAO_0000218,15604
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626098,1,A,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,Intermediate,,,1,12191,BAO_0000218,15604
,,,,Plasma,,,,U,,,22224,CHEMBL626099,1,A,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,Autocuration,,1969.0,0,12192,BAO_0000218,1806
,,,,Plasma,,,,U,,,22224,CHEMBL626100,1,A,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,Autocuration,,1969.0,0,12193,BAO_0000218,1806
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL626101,1,A,AUC 0-inf in dog,Intermediate,,1969.0,1,12194,BAO_0000218,17237
,10141.0,,Cavia porcellus,Plasma,,,,N,,,50512,CHEMBL626102,1,A,AUC 0-inf in guinea pig,Intermediate,,1969.0,1,12195,BAO_0000218,17237
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL626103,1,A,AUC 0-t in dog,Intermediate,,1969.0,1,12196,BAO_0000218,17237
,10141.0,,Cavia porcellus,Plasma,,,,N,,,50512,CHEMBL628391,1,A,AUC 0-t in guinea pig,Intermediate,,1969.0,1,12197,BAO_0000218,17237
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628392,1,A,The compound was tested for brain to plasma partition in rat,Intermediate,,,1,12198,BAO_0000218,15194
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628393,1,A,The compound was tested for brain to plasma partition in rat.,Intermediate,,,1,12199,BAO_0000218,15194
,,,,Blood,,,,U,,,22224,CHEMBL628394,1,A,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,Autocuration,,178.0,0,12200,BAO_0000019,8787
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628395,1,A,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,Intermediate,,,1,12201,BAO_0000218,17025
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL628396,1,A,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,Autocuration,,,0,12202,BAO_0000218,17025
,9986.0,,Oryctolagus cuniculus,,,,,N,,,50592,CHEMBL628397,1,A,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,Intermediate,,,1,12203,BAO_0000218,17025
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628398,1,A,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,Intermediate,,,1,12204,BAO_0000218,17025
,9544.0,,Macaca mulatta,,,,,N,,,50797,CHEMBL628399,1,A,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,Intermediate,,,1,12205,BAO_0000218,4236
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628400,1,A,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,Intermediate,,,1,12206,BAO_0000218,15343
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874907,1,A,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,Intermediate,,,1,12207,BAO_0000218,15343
,,,,,,,,U,,,22224,CHEMBL628401,1,A,Area under curve of the compound was determined,Autocuration,,,0,12208,BAO_0000019,17720
,314293.0,,Simiiformes,Plasma,,,,U,,,22224,CHEMBL628402,1,A,AUC in monkeys at a dose of 1 mg/kg,Autocuration,,1969.0,0,12209,BAO_0000218,17788
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL628403,1,A,AUC in rats at a dose of 1 mg/kg,Intermediate,,1969.0,1,12210,BAO_0000218,17788
,,,,,,,,U,,,22224,CHEMBL628404,1,A,Compound was evaluated for the overall absorbance loss at pH of 2,Autocuration,,,0,12211,BAO_0000019,8778
,,,,,,,,U,,,22224,CHEMBL628405,1,A,Compound was evaluated for the overall absorbance loss at pH of 4,Autocuration,,,0,12212,BAO_0000019,8778
,,,,,,,,U,,,22224,CHEMBL628406,1,A,Compound was evaluated for the overall absorbance loss at pH of 7,Autocuration,,,0,12213,BAO_0000019,8778
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628407,1,A,Compound was evaluated for its absorption in the rats,Intermediate,,,1,12214,BAO_0000218,2249
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628408,1,A,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Intermediate,,1088.0,1,12215,BAO_0000218,8881
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL629171,1,A,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,Intermediate,,1088.0,1,12216,BAO_0000218,8881
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL629172,1,A,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Intermediate,,1088.0,1,12217,BAO_0000218,8881
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL629173,1,A,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,Intermediate,,1088.0,1,12218,BAO_0000218,8881
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629174,1,A,In vitro percent permeability into rat ileum,Intermediate,,,1,12219,BAO_0000218,15286
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629175,1,A,In vitro percent permeability into rat ileum; Range is 10-17,Intermediate,,,1,12220,BAO_0000218,15286
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629176,1,A,In vitro percent permeability into rat ileum; Range is 10-18,Intermediate,,,1,12221,BAO_0000218,15286
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629177,1,A,In vitro percent permeability into rat ileum; Range is 10-19,Intermediate,,,1,12222,BAO_0000218,15286
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629178,1,A,In vitro percent permeability into rat ileum; Range is 12-15,Intermediate,,,1,12223,BAO_0000218,15286
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631869,1,A,In vitro percent permeability into rat ileum; Range is 13-19,Intermediate,,,1,12224,BAO_0000218,15286
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631870,1,A,In vitro percent permeability into rat ileum; Range is 14-17,Intermediate,,,1,12225,BAO_0000218,15286
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631871,1,A,In vitro percent permeability into rat ileum; Range is 15-18,Intermediate,,,1,12226,BAO_0000218,15286
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631872,1,A,In vitro percent permeability into rat ileum; Range is 2-5,Intermediate,,,1,12227,BAO_0000218,15286
,,,,Ileum,,,,U,,,22224,CHEMBL875775,1,A,In vitro percent permeability into rat ileum; Range is 23-42,Autocuration,,2116.0,0,12228,BAO_0000221,15286
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631873,1,A,In vitro percent permeability into rat ileum; Range is 28-36,Intermediate,,,1,12229,BAO_0000218,15286
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631874,1,A,In vitro percent permeability into rat ileum; Range is 29-35,Intermediate,,,1,12230,BAO_0000218,15286
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631875,1,A,In vitro percent permeability into rat ileum; Range is 46-66,Intermediate,,,1,12231,BAO_0000218,15286
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631876,1,A,In vitro percent permeability into rat ileum; Range is 50-68,Intermediate,,,1,12232,BAO_0000218,15286
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631877,1,A,In vitro percent permeability into rat ileum; Range is 78-81,Intermediate,,,1,12233,BAO_0000218,15286
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631878,1,A,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,Intermediate,,,1,12234,BAO_0000218,15286
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631879,1,A,In vitro percent permeability into rat ileum; nd indicates not detected,Intermediate,,,1,12235,BAO_0000218,15286
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631880,1,A,In vitro percent permeability into rat ileum; nt indicates not detected,Intermediate,,,1,12236,BAO_0000218,15286
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631881,1,A,In vitro percent permeability into rat ileum; nt indicates not tested,Intermediate,,,1,12237,BAO_0000218,15286
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631882,1,A,Compound was tested for oral absorption in bile-duct cannulated rats,Intermediate,,,1,12238,BAO_0000218,13770
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630749,1,A,Compound was tested for oral absorption in bile-duct cannulated rats.,Intermediate,,,1,12239,BAO_0000218,13770
,9606.0,,Homo sapiens,,,,,N,,,50587,CHEMBL630750,1,A,Oral absorption using Caco-2 cell monolayers.,Intermediate,,,1,12240,BAO_0000218,5202
,9606.0,,Homo sapiens,,,,,N,,,50587,CHEMBL630253,1,A,Percent of the drug absorbed after administration to humans was determined,Intermediate,,,1,12241,BAO_0000218,14920
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL630254,1,A,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Intermediate,,1969.0,1,12242,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL630255,1,A,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Intermediate,,1969.0,1,12243,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL630256,1,A,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Intermediate,,1969.0,1,12244,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL875781,1,A,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",Intermediate,In vivo,2107.0,1,12245,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL630257,1,A,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",Intermediate,In vivo,2107.0,1,12246,BAO_0000218,13751
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL630258,1,A,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",Intermediate,In vivo,2107.0,1,12247,BAO_0000218,13751
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630259,1,A,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",Intermediate,,,1,12248,BAO_0000218,15807
,10116.0,,Rattus norvegicus,Striatum,,,,N,,,50597,CHEMBL630260,1,A,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",Intermediate,,2435.0,1,12249,BAO_0000218,15807
,10116.0,,Rattus norvegicus,Striatum,,,,N,,,50597,CHEMBL630261,1,A,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",Intermediate,,2435.0,1,12250,BAO_0000218,15807
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630262,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,Intermediate,,,1,12251,BAO_0000218,14950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630263,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,Intermediate,,,1,12252,BAO_0000218,14950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630264,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,Intermediate,,,1,12253,BAO_0000218,14950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630265,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,Intermediate,,,1,12254,BAO_0000218,14950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630266,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,Intermediate,,,1,12255,BAO_0000218,14950
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL630267,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,Intermediate,,2113.0,1,12256,BAO_0000218,14950
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL630268,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,Intermediate,,2113.0,1,12257,BAO_0000218,14950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630269,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,Intermediate,,,1,12258,BAO_0000218,14950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630270,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,Intermediate,,,1,12259,BAO_0000218,14950
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL630141,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,Intermediate,,2048.0,1,12260,BAO_0000218,14950
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL630142,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,Intermediate,,2048.0,1,12261,BAO_0000218,14950
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL630143,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,Intermediate,,2385.0,1,12262,BAO_0000218,14950
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL630144,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,Intermediate,,2385.0,1,12263,BAO_0000218,14950
,10116.0,,Rattus norvegicus,Prostate gland,,,,N,,,50597,CHEMBL630145,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,Intermediate,,2367.0,1,12264,BAO_0000218,14950
,10116.0,,Rattus norvegicus,Prostate gland,,,,N,,,50597,CHEMBL630146,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,Intermediate,,2367.0,1,12265,BAO_0000218,14950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630147,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,Intermediate,,,1,12266,BAO_0000218,14950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630148,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,Intermediate,,,1,12267,BAO_0000218,14950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630149,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,Intermediate,,,1,12268,BAO_0000218,14950
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL630150,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,Intermediate,,2106.0,1,12269,BAO_0000218,14950
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL630151,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,Intermediate,,2106.0,1,12270,BAO_0000218,14950
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL632031,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,Intermediate,,2046.0,1,12271,BAO_0000218,14950
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL632032,1,A,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,Intermediate,,2046.0,1,12272,BAO_0000218,14950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632033,1,A,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,Intermediate,,,1,12273,BAO_0000218,14950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632034,1,A,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,Intermediate,,,1,12274,BAO_0000218,14950
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL632035,1,A,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,Intermediate,,2385.0,1,12275,BAO_0000218,14950
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632036,1,A,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,Intermediate,,,1,12276,BAO_0000218,14950
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL632037,1,A,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,Intermediate,,2046.0,1,12277,BAO_0000218,14950
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL632038,1,A,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Intermediate,,178.0,1,12278,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL632039,1,A,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Intermediate,,178.0,1,12279,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL632040,1,A,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Intermediate,,178.0,1,12280,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL632041,1,A,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Intermediate,,178.0,1,12281,BAO_0000218,8631
,9615.0,,Canis lupus familiaris,Blood,,,,N,,,50588,CHEMBL632042,1,A,"Concentration of compound in blood of dog 2, after administering intravenously",Intermediate,,178.0,1,12282,BAO_0000218,9614
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL632043,1,A,"Concentration of compound in left ventricle of dog 1, after administering intravenously",Intermediate,,,1,12283,BAO_0000218,9614
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL632044,1,A,"Concentration of compound in left ventricle of dog 2, after administering intravenously",Intermediate,,,1,12284,BAO_0000218,9614
,9615.0,,Canis lupus familiaris,Liver,,,,N,,,50588,CHEMBL632045,1,A,"Concentration of compound in liver of dog 1, after administering intravenously",Intermediate,,2107.0,1,12285,BAO_0000218,9614
,9615.0,,Canis lupus familiaris,Liver,,,,N,,,50588,CHEMBL632046,1,A,"Concentration of compound in liver of dog 2, after administering intravenously",Intermediate,,2107.0,1,12286,BAO_0000218,9614
,9615.0,,Canis lupus familiaris,Lung,,,,N,,,50588,CHEMBL632047,1,A,"Concentration of compound in lung of dog 1, after administering intravenously",Intermediate,,2048.0,1,12287,BAO_0000218,9614
,9615.0,,Canis lupus familiaris,Lung,,,,N,,,50588,CHEMBL632048,1,A,"Concentration of compound in lung of dog 2, after administering intravenously",Intermediate,,2048.0,1,12288,BAO_0000218,9614
,9615.0,,Canis lupus familiaris,Muscle tissue,,,,N,,,50588,CHEMBL632049,1,A,"Concentration of compound in muscle of dog 1, after administering intravenously",Intermediate,,2385.0,1,12289,BAO_0000218,9614
,9615.0,,Canis lupus familiaris,Muscle tissue,,,,N,,,50588,CHEMBL876418,1,A,"Concentration of compound in muscle of dog 2, after administering intravenously",Intermediate,,2385.0,1,12290,BAO_0000218,9614
,9615.0,,Canis lupus familiaris,Spleen,,,,N,,,50588,CHEMBL632050,1,A,"Concentration of compound in spleen of dog 1,after administering intravenously",Intermediate,,2106.0,1,12291,BAO_0000218,9614
,9615.0,,Canis lupus familiaris,Spleen,,,,N,,,50588,CHEMBL632051,1,A,"Concentration of compound in spleen of dog 2, after administering intravenously",Intermediate,,2106.0,1,12292,BAO_0000218,9614
,,,,,,,,U,,,22224,CHEMBL632052,1,F,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,Autocuration,,,0,12293,BAO_0000218,10353
,,,,,,,,U,,,22224,CHEMBL632053,1,F,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,Autocuration,,,0,12294,BAO_0000218,10353
,,,,,,,,U,,,22224,CHEMBL632054,1,A,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,Autocuration,,,0,12295,BAO_0000218,10353
,,,,,,,,U,,,22224,CHEMBL632055,1,F,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,Autocuration,,,0,12296,BAO_0000218,10353
,,,,,,,,U,,,22224,CHEMBL631181,1,F,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,Autocuration,,,0,12297,BAO_0000218,10353
,,,,,,,,U,,,22224,CHEMBL631182,1,A,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,Autocuration,,,0,12298,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL631183,1,A,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,Autocuration,,,0,12299,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL631184,1,A,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,Autocuration,,,0,12300,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL629774,1,A,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,Autocuration,,,0,12301,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL629775,1,A,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,Autocuration,,,0,12302,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL876549,1,A,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,Autocuration,,,0,12303,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628172,1,A,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,Autocuration,,,0,12304,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628173,1,A,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,Autocuration,,,0,12305,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628174,1,A,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,Autocuration,,,0,12306,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628175,1,A,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,Autocuration,,,0,12307,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628176,1,A,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,Autocuration,,,0,12308,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628177,1,A,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,Autocuration,,,0,12309,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628178,1,A,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,Autocuration,,,0,12310,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628179,1,A,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,Autocuration,,,0,12311,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628180,1,A,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,Autocuration,,,0,12312,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628181,1,A,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,Autocuration,,,0,12313,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628182,1,A,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,Autocuration,,,0,12314,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628183,1,A,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,Autocuration,,,0,12315,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628184,1,A,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,Autocuration,,,0,12316,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628185,1,A,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,Autocuration,,,0,12317,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL875617,1,A,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,Autocuration,,,0,12318,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628186,1,A,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,Autocuration,,,0,12319,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628187,1,A,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,Autocuration,,,0,12320,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628188,1,A,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,Autocuration,,,0,12321,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628189,1,A,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,Autocuration,,,0,12322,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628190,1,A,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,Autocuration,,,0,12323,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628191,1,A,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,Autocuration,,,0,12324,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL626513,1,A,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,Autocuration,,,0,12325,BAO_0000218,9196
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626514,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",Intermediate,,2046.0,1,12326,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626515,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",Intermediate,,2046.0,1,12327,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626516,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",Intermediate,,2046.0,1,12328,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626517,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",Intermediate,,2046.0,1,12329,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626518,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",Intermediate,,2046.0,1,12330,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626519,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",Intermediate,,2046.0,1,12331,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626520,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",Intermediate,,2046.0,1,12332,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626521,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",Intermediate,,2046.0,1,12333,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626522,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",Intermediate,,2046.0,1,12334,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626523,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",Intermediate,,2046.0,1,12335,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626524,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",Intermediate,,2046.0,1,12336,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626688,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",Intermediate,,2046.0,1,12337,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626689,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",Intermediate,,2046.0,1,12338,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626690,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",Intermediate,,2046.0,1,12339,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626691,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",Intermediate,,2046.0,1,12340,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL627319,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",Intermediate,,2046.0,1,12341,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL624052,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",Intermediate,,2046.0,1,12342,BAO_0000218,8608
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL624053,1,A,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",Intermediate,,2046.0,1,12343,BAO_0000218,8608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624054,1,A,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,,,1,12344,BAO_0000218,8085
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624055,1,A,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,,,1,12345,BAO_0000218,8085
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624056,1,A,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,,,1,12346,BAO_0000218,8085
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL624057,1,A,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,,995.0,1,12347,BAO_0000218,8085
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL622281,1,A,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,,995.0,1,12348,BAO_0000218,8085
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL622282,1,A,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,,995.0,1,12349,BAO_0000218,8085
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL622283,1,A,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,,995.0,1,12350,BAO_0000218,8085
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL622284,1,A,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,,995.0,1,12351,BAO_0000218,8085
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL622285,1,A,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,,995.0,1,12352,BAO_0000218,8085
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL622286,1,A,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Intermediate,,995.0,1,12353,BAO_0000218,8085
,,,,,,,,U,,,22224,CHEMBL622287,1,P,Distribution coefficient (D %) between octanol and buffer of pH 7.4,Autocuration,,,0,12354,BAO_0000100,7657
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL622288,1,A,Partition coefficient (logD7.4),Intermediate,,,1,12355,BAO_0000218,8935
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL622289,1,A,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",Intermediate,,,1,12356,BAO_0000218,13792
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL622290,1,A,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Intermediate,,955.0,1,12357,BAO_0000218,13792
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL622291,1,A,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,Intermediate,,,1,12358,BAO_0000218,13792
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL622292,1,A,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Intermediate,,955.0,1,12359,BAO_0000218,13792
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL622293,1,A,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",Intermediate,,,1,12360,BAO_0000218,13792
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL622294,1,A,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Intermediate,,955.0,1,12361,BAO_0000218,13792
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL622295,1,A,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,Intermediate,,,1,12362,BAO_0000218,13792
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL622296,1,A,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Intermediate,,955.0,1,12363,BAO_0000218,13792
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL874409,1,A,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,Intermediate,,1969.0,1,12364,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622297,1,A,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Intermediate,,1969.0,1,12365,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622298,1,A,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Intermediate,,1969.0,1,12366,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622299,1,A,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Intermediate,,1969.0,1,12367,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622300,1,A,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Intermediate,,1969.0,1,12368,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622301,1,A,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Intermediate,,1969.0,1,12369,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622302,1,A,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Intermediate,,1969.0,1,12370,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622303,1,A,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Intermediate,,1969.0,1,12371,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622304,1,A,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Intermediate,,1969.0,1,12372,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622305,1,A,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,Intermediate,,1969.0,1,12373,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622306,1,A,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Intermediate,,1969.0,1,12374,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626864,1,A,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,Intermediate,,1969.0,1,12375,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626865,1,A,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Intermediate,,1969.0,1,12376,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626866,1,A,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,Intermediate,,1969.0,1,12377,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626867,1,A,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Intermediate,,1969.0,1,12378,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626868,1,A,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Intermediate,,1969.0,1,12379,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626869,1,A,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,Intermediate,,1969.0,1,12380,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626870,1,A,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Intermediate,,1969.0,1,12381,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626871,1,A,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,Intermediate,,1969.0,1,12382,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626872,1,A,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Intermediate,,1969.0,1,12383,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL632185,1,A,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Intermediate,,1969.0,1,12384,BAO_0000218,14103
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL632186,1,A,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,Intermediate,,1969.0,1,12385,BAO_0000218,14103
,,,,,,,,U,,,22224,CHEMBL629310,1,A,Amount of acetic acid produced by the compound,Autocuration,,,0,12386,BAO_0000019,12904
,,,,,,,,U,,,22224,CHEMBL629311,1,A,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,Autocuration,,,0,12387,BAO_0000019,12904
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629312,1,A,Log of (Cbrain/Cblood) in rats,Intermediate,,,1,12388,BAO_0000218,9663
,,,,,,,,U,,,22224,CHEMBL629313,1,A,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),Autocuration,,,0,12389,BAO_0000221,7652
,,,,,,,,U,,,22224,CHEMBL629314,1,A,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),Autocuration,,,0,12390,BAO_0000221,7652
,,,,,,,,U,,,22224,CHEMBL629315,1,A,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),Autocuration,,,0,12391,BAO_0000221,7652
,,,,,,,,U,,,22224,CHEMBL629316,1,B,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),Autocuration,,,0,12392,BAO_0000219,7652
,,,,,,,,U,,,22224,CHEMBL629317,1,A,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),Autocuration,,,0,12393,BAO_0000221,7652
,,,,,,,,U,,,22224,CHEMBL629318,1,A,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),Autocuration,,,0,12394,BAO_0000019,7652
,,,,,,,,U,,,22224,CHEMBL877497,1,A,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),Autocuration,,,0,12395,BAO_0000019,7652
,,,,,,,,U,,,22224,CHEMBL629319,1,A,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),Autocuration,,,0,12396,BAO_0000019,7652
,,,,,,,,U,,,22224,CHEMBL629320,1,A,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),Autocuration,,,0,12397,BAO_0000019,7652
,,,,,,,,U,,,22224,CHEMBL629496,1,A,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),Autocuration,,,0,12398,BAO_0000019,7652
,,,,,,,,U,,,22224,CHEMBL629497,1,A,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),Autocuration,,,0,12399,BAO_0000019,7652
,,,,,,,,U,,,22224,CHEMBL629498,1,A,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),Autocuration,,,0,12400,BAO_0000019,7652
,,,,,,,,U,,,22224,CHEMBL629499,1,A,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),Autocuration,,,0,12401,BAO_0000019,7652
,,,,,,,,U,,,22224,CHEMBL629500,1,A,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),Autocuration,,,0,12402,BAO_0000019,7652
,,,,,,,,U,,,22224,CHEMBL629501,1,A,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),Autocuration,,,0,12403,BAO_0000019,7652
,,,,,,,,U,,,22224,CHEMBL629502,1,A,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),Autocuration,,,0,12404,BAO_0000019,7652
,,,,,,,,U,,,22224,CHEMBL629503,1,F,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,Autocuration,In vivo,,0,12405,BAO_0000218,8267
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL629504,1,A,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,Intermediate,,,1,12406,BAO_0000218,8267
,,,,,,,,U,,,22224,CHEMBL629505,1,A,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,Autocuration,,,0,12407,BAO_0000019,14479
,,,,,,,,U,,,22224,CHEMBL629506,1,A,Compound was evaluated for total body clearance,Autocuration,,,0,12408,BAO_0000019,17515
,,,,,,,,U,,,22224,CHEMBL629507,1,A,Compound was evaluated for volume of distribution at steady state,Autocuration,,,0,12409,BAO_0000019,17515
,,,,,,,,U,,,22224,CHEMBL877498,1,A,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,Autocuration,,,0,12410,BAO_0000019,8142
,,,,,,,,U,,,22224,CHEMBL629508,1,A,Percentage of the diamine which is monoprotonated at pH 7.4,Autocuration,,,0,12411,BAO_0000019,14849
,,,,,,,,U,,,22224,CHEMBL629509,1,A,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,Autocuration,,,0,12412,BAO_0000019,7653
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL629510,1,A,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Intermediate,,178.0,1,12413,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL629511,1,A,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Intermediate,,178.0,1,12414,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL629512,1,A,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Intermediate,,178.0,1,12415,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL629513,1,A,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Intermediate,,178.0,1,12416,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL629514,1,A,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Intermediate,,178.0,1,12417,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL628447,1,A,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Intermediate,,178.0,1,12418,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL628448,1,A,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Intermediate,,178.0,1,12419,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL628449,1,A,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Intermediate,,178.0,1,12420,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631119,1,A,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Intermediate,,178.0,1,12421,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631120,1,A,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Intermediate,,178.0,1,12422,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631121,1,A,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Intermediate,,178.0,1,12423,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL874458,1,A,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,Intermediate,,178.0,1,12424,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631122,1,A,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Intermediate,,178.0,1,12425,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631123,1,A,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Intermediate,,178.0,1,12426,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631124,1,A,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Intermediate,,178.0,1,12427,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631125,1,A,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Intermediate,,178.0,1,12428,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631290,1,A,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Intermediate,,178.0,1,12429,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631291,1,A,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Intermediate,,178.0,1,12430,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631292,1,A,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Intermediate,,178.0,1,12431,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631293,1,A,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Intermediate,,178.0,1,12432,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631294,1,A,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Intermediate,,178.0,1,12433,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631295,1,A,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Intermediate,,178.0,1,12434,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631296,1,A,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Intermediate,,178.0,1,12435,BAO_0000218,8631
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631297,1,A,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Intermediate,,178.0,1,12436,BAO_0000218,8631
,,,,,,,,U,,,22224,CHEMBL631298,1,A,Maximum biodistribution (Bmax) was determined.,Autocuration,,,0,12437,BAO_0000218,10263
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL631299,1,A,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,Intermediate,,,1,12438,BAO_0000218,12364
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL631300,1,A,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,Intermediate,,,1,12439,BAO_0000218,12364
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL631301,1,A,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,Intermediate,,,1,12440,BAO_0000218,12364
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL630291,1,A,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,Intermediate,,,1,12441,BAO_0000218,12364
,,,,,,,,U,,,22224,CHEMBL630292,1,A,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,Autocuration,,,0,12442,BAO_0000218,14793
,,,,,,,,U,,,22224,CHEMBL630293,1,A,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,Autocuration,,,0,12443,BAO_0000218,14793
,,,,,,,,U,,,22224,CHEMBL630294,1,A,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,Autocuration,,,0,12444,BAO_0000218,14793
,,,,,,,,U,,,22224,CHEMBL630295,1,A,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,Autocuration,,,0,12445,BAO_0000218,14793
,,,,,,,,U,,,22224,CHEMBL630296,1,A,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,Autocuration,,,0,12446,BAO_0000218,14793
,,,,,,,,U,,,22224,CHEMBL626782,1,A,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,Autocuration,,,0,12447,BAO_0000218,14793
,,,,,,,,U,,,22224,CHEMBL626783,1,A,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,Autocuration,,,0,12448,BAO_0000218,14793
,,,,,,,,U,,,22224,CHEMBL626784,1,A,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,Autocuration,,,0,12449,BAO_0000218,14793
,,,,,,,,U,,,22224,CHEMBL626785,1,A,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,Autocuration,,,0,12450,BAO_0000218,14793
,,,,,,,,U,,,22224,CHEMBL626786,1,A,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,Autocuration,,,0,12451,BAO_0000218,14793
,,,,,,,,U,,,22224,CHEMBL626787,1,A,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,Autocuration,,,0,12452,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL626788,1,A,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,Autocuration,,,0,12453,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL625927,1,A,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,Autocuration,,,0,12454,BAO_0000218,9196
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625928,1,A,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12455,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625929,1,A,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,,178.0,1,12456,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625930,1,A,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Intermediate,,178.0,1,12457,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625931,1,A,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",Intermediate,,178.0,1,12458,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627230,1,A,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,Intermediate,,178.0,1,12459,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627231,1,A,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12460,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627232,1,A,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,,178.0,1,12461,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627233,1,A,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Intermediate,,178.0,1,12462,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL875470,1,A,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12463,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627234,1,A,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12464,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627235,1,A,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12465,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627236,1,A,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12466,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627237,1,A,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12467,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627238,1,A,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12468,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627239,1,A,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12469,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627240,1,A,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12470,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627241,1,A,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12471,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627242,1,A,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12472,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627243,1,A,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,Intermediate,,178.0,1,12473,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627244,1,A,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,,178.0,1,12474,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627245,1,A,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12475,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627246,1,A,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12476,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627247,1,A,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12477,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627248,1,A,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12478,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627249,1,A,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12479,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625569,1,A,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12480,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625570,1,A,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12481,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625571,1,A,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12482,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625572,1,A,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,,178.0,1,12483,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625573,1,A,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,,178.0,1,12484,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625574,1,A,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,Intermediate,,178.0,1,12485,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626245,1,A,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Intermediate,,178.0,1,12486,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626246,1,A,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12487,BAO_0000218,8374
,,,,,,,,U,,,22224,CHEMBL626247,1,A,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,Autocuration,,,0,12488,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL626248,1,A,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,Autocuration,,,0,12489,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL626249,1,A,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,Autocuration,,,0,12490,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL626420,1,A,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,Autocuration,,,0,12491,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL626421,1,A,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,Autocuration,,,0,12492,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL626422,1,A,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,Autocuration,,,0,12493,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL626423,1,A,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,Autocuration,,,0,12494,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL626424,1,A,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,Autocuration,,,0,12495,BAO_0000218,9196
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626425,1,A,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,Intermediate,,,1,12496,BAO_0000218,12023
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875476,1,A,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,Intermediate,,,1,12497,BAO_0000218,12023
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL626426,1,A,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,Intermediate,,,1,12498,BAO_0000218,12023
,,,,,,,,U,,,22224,CHEMBL626427,1,P,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,Autocuration,,,0,12499,BAO_0000100,10580
,,,,,,,,U,,,22224,CHEMBL626428,1,P,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,Autocuration,,,0,12500,BAO_0000100,10580
,,,,,,,,U,,,22224,CHEMBL626429,1,A,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,Autocuration,,,0,12501,BAO_0000019,16032
,,,,Urine,,,,U,,,22224,CHEMBL625025,1,A,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,Autocuration,,1088.0,0,12502,BAO_0000019,16032
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625026,1,A,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,,178.0,1,12503,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625027,1,A,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,,178.0,1,12504,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL874410,1,A,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,,178.0,1,12505,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625028,1,A,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,,178.0,1,12506,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625029,1,A,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,,178.0,1,12507,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625030,1,A,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,,178.0,1,12508,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625031,1,A,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,,178.0,1,12509,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625032,1,A,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,,178.0,1,12510,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625033,1,A,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,,178.0,1,12511,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625034,1,A,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,,178.0,1,12512,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624872,1,A,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,,948.0,1,12513,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624873,1,A,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,,948.0,1,12514,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624874,1,A,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,,948.0,1,12515,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624875,1,A,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,,948.0,1,12516,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624876,1,A,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,,948.0,1,12517,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624877,1,A,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,,948.0,1,12518,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624878,1,A,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,,948.0,1,12519,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624879,1,A,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,,948.0,1,12520,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624880,1,A,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,,948.0,1,12521,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624881,1,A,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,Intermediate,,948.0,1,12522,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL624882,1,A,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",Intermediate,,948.0,1,12523,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL624883,1,A,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,,2113.0,1,12524,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL624884,1,A,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,,2113.0,1,12525,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL624885,1,A,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,,2113.0,1,12526,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL624886,1,A,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,,2113.0,1,12527,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL624887,1,A,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,,2113.0,1,12528,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL624888,1,A,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,,2113.0,1,12529,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL624889,1,A,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,,2113.0,1,12530,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL624890,1,A,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,,2113.0,1,12531,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL621964,1,A,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,,2113.0,1,12532,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL621965,1,A,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,,2113.0,1,12533,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL621966,1,A,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,,2107.0,1,12534,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL621967,1,A,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,,2107.0,1,12535,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL622164,1,A,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,,2107.0,1,12536,BAO_0000218,8594
,,,,,,,,U,,,22224,CHEMBL623097,1,A,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),Autocuration,,,0,12537,BAO_0000019,7653
,,,,,,,,U,,,22224,CHEMBL623098,1,A,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),Autocuration,,,0,12538,BAO_0000019,7653
,,,,,,,,U,,,22224,CHEMBL623099,1,A,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,Autocuration,,,0,12539,BAO_0000019,7653
,,,,,,,,U,,,22224,CHEMBL623100,1,A,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,Autocuration,,,0,12540,BAO_0000019,7653
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628673,1,A,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",Intermediate,,,1,12541,BAO_0000218,9104
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628674,1,A,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",Intermediate,,,1,12542,BAO_0000218,9104
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628675,1,A,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",Intermediate,,,1,12543,BAO_0000218,9104
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627644,1,A,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",Intermediate,,,1,12544,BAO_0000218,9104
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627645,1,A,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",Intermediate,,,1,12545,BAO_0000218,9104
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627646,1,A,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",Intermediate,,,1,12546,BAO_0000218,9104
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627647,1,A,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",Intermediate,,,1,12547,BAO_0000218,9104
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627648,1,A,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",Intermediate,,,1,12548,BAO_0000218,9104
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627649,1,A,Free level in rat plasma,Intermediate,,,1,12549,BAO_0000218,12902
,,,,,,,,U,,,22224,CHEMBL628313,1,A,Level reaching in blood plasma of rat or human was determined,Autocuration,,,0,12550,BAO_0000019,6614
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628314,1,A,Log (Cbrain/Cblood) in rats,Intermediate,,,1,12551,BAO_0000218,9663
,,,,,,,,U,,,22224,CHEMBL628315,1,A,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,Autocuration,,,0,12552,BAO_0000019,17658
,,,,,,,,U,,,22224,CHEMBL628316,1,A,Mean percentage of compound transport through membrane; expressed as membrane transport,Autocuration,,,0,12553,BAO_0000019,17658
,,,,,,,,U,,,22224,CHEMBL628317,1,A,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,Autocuration,,,0,12554,BAO_0000218,14314
,,,,,,,,U,,,22224,CHEMBL628473,1,A,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,Autocuration,,,0,12555,BAO_0000019,7385
,,,,,,,,U,,,22224,CHEMBL628474,1,A,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",Autocuration,,,0,12556,BAO_0000019,7385
,,,,,,,,U,,,22224,CHEMBL628475,1,A,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,Autocuration,,,0,12557,BAO_0000019,7385
,,,,,,,,U,,,22224,CHEMBL628476,1,A,Net water uptake by a carrier mediated transport (%cm) mechanism,Autocuration,,,0,12558,BAO_0000019,1329
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL628477,1,A,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,Autocuration,,,0,12559,BAO_0000218,12187
,9669.0,,Mustela putorius furo,,,,,N,,,50506,CHEMBL628478,1,A,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,Intermediate,,,1,12560,BAO_0000218,12187
,9669.0,,Mustela putorius furo,,,,,N,,,50506,CHEMBL628479,1,A,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",Intermediate,,,1,12561,BAO_0000218,12187
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL628480,1,A,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,Autocuration,,,0,12562,BAO_0000218,12187
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL628481,1,A,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",Autocuration,,,0,12563,BAO_0000218,12187
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628482,1,A,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,Intermediate,,,1,12564,BAO_0000218,12187
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628483,1,A,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Intermediate,,,1,12565,BAO_0000218,12187
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL628484,1,A,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Intermediate,,1969.0,1,12566,BAO_0000218,9278
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL628485,1,A,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Intermediate,,1969.0,1,12567,BAO_0000218,9278
,9541.0,,Macaca fascicularis,Plasma,,,,N,,,100710,CHEMBL628486,1,A,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",Intermediate,,1969.0,1,12568,BAO_0000218,9278
,9606.0,,Homo sapiens,Plasma,,,,N,,,50587,CHEMBL628487,1,A,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",Intermediate,,1969.0,1,12569,BAO_0000218,9278
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL628488,1,A,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Intermediate,,1969.0,1,12570,BAO_0000218,9278
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL628489,1,A,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Intermediate,,1969.0,1,12571,BAO_0000218,9278
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL628490,1,A,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Intermediate,,1969.0,1,12572,BAO_0000218,9278
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL628491,1,A,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,Intermediate,,,1,12573,BAO_0000218,12186
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL877507,1,A,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,Intermediate,,,1,12574,BAO_0000218,12186
,,,,,,,,U,,,22224,CHEMBL628492,1,A,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Autocuration,,,0,12575,BAO_0000218,12186
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL628493,1,A,% metabolized in monkey S-9 after 2 hours (10 ug/mL),Autocuration,,,0,12576,BAO_0000019,12041
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL628494,1,A,% metabolized in monkey S-9 after 2 hours (1 ug/ml),Autocuration,,,0,12577,BAO_0000019,12041
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL628495,1,A,% metabolized in monkey S-9 after 2 hours (10 ug/ml),Autocuration,,,0,12578,BAO_0000019,12041
,9606.0,,Homo sapiens,,,,,N,,,50587,CHEMBL628496,1,A,Permeability in Caco-2 assay at 10E-6,Intermediate,,,1,12579,BAO_0000218,6737
,,,,Brain,,,,U,,,22224,CHEMBL628497,1,A,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,Autocuration,,955.0,0,12580,BAO_0000218,13758
,,,,Brain,,,,U,,,22224,CHEMBL628498,1,A,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,Autocuration,,955.0,0,12581,BAO_0000218,13758
,,,,,,,,U,,,22224,CHEMBL628499,1,A,Plasma protein binding was determined,Autocuration,,,0,12582,BAO_0000019,5676
,,,,,,,,U,,,22224,CHEMBL627656,1,A,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,Autocuration,,,0,12583,BAO_0000218,14793
,,,,,,,,U,,,22224,CHEMBL627657,1,A,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,Autocuration,,,0,12584,BAO_0000218,14793
,,,,,,,,U,,,22224,CHEMBL626808,1,A,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,Autocuration,,,0,12585,BAO_0000218,14793
,,,,,,,,U,,,22224,CHEMBL626809,1,A,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,Autocuration,,,0,12586,BAO_0000218,14793
,,,,,,,,U,,,22224,CHEMBL626810,1,A,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,Autocuration,,,0,12587,BAO_0000218,14793
,,,,,,,,U,,,22224,CHEMBL626811,1,A,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,Autocuration,,,0,12588,BAO_0000218,14793
,,,,,,,,U,,,22224,CHEMBL874465,1,A,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,Autocuration,,,0,12589,BAO_0000218,14793
,,,,,,,,U,,,22224,CHEMBL626812,1,A,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,Autocuration,,,0,12590,BAO_0000218,14793
,,,,,,,,U,,,22224,CHEMBL626813,1,A,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,Autocuration,,,0,12591,BAO_0000218,14793
,,,,,,,,U,,,22224,CHEMBL626814,1,A,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,Autocuration,,,0,12592,BAO_0000218,14793
,,,,,,,,U,,,22224,CHEMBL626815,1,A,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,Autocuration,,,0,12593,BAO_0000019,14000
,,,,,,,,U,,,22224,CHEMBL628566,1,A,Partition coefficient (logP),Autocuration,,,0,12594,BAO_0000019,5948
,,,,,,,,U,,,22229,CHEMBL628567,1,P,Calculated partition coefficient (clogP) (CLOGP3 V3.4),Autocuration,,,0,12595,BAO_0000100,13824
,,,,,,,,U,,,22229,CHEMBL628568,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12596,BAO_0000100,10778
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628569,1,A,C max in dog,Intermediate,In vivo,,1,12597,BAO_0000218,17237
,10141.0,,Cavia porcellus,,,,,N,,,50512,CHEMBL628570,1,A,C max in guinea pig,Intermediate,In vivo,,1,12598,BAO_0000218,17237
,,,,,,,,U,,,22224,CHEMBL628571,1,A,C max value was evaluated,Autocuration,In vivo,,0,12599,BAO_0000218,2809
,,,,,,,,U,,,22224,CHEMBL628572,1,A,Cmax value after oral dose of 0.1 mg//kg,Autocuration,In vivo,,0,12600,BAO_0000218,11954
,,,,,,,,U,,,22224,CHEMBL628573,1,A,Cmax value after oral dose of 0.3 mg/kg,Autocuration,In vivo,,0,12601,BAO_0000218,11954
,,,,,,,,U,,,22224,CHEMBL628574,1,A,Cmax value after oral dose of 1 mg/kg,Autocuration,In vivo,,0,12602,BAO_0000218,11954
,,,,,,,,U,,,22224,CHEMBL628575,1,A,Cmax value after oral dose of 10 mg/kg,Autocuration,In vivo,,0,12603,BAO_0000218,11954
,,,,,,,,U,,,22224,CHEMBL628576,1,A,Cmax value after oral dose of 23.4 mg/kg,Autocuration,In vivo,,0,12604,BAO_0000218,11954
,,,,,,,,U,,,22224,CHEMBL628577,1,A,Cmax value after oral dose of 3 mg/kg,Autocuration,In vivo,,0,12605,BAO_0000218,11954
,,,,,,,,U,,,22224,CHEMBL628578,1,A,Cmax value after oral dose of 3.87 mg/kg,Autocuration,In vivo,,0,12606,BAO_0000218,11954
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL874466,1,A,Cmax value in female Beagle dogs,Intermediate,In vivo,,1,12607,BAO_0000218,12768
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628579,1,A,Cmax value in male rats,Intermediate,In vivo,,1,12608,BAO_0000218,12768
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL628580,1,A,Cmax value in rat plasma when administered 20 mg/kg perorally,Intermediate,In vivo,1969.0,1,12609,BAO_0000218,12780
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL628581,1,A,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Intermediate,In vivo,1969.0,1,12610,BAO_0000218,15592
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL628582,1,A,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Intermediate,In vivo,1969.0,1,12611,BAO_0000218,15592
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628583,1,A,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,Intermediate,,,1,12612,BAO_0000218,17025
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL625782,1,A,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,Autocuration,,,0,12613,BAO_0000218,17025
,9986.0,,Oryctolagus cuniculus,,,,,N,,,50592,CHEMBL625783,1,A,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,Intermediate,,,1,12614,BAO_0000218,17025
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625784,1,A,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,Intermediate,,,1,12615,BAO_0000218,17025
,9544.0,,Macaca mulatta,Plasma,,,,N,,,50797,CHEMBL625785,1,A,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,Intermediate,,1969.0,1,12616,BAO_0000218,4236
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625786,1,A,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,Intermediate,,,1,12617,BAO_0000218,15791
,,,,,,,,U,,,22224,CHEMBL874467,1,A,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,Autocuration,,,0,12618,BAO_0000019,11149
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625787,1,A,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",Intermediate,,,1,12619,BAO_0000218,15592
,12721.0,,Human immunodeficiency virus,,,,,N,,,50677,CHEMBL625964,1,A,cytotoxicity against HIV protease enzyme.,Intermediate,,,1,12620,BAO_0000218,15778
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625965,1,A,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,Intermediate,,,1,12621,BAO_0000218,12745
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625966,1,A,Apparent clearance in mice after oral administration of 100 mg/kg of dose,Intermediate,,,1,12622,BAO_0000218,12745
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL625967,1,A,The plasma clearance in dog.,Intermediate,In vivo,1969.0,1,12623,BAO_0000218,13941
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625968,1,A,The plasma clearance in rat.,Intermediate,In vivo,1969.0,1,12624,BAO_0000218,13941
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625969,1,A,Clearance from plasma in male Sprague-Dawley rats,Intermediate,In vivo,1969.0,1,12625,BAO_0000218,16449
,9541.0,,Macaca fascicularis,Plasma,,,,N,,,100710,CHEMBL625970,1,A,Clearance from plasma in male cynomolgus monkeys,Intermediate,In vivo,1969.0,1,12626,BAO_0000218,16449
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL625971,1,A,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",Intermediate,In vivo,1969.0,1,12627,BAO_0000218,14224
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL625972,1,A,Clearance of compound in dog plasma,Intermediate,In vivo,1969.0,1,12628,BAO_0000218,14224
,9606.0,,Homo sapiens,Plasma,,,,N,,,50587,CHEMBL625973,1,A,Clearance of compound in human plasma,Intermediate,In vivo,1969.0,1,12629,BAO_0000218,14224
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625974,1,A,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,Intermediate,In vivo,,1,12630,BAO_0000218,14317
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625975,1,A,Clearance of compound when administered intravenously as an individual dose to a single dog.,Intermediate,In vivo,,1,12631,BAO_0000218,14317
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL625976,1,A,"Clearance (10 mg/kg, intravenously) in dog plasma",Intermediate,In vivo,1969.0,1,12632,BAO_0000218,14224
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625977,1,A,Clearance value in dog,Intermediate,In vivo,,1,12633,BAO_0000218,17237
,10141.0,,Cavia porcellus,,,,,N,,,50512,CHEMBL625978,1,A,Clearance value in guinea pig,Intermediate,In vivo,,1,12634,BAO_0000218,17237
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874468,1,A,Clearance values in rats after iv administration.,Intermediate,In vivo,,1,12635,BAO_0000218,14187
,,,,Plasma,,,,U,,,22224,CHEMBL625421,1,A,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,Autocuration,In vivo,1969.0,0,12636,BAO_0000218,4806
,9986.0,,Oryctolagus cuniculus,,,,,N,,,50592,CHEMBL625422,1,A,In vivo clearance (5 mg/kg) was determined in rabbits,Intermediate,In vivo,,1,12637,BAO_0000218,15025
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625423,1,A,Plasma Clearance rate was determined for the compound in rats,Intermediate,In vivo,,1,12638,BAO_0000218,13197
,9520.0,,Saimiri,,,,,U,,,22224,CHEMBL625424,1,A,Plasma Clearance rate was determined for the compound in squirrel monkeys,Autocuration,In vivo,,0,12639,BAO_0000218,13197
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625425,1,A,Plasma clearance in rat,Intermediate,In vivo,,1,12640,BAO_0000218,13960
,,,,,,,,U,,,22224,CHEMBL625426,1,A,Plasma clearance of the compound,Autocuration,In vivo,,0,12641,BAO_0000218,17820
,10141.0,,Cavia porcellus,,,,,N,,,50512,CHEMBL625427,1,A,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,Intermediate,In vivo,,1,12642,BAO_0000218,14706
,10141.0,,Cavia porcellus,,,,,N,,,50512,CHEMBL625428,1,A,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,Intermediate,In vivo,,1,12643,BAO_0000218,14706
,,,,,,,,U,,,22224,CHEMBL625429,1,A,Plasma clearance was determined,Autocuration,In vivo,,0,12644,BAO_0000218,6504
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625430,1,A,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,Intermediate,In vivo,,1,12645,BAO_0000218,14925
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625431,1,A,Plasma clearance rate was determined for the compound in rats,Intermediate,In vivo,,1,12646,BAO_0000218,13197
,9520.0,,Saimiri,,,,,U,,,22224,CHEMBL627307,1,A,Plasma clearance rate was determined for the compound in squirrel monkeys,Autocuration,In vivo,,0,12647,BAO_0000218,13197
,,,,,,,,U,,,22224,CHEMBL627308,1,A,Slow clearance (CL) was determined,Autocuration,In vivo,,0,12648,BAO_0000218,3437
,,,,,,,,U,,,22224,CHEMBL627309,1,A,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,Autocuration,,,0,12649,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL627310,1,A,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,Autocuration,,,0,12650,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL627311,1,A,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,Autocuration,,,0,12651,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL627312,1,A,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,Autocuration,,,0,12652,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL627313,1,A,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,Autocuration,,,0,12653,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL627314,1,A,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,Autocuration,,,0,12654,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL627315,1,A,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,Autocuration,,,0,12655,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL627316,1,A,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,Autocuration,,,0,12656,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL627317,1,A,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,Autocuration,,,0,12657,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL627318,1,A,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,Autocuration,,,0,12658,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL627999,1,A,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,Autocuration,,,0,12659,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628000,1,A,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,Autocuration,,,0,12660,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628001,1,A,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,Autocuration,,,0,12661,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL628002,1,A,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,Autocuration,,,0,12662,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL625610,1,A,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,Autocuration,,,0,12663,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL625611,1,A,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,Autocuration,,,0,12664,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL625612,1,A,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,Autocuration,,,0,12665,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL625613,1,A,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,Autocuration,,,0,12666,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL875479,1,A,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,Autocuration,,,0,12667,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL625614,1,A,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,Autocuration,,,0,12668,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL625615,1,A,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,Autocuration,,,0,12669,BAO_0000218,9196
,,,,,,,,U,,,22224,CHEMBL626302,1,A,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,Autocuration,,,0,12670,BAO_0000218,9196
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626303,1,A,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12671,BAO_0000218,8374
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627420,1,A,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Intermediate,,178.0,1,12672,BAO_0000218,8374
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627421,1,A,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,Intermediate,,,1,12673,BAO_0000218,13477
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625695,1,A,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,Intermediate,,,1,12674,BAO_0000218,13477
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625696,1,A,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,Intermediate,,,1,12675,BAO_0000218,13477
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL875606,1,A,Distribution of compound in mice brain was measured after 1 hr,Intermediate,,955.0,1,12676,BAO_0000218,10009
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL625697,1,A,Distribution of compound in mice brain was measured after 24 hr r,Intermediate,,955.0,1,12677,BAO_0000218,10009
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL625698,1,A,Distribution of compound in mice brain was measured after 2 hr,Intermediate,,955.0,1,12678,BAO_0000218,10009
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL625699,1,A,Distribution of compound in mice brain was measured after 3 hr,Intermediate,,955.0,1,12679,BAO_0000218,10009
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL625700,1,A,Distribution of compound in mice brain was measured after 6 hr,Intermediate,,955.0,1,12680,BAO_0000218,10009
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625701,1,A,Distribution of compound in mice liver was measured after 1 hr,Intermediate,,,1,12681,BAO_0000218,10009
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625702,1,A,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,Intermediate,,,1,12682,BAO_0000218,10009
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625703,1,A,Distribution of compound in mice liver was measured after 2 hr,Intermediate,,,1,12683,BAO_0000218,10009
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625704,1,A,Distribution of compound in mice liver was measured after 3 hr,Intermediate,,,1,12684,BAO_0000218,10009
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625705,1,A,Distribution of compound in mice liver was measured after 6 hr,Intermediate,,,1,12685,BAO_0000218,10009
,9615.0,,Canis lupus familiaris,Adrenal medulla,,,,N,,,50588,CHEMBL625706,1,A,Distribution in dog adrenal medulla 30 min after administration.,Intermediate,,1236.0,1,12686,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,Adrenal medulla,,,,N,,,50588,CHEMBL625707,1,A,Distribution in dog adrenal medulla 72 hours after administration.,Intermediate,,1236.0,1,12687,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625708,1,A,Distribution in female dog Ovary 24 hours after administration.,Intermediate,,,1,12688,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625709,1,A,Distribution in female dog Ovary 72 hours after administration.,Intermediate,,,1,12689,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624180,1,A,Distribution in female dog adipose 24 hours after administration.,Intermediate,,,1,12690,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624181,1,A,Distribution in female dog adipose 72 hours after administration.,Intermediate,,,1,12691,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,Adrenal cortex,,,,N,,,50588,CHEMBL624182,1,A,Distribution in female dog adrenal cortex 72 hours after administration.,Intermediate,,1235.0,1,12692,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,Adrenal cortex,,,,N,,,50588,CHEMBL624183,1,A,Distribution in female dog adrenal cortex 72 hours after administration.,Intermediate,,1235.0,1,12693,BAO_0000218,8170
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL624184,1,A,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,,2107.0,1,12694,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL877489,1,A,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,,2107.0,1,12695,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL624185,1,A,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,,2107.0,1,12696,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL624186,1,A,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,,2107.0,1,12697,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL624187,1,A,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,,2107.0,1,12698,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL624188,1,A,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,,2107.0,1,12699,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624189,1,A,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,,2048.0,1,12700,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624190,1,A,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,,2048.0,1,12701,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624191,1,A,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,,2048.0,1,12702,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624192,1,A,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,,2048.0,1,12703,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624193,1,A,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,,2048.0,1,12704,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624194,1,A,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,,2048.0,1,12705,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624891,1,A,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,,2048.0,1,12706,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624892,1,A,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,,2048.0,1,12707,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL624893,1,A,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,,2048.0,1,12708,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627632,1,A,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,,2048.0,1,12709,BAO_0000218,8594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627633,1,A,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,,,1,12710,BAO_0000218,8594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627634,1,A,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,,,1,12711,BAO_0000218,8594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627635,1,A,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,,,1,12712,BAO_0000218,8594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627636,1,A,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,,,1,12713,BAO_0000218,8594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626816,1,A,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,,,1,12714,BAO_0000218,8594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626817,1,A,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,,,1,12715,BAO_0000218,8594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626818,1,A,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,,,1,12716,BAO_0000218,8594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626819,1,A,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,,,1,12717,BAO_0000218,8594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626820,1,A,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,,,1,12718,BAO_0000218,8594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626821,1,A,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,,,1,12719,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626822,1,A,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Intermediate,,2046.0,1,12720,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626823,1,A,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Intermediate,,2046.0,1,12721,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626824,1,A,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Intermediate,,2046.0,1,12722,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626825,1,A,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Intermediate,,2046.0,1,12723,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626826,1,A,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Intermediate,,2046.0,1,12724,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626827,1,A,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Intermediate,,2046.0,1,12725,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626828,1,A,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Intermediate,,2046.0,1,12726,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626829,1,A,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Intermediate,,2046.0,1,12727,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL626830,1,A,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,,2046.0,1,12728,BAO_0000218,8594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627150,1,A,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,,,1,12729,BAO_0000218,8594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627151,1,A,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,,,1,12730,BAO_0000218,8594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627152,1,A,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Intermediate,,,1,12731,BAO_0000218,8594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627153,1,A,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Intermediate,,,1,12732,BAO_0000218,8594
,,,,,,,,U,,,22224,CHEMBL627154,1,A,Rate of acetate production by the compound was determined,Autocuration,,,0,12733,BAO_0000019,12904
,,,,,,,,U,,,22224,CHEMBL627155,1,A,Rate of acetate production by the compound was determined; Not determined,Autocuration,,,0,12734,BAO_0000019,12904
,,,,,,,,U,,,22224,CHEMBL627156,1,A,Rate of hydrolysis of nitrocefin by compound was evaluated in water,Autocuration,,,0,12735,BAO_0000019,3730
,,,,,,,,U,,,22224,CHEMBL627157,1,A,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,Autocuration,,,0,12736,BAO_0000019,3627
,9986.0,,Oryctolagus cuniculus,,,,,N,,,50592,CHEMBL627158,1,A,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,Intermediate,,,1,12737,BAO_0000218,13799
,9986.0,,Oryctolagus cuniculus,Plasma,,,,N,,,50592,CHEMBL627159,1,A,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,Intermediate,,1969.0,1,12738,BAO_0000218,13799
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627160,1,A,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,Intermediate,,,1,12739,BAO_0000218,13799
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628540,1,A,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,Intermediate,,,1,12740,BAO_0000218,13799
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL628541,1,A,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,Intermediate,,1969.0,1,12741,BAO_0000218,13799
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL628542,1,A,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,Intermediate,,1969.0,1,12742,BAO_0000218,13799
,,,,,,,,U,,,22229,CHEMBL628543,1,P,Solubility after at a pH 1.2,Autocuration,,,0,12743,BAO_0000100,6629
,,,,,,,,U,,,22229,CHEMBL628544,1,P,Solubility after at pH 1.2,Autocuration,,,0,12744,BAO_0000100,6629
,,,,,,,,U,,,22229,CHEMBL628545,1,P,Solubility after injection of water,Autocuration,,,0,12745,BAO_0000100,6629
,,,,,,,,U,,,22224,CHEMBL628546,1,A,Statistical significance of IC 50 values; Expressed as R value,Autocuration,,,0,12746,BAO_0000019,14000
,,,,,,,,U,,,22224,CHEMBL874455,1,A,Systemic availability with respect to methyldopa was determined,Autocuration,,,0,12747,BAO_0000019,8267
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628547,1,A,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,Intermediate,,,1,12748,BAO_0000218,13799
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL628548,1,A,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,Intermediate,,1969.0,1,12749,BAO_0000218,13799
,9986.0,,Oryctolagus cuniculus,Feces,,,,N,,,50592,CHEMBL628549,1,A,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",Intermediate,,1988.0,1,12750,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Feces,,,,N,,,50592,CHEMBL628550,1,A,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",Intermediate,,1988.0,1,12751,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Feces,,,,N,,,50592,CHEMBL628551,1,A,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",Intermediate,,1988.0,1,12752,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL628552,1,A,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",Intermediate,,1088.0,1,12753,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL628553,1,A,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",Intermediate,,1088.0,1,12754,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL628554,1,A,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",Intermediate,,1088.0,1,12755,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL628555,1,A,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",Intermediate,,1088.0,1,12756,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL628556,1,A,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",Intermediate,,1088.0,1,12757,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Kidney,,,,N,,,50592,CHEMBL628557,1,A,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",Intermediate,,2113.0,1,12758,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Feces,,,,N,,,50592,CHEMBL628558,1,A,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",Intermediate,,1988.0,1,12759,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Feces,,,,N,,,50592,CHEMBL628559,1,A,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",Intermediate,,1988.0,1,12760,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Feces,,,,N,,,50592,CHEMBL628560,1,A,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",Intermediate,,1988.0,1,12761,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL874456,1,A,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",Intermediate,,1088.0,1,12762,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Feces,,,,N,,,50592,CHEMBL628561,1,A,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",Intermediate,,1988.0,1,12763,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Feces,,,,N,,,50592,CHEMBL628562,1,A,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",Intermediate,,1988.0,1,12764,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL628563,1,A,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",Intermediate,,1088.0,1,12765,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL628564,1,A,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",Intermediate,,1088.0,1,12766,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL628565,1,A,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",Intermediate,,1088.0,1,12767,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL631248,1,A,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",Intermediate,,1088.0,1,12768,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL631249,1,A,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",Intermediate,,1088.0,1,12769,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Kidney,,,,N,,,50592,CHEMBL627214,1,A,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",Intermediate,,2113.0,1,12770,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Feces,,,,N,,,50592,CHEMBL874591,1,A,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",Intermediate,,1988.0,1,12771,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Feces,,,,N,,,50592,CHEMBL627215,1,A,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",Intermediate,,1988.0,1,12772,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Feces,,,,N,,,50592,CHEMBL625471,1,A,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,Intermediate,,1988.0,1,12773,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,,,,,N,,,50592,CHEMBL625472,1,A,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,Intermediate,,,1,12774,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,,,,,N,,,50592,CHEMBL625473,1,A,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,Intermediate,,,1,12775,BAO_0000218,7132
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625474,1,A,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,Intermediate,In vivo,,1,12776,BAO_0000218,13317
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625475,1,A,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,Intermediate,In vivo,,1,12777,BAO_0000218,15341
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625476,1,A,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,Intermediate,In vivo,,1,12778,BAO_0000218,15341
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625477,1,A,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,Intermediate,In vivo,,1,12779,BAO_0000218,15341
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625478,1,A,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,Intermediate,In vivo,,1,12780,BAO_0000218,15341
,10116.0,,Rattus norvegicus,esophageal tunica muscularis mucosae,,,,N,,,50597,CHEMBL625479,1,A,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,Intermediate,In vitro,,1,12781,BAO_0000218,12801
,10116.0,,Rattus norvegicus,esophageal tunica muscularis mucosae,,,,N,,,50597,CHEMBL625480,1,A,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,Intermediate,In vitro,,1,12782,BAO_0000218,12801
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625481,1,A,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,Intermediate,In vivo,1969.0,1,12783,BAO_0000218,14856
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625482,1,A,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,Intermediate,In vivo,,1,12784,BAO_0000218,14062
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625483,1,A,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,Intermediate,In vivo,,1,12785,BAO_0000218,14062
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625484,1,A,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,Intermediate,In vivo,,1,12786,BAO_0000218,14062
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625485,1,A,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,Intermediate,In vivo,,1,12787,BAO_0000218,14062
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL625486,1,A,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,Intermediate,In vivo,1969.0,1,12788,BAO_0000218,14346
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625487,1,A,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,Intermediate,In vivo,1969.0,1,12789,BAO_0000218,14346
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625488,1,A,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,Intermediate,In vivo,1969.0,1,12790,BAO_0000218,14346
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625489,1,A,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,Intermediate,In vivo,1969.0,1,12791,BAO_0000218,14346
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625490,1,A,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,Intermediate,In vivo,1969.0,1,12792,BAO_0000218,14346
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL625491,1,A,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,Intermediate,In vivo,1969.0,1,12793,BAO_0000218,14346
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625492,1,A,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,Intermediate,In vivo,1969.0,1,12794,BAO_0000218,14346
,9606.0,,Homo sapiens,Plasma,,,,N,,,50587,CHEMBL625493,1,A,plasma clearance in human,Intermediate,In vivo,1969.0,1,12795,BAO_0000218,15711
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625494,1,A,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,Intermediate,In vivo,,1,12796,BAO_0000218,14886
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625495,1,A,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,Intermediate,In vivo,,1,12797,BAO_0000218,14886
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625496,1,A,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,Intermediate,In vivo,,1,12798,BAO_0000218,14886
,,,,,,,,U,,,22229,CHEMBL625497,1,P,1-Octanol/water partition coefficient measured at 7.4,Autocuration,,,0,12799,BAO_0000100,4115
,,,,,,,,U,,,22229,CHEMBL625498,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12800,BAO_0000100,13733
,,,,,,,,U,,,22224,CHEMBL625499,1,A,Partition coefficient (logP),Autocuration,,,0,12801,BAO_0000019,12102
,,,,,,,,U,,,22229,CHEMBL625500,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12802,BAO_0000100,12676
,,,,,,,,U,,,22229,CHEMBL625501,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12803,BAO_0000100,13733
,,,,,,,,U,,,22229,CHEMBL625502,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12804,BAO_0000100,13740
,,,,,,,,U,,,22229,CHEMBL625503,1,P,Calculated partition coefficient (clogP) (relative to BAY K 8644),Autocuration,,,0,12805,BAO_0000100,12766
,,,,,,,,U,,,22229,CHEMBL625504,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12806,BAO_0000100,2764
,,,,,,,,U,,,22229,CHEMBL625505,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12807,BAO_0000100,12355
,,,,,,,,U,,,22229,CHEMBL625506,1,P,Calculated partition coefficient of the compound,Autocuration,,,0,12808,BAO_0000100,11314
,,,,,,,,U,,,22224,CHEMBL625507,1,A,Partition coefficient (logP),Autocuration,,,0,12809,BAO_0000019,12706
,,,,,,,,U,,,22229,CHEMBL625508,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12810,BAO_0000100,12645
,,,,,,,,U,,,22229,CHEMBL625509,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12811,BAO_0000100,13668
,,,,,,,,U,,,22229,CHEMBL625510,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12812,BAO_0000100,12819
,,,,,,,,U,,,22229,CHEMBL883125,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12813,BAO_0000100,13668
,,,,,,,,U,,,22229,CHEMBL625511,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12814,BAO_0000100,13017
,,,,,,,,U,,,22224,CHEMBL874650,1,A,Partition coefficient of the compound,Autocuration,,,0,12815,BAO_0000019,2448
,,,,,,,,U,,,22224,CHEMBL625512,1,A,Partition coefficient of the compound,Autocuration,,,0,12816,BAO_0000019,11526
,,,,,,,,U,,,22224,CHEMBL625513,1,A,Partition coefficient of compound was determined,Autocuration,,,0,12817,BAO_0000019,12426
,,,,,,,,U,,,22224,CHEMBL625514,1,A,Partition coefficient was determined,Autocuration,,,0,12818,BAO_0000019,2448
,,,,,,,,U,,,22229,CHEMBL625515,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12819,BAO_0000100,12001
,,,,,,,,U,,,22229,CHEMBL625516,1,P,partition coefficient of compound was determined,Autocuration,,,0,12820,BAO_0000100,12426
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625517,1,A,The total body administered intravenously in dog,Intermediate,In vivo,,1,12821,BAO_0000218,13204
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625518,1,A,The total body administered intravenously in rats,Intermediate,In vivo,,1,12822,BAO_0000218,13204
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625519,1,A,Time taken for the administration to female NIH mice weighing 25-30 g.,Intermediate,,,1,12823,BAO_0000218,13889
,,,,,,,,U,,,22224,CHEMBL625520,1,A,Time taken for the administration,Autocuration,,,0,12824,BAO_0000019,13889
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL874651,1,A,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,Intermediate,In vivo,,1,12825,BAO_0000218,17025
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL625521,1,A,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,Autocuration,In vivo,,0,12826,BAO_0000218,17025
,9986.0,,Oryctolagus cuniculus,,,,,N,,,50592,CHEMBL623171,1,A,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,Intermediate,In vivo,,1,12827,BAO_0000218,17025
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623853,1,A,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,Intermediate,In vivo,,1,12828,BAO_0000218,17025
,,,,,,,,U,,,22224,CHEMBL623854,1,A,Plasma clearance for the compound was determined.,Autocuration,,,0,12829,BAO_0000019,15067
,,,,,,,,U,,,22224,CHEMBL874405,1,P,CLog P value of the compound,Autocuration,,,0,12830,BAO_0000100,3091
,,,,,,,,U,,,22229,CHEMBL623855,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12831,BAO_0000100,15592
,,,,,,,,U,,,22229,CHEMBL623856,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12832,BAO_0000100,14738
,,,,,,,,U,,,22224,CHEMBL623857,1,P,ClogP value of the compound; nd ='no data',Autocuration,,,0,12833,BAO_0000100,14738
,,,,,,,,U,,,22224,CHEMBL623858,1,P,ClogP value of the compound; nd ='not determined',Autocuration,,,0,12834,BAO_0000100,14738
,,,,,,,,U,,,22224,CHEMBL623859,1,P,CLog P was determined,Autocuration,,,0,12835,BAO_0000100,6076
,,,,,,,,U,,,22229,CHEMBL839829,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12836,BAO_0000100,17840
,,,,,,,,U,,,22224,CHEMBL623860,1,A,CLogP was calculated,Autocuration,,,0,12837,BAO_0000019,13589
,,,,,,,,U,,,22224,CHEMBL623861,1,A,CLogP value was determined,Autocuration,,,0,12838,BAO_0000019,17655
,,,,,,,,U,,,22224,CHEMBL623862,1,A,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,Autocuration,,,0,12839,BAO_0000019,5867
,,,,,,,,U,,,22229,CHEMBL874406,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12840,BAO_0000100,5867
,,,,,,,,U,,,22229,CHEMBL623863,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12841,BAO_0000100,10783
,,,,,,,,U,,,22229,CHEMBL624021,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12842,BAO_0000100,14849
,9615.0,,Canis lupus familiaris,Adrenal medulla,,,,N,,,50588,CHEMBL624022,1,A,Distribution in female dog adrenal medulla 24 hours after administration.,Intermediate,,1236.0,1,12843,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,Adrenal medulla,,,,N,,,50588,CHEMBL624023,1,A,Distribution in female dog adrenal medulla 72 hours after administration.,Intermediate,,1236.0,1,12844,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624024,1,A,Distribution in female dog bile 24 hours after administration.,Intermediate,,,1,12845,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624025,1,A,Distribution in female dog bile 72 hr after administration.,Intermediate,,,1,12846,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624026,1,A,Distribution in female dog blood 24 hours after administration.,Intermediate,,,1,12847,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624027,1,A,Distribution in female dog blood 72 hours after administration.,Intermediate,,,1,12848,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624028,1,A,Distribution in female dog heart 24 hours after administration.,Intermediate,,,1,12849,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624029,1,A,Distribution in female dog heart 72 hours after administration.,Intermediate,,,1,12850,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624030,1,A,Distribution in female dog kidney 24 hours after administration.,Intermediate,,,1,12851,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624031,1,A,Distribution in female dog kidney 72 hours after administration.,Intermediate,,,1,12852,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,Intestine,,,,N,,,50588,CHEMBL624032,1,A,Distribution in female dog large intestine 24 hours after administration.,Intermediate,,160.0,1,12853,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,Intestine,,,,N,,,50588,CHEMBL874407,1,A,Distribution in female dog large intestine 72 hours after administration.,Intermediate,,160.0,1,12854,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624033,1,A,Distribution in female dog liver 24 hours after administration.,Intermediate,,,1,12855,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624034,1,A,Distribution in female dog liver 72 hours after administration.,Intermediate,,,1,12856,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624035,1,A,Distribution in female dog lung 24 hours after administration.,Intermediate,,,1,12857,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624036,1,A,Distribution in female dog lung 72 hours after administration.,Intermediate,,,1,12858,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,Muscle tissue,,,,N,,,50588,CHEMBL624037,1,A,Distribution in female dog muscle 24 hours after administration.,Intermediate,,2385.0,1,12859,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,Muscle tissue,,,,N,,,50588,CHEMBL624038,1,A,Distribution in female dog muscle 72 hours after administration.,Intermediate,,2385.0,1,12860,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624039,1,A,Distribution in female dog pancreas 24 hours after administration.,Intermediate,,,1,12861,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624040,1,A,Distribution in female dog pancreas 72 hours after administration.,Intermediate,,,1,12862,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,Intestine,,,,N,,,50588,CHEMBL624041,1,A,Distribution in female dog small intestine 24 hours after administration.,Intermediate,,160.0,1,12863,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,Intestine,,,,N,,,50588,CHEMBL624042,1,A,Distribution in female dog small intestine 72 hours after administration.,Intermediate,,160.0,1,12864,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,Spleen,,,,N,,,50588,CHEMBL624043,1,A,Distribution in female dog spleen 24 hours after administration.,Intermediate,,2106.0,1,12865,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,Spleen,,,,N,,,50588,CHEMBL624044,1,A,Distribution in female dog spleen 72 hours after administration.,Intermediate,,2106.0,1,12866,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,Stomach,,,,N,,,50588,CHEMBL624045,1,A,Distribution in female dog stomach 24 hours after administration.,Intermediate,,945.0,1,12867,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,Stomach,,,,N,,,50588,CHEMBL624046,1,A,Distribution in female dog stomach 72 hours after administration.,Intermediate,,945.0,1,12868,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,Thyroid gland,,,,N,,,50588,CHEMBL624047,1,A,Distribution in female dog thyroid 24 hours after administration.,Intermediate,,2046.0,1,12869,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,Thyroid gland,,,,N,,,50588,CHEMBL624048,1,A,Distribution in female dog thyroid 72 hours after administration.,Intermediate,,2046.0,1,12870,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL874408,1,A,Distribution in female dog urine 24 hours after administration.,Intermediate,,1088.0,1,12871,BAO_0000218,8170
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL624049,1,A,Distribution in female dog urine 72 hr after administration.,Intermediate,,1088.0,1,12872,BAO_0000218,8170
,,,,Plasma,,,,U,,,22224,CHEMBL624050,1,A,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,Autocuration,,1969.0,0,12873,BAO_0000218,14283
,,,,,,,,U,,,22224,CHEMBL624051,1,A,Plasma concentration at 7 hr after intravenous dosing,Autocuration,,,0,12874,BAO_0000019,5623
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623278,1,A,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,Intermediate,,,1,12875,BAO_0000218,13477
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623279,1,A,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,Intermediate,,,1,12876,BAO_0000218,13477
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623280,1,A,Plasma concentration of 3 mg/kg iv after 1 hr in rats,Intermediate,,,1,12877,BAO_0000218,13477
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623963,1,A,Plasma concentration of 3 mg/kg iv after 2 hr in rats,Intermediate,,,1,12878,BAO_0000218,13477
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623964,1,A,Plasma concentration of 3 mg/kg iv after 4 hr in rats,Intermediate,,,1,12879,BAO_0000218,13477
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623965,1,A,Plasma concentration of 3 mg/kg iv after 6 hr in rats,Intermediate,,,1,12880,BAO_0000218,13477
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623966,1,A,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,Intermediate,,,1,12881,BAO_0000218,13477
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874415,1,A,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,Intermediate,,,1,12882,BAO_0000218,13477
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623967,1,A,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,Intermediate,,,1,12883,BAO_0000218,13477
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623968,1,A,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,Intermediate,,,1,12884,BAO_0000218,13477
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623969,1,A,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,Intermediate,,,1,12885,BAO_0000218,13477
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628409,1,A,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,Intermediate,,,1,12886,BAO_0000218,13477
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628410,1,A,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,Intermediate,,,1,12887,BAO_0000218,13477
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628411,1,A,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,Intermediate,,,1,12888,BAO_0000218,13477
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628412,1,A,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,Intermediate,,,1,12889,BAO_0000218,13477
,,,,,,,,U,,,22224,CHEMBL628413,1,A,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,Autocuration,,,0,12890,BAO_0000019,12553
,,,,Plasma,,,,U,,,22224,CHEMBL628414,1,A,The concentration in plasmat; Not determined,Autocuration,,1969.0,0,12891,BAO_0000019,14548
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628415,1,A,Tissue level at 10 mg/kg/po in wistar rats in blood,Intermediate,,,1,12892,BAO_0000218,14393
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628416,1,A,Tissue level at 10 mg/kg/po in wistar rats in brown fat,Intermediate,,,1,12893,BAO_0000218,14393
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628417,1,A,Tissue level at 10 mg/kg/po in wistar rats in heart,Intermediate,,,1,12894,BAO_0000218,14393
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL874908,1,A,Tissue level at 10 mg/kg/po in wistar rats in liver,Intermediate,,2107.0,1,12895,BAO_0000218,14393
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628418,1,A,Tissue level at 10 mg/kg/po in wistar rats in plasma,Intermediate,,,1,12896,BAO_0000218,14393
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL628419,1,A,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,Intermediate,,2385.0,1,12897,BAO_0000218,14393
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628420,1,A,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,Intermediate,,,1,12898,BAO_0000218,14393
,,,,,,,,U,,,22224,CHEMBL628421,1,A,Water solubility at 37 degree C.,Autocuration,,,0,12899,BAO_0000019,1629
,,,,,,,,U,,,22229,CHEMBL626726,1,P,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,Autocuration,,,0,12900,BAO_0000100,8194
,,,,,,,,U,,,22229,CHEMBL626727,1,P,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,Autocuration,,,0,12901,BAO_0000100,8194
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626728,1,A,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,,178.0,1,12902,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626729,1,A,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,,178.0,1,12903,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626730,1,A,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,,178.0,1,12904,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626731,1,A,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,,178.0,1,12905,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL626732,1,A,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,,178.0,1,12906,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL626733,1,A,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,,948.0,1,12907,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL626734,1,A,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,,948.0,1,12908,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL626735,1,A,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,,948.0,1,12909,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL874909,1,A,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,,948.0,1,12910,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL626736,1,A,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,,948.0,1,12911,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL626737,1,A,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,,2113.0,1,12912,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL630999,1,A,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,,2113.0,1,12913,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL631000,1,A,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,,2113.0,1,12914,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL631001,1,A,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,,2113.0,1,12915,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL631002,1,A,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,,2113.0,1,12916,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL631003,1,A,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,,2107.0,1,12917,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL631004,1,A,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,,2107.0,1,12918,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL631005,1,A,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,,2107.0,1,12919,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL631006,1,A,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,,2107.0,1,12920,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL631007,1,A,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,,2107.0,1,12921,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL631008,1,A,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,,2048.0,1,12922,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL631009,1,A,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,,2048.0,1,12923,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL631010,1,A,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,,2048.0,1,12924,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL631011,1,A,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,,2048.0,1,12925,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL631012,1,A,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,,2048.0,1,12926,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL630271,1,A,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Intermediate,,2046.0,1,12927,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL630272,1,A,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Intermediate,,2046.0,1,12928,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL630273,1,A,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Intermediate,,2046.0,1,12929,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL630274,1,A,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Intermediate,,2046.0,1,12930,BAO_0000218,8594
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL630275,1,A,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Intermediate,,2046.0,1,12931,BAO_0000218,8594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875782,1,A,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,Intermediate,,,1,12932,BAO_0000218,8594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630276,1,A,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,Intermediate,,,1,12933,BAO_0000218,8594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630277,1,A,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,Intermediate,,,1,12934,BAO_0000218,8594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630278,1,A,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,Intermediate,,,1,12935,BAO_0000218,8594
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630279,1,A,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,Intermediate,,,1,12936,BAO_0000218,8594
,,,,,,,,U,,,22224,CHEMBL630280,1,A,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,Autocuration,,,0,12937,BAO_0000019,8151
,,,,,,,,U,,,22224,CHEMBL630281,1,A,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Autocuration,,,0,12938,BAO_0000019,8151
,9986.0,,Oryctolagus cuniculus,,,,,N,,,50592,CHEMBL630282,1,A,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,Intermediate,,,1,12939,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,,,,,N,,,50592,CHEMBL630283,1,A,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,Intermediate,,,1,12940,BAO_0000218,7132
,,,,,,,,U,,,22224,CHEMBL630284,1,A,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),Autocuration,,,0,12941,BAO_0000019,5797
,,,,,,,,U,,,22224,CHEMBL630285,1,A,Alkylating activity was determined,Autocuration,,,0,12942,BAO_0000019,7849
,,,,,,Microsomes,,U,,,22224,CHEMBL630286,1,A,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),Autocuration,,,0,12943,BAO_0000251,14220
,9986.0,,Oryctolagus cuniculus,,,,,N,,,50592,CHEMBL630069,1,A,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",Intermediate,,,1,12944,BAO_0000218,8650
,9986.0,,Oryctolagus cuniculus,,,,,N,,,50592,CHEMBL630070,1,A,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",Intermediate,,,1,12945,BAO_0000218,8650
,9986.0,,Oryctolagus cuniculus,,,,,N,,,50592,CHEMBL630071,1,A,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",Intermediate,,,1,12946,BAO_0000218,8650
,9986.0,,Oryctolagus cuniculus,,,,,N,,,50592,CHEMBL630072,1,A,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",Intermediate,,,1,12947,BAO_0000218,8650
,9986.0,,Oryctolagus cuniculus,,,,,N,,,50592,CHEMBL875110,1,A,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",Intermediate,,,1,12948,BAO_0000218,8650
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630073,1,A,Compound was tested for antidiuretic activity in rats,Intermediate,,,1,12949,BAO_0000218,7116
,,,,,,,,U,,,22224,CHEMBL630074,1,A,Compound was tested for inactivation kinetic values,Autocuration,,,0,12950,BAO_0000019,14131
,,,,,,,,U,,,22224,CHEMBL630075,1,A,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,Autocuration,In vivo,,0,12951,BAO_0000218,7415
,,,,,,,,U,,,22224,CHEMBL630076,1,A,Dissociation rate calculated from the first-order equation using the t1/2 value,Autocuration,,,0,12952,BAO_0000019,13178
,,,,,,,,U,,,22229,CHEMBL630077,1,P,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,Autocuration,,,0,12953,BAO_0000100,8815
,,,,,,,,U,,,22229,CHEMBL630078,1,P,Aqueous solubility was measured,Autocuration,,,0,12954,BAO_0000100,1450
,,,,,,,,U,,,22229,CHEMBL630079,1,P,Aqueous solubility was measured at a pH 4,Autocuration,,,0,12955,BAO_0000100,1450
,,,,,,,,U,,,22229,CHEMBL630080,1,P,Aqueous solubility (pH 7),Autocuration,,,0,12956,BAO_0000100,1450
,,,,,,,,U,,,22229,CHEMBL630081,1,P,Aqueous solubility was measured at a pH 9,Autocuration,,,0,12957,BAO_0000100,1450
,,,,,,,,U,,,22224,CHEMBL630082,1,A,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",Autocuration,,,0,12958,BAO_0000019,12711
,,,,,,,,U,,,22224,CHEMBL630083,1,A,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",Autocuration,,,0,12959,BAO_0000019,12711
,,,,,,,,U,,,22224,CHEMBL630084,1,A,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",Autocuration,,,0,12960,BAO_0000019,12711
,,,,,,,,U,,,22229,CHEMBL629198,1,P,Aqueous solubility of the compound,Autocuration,,,0,12961,BAO_0000100,15032
,,,,,,,,U,,,22229,CHEMBL629199,1,P,Aqueous solubility at 37 degree Celsius at pH 7.38,Autocuration,,,0,12962,BAO_0000100,9964
,,,,,,,,U,,,22229,CHEMBL629200,1,P,Aqueous solubility in pH 7.4 phosphate buffer,Autocuration,,,0,12963,BAO_0000100,14962
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL629201,1,A,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,Intermediate,,,1,12964,BAO_0000218,12487
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL629202,1,A,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,Intermediate,,,1,12965,BAO_0000218,12487
,9606.0,,Homo sapiens,,,,,N,,,50587,CHEMBL875111,1,A,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,Intermediate,,,1,12966,BAO_0000218,10026
,9606.0,,Homo sapiens,,,,,N,,,50587,CHEMBL629203,1,A,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,Intermediate,,,1,12967,BAO_0000218,10026
,9606.0,,Homo sapiens,,,,,N,,,50587,CHEMBL629204,1,A,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,Intermediate,,,1,12968,BAO_0000218,10026
,9606.0,,Homo sapiens,,,,,N,,,50587,CHEMBL629205,1,A,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,Intermediate,,,1,12969,BAO_0000218,10026
,9606.0,,Homo sapiens,,,,,N,,,50587,CHEMBL629206,1,A,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,Intermediate,,,1,12970,BAO_0000218,10026
,,,,,,,,U,,,22224,CHEMBL631185,1,A,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,Autocuration,,,0,12971,BAO_0000019,10026
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631186,1,A,Compound was evaluated for the average bile flow rat in rats,Intermediate,,,1,12972,BAO_0000218,7415
,9986.0,,Oryctolagus cuniculus,,,,,N,,,50592,CHEMBL631187,1,A,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",Intermediate,,,1,12973,BAO_0000218,17025
,9986.0,,Oryctolagus cuniculus,,,,,N,,,50592,CHEMBL631188,1,A,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",Intermediate,,,1,12974,BAO_0000218,17025
,,,,,,,,U,,,22224,CHEMBL876419,1,A,Average half life period was determined,Autocuration,,,0,12975,BAO_0000019,10184
,,,,,,,,U,,,22224,CHEMBL631189,1,A,Average half life period was determined,Autocuration,,,0,12976,BAO_0000019,10184
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL631190,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,Intermediate,,,1,12977,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL631191,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,Intermediate,,,1,12978,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL631192,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,Intermediate,,,1,12979,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL632400,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,Intermediate,,,1,12980,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL630564,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,Intermediate,,,1,12981,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL630565,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,Intermediate,,,1,12982,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL630566,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,Intermediate,,,1,12983,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL631229,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,Intermediate,,,1,12984,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL631230,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,Intermediate,,,1,12985,BAO_0000218,8613
,,,,,,,,U,,,22229,CHEMBL876428,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12986,BAO_0000100,6030
,,,,,,,,U,,,22229,CHEMBL631231,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12987,BAO_0000100,6147
,,,,,,,,U,,,22229,CHEMBL631232,1,P,Calculated partition coefficient (clogP) (MacLogP),Autocuration,,,0,12988,BAO_0000100,14556
,,,,,,,,U,,,22224,CHEMBL631233,1,A,Hydrophilicity was determined,Autocuration,,,0,12989,BAO_0000019,768
,,,,,,,,U,,,22229,CHEMBL631234,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12990,BAO_0000100,14452
,,,,,,,,U,,,22224,CHEMBL883126,1,A,Increased absorption was determined,Autocuration,,,0,12991,BAO_0000019,5237
,,,,,,,,U,,,22224,CHEMBL631235,1,P,Lipophilicity value was evaluated,Autocuration,,,0,12992,BAO_0000100,14378
,,,,,,,,U,,,22224,CHEMBL631236,1,P,Log P value of the compound.,Autocuration,,,0,12993,BAO_0000100,14418
,,,,,,,,U,,,22224,CHEMBL631237,1,A,Partition coefficient of compound was determined,Autocuration,,,0,12994,BAO_0000019,5249
,,,,,,,,U,,,22229,CHEMBL631238,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12995,BAO_0000100,14621
,,,,,,,,U,,,22229,CHEMBL876429,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12996,BAO_0000100,12542
,,,,,,,,U,,,22224,CHEMBL631414,1,A,Partition coefficient was measured by medchem software; Not calculated,Autocuration,,,0,12997,BAO_0000019,12542
,,,,,,,,U,,,22224,CHEMBL631415,1,P,Partition coefficient was measured by octanol-water using standard shake-flask method,Autocuration,,,0,12998,BAO_0000100,12542
,,,,,,,,U,,,22229,CHEMBL631416,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,12999,BAO_0000100,15462
,,,,,,,,U,,,22224,CHEMBL631417,1,A,Partition coefficient (logP),Autocuration,,,0,13000,BAO_0000019,14884
,,,,,,,,U,,,22229,CHEMBL631418,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13001,BAO_0000100,16526
,,,,,,,,U,,,22229,CHEMBL631419,1,P,The Octanol/Water partition coefficient CLogP,Autocuration,,,0,13002,BAO_0000100,13693
,,,,,,,,U,,,22224,CHEMBL631420,1,A,The pharmacokinetic parameter C Log p was reported,Autocuration,,,0,13003,BAO_0000019,13693
,,,,,,,,U,,,22229,CHEMBL631421,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13004,BAO_0000100,13779
,,,,,,,,U,,,22229,CHEMBL631422,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13005,BAO_0000100,14772
,,,,,,,,U,,,22229,CHEMBL631423,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13006,BAO_0000100,14393
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL876430,1,A,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Intermediate,In vivo,1969.0,1,13007,BAO_0000218,14793
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL631424,1,A,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,Intermediate,In vivo,1969.0,1,13008,BAO_0000218,14793
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL631425,1,A,Compound was administered intravenously in dog to evaluate plasma clearance values,Intermediate,In vivo,1969.0,1,13009,BAO_0000218,13744
,314293.0,,Simiiformes,Plasma,,,,U,,,22224,CHEMBL631426,1,A,Compound was administered intravenously in monkey to evaluate plasma clearance values,Autocuration,In vivo,1969.0,0,13010,BAO_0000218,13744
,10090.0,,Mus musculus,Plasma,,,,N,,,50594,CHEMBL631427,1,A,Compound was administered intravenously in mouse to evaluate plasma clearance values,Intermediate,In vivo,1969.0,1,13011,BAO_0000218,13744
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL631428,1,A,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,Intermediate,In vivo,1969.0,1,13012,BAO_0000218,13207
,9544.0,,Macaca mulatta,Liver,,Microsomes,,N,,,50797,CHEMBL631429,1,A,Intrinsic clearance in Rhesus liver microsome,Intermediate,In vitro,2107.0,1,13013,BAO_0000218,5669
,9615.0,,Canis lupus familiaris,Liver,,Microsomes,,N,,,50588,CHEMBL631430,1,A,Intrinsic clearance in dog liver microsome,Intermediate,In vitro,2107.0,1,13014,BAO_0000218,5669
,10116.0,,Rattus norvegicus,Liver,,Microsomes,,N,,,50597,CHEMBL631431,1,A,Intrinsic clearance in rat liver microsome,Intermediate,In vitro,2107.0,1,13015,BAO_0000218,5669
,9544.0,,Macaca mulatta,Plasma,,,,N,,,50797,CHEMBL631432,1,A,Low plasma clearance was calculated in rhesus monkey,Intermediate,In vivo,1969.0,1,13016,BAO_0000218,4853
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL631433,1,A,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,Intermediate,In vivo,,1,13017,BAO_0000218,16452
,,,,,,,,U,,,22224,CHEMBL631434,1,A,Plasma clearance after intravenous dose of 0.3 mg/kg,Autocuration,In vivo,,0,13018,BAO_0000218,11954
,,,,,,,,U,,,22224,CHEMBL631435,1,A,Plasma clearance after intravenous dose of 1 mg/kg,Autocuration,In vivo,,0,13019,BAO_0000218,11954
,,,,,,,,U,,,22224,CHEMBL631436,1,A,Plasma clearance after intravenous dose of 3 mg/kg,Autocuration,In vivo,,0,13020,BAO_0000218,11954
,,,,,,,,U,,,22224,CHEMBL631437,1,A,Plasma clearance after intravenous dose of 3.87 mg/kg,Autocuration,In vivo,,0,13021,BAO_0000218,11954
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631438,1,A,Plasma clearance after peroral administration at 10 mpk in Rat,Intermediate,In vivo,,1,13022,BAO_0000218,5669
,9544.0,,Macaca mulatta,,,,,N,,,50797,CHEMBL876431,1,A,Plasma clearance after peroral administration at 10 mpk in Rhesus,Intermediate,In vivo,,1,13023,BAO_0000218,5669
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL631439,1,A,Plasma clearance after peroral administration at 10 mpk in dog,Intermediate,In vivo,,1,13024,BAO_0000218,5669
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631440,1,A,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,Intermediate,In vivo,,1,13025,BAO_0000218,13662
,,,,,,,,U,,,22224,CHEMBL631441,1,A,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),Autocuration,,,0,13026,BAO_0000019,8272
,,,,,,,,U,,,22224,CHEMBL631442,1,A,Critical Micellar concentration was determined,Autocuration,,,0,13027,BAO_0000019,13410
,,,,,,,,U,,,22224,CHEMBL626525,1,A,Critical Micellar concentration of the compound. was determined,Autocuration,,,0,13028,BAO_0000019,13410
,,,,,,,,U,,,22224,CHEMBL627168,1,A,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,Autocuration,,,0,13029,BAO_0000019,12628
,,,,,,,,U,,,22224,CHEMBL875618,1,A,Critical micellar concentration was measured in water by the dye solubilization method,Autocuration,,,0,13030,BAO_0000019,9675
,,,,,,,,U,,,22224,CHEMBL626612,1,B,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,Autocuration,,,0,13031,BAO_0000019,12628
,,,,,,,,U,,,22224,CHEMBL626613,1,A,CMR value (relative to BAY K 8644),Autocuration,,,0,13032,BAO_0000019,12766
,,,,,,,,U,,,22224,CHEMBL626614,1,A,Carbamoylating activity was determined,Autocuration,,,0,13033,BAO_0000019,7849
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL626615,1,A,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,Autocuration,,,0,13034,BAO_0000218,12187
,,,,,,,,U,,,22224,CHEMBL626616,1,A,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,Autocuration,,,0,13035,BAO_0000019,2040
,,,,,,,,U,,,22224,CHEMBL626617,1,A,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,Autocuration,,,0,13036,BAO_0000019,2040
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL626618,1,A,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,Intermediate,In vivo,1969.0,1,13037,BAO_0000218,14180
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626619,1,A,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,Intermediate,In vivo,1969.0,1,13038,BAO_0000218,14180
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626620,1,A,"Clearance rate at 0.46 mg/kg, iv, in dogs",Intermediate,In vivo,,1,13039,BAO_0000218,14474
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626621,1,A,"Clearance rate at 5.5 mg/kg, iv, in rat",Intermediate,In vivo,,1,13040,BAO_0000218,14474
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL626622,1,A,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,Intermediate,In vivo,,1,13041,BAO_0000218,14548
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL626623,1,A,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,Intermediate,In vivo,,1,13042,BAO_0000218,14548
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626624,1,A,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,Intermediate,In vivo,,1,13043,BAO_0000218,14548
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626625,1,A,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,Intermediate,In vivo,,1,13044,BAO_0000218,14548
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL626626,1,A,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Intermediate,Ex vivo,2107.0,1,13045,BAO_0000218,6125
,,,,,,,,U,,,22224,CHEMBL626627,1,A,Tested for the total clearance of the compound,Autocuration,In vivo,,0,13046,BAO_0000218,6874
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626628,1,A,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,Intermediate,In vivo,,1,13047,BAO_0000218,15343
,,,,,,,,U,,,22224,CHEMBL626629,1,A,Total body clearance was determined,Autocuration,In vivo,,0,13048,BAO_0000218,6236
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626630,1,A,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Intermediate,,,1,13049,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626631,1,A,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Intermediate,,,1,13050,BAO_0000218,11510
,,,,,,,,U,,,22229,CHEMBL626632,1,P,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,Autocuration,,,0,13051,BAO_0000100,8194
,,,,,,,,U,,,22229,CHEMBL626633,1,P,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,Autocuration,,,0,13052,BAO_0000100,8194
,,,,,,,,U,,,22229,CHEMBL626634,1,P,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,Autocuration,,,0,13053,BAO_0000100,8194
,,,,,,,,U,,,22229,CHEMBL626635,1,P,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,Autocuration,,,0,13054,BAO_0000100,8194
,,,,,,,,U,,,22229,CHEMBL626636,1,P,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,Autocuration,,,0,13055,BAO_0000100,8194
,,,,,,,,U,,,22229,CHEMBL626637,1,P,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,Autocuration,,,0,13056,BAO_0000100,8194
,4754.0,,Pneumocystis carinii,,,,,N,,,50339,CHEMBL626638,1,A,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),Intermediate,,,1,13057,BAO_0000218,13273
,4754.0,,Pneumocystis carinii,,,,,N,,,50339,CHEMBL626639,1,A,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,Intermediate,,,1,13058,BAO_0000218,13273
,4754.0,,Pneumocystis carinii,,,,,N,,,50339,CHEMBL626640,1,A,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,Intermediate,,,1,13059,BAO_0000218,13273
,4754.0,,Pneumocystis carinii,,,,,N,,,50339,CHEMBL626641,1,A,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,Intermediate,,,1,13060,BAO_0000218,13273
,4754.0,,Pneumocystis carinii,,,,,N,,,50339,CHEMBL627272,1,A,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,Intermediate,,,1,13061,BAO_0000218,13273
,4754.0,,Pneumocystis carinii,,,,,N,,,50339,CHEMBL627273,1,A,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,Intermediate,,,1,13062,BAO_0000218,13273
,4754.0,,Pneumocystis carinii,,,,,N,,,50339,CHEMBL627441,1,A,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),Intermediate,,,1,13063,BAO_0000218,13273
,4754.0,,Pneumocystis carinii,,,,,N,,,50339,CHEMBL628355,1,A,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),Intermediate,,,1,13064,BAO_0000218,13273
,4754.0,,Pneumocystis carinii,,,,,N,,,50339,CHEMBL628356,1,A,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),Intermediate,,,1,13065,BAO_0000218,13273
,4754.0,,Pneumocystis carinii,,,,,N,,,50339,CHEMBL628357,1,A,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),Intermediate,,,1,13066,BAO_0000218,13273
,4754.0,,Pneumocystis carinii,,,,,N,,,50339,CHEMBL628358,1,A,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),Intermediate,,,1,13067,BAO_0000218,13273
,4754.0,,Pneumocystis carinii,,,,,N,,,50339,CHEMBL622307,1,A,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),Intermediate,,,1,13068,BAO_0000218,13273
,,,,,,,,U,,,22224,CHEMBL622527,1,A,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,Autocuration,,,0,13069,BAO_0000019,13118
,,,,,,,,U,,,22224,CHEMBL622528,1,A,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,Autocuration,,,0,13070,BAO_0000019,13118
,,,,,,,,U,,,22224,CHEMBL622529,1,A,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,Autocuration,,,0,13071,BAO_0000019,13118
,,,,,,,,U,,,22224,CHEMBL622992,1,A,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,Autocuration,,,0,13072,BAO_0000019,13118
,,,,,,,,U,,,22224,CHEMBL622993,1,A,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,Autocuration,,,0,13073,BAO_0000019,13118
,,,,,,,,U,,,22224,CHEMBL622994,1,A,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,Autocuration,,,0,13074,BAO_0000019,13118
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622995,1,A,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",Intermediate,,,1,13075,BAO_0000218,10633
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622996,1,A,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",Intermediate,,,1,13076,BAO_0000218,10633
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622997,1,A,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",Intermediate,,,1,13077,BAO_0000218,10633
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622998,1,A,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",Intermediate,,,1,13078,BAO_0000218,10633
,,,,,,,,U,,,22224,CHEMBL622999,1,A,Cp max following ip administration at 1 mg/kg,Autocuration,,,0,13079,BAO_0000218,5767
,,,,Plasma,,,,U,,,22224,CHEMBL623000,1,A,Maximum concentration in plasma was reported at 0.5 hour,Autocuration,In vivo,1969.0,0,13080,BAO_0000218,3302
,,,,Plasma,,,,U,,,22224,CHEMBL623001,1,A,Maximum concentration in plasma was reported at 2 hour,Autocuration,In vivo,1969.0,0,13081,BAO_0000218,3302
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL623002,1,A,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,Intermediate,,,1,13082,BAO_0000218,12467
,,,,,,,,U,,,22229,CHEMBL623003,1,P,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),Autocuration,,,0,13083,BAO_0000100,11778
,,,,,,,,U,,,22224,CHEMBL623004,1,A,Steady state concentration was evaluated,Autocuration,,,0,13084,BAO_0000019,4321
,,,,,,,,U,,,22224,CHEMBL623005,1,A,Partition coefficient (logP),Autocuration,,,0,13085,BAO_0000019,14884
,,,,,,,,U,,,22224,CHEMBL623006,1,A,Partition coefficient (logD7.4),Autocuration,,,0,13086,BAO_0000019,15234
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL623007,1,A,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,Intermediate,In vivo,2107.0,1,13087,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL623008,1,A,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,Intermediate,In vivo,10000001.0,1,13088,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL876654,1,A,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,Intermediate,In vivo,2037.0,1,13089,BAO_0000218,14198
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623009,1,A,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,Intermediate,In vivo,,1,13090,BAO_0000218,14198
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623010,1,A,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,Intermediate,In vivo,,1,13091,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL623011,1,A,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,Intermediate,In vivo,948.0,1,13092,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL623012,1,A,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,Intermediate,In vivo,160.0,1,13093,BAO_0000218,14198
,,,,,,,,U,,,22224,CHEMBL623013,1,A,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,Autocuration,,,0,13094,BAO_0000019,8151
,,,,,,,,U,,,22224,CHEMBL623014,1,A,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Autocuration,,,0,13095,BAO_0000019,8151
,,,,Urine,,,,U,,,22224,CHEMBL623015,1,A,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,Autocuration,,1088.0,0,13096,BAO_0000019,8151
,,,,Urine,,,,U,,,22224,CHEMBL623016,1,A,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Autocuration,,1088.0,0,13097,BAO_0000019,8151
,,,,Urine,,,,U,,,22224,CHEMBL624858,1,A,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,Autocuration,,1088.0,0,13098,BAO_0000019,8151
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624859,1,A,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,Intermediate,,,1,13099,BAO_0000218,8151
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624860,1,A,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Intermediate,,,1,13100,BAO_0000218,8151
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624861,1,A,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Intermediate,,,1,13101,BAO_0000218,8151
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624862,1,A,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,Intermediate,,,1,13102,BAO_0000218,8151
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624863,1,A,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,Intermediate,,,1,13103,BAO_0000218,8151
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876655,1,A,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Intermediate,,,1,13104,BAO_0000218,8151
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624864,1,A,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,Intermediate,,,1,13105,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624865,1,A,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,Intermediate,,,1,13106,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624866,1,A,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Intermediate,,,1,13107,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624867,1,F,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,Expert,,,1,13108,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL624868,1,A,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,Intermediate,,,1,13109,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628450,1,A,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,Intermediate,,,1,13110,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628451,1,A,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,Intermediate,,,1,13111,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628452,1,A,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,Intermediate,,,1,13112,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628453,1,A,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Intermediate,,,1,13113,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628454,1,A,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,Intermediate,,,1,13114,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628455,1,A,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,Intermediate,,,1,13115,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628456,1,A,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,Intermediate,,,1,13116,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628457,1,A,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Intermediate,,,1,13117,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL877505,1,A,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,Intermediate,,,1,13118,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628458,1,A,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,Intermediate,,,1,13119,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628459,1,A,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,Intermediate,,,1,13120,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628460,1,A,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,Intermediate,,,1,13121,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628461,1,A,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,Intermediate,,,1,13122,BAO_0000218,6996
,,,,,,,,U,,,22224,CHEMBL628462,1,B,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",Autocuration,,,0,13123,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628463,1,A,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Intermediate,,,1,13124,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625666,1,F,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",Expert,,,1,13125,BAO_0000218,6996
,,,,,,,,U,,,22224,CHEMBL625667,1,B,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Autocuration,,,0,13126,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625668,1,A,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Expert,,,1,13127,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625669,1,A,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Intermediate,,,1,13128,BAO_0000218,6996
,,,,,,,,U,,,22224,CHEMBL625670,1,A,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,Autocuration,,,0,13129,BAO_0000019,7114
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625671,1,A,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,Intermediate,,,1,13130,BAO_0000218,7114
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL625672,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,Intermediate,,,1,13131,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL625673,1,A,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,Intermediate,,,1,13132,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL625674,1,A,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,Intermediate,,,1,13133,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL625675,1,A,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,Intermediate,,,1,13134,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL627637,1,A,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,Intermediate,,,1,13135,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL627638,1,A,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,Intermediate,,,1,13136,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL627639,1,A,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,Intermediate,,,1,13137,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL627640,1,A,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,Intermediate,,,1,13138,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL627641,1,A,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,Intermediate,,,1,13139,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL627642,1,A,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,Intermediate,,,1,13140,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL877506,1,A,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,Intermediate,,,1,13141,BAO_0000218,8613
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627275,1,A,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,Intermediate,,,1,13142,BAO_0000218,8613
,9669.0,,Mustela putorius furo,,,,,N,,,50506,CHEMBL627643,1,A,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",Intermediate,,,1,13143,BAO_0000218,11219
,9669.0,,Mustela putorius furo,,,,,N,,,50506,CHEMBL631246,1,A,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",Intermediate,,,1,13144,BAO_0000218,11219
,9669.0,,Mustela putorius furo,,,,,N,,,50506,CHEMBL631247,1,A,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",Intermediate,,,1,13145,BAO_0000218,11219
,9669.0,,Mustela putorius furo,,,,,N,,,50506,CHEMBL629532,1,A,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,Intermediate,,,1,13146,BAO_0000218,11219
,9669.0,,Mustela putorius furo,,,,,N,,,50506,CHEMBL629533,1,A,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,Intermediate,,,1,13147,BAO_0000218,11219
,9669.0,,Mustela putorius furo,,,,,N,,,50506,CHEMBL629534,1,A,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,Intermediate,,,1,13148,BAO_0000218,11219
,9669.0,,Mustela putorius furo,,,,,N,,,50506,CHEMBL629535,1,A,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,Intermediate,,,1,13149,BAO_0000218,11219
,,,,,,,,U,,,22224,CHEMBL625932,1,A,Pharmacokinetic parameter :drug bound to plasma was reported,Autocuration,,,0,13150,BAO_0000019,14837
,,,,,,,,U,,,22224,CHEMBL625933,1,A,compound was evaluated for drug bound in plasma,Autocuration,,,0,13151,BAO_0000019,14837
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625934,1,A,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,Intermediate,,,1,13152,BAO_0000218,15343
,9347.0,,Eutheria,,,,,U,,,22224,CHEMBL625935,1,A,Bioavailability,Autocuration,,,0,13153,BAO_0000218,13761
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625936,1,A,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,Intermediate,,,1,13154,BAO_0000218,14810
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625937,1,A,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,Intermediate,,,1,13155,BAO_0000218,14810
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625938,1,A,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,Intermediate,,,1,13156,BAO_0000218,13249
,10116.0,,Rattus norvegicus,Bile,,,,N,,,50597,CHEMBL625939,1,A,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,Intermediate,,1970.0,1,13157,BAO_0000218,9267
,10116.0,,Rattus norvegicus,Bile,,,,N,,,50597,CHEMBL625940,1,A,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,Intermediate,,1970.0,1,13158,BAO_0000218,9267
,10116.0,,Rattus norvegicus,Bile,,,,N,,,50597,CHEMBL874464,1,A,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,Intermediate,,1970.0,1,13159,BAO_0000218,9267
,10116.0,,Rattus norvegicus,Bile,,,,N,,,50597,CHEMBL625941,1,A,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,Intermediate,,1970.0,1,13160,BAO_0000218,9267
,10116.0,,Rattus norvegicus,Bile,,,,N,,,50597,CHEMBL625942,1,A,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,Intermediate,,1970.0,1,13161,BAO_0000218,9267
,10116.0,,Rattus norvegicus,Bile,,,,N,,,50597,CHEMBL625943,1,A,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,Intermediate,,1970.0,1,13162,BAO_0000218,9267
,9606.0,,Homo sapiens,Serum,,,,N,,,50587,CHEMBL625944,1,A,In vitro protein binding in human serum at 5 ug/ml,Intermediate,,1977.0,1,13163,BAO_0000218,15549
,,,,,,,,U,,,22224,CHEMBL625945,1,A,Serum protein binding ability was measured,Autocuration,,,0,13164,BAO_0000019,10929
,,,,,,,,U,,,22224,CHEMBL625946,1,A,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),Autocuration,,,0,13165,BAO_0000019,15444
,9615.0,,Canis lupus familiaris,,,,,U,,,22224,CHEMBL625947,1,A,Oral bioavailability in dog,Autocuration,In vivo,,0,13166,BAO_0000218,12860
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625948,1,A,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Intermediate,In vivo,,1,13167,BAO_0000218,12170
,,,,,,,,U,,,22224,CHEMBL625949,1,A,Absolute oral bioavailability at an iv dose of 14 mg/kg,Autocuration,In vivo,,0,13168,BAO_0000218,15173
,,,,,,,,U,,,22224,CHEMBL625950,1,A,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,Autocuration,In vivo,,0,13169,BAO_0000218,15173
,9347.0,,Eutheria,,,,,U,,,22224,CHEMBL625951,1,A,Oral bioavailability (dose 15 mg/kg i.v.),Autocuration,In vivo,,0,13170,BAO_0000218,15173
,,,,,,,,U,,,22224,CHEMBL625952,1,A,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,Autocuration,In vivo,,0,13171,BAO_0000218,15173
,,,,,,,,U,,,22224,CHEMBL625953,1,A,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,Autocuration,In vivo,,0,13172,BAO_0000218,15173
,,,,,,,,U,,,22224,CHEMBL625954,1,A,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,Autocuration,In vivo,,0,13173,BAO_0000218,15173
,,,,,,,,U,,,22224,CHEMBL882959,1,A,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,Autocuration,In vivo,,0,13174,BAO_0000218,15173
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625955,1,A,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,Intermediate,In vivo,,1,13175,BAO_0000218,11767
,9669.0,,Mustela putorius furo,,,,,U,,,22224,CHEMBL625956,1,A,Bioavailability in ferret,Autocuration,In vivo,,0,13176,BAO_0000218,11219
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL625957,1,A,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,Intermediate,In vivo,,1,13177,BAO_0000218,12186
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625958,1,A,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Intermediate,,,1,13178,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625959,1,A,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Intermediate,,,1,13179,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626642,1,A,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Intermediate,,,1,13180,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631330,1,A,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Intermediate,,,1,13181,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631331,1,A,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Intermediate,,,1,13182,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631332,1,A,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Intermediate,,,1,13183,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631333,1,A,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Intermediate,,,1,13184,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632018,1,A,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Intermediate,,,1,13185,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632019,1,A,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Intermediate,,,1,13186,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632020,1,A,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Intermediate,,,1,13187,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632021,1,A,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Intermediate,,,1,13188,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632022,1,A,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Intermediate,,,1,13189,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632023,1,A,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Intermediate,,,1,13190,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632024,1,A,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Intermediate,,,1,13191,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874472,1,A,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Intermediate,,,1,13192,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632025,1,A,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Intermediate,,,1,13193,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632026,1,A,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Intermediate,,,1,13194,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632027,1,A,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Intermediate,,,1,13195,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632028,1,A,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Intermediate,,,1,13196,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626430,1,A,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Intermediate,,,1,13197,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626431,1,A,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Intermediate,,,1,13198,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626432,1,A,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Intermediate,,,1,13199,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626433,1,A,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Intermediate,,,1,13200,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626434,1,A,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Intermediate,,,1,13201,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627280,1,A,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Intermediate,,,1,13202,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627281,1,A,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Intermediate,,,1,13203,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627282,1,A,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Intermediate,,,1,13204,BAO_0000218,11510
,,,,,,,,U,,,22224,CHEMBL627283,1,A,Total body clearance was measured at given dose,Autocuration,,,0,13205,BAO_0000019,7199
,,,,,,,,U,,,22224,CHEMBL627284,1,A,Total body clearance was measured at given dose.,Autocuration,,,0,13206,BAO_0000218,7199
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627285,1,A,Metabolic clearance from the body in rat,Intermediate,,,1,13207,BAO_0000218,7095
,,,,,,,,U,,,22224,CHEMBL627286,1,A,Renal clearance from the body,Autocuration,In vivo,,0,13208,BAO_0000218,7095
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875477,1,A,Renal clearance from the body in rat,Intermediate,In vivo,,1,13209,BAO_0000218,7095
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627287,1,A,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,Intermediate,In vivo,,1,13210,BAO_0000218,12528
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL627288,1,A,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,Intermediate,In vivo,,1,13211,BAO_0000218,12528
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627289,1,A,Total clearance from the body in rat,Intermediate,,,1,13212,BAO_0000218,7095
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627290,1,A,Clearance into cortex from rat plasma or PBS,Intermediate,In vivo,1969.0,1,13213,BAO_0000218,14223
,,,,,,,,U,,,22224,CHEMBL627291,1,A,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,Autocuration,In vivo,,0,13214,BAO_0000218,13569
,,,,,,,,U,,,22224,CHEMBL627292,1,A,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,Autocuration,In vivo,,0,13215,BAO_0000218,13569
,,,,,,,,U,,,22224,CHEMBL627293,1,A,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,Autocuration,In vivo,,0,13216,BAO_0000218,13569
,,,,,,,,U,,,22224,CHEMBL627294,1,A,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,Autocuration,In vivo,,0,13217,BAO_0000218,13569
,,,,,,,,U,,,22224,CHEMBL875478,1,A,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,Autocuration,In vivo,,0,13218,BAO_0000218,13569
,,,,,,,,U,,,22224,CHEMBL627295,1,A,Clearance was determined,Autocuration,In vivo,,0,13219,BAO_0000218,13979
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627296,1,A,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,Intermediate,In vivo,,1,13220,BAO_0000218,14315
,9986.0,,Oryctolagus cuniculus,,,,,N,,,50592,CHEMBL626119,1,A,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,Intermediate,In vivo,,1,13221,BAO_0000218,14315
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626120,1,A,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,Intermediate,In vivo,,1,13222,BAO_0000218,14315
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626121,1,A,Clearance in rat after iv dose (100 ug/kg),Intermediate,In vivo,,1,13223,BAO_0000218,12174
,10141.0,,Cavia porcellus,,,,,U,,,22224,CHEMBL626122,1,A,Clearance in guinea pig,Autocuration,In vivo,,0,13224,BAO_0000218,12797
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626123,1,A,Compound was evaluated for clearance in rat,Intermediate,In vivo,,1,13225,BAO_0000218,12797
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL623456,1,A,Compound was evaluated for the clearance in dog,Intermediate,In vivo,,1,13226,BAO_0000218,12797
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623457,1,A,Compound was evaluated for the clearance in rat,Intermediate,In vivo,,1,13227,BAO_0000218,12797
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623458,1,A,Compound was tested in vivo for clearance after iv administration in the rat,Intermediate,In vivo,,1,13228,BAO_0000218,11500
,,,,,,,,U,,,22224,CHEMBL623459,1,A,IV clearance determined at an iv dose of 14 mg/kg,Autocuration,In vivo,,0,13229,BAO_0000218,15173
,,,,,,,,U,,,22224,CHEMBL875484,1,A,IV clearance determined at an iv dose of 15.2 mg/kg,Autocuration,In vivo,,0,13230,BAO_0000218,15173
,,,,,,,,U,,,22224,CHEMBL623460,1,A,IV clearance determined at an iv dose of 15 mg/kg,Autocuration,In vivo,,0,13231,BAO_0000218,15173
,,,,,,,,U,,,22224,CHEMBL623461,1,A,IV clearance determined at an peroral dose of 30 mg/kg.,Autocuration,In vivo,,0,13232,BAO_0000218,15173
,,,,,,,,U,,,22224,CHEMBL623462,1,A,IV clearance determined at an peroral dose of 30.2 mg/kg.,Autocuration,In vivo,,0,13233,BAO_0000218,15173
,,,,,,,,U,,,22224,CHEMBL627386,1,A,IV clearance determined at an peroral dose of 30.3 mg/kg.,Autocuration,In vivo,,0,13234,BAO_0000218,15173
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL627387,1,A,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,Intermediate,In vivo,2113.0,1,13235,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627388,1,A,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,Intermediate,In vivo,2107.0,1,13236,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627389,1,A,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,Intermediate,In vivo,2048.0,1,13237,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL627390,1,A,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,Intermediate,In vivo,2385.0,1,13238,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627391,1,A,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,Intermediate,In vivo,1969.0,1,13239,BAO_0000218,14198
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627392,1,A,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,Intermediate,In vivo,,1,13240,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL627393,1,A,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,Intermediate,In vivo,2106.0,1,13241,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Trachea,,,,N,,,50597,CHEMBL627394,1,A,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,Intermediate,In vivo,3126.0,1,13242,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL627395,1,A,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,Intermediate,In vivo,10000001.0,1,13243,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL875485,1,A,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,Intermediate,In vivo,2037.0,1,13244,BAO_0000218,14198
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627396,1,A,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,Intermediate,In vivo,,1,13245,BAO_0000218,14198
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627397,1,A,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,Intermediate,In vivo,,1,13246,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL627398,1,A,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,Intermediate,In vivo,948.0,1,13247,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL627399,1,A,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,Intermediate,In vivo,10000001.0,1,13248,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL627400,1,A,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,Intermediate,In vivo,2113.0,1,13249,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627401,1,A,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,Intermediate,In vivo,2107.0,1,13250,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627402,1,A,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,Intermediate,In vivo,2048.0,1,13251,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL627403,1,A,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,Intermediate,In vivo,2385.0,1,13252,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL627404,1,A,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,Intermediate,In vivo,1969.0,1,13253,BAO_0000218,14198
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623101,1,A,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,Intermediate,In vivo,,1,13254,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL877480,1,A,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,Intermediate,In vivo,2106.0,1,13255,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Trachea,,,,N,,,50597,CHEMBL623102,1,A,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,Intermediate,In vivo,3126.0,1,13256,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL623103,1,A,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,Intermediate,In vivo,10000001.0,1,13257,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL623104,1,A,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,Intermediate,In vivo,2037.0,1,13258,BAO_0000218,14198
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623105,1,A,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,Intermediate,In vivo,,1,13259,BAO_0000218,14198
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623106,1,A,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,Intermediate,In vivo,,1,13260,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL623107,1,A,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,Intermediate,In vivo,948.0,1,13261,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL623108,1,A,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,Intermediate,In vivo,160.0,1,13262,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL623109,1,A,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,Intermediate,In vivo,2113.0,1,13263,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL623110,1,A,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,Intermediate,In vivo,2107.0,1,13264,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL623111,1,A,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,Intermediate,In vivo,2048.0,1,13265,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL625060,1,A,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,Intermediate,In vivo,2385.0,1,13266,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625061,1,A,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,Intermediate,In vivo,1969.0,1,13267,BAO_0000218,14198
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625062,1,A,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,Intermediate,In vivo,,1,13268,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL625063,1,A,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,Intermediate,In vivo,2106.0,1,13269,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Trachea,,,,N,,,50597,CHEMBL625064,1,A,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,Intermediate,In vivo,3126.0,1,13270,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Bone,,,,N,,,50597,CHEMBL625065,1,A,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,Intermediate,In vivo,10000001.0,1,13271,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL625066,1,A,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,Intermediate,In vivo,2037.0,1,13272,BAO_0000218,14198
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625067,1,A,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,Intermediate,In vivo,,1,13273,BAO_0000218,14198
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625068,1,A,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,Intermediate,In vivo,,1,13274,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL622159,1,A,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,Intermediate,In vivo,948.0,1,13275,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Intestine,,,,N,,,50597,CHEMBL622160,1,A,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,Intermediate,In vivo,160.0,1,13276,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL622161,1,A,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,Intermediate,In vivo,2113.0,1,13277,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL622162,1,A,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,Intermediate,In vivo,2048.0,1,13278,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL622163,1,A,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,Intermediate,In vivo,2385.0,1,13279,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622313,1,A,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,Intermediate,In vivo,1969.0,1,13280,BAO_0000218,14198
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622314,1,A,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,Intermediate,In vivo,,1,13281,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL622315,1,A,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,Intermediate,In vivo,2106.0,1,13282,BAO_0000218,14198
,10116.0,,Rattus norvegicus,Trachea,,,,N,,,50597,CHEMBL622316,1,A,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,Intermediate,In vivo,3126.0,1,13283,BAO_0000218,14198
,562.0,,Escherichia coli,,,,,N,,,50212,CHEMBL877486,1,A,Normal diffusion coefficient in water for Escherichia coli,Intermediate,,,1,13284,BAO_0000218,15599
,,,,,,,,U,,,22224,CHEMBL622317,1,A,Average max percent decrease in RVR (renal vascular resistance) was determined,Autocuration,,,0,13285,BAO_0000019,8204
,,,,,,,,U,,,22224,CHEMBL622318,1,A,Average max percent decrease in RVR (renal vascular resistance) was determined.,Autocuration,,,0,13286,BAO_0000019,8204
,,,,,,,,U,,,22224,CHEMBL622319,1,A,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,Autocuration,,,0,13287,BAO_0000019,6154
,,,,,,,,U,,,22224,CHEMBL622320,1,A,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,Autocuration,,,0,13288,BAO_0000019,6154
,,,,,,,,U,,,22224,CHEMBL622321,1,A,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,Autocuration,,,0,13289,BAO_0000019,6154
,,,,,,,,U,,,22224,CHEMBL622322,1,A,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,Autocuration,,,0,13290,BAO_0000019,6154
,,,,,,,,U,,,22224,CHEMBL622323,1,A,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,Autocuration,,,0,13291,BAO_0000019,7114
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622324,1,A,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,Intermediate,,,1,13292,BAO_0000218,7114
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622325,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Intermediate,,1088.0,1,13293,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622326,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Intermediate,,1088.0,1,13294,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL877487,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",Intermediate,,1088.0,1,13295,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622327,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Intermediate,,1088.0,1,13296,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622328,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",Intermediate,,1088.0,1,13297,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622329,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Intermediate,,1088.0,1,13298,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622330,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Intermediate,,1088.0,1,13299,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622331,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Intermediate,,1088.0,1,13300,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622332,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Intermediate,,1088.0,1,13301,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622333,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",Intermediate,,1088.0,1,13302,BAO_0000218,8133
,314293.0,,Simiiformes,Urine,,,,U,,,22224,CHEMBL627658,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Autocuration,,1088.0,0,13303,BAO_0000218,8133
,314293.0,,Simiiformes,Urine,,,,U,,,22224,CHEMBL630428,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",Autocuration,,1088.0,0,13304,BAO_0000218,8133
,314293.0,,Simiiformes,Urine,,,,U,,,22224,CHEMBL630429,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Autocuration,,1088.0,0,13305,BAO_0000218,8133
,314293.0,,Simiiformes,Urine,,,,U,,,22224,CHEMBL630430,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",Autocuration,,1088.0,0,13306,BAO_0000218,8133
,314293.0,,Simiiformes,Urine,,,,U,,,22224,CHEMBL630431,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",Autocuration,,1088.0,0,13307,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL630432,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Intermediate,,1088.0,1,13308,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL630433,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Intermediate,,1088.0,1,13309,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL630434,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Intermediate,,1088.0,1,13310,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL629372,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Intermediate,,1088.0,1,13311,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL629553,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",Intermediate,,1088.0,1,13312,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL629554,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Intermediate,,1088.0,1,13313,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL874447,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Intermediate,,1088.0,1,13314,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL629555,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Intermediate,,1088.0,1,13315,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL629556,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Intermediate,,1088.0,1,13316,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL629557,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",Intermediate,,1088.0,1,13317,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL629558,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Intermediate,,1088.0,1,13318,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL629559,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Intermediate,,1088.0,1,13319,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL629560,1,A,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Intermediate,,1088.0,1,13320,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL629561,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Intermediate,,1088.0,1,13321,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL629562,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Intermediate,,1088.0,1,13322,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL629563,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Intermediate,,1088.0,1,13323,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL629564,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Intermediate,,1088.0,1,13324,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL629565,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Intermediate,,1088.0,1,13325,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL629566,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Intermediate,,1088.0,1,13326,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL629567,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",Intermediate,,1088.0,1,13327,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL629568,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Intermediate,,1088.0,1,13328,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL629569,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",Intermediate,,1088.0,1,13329,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL629570,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Intermediate,,1088.0,1,13330,BAO_0000218,8133
,314293.0,,Simiiformes,Urine,,,,U,,,22224,CHEMBL629571,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Autocuration,,1088.0,0,13331,BAO_0000218,8133
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL629572,1,A,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Autocuration,In vivo,,0,13332,BAO_0000218,12170
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL629573,1,A,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Autocuration,In vivo,,0,13333,BAO_0000218,12170
,9347.0,,Eutheria,,,,,U,,,22224,CHEMBL629574,1,A,Bioavailability (dose 20 mg/kg),Autocuration,In vivo,,0,13334,BAO_0000218,4985
,9615.0,,Canis lupus familiaris,,,,,U,,,22224,CHEMBL629575,1,A,Bioavailability in dog,Autocuration,In vivo,,0,13335,BAO_0000218,15145
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL874448,1,A,Bioavailability in rat (Sprague-Dawley) (male),Autocuration,In vivo,,0,13336,BAO_0000218,14080
,9443.0,,Primates,,,,,U,,,22224,CHEMBL629576,1,A,Bioavailability in monkey (dose 10 mg/kg i.d.),Autocuration,In vivo,,0,13337,BAO_0000218,11219
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL629577,1,A,Bioavailability in rat,Autocuration,In vivo,,0,13338,BAO_0000218,15145
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL629578,1,A,Bioavailability in rat,Autocuration,In vivo,,0,13339,BAO_0000218,15145
,9615.0,,Canis lupus familiaris,,,,,U,,,22224,CHEMBL629579,1,A,Bioavailability in dog (dose 3.0 mg/kg p.o.),Autocuration,In vivo,,0,13340,BAO_0000218,1202
,9615.0,,Canis lupus familiaris,,,,,U,,,22224,CHEMBL882958,1,A,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,Autocuration,In vivo,,0,13341,BAO_0000218,1202
,9598.0,,Pan troglodytes,,,,,N,,,50505,CHEMBL629580,1,A,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,Intermediate,In vivo,,1,13342,BAO_0000218,1202
,9347.0,,Eutheria,,,,,U,,,22224,CHEMBL629581,1,A,Bioavailability,Autocuration,In vivo,,0,13343,BAO_0000218,4026
,9520.0,,Saimiri,,,,,U,,,22224,CHEMBL629582,1,A,Bioavailability in squirrel monkey,Autocuration,In vivo,,0,13344,BAO_0000218,1492
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628522,1,A,Bioavailability was evaluated in dog,Intermediate,In vivo,,1,13345,BAO_0000218,12793
,10026.0,,Cricetinae,,,,,N,,,100712,CHEMBL625432,1,A,Bioavailability was evaluated in hamster,Intermediate,In vivo,,1,13346,BAO_0000218,12793
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL625433,1,A,Bioavailability in rat,Autocuration,In vivo,,0,13347,BAO_0000218,12793
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625434,1,A,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Intermediate,In vivo,1969.0,1,13348,BAO_0000218,14793
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL625435,1,A,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,Intermediate,In vivo,1969.0,1,13349,BAO_0000218,14793
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL625436,1,A,Bioavailability in rat (dose 10 mg/kg p.o.),Autocuration,In vivo,,0,13350,BAO_0000218,14793
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL874588,1,A,Bioavailability was measured in cynomolgus monkeys.,Intermediate,In vivo,,1,13351,BAO_0000218,14731
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625437,1,A,Bioavailability was measured in nude mice.,Intermediate,In vivo,,1,13352,BAO_0000218,14731
,9669.0,,Mustela putorius furo,,,,,U,,,22224,CHEMBL625438,1,A,Bioavailability in ferret (dose 10 mg/kg i.d.),Autocuration,In vivo,,0,13353,BAO_0000218,12187
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL625439,1,A,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),Autocuration,In vivo,,0,13354,BAO_0000218,12187
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL625440,1,A,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",Autocuration,In vivo,,0,13355,BAO_0000218,12187
,314293.0,,Simiiformes,,,,,U,,,22224,CHEMBL625441,1,A,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),Autocuration,In vivo,,0,13356,BAO_0000218,12187
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL625442,1,A,Bioavailability in rat (dose 10 mg/kg i.d.),Autocuration,In vivo,,0,13357,BAO_0000218,12187
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625443,1,A,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Intermediate,In vivo,,1,13358,BAO_0000218,12187
,,,,,,,,U,,,22224,CHEMBL625444,1,A,Bioavailability was determined; extremely poor,Autocuration,In vivo,,0,13359,BAO_0000218,17431
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625445,1,A,% bioavailability in mice after oral administration of prodrug,Intermediate,In vivo,,1,13360,BAO_0000218,13318
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625446,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,Intermediate,In vivo,,1,13361,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL882960,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,Intermediate,In vivo,,1,13362,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625447,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,Intermediate,In vivo,,1,13363,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625448,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,Intermediate,In vivo,,1,13364,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625449,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,Intermediate,In vivo,,1,13365,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL874589,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),Intermediate,In vivo,,1,13366,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625450,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,Intermediate,In vivo,,1,13367,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625451,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,Intermediate,In vivo,,1,13368,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626584,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,Intermediate,In vivo,,1,13369,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626585,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,Intermediate,In vivo,,1,13370,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626586,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,Intermediate,In vivo,,1,13371,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626587,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,Intermediate,In vivo,,1,13372,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626588,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,Intermediate,In vivo,,1,13373,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626589,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,Intermediate,In vivo,,1,13374,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626590,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,Intermediate,In vivo,,1,13375,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626591,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,Intermediate,In vivo,,1,13376,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL627181,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,Intermediate,In vivo,,1,13377,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628083,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,Intermediate,In vivo,,1,13378,BAO_0000218,9025
,,,,,,,,U,,,22224,CHEMBL628084,1,A,IV clearance determined at an peroral dose of 15 mg/kg.,Autocuration,In vivo,,0,13379,BAO_0000218,15173
,102285.0,,Hymenolepis nana,,,,,N,,,50064,CHEMBL628085,1,F,Mouse oral clearance was measured against Hymenolepiasis nana.,Expert,In vivo,,1,13380,BAO_0000218,7732
,6339.0,,Heligmosomoides polygyrus,,,,,N,,,50545,CHEMBL628086,1,F,Mouse oral clearance was measured against Nematospiroides dubius,Expert,In vivo,,1,13381,BAO_0000218,7732
,,,,,,,,U,,,22224,CHEMBL628087,1,F,Mouse oral clearance was measured against N. dubius; NT is Not Tested,Autocuration,In vivo,,0,13382,BAO_0000218,7732
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL628088,1,A,Mouse oral clearance was measured against N. nana; NT is Not Tested,Intermediate,In vivo,,1,13383,BAO_0000218,7732
,,,,,,,,U,,,22224,CHEMBL628089,1,B,Mouse oral clearance was measured against N. nana; NT is Not Tested,Autocuration,In vivo,,0,13384,BAO_0000218,7732
,,,,,,,,U,,,22224,CHEMBL628090,1,A,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,Autocuration,In vivo,,0,13385,BAO_0000218,8328
,,,,,,,,U,,,22224,CHEMBL628091,1,A,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,Autocuration,In vivo,,0,13386,BAO_0000218,8328
,,,,,,,,U,,,22224,CHEMBL628092,1,A,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,Autocuration,In vivo,,0,13387,BAO_0000218,8328
,,,,,,,,U,,,22224,CHEMBL628093,1,A,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,Autocuration,In vivo,,0,13388,BAO_0000218,8328
,,,,,,,,U,,,22224,CHEMBL875607,1,A,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,Autocuration,In vivo,,0,13389,BAO_0000218,8328
,,,,,,,,U,,,22224,CHEMBL625710,1,A,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,Autocuration,In vivo,,0,13390,BAO_0000218,8328
,,,,,,,,U,,,22224,CHEMBL625711,1,A,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,Autocuration,In vivo,,0,13391,BAO_0000218,8328
,,,,,,,,U,,,22224,CHEMBL625712,1,A,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,Autocuration,In vivo,,0,13392,BAO_0000218,8328
,,,,,,,,U,,,22224,CHEMBL625713,1,A,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,Autocuration,In vivo,,0,13393,BAO_0000218,8328
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625714,1,A,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,Intermediate,In vivo,,1,13394,BAO_0000218,13376
,9544.0,,Macaca mulatta,,,,,N,,,50797,CHEMBL625715,1,A,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,Intermediate,In vivo,,1,13395,BAO_0000218,13477
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625716,1,A,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,Intermediate,In vivo,,1,13396,BAO_0000218,13477
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625717,1,A,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,Intermediate,In vivo,,1,13397,BAO_0000218,13477
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625718,1,A,Plasma clearance was determined for the compound in rats,Intermediate,In vivo,,1,13398,BAO_0000218,13313
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625719,1,A,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,Intermediate,In vivo,,1,13399,BAO_0000218,12504
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625720,1,A,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,Intermediate,In vivo,,1,13400,BAO_0000218,12504
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625721,1,A,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,Intermediate,In vivo,,1,13401,BAO_0000218,12504
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625722,1,A,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,Intermediate,In vivo,,1,13402,BAO_0000218,12504
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625723,1,A,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,Intermediate,In vivo,,1,13403,BAO_0000218,13129
,6339.0,,Heligmosomoides polygyrus,,,,,N,,,50545,CHEMBL625724,1,A,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,Intermediate,In vivo,,1,13404,BAO_0000218,7732
,6339.0,,Heligmosomoides polygyrus,,,,,N,,,50545,CHEMBL625725,1,A,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,Intermediate,In vivo,,1,13405,BAO_0000218,7732
,6339.0,,Heligmosomoides polygyrus,,,,,N,,,50545,CHEMBL625726,1,A,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,Intermediate,In vivo,,1,13406,BAO_0000218,7732
,6339.0,,Heligmosomoides polygyrus,,,,,N,,,50545,CHEMBL875608,1,A,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,Intermediate,In vivo,,1,13407,BAO_0000218,7732
,6339.0,,Heligmosomoides polygyrus,,,,,N,,,50545,CHEMBL625727,1,A,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,Intermediate,In vivo,,1,13408,BAO_0000218,7732
,10116.0,,Rattus norvegicus,Urine,,,,U,,,22224,CHEMBL625728,1,A,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,Autocuration,In vivo,1088.0,0,13409,BAO_0000218,9278
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL625729,1,A,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,Autocuration,In vivo,,0,13410,BAO_0000218,9278
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL625730,1,A,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,Autocuration,In vivo,,0,13411,BAO_0000218,9278
,10116.0,,Rattus norvegicus,Urine,,,,U,,,22224,CHEMBL625731,1,A,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,Autocuration,In vivo,1088.0,0,13412,BAO_0000218,9278
,10116.0,,Rattus norvegicus,Urine,,,,U,,,22224,CHEMBL626417,1,A,Urinary clearance was determined in rat at 25 mg/kg os dosage,Autocuration,In vivo,1088.0,0,13413,BAO_0000218,9278
,9606.0,,Homo sapiens,Urine,,,,N,,,50587,CHEMBL626418,1,A,Urinary clearance was determined at 100 mg/kg oral dosage in human,Intermediate,In vivo,1088.0,1,13414,BAO_0000218,9278
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL626419,1,A,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,Intermediate,In vivo,1088.0,1,13415,BAO_0000218,9278
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL626592,1,A,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,Intermediate,In vivo,1969.0,1,13416,BAO_0000218,5932
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626593,1,A,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Intermediate,In vivo,1969.0,1,13417,BAO_0000218,5932
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626594,1,A,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Intermediate,In vivo,,1,13418,BAO_0000218,5182
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625035,1,A,Clearance rate in dogs,Intermediate,In vivo,,1,13419,BAO_0000218,10499
,,,,,,,,U,,,22224,CHEMBL625036,1,A,Compound was measured for intrinsic clearance,Autocuration,In vitro,,0,13420,BAO_0000019,6051
,,,,,,,,U,,,22229,CHEMBL625037,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13421,BAO_0000100,17508
,,,,,,,,U,,,22229,CHEMBL625038,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13422,BAO_0000100,6228
,,,,,,,,U,,,22229,CHEMBL625039,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13423,BAO_0000100,6231
,,,,,,,,U,,,22229,CHEMBL625040,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13424,BAO_0000100,17740
,,,,,,,,U,,,22229,CHEMBL625041,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13425,BAO_0000100,6495
,,,,,,,,U,,,22229,CHEMBL625042,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13426,BAO_0000100,2171
,,,,,,,,U,,,22224,CHEMBL874411,1,A,Partition coefficient of the compound,Autocuration,,,0,13427,BAO_0000019,3255
,,,,,,,,U,,,22224,CHEMBL625043,1,A,Permeability,Autocuration,,,0,13428,BAO_0000019,6821
,,,,,,,,U,,,22229,CHEMBL625044,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13429,BAO_0000100,2685
,,,,,,,,U,,,22224,CHEMBL625045,1,A,Partition coefficient (logD),Autocuration,,,0,13430,BAO_0000019,17584
,,,,,,,,U,,,22229,CHEMBL625046,1,P,Calculated partition coefficient (clogP) (CLOGP3 V3.4),Autocuration,,,0,13431,BAO_0000100,13824
,,,,,,,,U,,,22229,CHEMBL625047,1,P,Calculated partition coefficient (clogP) (CLOGP3 V3.4),Autocuration,,,0,13432,BAO_0000100,13824
,,,,,,,,U,,,22229,CHEMBL625048,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13433,BAO_0000100,16479
,,,,,,,,U,,,22229,CHEMBL625049,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13434,BAO_0000100,11997
,,,,,,,,U,,,22229,CHEMBL625050,1,P,Calculated logarithm of partition coefficient (P) was determined,Autocuration,,,0,13435,BAO_0000100,2988
,,,,,,,,U,,,22229,CHEMBL625051,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13436,BAO_0000100,931
,,,,,,,,U,,,22229,CHEMBL874412,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13437,BAO_0000100,4381
,,,,,,,,U,,,22229,CHEMBL625052,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13438,BAO_0000100,4397
,,,,,,,,U,,,22229,CHEMBL625053,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13439,BAO_0000100,5889
,,,,,,,,U,,,22224,CHEMBL623250,1,A,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,Autocuration,,,0,13440,BAO_0000019,6154
,,,,,,,,U,,,22224,CHEMBL623251,1,A,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,Autocuration,,,0,13441,BAO_0000019,6154
,,,,,,,,U,,,22224,CHEMBL623252,1,A,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,Autocuration,,,0,13442,BAO_0000019,6154
,,,,,,,,U,,,22224,CHEMBL623253,1,A,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,Autocuration,,,0,13443,BAO_0000019,6154
,,,,,,,,U,,,22224,CHEMBL623254,1,A,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,Autocuration,,,0,13444,BAO_0000019,6154
,,,,,,,,U,,,22224,CHEMBL623255,1,A,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,Autocuration,,,0,13445,BAO_0000019,6154
,,,,,,,,U,,,22224,CHEMBL626831,1,A,Percent degradation of compound at a pH of 1 over a 18 hr period,Autocuration,,,0,13446,BAO_0000019,6887
,,,,,,,,U,,,22224,CHEMBL877494,1,A,Percent degradation of compound at pH of 1 over an 18 hr period,Autocuration,,,0,13447,BAO_0000019,6887
,,,,,,,,U,,,22224,CHEMBL626832,1,A,Delta Logarithm of Partition Coefficient value was determined.,Autocuration,,,0,13448,BAO_0000019,14116
,,,,,,,,U,,,22224,CHEMBL626833,1,A,Delta logPoct-cyc,Autocuration,,,0,13449,BAO_0000019,11137
,,,,,,,,U,,,22224,CHEMBL626834,1,P,Lipophilicity estimated on reversed phase TLC,Autocuration,,,0,13450,BAO_0000100,7230
,,,,,,,,U,,,22224,CHEMBL626835,1,A,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,Autocuration,,,0,13451,BAO_0000019,15741
,,,,,,,,U,,,22224,CHEMBL626836,1,A,Delta logPoct-cyc,Autocuration,,,0,13452,BAO_0000019,9663
,,,,,,,,U,,,22229,CHEMBL626837,1,P,Change in logarithm of partition coefficient of the compound,Autocuration,,,0,13453,BAO_0000100,9663
,,,,,,,,U,,,22224,CHEMBL626838,1,A,Delta logD (pH 6.5),Autocuration,,,0,13454,BAO_0000019,13807
,,,,,,,,U,,,22224,CHEMBL626839,1,P,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",Autocuration,,,0,13455,BAO_0000100,13807
,,,,,,,,U,,,22224,CHEMBL626840,1,A,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,Autocuration,,,0,13456,BAO_0000019,17425
,,,,,,,,U,,,22224,CHEMBL626841,1,A,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),Autocuration,,,0,13457,BAO_0000019,12143
,,,,,,,,U,,,22224,CHEMBL626842,1,A,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,Autocuration,,,0,13458,BAO_0000219,12608
,,,,,,,,U,,,22224,CHEMBL626843,1,A,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,Autocuration,,,0,13459,BAO_0000219,12608
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626844,1,A,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,Intermediate,,,1,13460,BAO_0000218,8649
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL877495,1,A,Amount of deuterium retained was reported after normal workup in rats,Intermediate,,,1,13461,BAO_0000218,8649
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626845,1,A,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,Intermediate,,,1,13462,BAO_0000218,8649
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626846,1,A,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,Intermediate,,,1,13463,BAO_0000218,8649
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626847,1,A,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,Intermediate,,,1,13464,BAO_0000218,8649
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628677,1,A,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,Intermediate,,,1,13465,BAO_0000218,8649
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628678,1,A,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,Intermediate,,,1,13466,BAO_0000218,8649
,,,,,,,,U,,,22224,CHEMBL628679,1,A,Compound was subjected to electrochemical oxidation,Autocuration,,,0,13467,BAO_0000019,9659
,,,,,,,,U,,,22224,CHEMBL628680,1,A,Compound was subjected to photochemical oxidation,Autocuration,,,0,13468,BAO_0000019,9659
,,,,,,,,U,,,22224,CHEMBL628681,1,A,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,Autocuration,,,0,13469,BAO_0000019,9659
,,,,,,,,U,,,22224,CHEMBL628682,1,A,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,Autocuration,,,0,13470,BAO_0000019,9659
,,,,,,,,U,,,22224,CHEMBL628683,1,A,Oxidation of compound by methemoglobin in presence of hydroperoxide,Autocuration,,,0,13471,BAO_0000019,9659
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628684,1,A,Percent diffusion through fuzzy rat skin after 48 h of incubation,Intermediate,,,1,13472,BAO_0000218,9607
,,,,,,,,U,,,22229,CHEMBL877501,1,P,Dissociation constant (pKa),Autocuration,,,0,13473,BAO_0000100,7057
,,,,,,,,U,,,22224,CHEMBL628685,1,P,Dissociation constant value of the compound; ND means not determined.,Autocuration,,,0,13474,BAO_0000100,7057
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL628686,1,A,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,Intermediate,,178.0,1,13475,BAO_0000218,7911
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL628687,1,A,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Intermediate,,178.0,1,13476,BAO_0000218,7911
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628688,1,A,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,Intermediate,,,1,13477,BAO_0000218,7911
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628689,1,A,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Intermediate,,,1,13478,BAO_0000218,7911
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL628690,1,A,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,Intermediate,,2107.0,1,13479,BAO_0000218,7911
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL629363,1,A,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Intermediate,,2107.0,1,13480,BAO_0000218,7911
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL629364,1,A,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,Intermediate,,2106.0,1,13481,BAO_0000218,7911
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL629365,1,A,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Intermediate,,2106.0,1,13482,BAO_0000218,7911
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629366,1,A,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,Intermediate,,,1,13483,BAO_0000218,7911
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL629367,1,A,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,Intermediate,,1088.0,1,13484,BAO_0000218,7911
,10116.0,,Rattus norvegicus,Feces,,,,N,,,50597,CHEMBL629368,1,A,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Intermediate,,1988.0,1,13485,BAO_0000218,7911
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL877502,1,A,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Intermediate,,1088.0,1,13486,BAO_0000218,7911
,10090.0,,Mus musculus,Cerebellum,,,,N,,,50594,CHEMBL629369,1,A,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,Intermediate,,2037.0,1,13487,BAO_0000218,13792
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL629370,1,A,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,Intermediate,,955.0,1,13488,BAO_0000218,13792
,314293.0,,Simiiformes,Urine,,,,U,,,22224,CHEMBL629371,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",Autocuration,,1088.0,0,13489,BAO_0000218,8133
,314293.0,,Simiiformes,Urine,,,,U,,,22224,CHEMBL626276,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Autocuration,,1088.0,0,13490,BAO_0000218,8133
,314293.0,,Simiiformes,Urine,,,,U,,,22224,CHEMBL626277,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Autocuration,,1088.0,0,13491,BAO_0000218,8133
,314293.0,,Simiiformes,Urine,,,,U,,,22224,CHEMBL631250,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Autocuration,,1088.0,0,13492,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631251,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Intermediate,,1088.0,1,13493,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631252,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Intermediate,,1088.0,1,13494,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631253,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",Intermediate,,1088.0,1,13495,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631254,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Intermediate,,1088.0,1,13496,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631255,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Intermediate,,1088.0,1,13497,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631256,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Intermediate,,1088.0,1,13498,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631257,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Intermediate,,1088.0,1,13499,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628009,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",Intermediate,,1088.0,1,13500,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628010,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Intermediate,,1088.0,1,13501,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628011,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Intermediate,,1088.0,1,13502,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628012,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",Intermediate,,1088.0,1,13503,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628013,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Intermediate,,1088.0,1,13504,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628014,1,A,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Intermediate,,1088.0,1,13505,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL628015,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",Intermediate,,1088.0,1,13506,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL628016,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Intermediate,,1088.0,1,13507,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL874461,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",Intermediate,,1088.0,1,13508,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL628017,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Intermediate,,1088.0,1,13509,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL628018,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Intermediate,,1088.0,1,13510,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL628019,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Intermediate,,1088.0,1,13511,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL628020,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Intermediate,,1088.0,1,13512,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL628021,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Intermediate,,1088.0,1,13513,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL628022,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Intermediate,,1088.0,1,13514,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL628023,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Intermediate,,1088.0,1,13515,BAO_0000218,8133
,314293.0,,Simiiformes,Urine,,,,U,,,22224,CHEMBL628024,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Autocuration,,1088.0,0,13516,BAO_0000218,8133
,314293.0,,Simiiformes,Urine,,,,U,,,22224,CHEMBL628025,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",Autocuration,,1088.0,0,13517,BAO_0000218,8133
,314293.0,,Simiiformes,Urine,,,,U,,,22224,CHEMBL628026,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Autocuration,,1088.0,0,13518,BAO_0000218,8133
,314293.0,,Simiiformes,Urine,,,,U,,,22224,CHEMBL628027,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Autocuration,,1088.0,0,13519,BAO_0000218,8133
,314293.0,,Simiiformes,Urine,,,,U,,,22224,CHEMBL628028,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Autocuration,,1088.0,0,13520,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628029,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Intermediate,,1088.0,1,13521,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628030,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",Intermediate,,1088.0,1,13522,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628031,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Intermediate,,1088.0,1,13523,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628032,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",Intermediate,,1088.0,1,13524,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628033,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Intermediate,,1088.0,1,13525,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628034,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",Intermediate,,1088.0,1,13526,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628035,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Intermediate,,1088.0,1,13527,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628036,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",Intermediate,,1088.0,1,13528,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL874462,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Intermediate,,1088.0,1,13529,BAO_0000218,8133
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628037,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,Intermediate,In vivo,,1,13530,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628123,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,Intermediate,In vivo,,1,13531,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628124,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,Intermediate,In vivo,,1,13532,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628125,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,Intermediate,In vivo,,1,13533,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628126,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,Intermediate,In vivo,,1,13534,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628127,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),Intermediate,In vivo,,1,13535,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628128,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,Intermediate,In vivo,,1,13536,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628129,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,Intermediate,In vivo,,1,13537,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628130,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,Intermediate,In vivo,,1,13538,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628131,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,Intermediate,In vivo,,1,13539,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628132,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,Intermediate,In vivo,,1,13540,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628133,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,Intermediate,In vivo,,1,13541,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628134,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,Intermediate,In vivo,,1,13542,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628135,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,Intermediate,In vivo,,1,13543,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628136,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,Intermediate,In vivo,,1,13544,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628137,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,Intermediate,In vivo,,1,13545,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628138,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,Intermediate,In vivo,,1,13546,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628139,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,Intermediate,In vivo,,1,13547,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628140,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,Intermediate,In vivo,,1,13548,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628141,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,Intermediate,In vivo,,1,13549,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628142,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,Intermediate,In vivo,,1,13550,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628143,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,Intermediate,In vivo,,1,13551,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628144,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,Intermediate,In vivo,,1,13552,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628145,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,Intermediate,In vivo,,1,13553,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL628146,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,Intermediate,In vivo,,1,13554,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625355,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,Intermediate,In vivo,,1,13555,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625356,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,Intermediate,In vivo,,1,13556,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625357,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,Intermediate,In vivo,,1,13557,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625527,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,Intermediate,In vivo,,1,13558,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL875473,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),Intermediate,In vivo,,1,13559,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL625528,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,Intermediate,In vivo,,1,13560,BAO_0000218,9025
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626304,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,Intermediate,In vivo,,1,13561,BAO_0000218,9025
,9615.0,,Canis lupus familiaris,Artery,,,,N,,,50588,CHEMBL624138,1,A,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,Intermediate,In vivo,1637.0,1,13562,BAO_0000218,9025
,,,,,,,,U,,,22229,CHEMBL624139,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13563,BAO_0000100,6448
,,,,,,,,U,,,22229,CHEMBL624140,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13564,BAO_0000100,17221
,,,,,,,,U,,,22229,CHEMBL624141,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13565,BAO_0000100,6545
,,,,,,,,U,,,22229,CHEMBL624142,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13566,BAO_0000100,577
,,,,,,,,U,,,22229,CHEMBL624143,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13567,BAO_0000100,6285
,,,,,,,,U,,,22229,CHEMBL624144,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13568,BAO_0000100,6500
,,,,,,,,U,,,22229,CHEMBL624145,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13569,BAO_0000100,6716
,,,,,,,,U,,,22229,CHEMBL624146,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13570,BAO_0000100,13658
,,,,,,,,U,,,22229,CHEMBL624147,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13571,BAO_0000100,6549
,,,,,,,,U,,,22229,CHEMBL883123,1,P,Calculated partition coefficient (clogP) (MacLogP),Autocuration,,,0,13572,BAO_0000100,14685
,,,,,,,,U,,,22224,CHEMBL624148,1,A,Partition coefficient (logP),Autocuration,,,0,13573,BAO_0000019,6893
,,,,,,,,U,,,22224,CHEMBL874416,1,A,Kinetic parameter was determined,Autocuration,,,0,13574,BAO_0000019,3687
,,,,,,,,U,,,22229,CHEMBL624149,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13575,BAO_0000100,4207
,,,,,,,,U,,,22229,CHEMBL624150,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13576,BAO_0000100,4626
,,,,,,,,U,,,22224,CHEMBL624151,1,P,Lipophilicity was determined,Autocuration,,,0,13577,BAO_0000100,1021
,,,,,,,,U,,,22224,CHEMBL624152,1,P,Lipophilicity was determined,Autocuration,,,0,13578,BAO_0000100,3777
,,,,,,,,U,,,22224,CHEMBL622139,1,P,Lipophilicity was determined,Autocuration,,,0,13579,BAO_0000100,17533
,,,,,,,,U,,,22229,CHEMBL622140,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13580,BAO_0000100,6524
,,,,,,,,U,,,22224,CHEMBL622141,1,P,Lipophilicity was determined,Autocuration,,,0,13581,BAO_0000100,17533
,,,,,,,,U,,,22224,CHEMBL622142,1,P,Lipophilicity in octanol-water,Autocuration,,,0,13582,BAO_0000100,6480
,,,,,,,,U,,,22229,CHEMBL622143,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13583,BAO_0000100,17606
,,,,,,,,U,,,22229,CHEMBL622144,1,P,Octanol-water partition coefficient was determined,Autocuration,,,0,13584,BAO_0000100,6863
,,,,,,,,U,,,22224,CHEMBL877473,1,A,Partition coefficient (logP),Autocuration,,,0,13585,BAO_0000019,1356
,,,,,,,,U,,,22229,CHEMBL622145,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13586,BAO_0000100,3326
,,,,,,,,U,,,22224,CHEMBL622146,1,A,Partition coefficient was determined; ND means not determined,Autocuration,,,0,13587,BAO_0000019,1356
,,,,,,,,U,,,22229,CHEMBL622147,1,P,Calculated partition coefficient (clogP),Autocuration,,,0,13588,BAO_0000100,12984
,,,,,,,,U,,,22224,CHEMBL622148,1,A,Partition coefficient of the compound,Autocuration,,,0,13589,BAO_0000019,17363
,,,,,,,,U,,,22224,CHEMBL883124,1,A,Permeability was determined,Autocuration,,,0,13590,BAO_0000019,6827
,,,,,,,,U,,,22229,CHEMBL622149,1,P,The compound was evaluated for the partition coefficient,Autocuration,,,0,13591,BAO_0000100,261
,,,,,,,,U,,,22224,CHEMBL622150,1,A,Partition coefficient (logP),Autocuration,,,0,13592,BAO_0000019,2685
,,,,,,,,U,,,22224,CHEMBL622151,1,P,The lipophilicity was reported,Autocuration,,,0,13593,BAO_0000100,414
,,,,,,,,U,,,22229,CHEMBL622152,1,P,logarithm of the octanol-water partition coefficient for the compound,Autocuration,,,0,13594,BAO_0000100,15769
,,,,,,,,U,,,22224,CHEMBL622153,1,A,Clogp value was determined,Autocuration,,,0,13595,BAO_0000019,17248
,,,,,,,,U,,,22224,CHEMBL877474,1,A,Clp at a dose of 1.5 mg/kg,Autocuration,In vivo,,0,13596,BAO_0000218,16935
,,,,,,,,U,,,22224,CHEMBL622154,1,A,Clp at a dose of 2.0 mg/kg,Autocuration,In vivo,,0,13597,BAO_0000218,16935
,,,,Plasma,,,,U,,,22224,CHEMBL622155,1,A,"Clp, plasma clearance at a dose of 10 mg/kg",Autocuration,In vivo,1969.0,0,13598,BAO_0000218,14832
,,,,Plasma,,,,U,,,22224,CHEMBL622156,1,A,"Clp, plasma clearance at a dose of 50 mg/kg",Autocuration,In vivo,1969.0,0,13599,BAO_0000218,14832
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622157,1,A,Compound was tested for plasma clearance in rat,Intermediate,In vivo,1969.0,1,13600,BAO_0000218,2399
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622158,1,A,Compound was tested for plasma clearance in rat; Not determined,Intermediate,In vivo,1969.0,1,13601,BAO_0000218,2399
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622807,1,A,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,Intermediate,In vivo,,1,13602,BAO_0000218,6227
,9544.0,,Macaca mulatta,,,,,N,,,50797,CHEMBL622808,1,A,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,Intermediate,In vivo,,1,13603,BAO_0000218,6227
,,,,,,,,U,,,22224,CHEMBL622809,1,A,Plasma clearance by iv administration at a dose 0.003 ug/mL,Autocuration,In vivo,,0,13604,BAO_0000218,5623
,,,,,,,,U,,,22224,CHEMBL622810,1,A,Plasma clearance determined,Autocuration,In vivo,,0,13605,BAO_0000218,4854
,10026.0,,Cricetinae,,,,,N,,,100712,CHEMBL876653,1,A,Plasma clearance after iv administration at 3 mg/kg in hamster,Intermediate,In vivo,,1,13606,BAO_0000218,4493
,10026.0,,Cricetinae,,,,,N,,,100712,CHEMBL622811,1,A,Plasma clearance after iv administration at 4 mg/kg in hamster,Intermediate,In vivo,,1,13607,BAO_0000218,4493
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622986,1,A,Rate of clearance in rat was determined,Intermediate,In vivo,,1,13608,BAO_0000218,14956
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622987,1,A,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,Intermediate,In vivo,1969.0,1,13609,BAO_0000218,15372
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622988,1,A,Total plasma clearance after iv dose of 5.10 mg/kg in rats,Intermediate,In vivo,1969.0,1,13610,BAO_0000218,15372
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622989,1,A,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,Intermediate,In vivo,1969.0,1,13611,BAO_0000218,15372
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622990,1,A,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,Intermediate,In vivo,1969.0,1,13612,BAO_0000218,15372
,314293.0,,Simiiformes,Plasma,,,,U,,,22224,CHEMBL622991,1,A,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,Autocuration,In vivo,1969.0,0,13613,BAO_0000218,15604
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL622227,1,A,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,Intermediate,In vivo,1969.0,1,13614,BAO_0000218,15604
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL622228,1,A,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,Intermediate,In vivo,1969.0,1,13615,BAO_0000218,15604
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622229,1,A,Clpl value in rat,Intermediate,In vivo,,1,13616,BAO_0000218,14964
,10141.0,,Cavia porcellus,,,,,N,,,50512,CHEMBL622230,1,A,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,Intermediate,In vivo,,1,13617,BAO_0000218,15240
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL622231,1,A,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,Intermediate,In vivo,,1,13618,BAO_0000218,16449
,9541.0,,Macaca fascicularis,,,,,N,,,100710,CHEMBL622232,1,A,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,Intermediate,In vivo,,1,13619,BAO_0000218,16449
,,,,,,,,U,,,22224,CHEMBL622233,1,A,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,Autocuration,In vivo,,0,13620,BAO_0000218,12902
,,,,,,,,U,,,22224,CHEMBL622234,1,A,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,Autocuration,In vivo,,0,13621,BAO_0000218,12902
,,,,,,,,U,,,22224,CHEMBL622235,1,A,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,Autocuration,In vivo,,0,13622,BAO_0000218,12902
,,,,,,,,U,,,22224,CHEMBL622236,1,A,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,Autocuration,In vivo,,0,13623,BAO_0000218,12902
,,,,,,,,U,,,22224,CHEMBL622237,1,A,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,Autocuration,In vivo,,0,13624,BAO_0000218,12902
,,,,,,,,U,,,22224,CHEMBL877482,1,A,Cmax in minutes at a po dose of 10.0(pmol/g/h).,Autocuration,In vivo,,0,13625,BAO_0000218,12902
,,,,,,,,U,,,22224,CHEMBL622238,1,A,Cmax in minutes at a po dose of 20.0(pmol/g/h).,Autocuration,In vivo,,0,13626,BAO_0000218,12902
,,,,,,,,U,,,22224,CHEMBL622239,1,A,Cmax in minutes at a po dose of 40.0(pmol/g/h).,Autocuration,In vivo,,0,13627,BAO_0000218,12902
,,,,Blood,,,,U,,,22224,CHEMBL622240,1,A,Cmax was calculated as maximum concentration reached in the blood,Autocuration,In vivo,178.0,0,13628,BAO_0000218,11149
,,,,Blood,,,,U,,,22224,CHEMBL622241,1,A,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,Autocuration,In vivo,178.0,0,13629,BAO_0000218,11149
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631013,1,A,Cmax was determine after peroral administration at 10 mpk in Rat,Intermediate,In vivo,,1,13630,BAO_0000218,5669
,9544.0,,Macaca mulatta,,,,,N,,,50797,CHEMBL631014,1,A,Cmax was determine after peroral administration at 10 mpk in Rhesus,Intermediate,In vivo,,1,13631,BAO_0000218,5669
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL631015,1,A,Cmax was determine after peroral administration at 10 mpk in dog,Intermediate,In vivo,,1,13632,BAO_0000218,5669
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631016,1,A,Cmax was determine after peroral administration at 160 mpk in Rat,Intermediate,In vivo,,1,13633,BAO_0000218,5669
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631017,1,A,Cmax was determine after peroral administration at 20 mpk in Rat,Intermediate,In vivo,,1,13634,BAO_0000218,5669
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631018,1,A,Cmax was determine after peroral administration at 50 mpk in Rat,Intermediate,In vivo,,1,13635,BAO_0000218,5669
,,,,,,,,U,,,22224,CHEMBL631019,1,A,Cmax was determined,Autocuration,In vivo,,0,13636,BAO_0000218,4236
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL875761,1,A,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,Intermediate,,955.0,1,13637,BAO_0000218,13792
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL631020,1,A,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,Intermediate,,955.0,1,13638,BAO_0000218,13792
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL631669,1,A,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,Intermediate,,955.0,1,13639,BAO_0000218,13792
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL631670,1,A,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,Intermediate,,955.0,1,13640,BAO_0000218,13792
,10090.0,,Mus musculus,Striatum,,,,N,,,50594,CHEMBL631671,1,A,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,Intermediate,,2435.0,1,13641,BAO_0000218,13792
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631672,1,A,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,Intermediate,,178.0,1,13642,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631673,1,A,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,Intermediate,,178.0,1,13643,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631856,1,A,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,Intermediate,,178.0,1,13644,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631857,1,A,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,Intermediate,,178.0,1,13645,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631858,1,A,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,Intermediate,,178.0,1,13646,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631859,1,A,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,Intermediate,,178.0,1,13647,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631860,1,A,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,Intermediate,,178.0,1,13648,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631861,1,A,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,Intermediate,,178.0,1,13649,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631862,1,A,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,Intermediate,,178.0,1,13650,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631863,1,A,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,Intermediate,,178.0,1,13651,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631864,1,A,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,Intermediate,,178.0,1,13652,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631865,1,A,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,Intermediate,,178.0,1,13653,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631866,1,A,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,Intermediate,,178.0,1,13654,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL629360,1,A,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,Intermediate,,178.0,1,13655,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL629361,1,A,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,Intermediate,,178.0,1,13656,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL629362,1,A,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,Intermediate,,178.0,1,13657,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL630740,1,A,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,Intermediate,,178.0,1,13658,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL630741,1,A,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,Intermediate,,178.0,1,13659,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL630742,1,A,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,Intermediate,,178.0,1,13660,BAO_0000218,8418
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630743,1,A,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,Intermediate,,,1,13661,BAO_0000218,8418
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630744,1,A,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,Intermediate,,,1,13662,BAO_0000218,8418
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630745,1,A,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,Intermediate,,,1,13663,BAO_0000218,8418
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630746,1,A,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,Intermediate,,,1,13664,BAO_0000218,8418
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630747,1,A,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,Intermediate,,,1,13665,BAO_0000218,8418
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630748,1,A,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,Intermediate,,,1,13666,BAO_0000218,8418
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632056,1,A,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,Intermediate,,,1,13667,BAO_0000218,8418
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632057,1,A,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,Intermediate,,,1,13668,BAO_0000218,8418
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632058,1,A,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,Intermediate,,,1,13669,BAO_0000218,8418
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632059,1,A,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,Intermediate,,,1,13670,BAO_0000218,8418
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632060,1,A,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,Intermediate,,,1,13671,BAO_0000218,8418
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632061,1,A,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,Intermediate,,,1,13672,BAO_0000218,8418
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629207,1,A,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,Intermediate,,,1,13673,BAO_0000218,8418
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629208,1,A,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,Intermediate,,,1,13674,BAO_0000218,8418
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629209,1,A,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,Intermediate,,,1,13675,BAO_0000218,8418
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629210,1,A,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,Intermediate,,,1,13676,BAO_0000218,8418
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629211,1,A,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,Intermediate,,,1,13677,BAO_0000218,8418
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629212,1,A,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,Intermediate,,,1,13678,BAO_0000218,8418
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629213,1,A,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,Intermediate,,,1,13679,BAO_0000218,8418
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL629214,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Intermediate,,1088.0,1,13680,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL629215,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",Intermediate,,1088.0,1,13681,BAO_0000218,8133
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL635154,1,A,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",Intermediate,,1088.0,1,13682,BAO_0000218,8133
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629216,1,A,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Intermediate,,,1,13683,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629217,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,Intermediate,,,1,13684,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629218,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,13685,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629219,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Intermediate,,,1,13686,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629220,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Intermediate,,,1,13687,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629221,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Intermediate,,,1,13688,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631127,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,13689,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631128,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,Intermediate,,,1,13690,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631129,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,13691,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631130,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Intermediate,,,1,13692,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631131,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Intermediate,,,1,13693,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631132,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Intermediate,,,1,13694,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631133,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,13695,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631134,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,Intermediate,,,1,13696,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875120,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,13697,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631135,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Intermediate,,,1,13698,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631136,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),Intermediate,,,1,13699,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631137,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Intermediate,,,1,13700,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631138,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,13701,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631139,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,Intermediate,,,1,13702,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631140,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,13703,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631141,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Intermediate,,,1,13704,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631142,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Intermediate,,,1,13705,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631143,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Intermediate,,,1,13706,BAO_0000218,6996
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631144,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Intermediate,,,1,13707,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL631145,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,Intermediate,,,1,13708,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL631146,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Intermediate,,,1,13709,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL631147,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,Intermediate,,,1,13710,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL631148,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,13711,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL631149,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,13712,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL631150,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),Intermediate,,,1,13713,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL631151,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,13714,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL631152,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,13715,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL631443,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,13716,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL631444,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),Intermediate,,,1,13717,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL631445,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Intermediate,,,1,13718,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL631446,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Intermediate,,,1,13719,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL631447,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),Intermediate,,,1,13720,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL631448,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Intermediate,,,1,13721,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL631449,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,Intermediate,,,1,13722,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL631450,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),Intermediate,,,1,13723,BAO_0000218,6996
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL629724,1,A,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Intermediate,,,1,13724,BAO_0000218,6996
,10090.0,,Mus musculus,Zone of skin,,,,N,,,50594,CHEMBL629725,1,A,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,In vivo,14.0,1,13725,BAO_0000218,9716
,10090.0,,Mus musculus,Zone of skin,,,,N,,,50594,CHEMBL629726,1,A,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,In vivo,14.0,1,13726,BAO_0000218,9716
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL629727,1,A,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,In vivo,2106.0,1,13727,BAO_0000218,9716
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL630404,1,A,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,In vivo,2106.0,1,13728,BAO_0000218,9716
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL630405,1,A,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,In vivo,2106.0,1,13729,BAO_0000218,9716
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL630406,1,A,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,In vivo,2106.0,1,13730,BAO_0000218,9716
,10090.0,,Mus musculus,Stomach,,,,N,,,50594,CHEMBL630407,1,A,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,In vivo,945.0,1,13731,BAO_0000218,9716
,10090.0,,Mus musculus,Stomach,,,,N,,,50594,CHEMBL630573,1,A,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,In vivo,945.0,1,13732,BAO_0000218,9716
,10090.0,,Mus musculus,Stomach,,,,N,,,50594,CHEMBL630574,1,A,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,In vivo,945.0,1,13733,BAO_0000218,9716
,10090.0,,Mus musculus,Stomach,,,,N,,,50594,CHEMBL630575,1,A,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,In vivo,945.0,1,13734,BAO_0000218,9716
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL630576,1,A,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,In vivo,,1,13735,BAO_0000218,9716
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL630577,1,A,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,In vivo,,1,13736,BAO_0000218,9716
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL630578,1,A,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,In vivo,,1,13737,BAO_0000218,9716
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL630579,1,A,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Intermediate,In vivo,,1,13738,BAO_0000218,9716
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL630580,1,A,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),Intermediate,,2113.0,1,13739,BAO_0000218,12192
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL630581,1,A,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,Intermediate,,2113.0,1,13740,BAO_0000218,12192
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL630582,1,A,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),Intermediate,,2113.0,1,13741,BAO_0000218,12192
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL630583,1,A,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,Intermediate,,,1,13742,BAO_0000218,12192
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL630584,1,A,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),Intermediate,,,1,13743,BAO_0000218,12192
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL630585,1,A,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,Intermediate,,,1,13744,BAO_0000218,12192
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL630586,1,A,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),Intermediate,,,1,13745,BAO_0000218,12192
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL630587,1,A,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,Intermediate,,,1,13746,BAO_0000218,12192
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL630588,1,A,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),Intermediate,,,1,13747,BAO_0000218,12192
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL630589,1,A,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,Intermediate,,,1,13748,BAO_0000218,12192
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL630590,1,A,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),Intermediate,,,1,13749,BAO_0000218,12192
,,,,Feces,,,,U,,,22224,CHEMBL630591,1,A,Removal of 238-Plutonium(IV) in feces at 24 h,Autocuration,,1988.0,0,13750,BAO_0000019,12192
,,,,Feces,,,,U,,,22224,CHEMBL630592,1,A,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),Autocuration,,1988.0,0,13751,BAO_0000019,12192
,,,,,,,,U,,,22224,CHEMBL630593,1,A,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,Autocuration,,,0,13752,BAO_0000019,12192
,,,,,,,,U,,,22224,CHEMBL630594,1,A,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),Autocuration,,,0,13753,BAO_0000019,12192
,,,,Urine,,,,U,,,22224,CHEMBL630595,1,A,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),Autocuration,,1088.0,0,13754,BAO_0000019,12192
,,,,Urine,,,,U,,,22224,CHEMBL630596,1,A,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),Autocuration,,1088.0,0,13755,BAO_0000019,12192
,,,,Urine,,,,U,,,22224,CHEMBL630597,1,A,Removal of 238-Plutonium(IV) in urine after 0-24 h,Autocuration,,1088.0,0,13756,BAO_0000019,12192
,,,,Urine,,,,U,,,22224,CHEMBL630598,1,A,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),Autocuration,,1088.0,0,13757,BAO_0000019,12192
,,,,Urine,,,,U,,,22224,CHEMBL630599,1,A,Removal of 238-Plutonium(IV) in urine after 0-4 h,Autocuration,,1088.0,0,13758,BAO_0000019,12192
,,,,Urine,,,,U,,,22224,CHEMBL630600,1,A,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),Autocuration,,1088.0,0,13759,BAO_0000019,12192
,,,,Urine,,,,U,,,22224,CHEMBL630601,1,A,Removal of 238-Plutonium(IV) in urine after 4-24 h,Autocuration,,1088.0,0,13760,BAO_0000019,12192
,,,,Urine,,,,U,,,22224,CHEMBL630602,1,A,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),Autocuration,,1088.0,0,13761,BAO_0000019,12192
,,,,Urine,,,,U,,,22224,CHEMBL630603,1,A,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),Autocuration,,1088.0,0,13762,BAO_0000019,12192
,,,,Urine,,,,U,,,22224,CHEMBL630604,1,A,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),Autocuration,,1088.0,0,13763,BAO_0000019,12192
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624869,1,A,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,178.0,1,13764,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL624870,1,A,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,178.0,1,13765,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL623189,1,A,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,178.0,1,13766,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL623190,1,A,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,178.0,1,13767,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL623191,1,A,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,178.0,1,13768,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623192,1,A,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,,1,13769,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623193,1,A,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,,1,13770,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623194,1,A,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,,1,13771,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623195,1,A,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,,1,13772,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623196,1,A,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,,1,13773,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623197,1,A,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,Intermediate,,,1,13774,BAO_0000218,11836
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623198,1,A,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Intermediate,,,1,13775,BAO_0000218,11836
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623199,1,A,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,Intermediate,,,1,13776,BAO_0000218,11836
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623200,1,A,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,Intermediate,,2385.0,1,13777,BAO_0000218,11836
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623201,1,A,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,Intermediate,,2385.0,1,13778,BAO_0000218,11836
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623202,1,A,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,Intermediate,,2385.0,1,13779,BAO_0000218,11836
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623203,1,A,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,Intermediate,,2385.0,1,13780,BAO_0000218,11836
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623204,1,A,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,Intermediate,,2385.0,1,13781,BAO_0000218,11836
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623205,1,A,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,Intermediate,,2385.0,1,13782,BAO_0000218,11836
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623206,1,A,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Intermediate,,2385.0,1,13783,BAO_0000218,11836
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623207,1,A,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,Intermediate,,2385.0,1,13784,BAO_0000218,11836
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623208,1,A,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,Intermediate,,2385.0,1,13785,BAO_0000218,11836
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623209,1,A,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Intermediate,,2385.0,1,13786,BAO_0000218,11836
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL623210,1,A,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,Intermediate,,2385.0,1,13787,BAO_0000218,11836
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623211,1,A,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Intermediate,,,1,13788,BAO_0000218,11836
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL623212,1,A,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Intermediate,,995.0,1,13789,BAO_0000218,11836
,,,,,,,,U,,,22224,CHEMBL623213,1,A,Tested in vitro for intrinsic activity relative to quinpirole,Autocuration,,,0,13790,BAO_0000019,12640
,,,,,,,,U,,,22224,CHEMBL623214,1,A,"Relative ion enhancement, determined in pulsed ultrafiltration",Autocuration,,,0,13791,BAO_0000019,14218
,,,,,,,,U,,,22224,CHEMBL623215,1,A,% ionization at the pH 7.4 at 37 degree Centigrade,Autocuration,,,0,13792,BAO_0000019,11296
,,,,,,,,U,,,22224,CHEMBL623216,1,A,Percentage ionization was measured,Autocuration,,,0,13793,BAO_0000019,10929
,9913.0,,Bos taurus,,,,,N,,,50591,CHEMBL623217,1,A,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,Intermediate,,,1,13794,BAO_0000218,13841
,,,,,,,,U,,,22224,CHEMBL623218,1,A,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,Autocuration,,,0,13795,BAO_0000019,10431
,,,,,,,,U,,,22224,CHEMBL623913,1,A,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,Autocuration,,,0,13796,BAO_0000019,10431
,,,,,,,,U,,,22224,CHEMBL623914,1,A,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,Autocuration,,,0,13797,BAO_0000019,10431
,,,,,,,,U,,,22229,CHEMBL623915,1,P,Compound was evaluated for the partition coefficient in octanol/water,Autocuration,,,0,13798,BAO_0000100,8826
,,,,,,,,U,,,22229,CHEMBL624080,1,P,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),Autocuration,,,0,13799,BAO_0000100,8826
,,,,,,,,U,,,22224,CHEMBL624081,1,A,Equilibrium constant measured by the pulse radiolysis at pH 7,Autocuration,,,0,13800,BAO_0000019,9884
,9606.0,,Homo sapiens,,,,,N,,,50587,CHEMBL624082,1,A,In vitro hydrolytic rate constant determined in human blood,Intermediate,,,1,13801,BAO_0000218,9827
,9606.0,,Homo sapiens,,,,,N,,,50587,CHEMBL625054,1,A,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,Intermediate,,,1,13802,BAO_0000218,10009
,,,,,,,,U,,,22224,CHEMBL877485,1,A,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,Autocuration,,,0,13803,BAO_0000019,10009
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625055,1,A,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,Intermediate,,,1,13804,BAO_0000218,10009
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625056,1,A,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,Intermediate,,,1,13805,BAO_0000218,10009
,9606.0,,Homo sapiens,,,,,N,,,50587,CHEMBL625057,1,A,In vitro oxidation of compound in presence of human plasma,Intermediate,,,1,13806,BAO_0000218,10009
,,,,,,,,U,,,22224,CHEMBL625058,1,A,In vitro oxidation of compound in presence of hydrogen peroxide,Autocuration,,,0,13807,BAO_0000019,10009
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625059,1,A,In vitro oxidation of compound in presence of mouse brain homogenate,Intermediate,,,1,13808,BAO_0000218,10009
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629536,1,A,In vitro oxidation of compound in presence of mouse liver homogenate,Intermediate,,,1,13809,BAO_0000218,10009
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629537,1,A,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Intermediate,,,1,13810,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629538,1,A,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Intermediate,,,1,13811,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629539,1,A,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Intermediate,,,1,13812,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL874445,1,A,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Intermediate,,,1,13813,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629540,1,A,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Intermediate,,,1,13814,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629541,1,A,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Intermediate,,,1,13815,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629542,1,A,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Intermediate,,,1,13816,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630243,1,A,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Intermediate,,,1,13817,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630244,1,A,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Intermediate,,,1,13818,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630245,1,A,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Intermediate,,,1,13819,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630246,1,A,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Intermediate,,,1,13820,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630247,1,A,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Intermediate,,,1,13821,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630248,1,A,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Intermediate,,,1,13822,BAO_0000218,11510
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL630249,1,A,Biodistribution in rat blood at 240 minutes after dose administration.,Intermediate,In vivo,178.0,1,13823,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL630250,1,A,Biodistribution in rat blood at 30 minutes after dose administration.,Intermediate,In vivo,178.0,1,13824,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL630251,1,A,Biodistribution in rat blood at 360 minutes after dose administration.,Intermediate,In vivo,178.0,1,13825,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL630252,1,A,Biodistribution in rat blood at 3 hr after dose administration.,Intermediate,In vivo,178.0,1,13826,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL630408,1,A,Biodistribution in rat blood at 60 minutes after dose administration.,Intermediate,In vivo,178.0,1,13827,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL630409,1,A,Biodistribution in rat cerebellum at 120 minutes after dose administration.,Intermediate,In vivo,2037.0,1,13828,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL874446,1,A,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,Intermediate,In vivo,2037.0,1,13829,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL630410,1,A,Biodistribution in rat cerebellum at 15 minutes after dose administration.,Intermediate,In vivo,2037.0,1,13830,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL630411,1,A,Biodistribution in rat cerebellum at 240 minutes after dose administration.,Intermediate,In vivo,2037.0,1,13831,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL630412,1,A,Biodistribution in rat cerebellum at 30 minutes after dose administration.,Intermediate,In vivo,2037.0,1,13832,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL630413,1,A,Biodistribution in rat cerebellum at 360 minutes after dose administration.,Intermediate,In vivo,2037.0,1,13833,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL630414,1,A,Biodistribution in rat cerebellum at 3 hr after dose administration.,Intermediate,In vivo,2037.0,1,13834,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL630415,1,A,Biodistribution in rat cerebellum at 60 minutes after dose administration.,Intermediate,In vivo,2037.0,1,13835,BAO_0000218,13100
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630416,1,A,Biodistribution in rat cortex at 120 minutes after dose administration.,Intermediate,In vivo,,1,13836,BAO_0000218,13100
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630417,1,A,Biodistribution in rat cortex at 1440 minutes after dose administration.,Intermediate,In vivo,,1,13837,BAO_0000218,13100
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630418,1,A,Biodistribution in rat cortex at 15 minutes after dose administration.,Intermediate,In vivo,,1,13838,BAO_0000218,13100
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630419,1,A,Biodistribution in rat cortex at 240 minutes after dose administration.,Intermediate,In vivo,,1,13839,BAO_0000218,13100
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630420,1,A,Biodistribution in rat cortex at 30 minutes after dose administration.,Intermediate,In vivo,,1,13840,BAO_0000218,13100
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630421,1,A,Biodistribution in rat cortex at 360 minutes after dose administration.,Intermediate,In vivo,,1,13841,BAO_0000218,13100
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630422,1,A,Biodistribution in rat cortex at 3 hr after dose administration.,Intermediate,In vivo,,1,13842,BAO_0000218,13100
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630423,1,A,Biodistribution in rat cortex at 60 minutes after dose administration.,Intermediate,In vivo,,1,13843,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL630424,1,A,Biodistribution in rat heart at 120 minutes after dose administration.,Intermediate,In vivo,948.0,1,13844,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL630425,1,A,Biodistribution in rat heart at 15 minutes after dose administration.,Intermediate,In vivo,948.0,1,13845,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL629462,1,A,Biodistribution in rat heart at 240 minutes after dose administration.,Intermediate,In vivo,948.0,1,13846,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL630426,1,A,Biodistribution in rat heart at 30 minutes after dose administration.,Intermediate,In vivo,948.0,1,13847,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL630427,1,A,Biodistribution in rat heart at 360 minutes after dose administration.,Intermediate,In vivo,948.0,1,13848,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL625877,1,A,Biodistribution in rat heart at 3 hr after dose administration.,Intermediate,In vivo,948.0,1,13849,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL625878,1,A,Biodistribution in rat heart at 60 minutes after dose administration.,Intermediate,In vivo,948.0,1,13850,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL625879,1,A,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,Intermediate,In vivo,10000000.0,1,13851,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL625880,1,A,Biodistribution in rat hippocampus at 240 minutes after dose administration.,Intermediate,In vivo,10000000.0,1,13852,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL625881,1,A,Biodistribution in rat hippocampus at 30 minutes after dose administration.,Intermediate,In vivo,10000000.0,1,13853,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL625882,1,A,Biodistribution in rat hippocampus at 360 minutes after dose administration.,Intermediate,In vivo,10000000.0,1,13854,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL625883,1,A,Biodistribution in rat hippocampus at 15 minutes after dose administration.,Intermediate,In vivo,10000000.0,1,13855,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL625884,1,A,Biodistribution in rat kidney at 120 minutes after dose administration.,Intermediate,In vivo,2113.0,1,13856,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL625885,1,A,Biodistribution in rat kidney at 1440 minutes after dose administration.,Intermediate,In vivo,2113.0,1,13857,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL628649,1,A,Biodistribution in rat kidney at 15 minutes after dose administration.,Intermediate,In vivo,2113.0,1,13858,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL628650,1,A,Biodistribution in rat kidney at 240 minutes after dose administration.,Intermediate,In vivo,2113.0,1,13859,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL628651,1,A,Biodistribution in rat kidney at 30 minutes after dose administration.,Intermediate,In vivo,2113.0,1,13860,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL628652,1,A,Biodistribution in rat kidney at 360 minutes after dose administration.,Intermediate,In vivo,2113.0,1,13861,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL628653,1,A,Biodistribution in rat kidney at 60 minutes after dose administration.,Intermediate,In vivo,2113.0,1,13862,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL628654,1,A,Biodistribution in rat liver at 120 minutes after dose administration.,Intermediate,In vivo,2107.0,1,13863,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL628655,1,A,Biodistribution in rat liver at 1440 minutes after dose administration.,Intermediate,In vivo,2107.0,1,13864,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625238,1,A,Biodistribution in rat liver at 15 minutes after dose administration.,Intermediate,In vivo,2107.0,1,13865,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625239,1,A,Biodistribution in rat liver at 240 minutes after dose administration.,Intermediate,In vivo,2107.0,1,13866,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625240,1,A,Biodistribution in rat liver at 30 minutes after dose administration.,Intermediate,In vivo,2107.0,1,13867,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625241,1,A,Biodistribution in rat liver at 360 minutes after dose administration.,Intermediate,In vivo,2107.0,1,13868,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625242,1,A,Biodistribution in rat liver at 60 minutes after dose administration.,Intermediate,In vivo,2107.0,1,13869,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL874587,1,A,Biodistribution in rat lung at 120 minutes after dose administration.,Intermediate,In vivo,2048.0,1,13870,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL625405,1,A,Biodistribution in rat lung at 1440 minutes after dose administration.,Intermediate,In vivo,2048.0,1,13871,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL625406,1,A,Biodistribution in rat lung at 15 minutes after dose administration.,Intermediate,In vivo,2048.0,1,13872,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL625407,1,A,Biodistribution in rat lung at 240 minutes after dose administration.,Intermediate,In vivo,2048.0,1,13873,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL625408,1,A,Biodistribution in rat lung at 30 minutes after dose administration.,Intermediate,In vivo,2048.0,1,13874,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL625409,1,A,Biodistribution in rat lung at 360 minutes after dose administration.,Intermediate,In vivo,2048.0,1,13875,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Thoracic aorta,,,,N,,,50597,CHEMBL625410,1,A,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,Intermediate,,1515.0,1,13876,BAO_0000218,12361
,10116.0,,Rattus norvegicus,Thoracic aorta,,,,N,,,50597,CHEMBL625411,1,A,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,Intermediate,,1515.0,1,13877,BAO_0000218,12361
,10116.0,,Rattus norvegicus,Thoracic aorta,,,,N,,,50597,CHEMBL625412,1,A,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,Intermediate,,1515.0,1,13878,BAO_0000218,12361
,10116.0,,Rattus norvegicus,Thoracic aorta,,,,N,,,50597,CHEMBL625413,1,A,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,Intermediate,,1515.0,1,13879,BAO_0000218,12361
,10116.0,,Rattus norvegicus,Thoracic aorta,,,,N,,,50597,CHEMBL625414,1,A,Percent of maximal contractile response to compound in rat thoracic aorta strips v,Intermediate,,1515.0,1,13880,BAO_0000218,12361
,10116.0,,Rattus norvegicus,Thoracic aorta,,,,N,,,50597,CHEMBL625415,1,A,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,Intermediate,,1515.0,1,13881,BAO_0000218,12361
,10116.0,,Rattus norvegicus,Thoracic aorta,,,,N,,,50597,CHEMBL625416,1,A,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,Intermediate,,1515.0,1,13882,BAO_0000218,12361
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL625417,1,A,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,Intermediate,,1088.0,1,13883,BAO_0000218,12712
,10116.0,,Rattus norvegicus,Feces,,,,N,,,50597,CHEMBL625418,1,A,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,Intermediate,,1988.0,1,13884,BAO_0000218,7415
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL625419,1,A,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,Intermediate,,1088.0,1,13885,BAO_0000218,7415
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625420,1,A,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,Intermediate,,,1,13886,BAO_0000218,7415
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626996,1,A,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,Intermediate,,,1,13887,BAO_0000218,7415
,10116.0,,Rattus norvegicus,Feces,,,,N,,,50597,CHEMBL626997,1,A,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",Intermediate,,1988.0,1,13888,BAO_0000218,7415
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626998,1,A,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",Intermediate,,1088.0,1,13889,BAO_0000218,7415
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626999,1,A,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",Intermediate,,,1,13890,BAO_0000218,7415
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627000,1,A,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,Intermediate,,,1,13891,BAO_0000218,8050
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627001,1,A,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,Intermediate,,,1,13892,BAO_0000218,8050
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627002,1,A,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,Intermediate,,,1,13893,BAO_0000218,8050
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627003,1,A,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,Intermediate,,,1,13894,BAO_0000218,8050
,10090.0,,Mus musculus,Urine,,,,N,,,50594,CHEMBL627004,1,A,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,Intermediate,,1088.0,1,13895,BAO_0000218,8050
,10090.0,,Mus musculus,Urine,,,,N,,,50594,CHEMBL627005,1,A,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,Intermediate,,1088.0,1,13896,BAO_0000218,8050
,10090.0,,Mus musculus,Urine,,,,N,,,50594,CHEMBL874594,1,A,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,Intermediate,,1088.0,1,13897,BAO_0000218,8050
,10090.0,,Mus musculus,Urine,,,,N,,,50594,CHEMBL627006,1,A,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,Intermediate,,1088.0,1,13898,BAO_0000218,8050
,10090.0,,Mus musculus,Urine,,,,N,,,50594,CHEMBL627007,1,A,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,Intermediate,,1088.0,1,13899,BAO_0000218,8050
,10090.0,,Mus musculus,Urine,,,,N,,,50594,CHEMBL627884,1,A,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,Intermediate,,1088.0,1,13900,BAO_0000218,8050
,10090.0,,Mus musculus,Urine,,,,N,,,50594,CHEMBL627885,1,A,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,Intermediate,,1088.0,1,13901,BAO_0000218,8050
,10090.0,,Mus musculus,Urine,,,,N,,,50594,CHEMBL627886,1,A,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,Intermediate,,1088.0,1,13902,BAO_0000218,8050
,10090.0,,Mus musculus,Urine,,,,N,,,50594,CHEMBL627887,1,A,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,Intermediate,,1088.0,1,13903,BAO_0000218,8050
,10090.0,,Mus musculus,Urine,,,,N,,,50594,CHEMBL627888,1,A,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,Intermediate,,1088.0,1,13904,BAO_0000218,8050
,10090.0,,Mus musculus,Urine,,,,N,,,50594,CHEMBL628057,1,A,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,Intermediate,,1088.0,1,13905,BAO_0000218,8050
,10090.0,,Mus musculus,Urine,,,,N,,,50594,CHEMBL627405,1,A,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,Intermediate,,1088.0,1,13906,BAO_0000218,8050
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627406,1,A,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Intermediate,,1088.0,1,13907,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627407,1,A,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Intermediate,,1088.0,1,13908,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627408,1,A,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Intermediate,,1088.0,1,13909,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627409,1,A,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Intermediate,,1088.0,1,13910,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL875486,1,A,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Intermediate,,1088.0,1,13911,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627410,1,A,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Intermediate,,1088.0,1,13912,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627411,1,A,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Intermediate,,1088.0,1,13913,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627412,1,A,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Intermediate,,1088.0,1,13914,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627413,1,A,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Intermediate,,1088.0,1,13915,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627414,1,A,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Intermediate,,1088.0,1,13916,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627415,1,A,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Intermediate,,1088.0,1,13917,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627416,1,A,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,Intermediate,,1088.0,1,13918,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627417,1,A,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Intermediate,,1088.0,1,13919,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627418,1,A,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Intermediate,,1088.0,1,13920,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627419,1,A,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Intermediate,,1088.0,1,13921,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627320,1,A,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Intermediate,,1088.0,1,13922,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627321,1,A,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Intermediate,,1088.0,1,13923,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL627322,1,A,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2113.0,1,13924,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL627323,1,A,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2113.0,1,13925,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL627491,1,A,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,2113.0,1,13926,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL627492,1,A,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2113.0,1,13927,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL627493,1,A,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2113.0,1,13928,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627494,1,A,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2107.0,1,13929,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627495,1,A,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2107.0,1,13930,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627496,1,A,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,2107.0,1,13931,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627497,1,A,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2107.0,1,13932,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL627498,1,A,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2107.0,1,13933,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627499,1,A,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2048.0,1,13934,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627500,1,A,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2048.0,1,13935,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627501,1,A,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,2048.0,1,13936,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL625616,1,A,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2048.0,1,13937,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL625617,1,A,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2048.0,1,13938,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL625618,1,A,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2385.0,1,13939,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL625619,1,A,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2385.0,1,13940,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL625620,1,A,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,2385.0,1,13941,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL625621,1,A,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2385.0,1,13942,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL625622,1,A,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2385.0,1,13943,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL625788,1,A,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2106.0,1,13944,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL625789,1,A,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2106.0,1,13945,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL625790,1,A,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,2106.0,1,13946,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL625791,1,A,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2106.0,1,13947,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL622334,1,A,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2106.0,1,13948,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL622335,1,A,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2046.0,1,13949,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL622336,1,A,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2046.0,1,13950,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL622337,1,A,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,2046.0,1,13951,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL622338,1,A,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2046.0,1,13952,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL622339,1,A,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2046.0,1,13953,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL624153,1,A,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,,1,13954,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628430,1,A,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,,1,13955,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628431,1,A,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,,1,13956,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628432,1,A,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,,1,13957,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628433,1,A,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,,1,13958,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL628434,1,A,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,In vivo,2106.0,1,13959,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL626789,1,A,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,In vivo,2106.0,1,13960,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL626790,1,A,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",Intermediate,In vivo,2106.0,1,13961,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL626791,1,A,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,In vivo,2106.0,1,13962,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL626792,1,A,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,In vivo,2106.0,1,13963,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL626793,1,A,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,In vivo,2106.0,1,13964,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627436,1,A,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Intermediate,,,1,13965,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627437,1,A,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Intermediate,,,1,13966,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627438,1,A,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Intermediate,,,1,13967,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627439,1,A,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Intermediate,,,1,13968,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627440,1,A,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Intermediate,,,1,13969,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627602,1,A,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Intermediate,,,1,13970,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627603,1,A,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Intermediate,,,1,13971,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627604,1,A,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Intermediate,,,1,13972,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627605,1,A,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Intermediate,,,1,13973,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627606,1,A,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Intermediate,,,1,13974,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627607,1,A,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Intermediate,,,1,13975,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627608,1,A,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Intermediate,,,1,13976,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627609,1,A,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Intermediate,,,1,13977,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627610,1,A,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Intermediate,,,1,13978,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627611,1,A,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Intermediate,,,1,13979,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627612,1,A,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Intermediate,,,1,13980,BAO_0000218,11510
,,,,,,,,U,,,22229,CHEMBL627613,1,P,Octanol:water partition coefficient is evaluated,Autocuration,,,0,13981,BAO_0000100,8362
,,,,,,,,U,,,22224,CHEMBL627614,1,P,Partition coefficient in 1-octanol/water system,Autocuration,,,0,13982,BAO_0000100,8257
,,,,,,,,U,,,22224,CHEMBL627615,1,P,Partition coefficient in 1-octanol/water system measured using radio active compounds,Autocuration,,,0,13983,BAO_0000100,8257
,,,,,,,,U,,,22224,CHEMBL627616,1,P,Partition coefficient in octanol/water system was determined,Autocuration,,,0,13984,BAO_0000100,9468
,,,,,,,,U,,,22224,CHEMBL627617,1,P,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,Autocuration,,,0,13985,BAO_0000100,9468
,,,,,,,,U,,,22224,CHEMBL627618,1,A,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,Autocuration,,,0,13986,BAO_0000019,10568
,,,,,,,,U,,,22224,CHEMBL627619,1,A,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",Autocuration,,,0,13987,BAO_0000019,10568
,,,,,,,,U,,,22224,CHEMBL627620,1,A,Pseudo-first-order rate constant of the compound,Autocuration,,,0,13988,BAO_0000019,15359
,,,,,,,,U,,,22224,CHEMBL627621,1,A,Pseudo-first-order rate constant with 1-min time point,Autocuration,,,0,13989,BAO_0000019,15359
,,,,,,,,U,,,22224,CHEMBL627622,1,A,Pseudo-first-order rate constant without 1-min time point,Autocuration,,,0,13990,BAO_0000019,15359
,,,,,,,,U,,,22224,CHEMBL627623,1,A,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,Autocuration,,,0,13991,BAO_0000019,10431
,,,,,,,,U,,,22224,CHEMBL627624,1,A,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,Autocuration,,,0,13992,BAO_0000019,10431
,,,,,,,,U,,,22224,CHEMBL627625,1,A,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,Autocuration,,,0,13993,BAO_0000019,10431
,,,,,,,,U,,,22224,CHEMBL628523,1,A,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,Autocuration,,,0,13994,BAO_0000019,15704
,,,,,,,,U,,,22224,CHEMBL628524,1,A,The alkaline hydrolysis second order rate constant(K OH) of the compound,Autocuration,,,0,13995,BAO_0000019,15287
,,,,,,,,U,,,22224,CHEMBL628525,1,A,The efflux rate constant of the compound,Autocuration,,,0,13996,BAO_0000019,7516
,,,,,,,,U,,,22224,CHEMBL625732,1,A,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,Autocuration,,,0,13997,BAO_0000019,12973
,,,,,,,,U,,,22224,CHEMBL625733,1,A,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,Autocuration,,,0,13998,BAO_0000019,12973
,,,,,,,,U,,,22224,CHEMBL625734,1,F,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,Autocuration,,,0,13999,BAO_0000019,12973
,,,,,,,,U,,,22224,CHEMBL625913,1,A,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,Autocuration,,,0,14000,BAO_0000019,12973
,,,,,,,,U,,,22224,CHEMBL625914,1,A,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,Autocuration,,,0,14001,BAO_0000019,8696
,,,,,,,,U,,,22224,CHEMBL625915,1,A,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,Autocuration,,,0,14002,BAO_0000019,15052
,,,,,,,,U,,,22224,CHEMBL625916,1,A,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,Autocuration,,,0,14003,BAO_0000019,15052
,,,,,,,,U,,,22224,CHEMBL625917,1,A,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),Autocuration,,,0,14004,BAO_0000019,10503
,,,,,,,,U,,,22224,CHEMBL625918,1,A,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,14005,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL625919,1,A,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,14006,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL625920,1,A,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,14007,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL874453,1,A,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,14008,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL625921,1,A,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,14009,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL625922,1,A,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,Autocuration,,,0,14010,BAO_0000019,10503
,,,,,,,,U,,,22224,CHEMBL625923,1,A,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,14011,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL625924,1,A,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,14012,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL625925,1,A,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,14013,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL625926,1,A,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,14014,BAO_0000019,8354
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL627704,1,A,Biodistribution in rat lung at 60 minutes after dose administration.,Intermediate,In vivo,2048.0,1,14015,BAO_0000218,13100
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627705,1,A,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,Intermediate,In vivo,,1,14016,BAO_0000218,13100
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627706,1,A,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,Intermediate,In vivo,,1,14017,BAO_0000218,13100
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627707,1,A,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,Intermediate,In vivo,,1,14018,BAO_0000218,13100
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627708,1,A,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,Intermediate,In vivo,,1,14019,BAO_0000218,13100
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628361,1,A,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,Intermediate,In vivo,,1,14020,BAO_0000218,13100
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628362,1,A,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,Intermediate,In vivo,,1,14021,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Striatum,,,,N,,,50597,CHEMBL628363,1,A,Biodistribution in rat striatum at 120 minutes after dose administration.,Intermediate,In vivo,2435.0,1,14022,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Striatum,,,,N,,,50597,CHEMBL628364,1,A,Biodistribution in rat striatum at 1440 minutes after dose administration.,Intermediate,In vivo,2435.0,1,14023,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Striatum,,,,N,,,50597,CHEMBL628365,1,A,Biodistribution in rat striatum at 15 minutes after dose administration.,Intermediate,In vivo,2435.0,1,14024,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Striatum,,,,N,,,50597,CHEMBL874454,1,A,Biodistribution in rat striatum at 240 minutes after dose administration.,Intermediate,In vivo,2435.0,1,14025,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Striatum,,,,N,,,50597,CHEMBL628531,1,A,Biodistribution in rat striatum at 30 minutes after dose administration.,Intermediate,In vivo,2435.0,1,14026,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Striatum,,,,N,,,50597,CHEMBL628532,1,A,Biodistribution in rat striatum at 360 minutes after dose administration.,Intermediate,In vivo,2435.0,1,14027,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Striatum,,,,N,,,50597,CHEMBL628533,1,A,Biodistribution in rat striatum at 3 hr after dose administration.,Intermediate,In vivo,2435.0,1,14028,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Striatum,,,,N,,,50597,CHEMBL628534,1,A,Biodistribution in rat striatum at 60 minutes after dose administration.,Intermediate,In vivo,2435.0,1,14029,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL628535,1,A,Biodistribution in rat thyroid at 120 minutes after dose administration.,Intermediate,In vivo,2046.0,1,14030,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL628536,1,A,Biodistribution in rat thyroid at 1440 minutes after dose administration.,Intermediate,In vivo,2046.0,1,14031,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL628537,1,A,Biodistribution in rat thyroid at 15 minutes after dose administration.,Intermediate,In vivo,2046.0,1,14032,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL628538,1,A,Biodistribution in rat thyroid at 240 minutes after dose administration.,Intermediate,In vivo,2046.0,1,14033,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL628539,1,A,Biodistribution in rat thyroid at 30 minutes after dose administration.,Intermediate,In vivo,2046.0,1,14034,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL630297,1,A,Biodistribution in rat thyroid at 360 minutes after dose administration.,Intermediate,In vivo,2046.0,1,14035,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL630298,1,A,Biodistribution in rat thyroid at 60 minutes after dose administration.,Intermediate,In vivo,2046.0,1,14036,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL630299,1,A,Biodistribution in rest of brain of rat 120 minutes after dose administration.,Intermediate,In vivo,955.0,1,14037,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL628094,1,A,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,Intermediate,In vivo,955.0,1,14038,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL628095,1,A,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,Intermediate,In vivo,955.0,1,14039,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL874648,1,A,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,Intermediate,In vivo,955.0,1,14040,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL628096,1,A,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,Intermediate,In vivo,955.0,1,14041,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL628097,1,A,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,Intermediate,In vivo,955.0,1,14042,BAO_0000218,13100
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL628098,1,A,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,Intermediate,In vivo,955.0,1,14043,BAO_0000218,13100
,,,,,,,,U,,,22224,CHEMBL628099,1,A,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",Autocuration,,,0,14044,BAO_0000019,13331
,,,,,,,,U,,,22224,CHEMBL628100,1,A,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",Autocuration,,,0,14045,BAO_0000019,13331
,,,,,,,,U,,,22224,CHEMBL628101,1,A,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),Autocuration,,,0,14046,BAO_0000019,13331
,,,,,,,,U,,,22224,CHEMBL628102,1,A,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",Autocuration,,,0,14047,BAO_0000019,13331
,,,,,,,,U,,,22224,CHEMBL628103,1,A,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",Autocuration,,,0,14048,BAO_0000019,13331
,,,,,,,,U,,,22224,CHEMBL628104,1,A,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",Autocuration,,,0,14049,BAO_0000019,13331
,,,,,,,,U,,,22224,CHEMBL628105,1,A,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",Autocuration,,,0,14050,BAO_0000019,13331
,,,,,,,,U,,,22224,CHEMBL628106,1,A,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",Autocuration,,,0,14051,BAO_0000019,13331
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628107,1,A,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,Intermediate,,1088.0,1,14052,BAO_0000218,10086
,,,,Urine,,,,U,,,22224,CHEMBL628108,1,F,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,Autocuration,,1088.0,0,14053,BAO_0000218,10086
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628109,1,A,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,Intermediate,,1088.0,1,14054,BAO_0000218,10086
,,,,Urine,,,,U,,,22224,CHEMBL625299,1,F,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,Autocuration,,1088.0,0,14055,BAO_0000218,10086
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL625300,1,A,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,Intermediate,,1088.0,1,14056,BAO_0000218,10086
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL625301,1,A,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,Intermediate,,1088.0,1,14057,BAO_0000218,10086
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL625302,1,A,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,Intermediate,,1088.0,1,14058,BAO_0000218,10086
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL874649,1,A,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,Intermediate,,1088.0,1,14059,BAO_0000218,10086
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625303,1,A,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,Intermediate,,,1,14060,BAO_0000218,13248
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625463,1,A,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,Intermediate,,,1,14061,BAO_0000218,13248
,9606.0,,Homo sapiens,Liver,,,,N,,,50587,CHEMBL625464,1,A,In vitro metabolism in human liver microsomes,Intermediate,,2107.0,1,14062,BAO_0000218,14527
,9606.0,,Homo sapiens,,,,,N,,,50587,CHEMBL625465,1,A,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,Intermediate,,,1,14063,BAO_0000218,3008
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL625466,1,A,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Intermediate,,1088.0,1,14064,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL625467,1,A,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Intermediate,,1088.0,1,14065,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL625468,1,A,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Intermediate,,1088.0,1,14066,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL625469,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,Intermediate,,1088.0,1,14067,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL625470,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,Intermediate,,1088.0,1,14068,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL632418,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,Intermediate,,1088.0,1,14069,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL627250,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,Intermediate,,1088.0,1,14070,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL627251,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,Intermediate,,1088.0,1,14071,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL627252,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,Intermediate,,1088.0,1,14072,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL627253,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,Intermediate,,1088.0,1,14073,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL627254,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,Intermediate,,1088.0,1,14074,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL875471,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,Intermediate,,1088.0,1,14075,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL627255,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,Intermediate,,1088.0,1,14076,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL627256,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,Intermediate,,1088.0,1,14077,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL627257,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,Intermediate,,1088.0,1,14078,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL627258,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,Intermediate,,1088.0,1,14079,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL627259,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,Intermediate,,1088.0,1,14080,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL627260,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,Intermediate,,1088.0,1,14081,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623256,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,Intermediate,,1088.0,1,14082,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL874413,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,Intermediate,,1088.0,1,14083,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623257,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,Intermediate,,1088.0,1,14084,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623258,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,Intermediate,,1088.0,1,14085,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623259,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,Intermediate,,1088.0,1,14086,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623260,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,Intermediate,,1088.0,1,14087,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623261,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,Intermediate,,1088.0,1,14088,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623262,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,Intermediate,,1088.0,1,14089,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623263,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,Intermediate,,1088.0,1,14090,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623264,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,Intermediate,,1088.0,1,14091,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623265,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,Intermediate,,1088.0,1,14092,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623266,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,Intermediate,,1088.0,1,14093,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623267,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,Intermediate,,1088.0,1,14094,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623268,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,Intermediate,,1088.0,1,14095,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623269,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,Intermediate,,1088.0,1,14096,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623270,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,Intermediate,,1088.0,1,14097,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623271,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,Intermediate,,1088.0,1,14098,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623272,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,Intermediate,,1088.0,1,14099,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623273,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,Intermediate,,1088.0,1,14100,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623274,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,Intermediate,,1088.0,1,14101,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL874414,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,Intermediate,,1088.0,1,14102,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623275,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,Intermediate,,1088.0,1,14103,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL629150,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,Intermediate,,1088.0,1,14104,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623276,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,Intermediate,,1088.0,1,14105,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623277,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,Intermediate,,1088.0,1,14106,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623112,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,Intermediate,,1088.0,1,14107,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623113,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,Intermediate,,1088.0,1,14108,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623800,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,Intermediate,,1088.0,1,14109,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623801,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,Intermediate,,1088.0,1,14110,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL623802,1,A,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Intermediate,In vivo,2106.0,1,14111,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL623803,1,A,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,995.0,1,14112,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL623970,1,A,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,995.0,1,14113,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Uterus,,,,N,,,50597,CHEMBL623971,1,A,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,995.0,1,14114,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL623972,1,A,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),Intermediate,In vivo,178.0,1,14115,BAO_0000218,14045
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL623973,1,A,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),Intermediate,In vivo,178.0,1,14116,BAO_0000218,14045
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL623974,1,A,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),Intermediate,In vivo,178.0,1,14117,BAO_0000218,14045
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL623975,1,A,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),Intermediate,In vivo,178.0,1,14118,BAO_0000218,14045
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL623976,1,A,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),Intermediate,In vivo,955.0,1,14119,BAO_0000218,14045
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL623977,1,A,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),Intermediate,In vivo,955.0,1,14120,BAO_0000218,14045
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL623978,1,A,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),Intermediate,In vivo,955.0,1,14121,BAO_0000218,14045
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL623979,1,A,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),Intermediate,In vivo,955.0,1,14122,BAO_0000218,14045
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623980,1,A,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),Intermediate,In vivo,,1,14123,BAO_0000218,14045
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL623981,1,A,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),Intermediate,In vivo,,1,14124,BAO_0000218,14045
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626278,1,A,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),Intermediate,In vivo,,1,14125,BAO_0000218,14045
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626279,1,A,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),Intermediate,In vivo,,1,14126,BAO_0000218,14045
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL626280,1,A,Biodistribution in mice bladder plus excreted urine was determined,Intermediate,In vivo,,1,14127,BAO_0000218,14045
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL626281,1,A,"Percentage biodistribution in mouse blood, 10 minutes post injection",Intermediate,,,1,14128,BAO_0000218,14045
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL626282,1,A,"Percentage biodistribution in mouse blood, 30 minutes post injection",Intermediate,,,1,14129,BAO_0000218,14045
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL626283,1,A,"Percentage biodistribution in mouse blood, 5 minutes post injection",Intermediate,,,1,14130,BAO_0000218,14045
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL626284,1,A,"Percentage biodistribution in mouse blood, 60 minutes post injection",Intermediate,,,1,14131,BAO_0000218,14045
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL626285,1,A,"Percentage biodistribution in mouse brain, 10 minutes post injection",Intermediate,,955.0,1,14132,BAO_0000218,14045
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL626286,1,A,"Percentage biodistribution in mouse brain, 30 minutes post injection",Intermediate,,955.0,1,14133,BAO_0000218,14045
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL626287,1,A,"Percentage biodistribution in mouse brain, 5 minutes post injection",Intermediate,,955.0,1,14134,BAO_0000218,14045
,10090.0,,Mus musculus,Brain,,,,N,,,50594,CHEMBL626288,1,A,"Percentage biodistribution in mouse brain, 60 minutes post injection",Intermediate,,955.0,1,14135,BAO_0000218,14045
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL626289,1,A,"Percentage biodistribution in mouse heart, 10 minutes post injection",Intermediate,,,1,14136,BAO_0000218,14045
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL626290,1,A,"Percentage biodistribution in mouse heart, 30 minutes post injection",Intermediate,,,1,14137,BAO_0000218,14045
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL626291,1,A,"Percentage biodistribution in mouse heart, 5 minutes post injection",Intermediate,,,1,14138,BAO_0000218,14045
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL839888,1,A,"Percentage biodistribution in mouse heart, 60 minutes post injection",Intermediate,,,1,14139,BAO_0000218,14045
,10090.0,,Mus musculus,Intestine,,,,N,,,50594,CHEMBL626292,1,A,"Percentage biodistribution in mouse intestine, 10 minutes post injection",Intermediate,,160.0,1,14140,BAO_0000218,14045
,10090.0,,Mus musculus,Intestine,,,,N,,,50594,CHEMBL626293,1,A,"Percentage biodistribution in mouse intestine, 30 minutes post injection",Intermediate,,160.0,1,14141,BAO_0000218,14045
,10090.0,,Mus musculus,Intestine,,,,N,,,50594,CHEMBL626294,1,A,"Percentage biodistribution in mouse intestine, 5 minutes post injection",Intermediate,,160.0,1,14142,BAO_0000218,14045
,10090.0,,Mus musculus,Intestine,,,,N,,,50594,CHEMBL626295,1,A,"Percentage biodistribution in mouse intestine, 60 minutes post injection",Intermediate,,160.0,1,14143,BAO_0000218,14045
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL627659,1,A,"Percentage biodistribution in mouse liver, 10 minutes post injection",Intermediate,,2107.0,1,14144,BAO_0000218,14045
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL627660,1,A,"Percentage biodistribution in mouse liver, 30 minutes of post injection",Intermediate,,2107.0,1,14145,BAO_0000218,14045
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL627661,1,A,"Percentage biodistribution in mouse liver, 5 minutes post injection",Intermediate,,2107.0,1,14146,BAO_0000218,14045
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL627662,1,A,Biodistribution in mice liver at 60 minutes of post injection,Intermediate,In vivo,2107.0,1,14147,BAO_0000218,14045
,10090.0,,Mus musculus,Lung,,,,N,,,50594,CHEMBL627663,1,A,Biodistribution in mice lungs at 10 min of post injection,Intermediate,In vivo,2048.0,1,14148,BAO_0000218,14045
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627664,1,A,"Percentage biodistribution in mouse lung, 30 minutes post injection",Intermediate,,,1,14149,BAO_0000218,14045
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL627665,1,A,"Percentage biodistribution in mousee lung, 5 minutes post injection",Intermediate,,,1,14150,BAO_0000218,14045
,10090.0,,Mus musculus,Lung,,,,N,,,50594,CHEMBL627666,1,A,Biodistribution in mice lungs at 60 min of post injection,Intermediate,In vivo,2048.0,1,14151,BAO_0000218,14045
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL627667,1,A,Percentage biodistribution in mouse spleen,Intermediate,,2106.0,1,14152,BAO_0000218,14045
,10090.0,,Mus musculus,Stomach,,,,N,,,50594,CHEMBL627668,1,A,Percentage biodistribution in mouse stomach,Intermediate,,945.0,1,14153,BAO_0000218,14045
,10090.0,,Mus musculus,Urine,,,,N,,,50594,CHEMBL627669,1,A,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,Intermediate,,1088.0,1,14154,BAO_0000218,11745
,,,,Urinary bladder,,,,U,,,22224,CHEMBL627670,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,Autocuration,In vivo,1255.0,0,14155,BAO_0000218,13257
,,,,Blood,,,,U,,,22224,CHEMBL627671,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,Autocuration,In vivo,178.0,0,14156,BAO_0000218,13257
,,,,Bone element,,,,U,,,22224,CHEMBL627672,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,Autocuration,In vivo,1474.0,0,14157,BAO_0000218,13257
,,,,,,,,U,,,22224,CHEMBL627673,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,Autocuration,In vivo,,0,14158,BAO_0000218,13257
,,,,Kidney,,,,U,,,22224,CHEMBL627674,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,Autocuration,In vivo,2113.0,0,14159,BAO_0000218,13257
,,,,Liver,,,,U,,,22224,CHEMBL627675,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,Autocuration,In vivo,2107.0,0,14160,BAO_0000218,13257
,,,,Lung,,,,U,,,22224,CHEMBL627676,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,Autocuration,In vivo,2048.0,0,14161,BAO_0000218,13257
,,,,Muscle tissue,,,,U,,,22224,CHEMBL627677,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,Autocuration,In vivo,2385.0,0,14162,BAO_0000218,13257
,,,,,,,,U,,,22224,CHEMBL627678,1,A,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,14163,BAO_0000019,8354
,10116.0,,Rattus norvegicus,Serum,,,,N,,,50597,CHEMBL627679,1,A,Affinity for protein binding expressed as association constant in fresh rat serum,Intermediate,,1977.0,1,14164,BAO_0000218,7095
,,,,,,,,U,,,22224,CHEMBL627680,1,A,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,Autocuration,,,0,14165,BAO_0000019,12185
,,,,,,,,U,,,22224,CHEMBL627681,1,A,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,Autocuration,,,0,14166,BAO_0000019,12185
,,,,,,,,U,,,22224,CHEMBL627682,1,A,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,Autocuration,,,0,14167,BAO_0000019,12185
,,,,,,,,U,,,22224,CHEMBL627683,1,A,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,Autocuration,,,0,14168,BAO_0000019,12185
,,,,,,,,U,,,22224,CHEMBL627684,1,A,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,Autocuration,,,0,14169,BAO_0000019,12686
,,,,,,,,U,,,22224,CHEMBL874441,1,A,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",Autocuration,,,0,14170,BAO_0000019,12686
,,,,,,,,U,,,22224,CHEMBL627685,1,A,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,Autocuration,,,0,14171,BAO_0000019,12686
,,,,,,,,U,,,22224,CHEMBL627686,1,A,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",Autocuration,,,0,14172,BAO_0000019,12686
,,,,,,,,U,,,22224,CHEMBL627687,1,A,Apparent rate constant Koff for inactivation of dTMP synthase.,Autocuration,,,0,14173,BAO_0000019,8057
,,,,,,,,U,,,22224,CHEMBL627688,1,A,The irreversible inhibitor activity by second order rate equation.,Autocuration,,,0,14174,BAO_0000019,15778
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628038,1,A,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,Intermediate,,,1,14175,BAO_0000218,12375
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628039,1,A,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,Intermediate,,,1,14176,BAO_0000218,12375
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628040,1,A,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,Intermediate,,,1,14177,BAO_0000218,12375
,,,,,,,,U,,,22224,CHEMBL628041,1,A,Dissociation rate calculated from the first-order equation using t1/2 value,Autocuration,,,0,14178,BAO_0000019,13588
,,,,,,,,U,,,22224,CHEMBL630226,1,A,The compound was tested for Binding constant against DNA,Autocuration,,,0,14179,BAO_0000019,15039
,,,,,,,,U,,,22224,CHEMBL628042,1,A,First order rate constant for cyclization of the compound,Autocuration,,,0,14180,BAO_0000019,9500
,,,,,,,,U,,,22224,CHEMBL625232,1,A,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,Autocuration,,,0,14181,BAO_0000019,10014
,,,,,,,,U,,,22224,CHEMBL625233,1,A,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,Autocuration,,,0,14182,BAO_0000019,10014
,,,,,,,,U,,,22224,CHEMBL625979,1,A,Hydrolysis rate constant was determined,Autocuration,,,0,14183,BAO_0000019,568
,,,,,,,,U,,,22224,CHEMBL625980,1,A,Observed first order rate constant,Autocuration,,,0,14184,BAO_0000019,10026
,,,,,,,,U,,,22224,CHEMBL625981,1,A,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,Autocuration,,,0,14185,BAO_0000019,10281
,,,,,,,,U,,,22224,CHEMBL625982,1,A,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,Autocuration,,,0,14186,BAO_0000019,10281
,,,,,,,,U,,,22224,CHEMBL625983,1,A,Second-order rate constant for attack on PNPA at 25 degree Centigrade,Autocuration,,,0,14187,BAO_0000019,9680
,,,,,,,,U,,,22224,CHEMBL625984,1,A,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14188,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL625985,1,A,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14189,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL625986,1,A,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14190,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL625987,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14191,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL625988,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14192,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL625989,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14193,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL625990,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14194,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL625991,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14195,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL625992,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14196,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL625993,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14197,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL631973,1,A,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14198,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL632143,1,A,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14199,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL632144,1,A,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14200,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL632145,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14201,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL632146,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14202,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL632147,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14203,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL632148,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14204,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL632149,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14205,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL632150,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14206,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL632151,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14207,BAO_0000019,13028
,9606.0,,Homo sapiens,,,,,N,,,50587,CHEMBL632152,1,A,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,Intermediate,,,1,14208,BAO_0000218,3008
,9606.0,,Homo sapiens,,,,,N,,,50587,CHEMBL632153,1,A,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,Intermediate,,,1,14209,BAO_0000218,4509
,9606.0,,Homo sapiens,,,,,N,,,50587,CHEMBL632154,1,A,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,Intermediate,,,1,14210,BAO_0000218,4509
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL632155,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,Intermediate,,,1,14211,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL632156,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,Intermediate,,,1,14212,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL632157,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,Intermediate,,,1,14213,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL632158,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,Intermediate,,,1,14214,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL632159,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,Intermediate,,,1,14215,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL626305,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,Intermediate,,,1,14216,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL626306,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,Intermediate,,,1,14217,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL626307,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,Intermediate,,,1,14218,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL626308,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,Intermediate,,,1,14219,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL626479,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,Intermediate,,,1,14220,BAO_0000218,8613
,10298.0,,Human herpesvirus 1,,,,,N,,,50602,CHEMBL626480,1,A,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,Intermediate,,,1,14221,BAO_0000218,8613
,,,,,,,,U,,,22229,CHEMBL626481,1,P,Calculated partition coefficient (clogP) (MlogP),Autocuration,,,0,14222,BAO_0000100,6021
,,,,,,,,U,,,22224,CHEMBL626482,1,A,Equipotent potent ratio relative to carbachol (nicotinic activity),Autocuration,,,0,14223,BAO_0000019,9348
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626483,1,A,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",Intermediate,,,1,14224,BAO_0000218,15592
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL626484,1,A,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",Intermediate,,,1,14225,BAO_0000218,15592
,,,,,,,,U,,,22229,CHEMBL626485,1,P,Solubility at pH 7.4 in micro g/mL;NA denotes available,Autocuration,,,0,14226,BAO_0000100,15592
,,,,,,,,U,,,22229,CHEMBL626486,1,P,Solubility at pH 7.4 in micro g/mL;NA denotes not available,Autocuration,,,0,14227,BAO_0000100,15592
,,,,,,,,U,,,22229,CHEMBL626487,1,P,Solubility at pH 7.4 in ug/mL;NA denotes not available,Autocuration,,,0,14228,BAO_0000100,15592
,9615.0,,Canis lupus familiaris,Plasma,,,,N,,,50588,CHEMBL626488,1,A,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Intermediate,In vivo,1969.0,1,14229,BAO_0000218,15592
,10116.0,,Rattus norvegicus,Serum,,,,N,,,50597,CHEMBL626489,1,A,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,Intermediate,,1977.0,1,14230,BAO_0000218,7095
,,,,,,,,U,,,22224,CHEMBL626490,1,A,Area under the MAP curve measured over 5 min; ND means Not determined,Autocuration,,,0,14231,BAO_0000019,16618
,,,,,,,,U,,,22224,CHEMBL626491,1,P,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,Autocuration,,,0,14232,BAO_0000100,16835
,,,,,,,,U,,,22229,CHEMBL626492,1,P,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,Autocuration,,,0,14233,BAO_0000100,15284
,,,,,,,,U,,,22224,CHEMBL626493,1,A,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,Autocuration,,,0,14234,BAO_0000019,15750
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626494,1,A,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,Intermediate,In vivo,,1,14235,BAO_0000218,16618
,,,,,,,,U,,,22224,CHEMBL626495,1,A,Half life after oral tested,Autocuration,In vivo,,0,14236,BAO_0000218,16618
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626496,1,A,Half life was determined in plasma of rat; NT indicates not tested,Intermediate,,1969.0,1,14237,BAO_0000218,15812
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626497,1,A,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,Intermediate,In vivo,,1,14238,BAO_0000218,16618
,,,,,,,,U,,,22224,CHEMBL626498,1,A,Oral bioavailability after oral tested,Autocuration,In vivo,,0,14239,BAO_0000218,16618
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626499,1,A,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),Intermediate,,,1,14240,BAO_0000218,13098
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626500,1,A,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),Intermediate,,,1,14241,BAO_0000218,13098
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626501,1,A,half life was determined in plasma of rat; NT indicates not tested,Intermediate,,1969.0,1,14242,BAO_0000218,15812
,10116.0,,Rattus norvegicus,Plasma,,,,N,,,50597,CHEMBL626502,1,A,half life was determined in plasma of rat; NT means not tested,Intermediate,,1969.0,1,14243,BAO_0000218,15812
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626503,1,A,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,Intermediate,,,1,14244,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626504,1,A,Mean sodium excretion in rats (Control/Drug treatment value); inactive,Intermediate,,,1,14245,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626505,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,Intermediate,,,1,14246,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626506,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,Intermediate,,,1,14247,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626507,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,Intermediate,,,1,14248,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626508,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,Intermediate,,,1,14249,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626509,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,Intermediate,,,1,14250,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875480,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,Intermediate,,,1,14251,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626510,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,Intermediate,,,1,14252,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626511,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,Intermediate,,,1,14253,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL626512,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,Intermediate,,,1,14254,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628208,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,Intermediate,,,1,14255,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628209,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,Intermediate,,,1,14256,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628210,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,Intermediate,,,1,14257,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628211,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,Intermediate,,,1,14258,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628212,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,Intermediate,,,1,14259,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628213,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,Intermediate,,,1,14260,BAO_0000218,11510
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628214,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,Intermediate,,1088.0,1,14261,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628215,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,Intermediate,,1088.0,1,14262,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628216,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,Intermediate,,1088.0,1,14263,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626595,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,Intermediate,,1088.0,1,14264,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626596,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,Intermediate,,1088.0,1,14265,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626597,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,Intermediate,,1088.0,1,14266,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626598,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,Intermediate,,1088.0,1,14267,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL622242,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,Intermediate,,1088.0,1,14268,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL622243,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,Intermediate,,1088.0,1,14269,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL622244,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,Intermediate,,1088.0,1,14270,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL622245,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,Intermediate,,1088.0,1,14271,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL622246,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,Intermediate,,1088.0,1,14272,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL622247,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,Intermediate,,1088.0,1,14273,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL622248,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,Intermediate,,1088.0,1,14274,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL877483,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,Intermediate,,1088.0,1,14275,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL622249,1,A,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,Intermediate,,1088.0,1,14276,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622250,1,A,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Intermediate,,1088.0,1,14277,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622251,1,A,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Intermediate,,1088.0,1,14278,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622252,1,A,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Intermediate,,1088.0,1,14279,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622253,1,A,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Intermediate,,1088.0,1,14280,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622254,1,A,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Intermediate,,1088.0,1,14281,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622255,1,A,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Intermediate,,1088.0,1,14282,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622256,1,A,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Intermediate,,1088.0,1,14283,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622257,1,A,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Intermediate,,1088.0,1,14284,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622258,1,A,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Intermediate,,1088.0,1,14285,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622259,1,A,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Intermediate,,1088.0,1,14286,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622927,1,A,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Intermediate,,1088.0,1,14287,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622928,1,A,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Intermediate,,1088.0,1,14288,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL622929,1,A,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Intermediate,,1088.0,1,14289,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL623182,1,A,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Intermediate,,1088.0,1,14290,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL623183,1,A,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Intermediate,,1088.0,1,14291,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623184,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,Intermediate,,1088.0,1,14292,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623185,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Intermediate,,1088.0,1,14293,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL877484,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Intermediate,,1088.0,1,14294,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL627274,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Intermediate,,1088.0,1,14295,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623186,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,Intermediate,,1088.0,1,14296,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623187,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,Intermediate,,1088.0,1,14297,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL623188,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Intermediate,,1088.0,1,14298,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628055,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,Intermediate,,1088.0,1,14299,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628056,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Intermediate,,1088.0,1,14300,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628200,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,Intermediate,,1088.0,1,14301,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628201,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Intermediate,,1088.0,1,14302,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628202,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,Intermediate,,1088.0,1,14303,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628203,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Intermediate,,1088.0,1,14304,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628204,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,Intermediate,,1088.0,1,14305,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628205,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Intermediate,,1088.0,1,14306,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628206,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,Intermediate,,1088.0,1,14307,BAO_0000218,12582
,,,,Prostate gland,,,,U,,,22224,CHEMBL628207,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),Autocuration,In vivo,2367.0,0,14308,BAO_0000218,13257
,,,,Prostate gland,,,,U,,,22224,CHEMBL627220,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,Autocuration,In vivo,2367.0,0,14309,BAO_0000218,13257
,,,,Muscle tissue,,,,U,,,22224,CHEMBL627221,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,Autocuration,In vivo,2385.0,0,14310,BAO_0000218,13257
,,,,Prostate gland,,,,U,,,22224,CHEMBL627222,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),Autocuration,In vivo,2367.0,0,14311,BAO_0000218,13257
,,,,,,,,U,,,22224,CHEMBL627223,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,Autocuration,In vivo,,0,14312,BAO_0000218,13257
,,,,Muscle tissue,,,,U,,,22224,CHEMBL632062,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,Autocuration,In vivo,2385.0,0,14313,BAO_0000218,13257
,,,,Spleen,,,,U,,,22224,CHEMBL632063,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,Autocuration,In vivo,2106.0,0,14314,BAO_0000218,13257
,,,,Urinary bladder,,,,U,,,22224,CHEMBL632064,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,Autocuration,In vivo,1255.0,0,14315,BAO_0000218,13257
,,,,Blood,,,,U,,,22224,CHEMBL632065,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,Autocuration,In vivo,178.0,0,14316,BAO_0000218,13257
,,,,Bone element,,,,U,,,22224,CHEMBL632066,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,Autocuration,In vivo,1474.0,0,14317,BAO_0000218,13257
,,,,,,,,U,,,22224,CHEMBL632067,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,Autocuration,In vivo,,0,14318,BAO_0000218,13257
,,,,Kidney,,,,U,,,22224,CHEMBL629188,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,Autocuration,In vivo,2113.0,0,14319,BAO_0000218,13257
,,,,Liver,,,,U,,,22224,CHEMBL629189,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,Autocuration,In vivo,2107.0,0,14320,BAO_0000218,13257
,,,,Lung,,,,U,,,22224,CHEMBL629190,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,Autocuration,In vivo,2048.0,0,14321,BAO_0000218,13257
,,,,Muscle tissue,,,,U,,,22224,CHEMBL629191,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,Autocuration,In vivo,2385.0,0,14322,BAO_0000218,13257
,,,,Prostate gland,,,,U,,,22224,CHEMBL629192,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),Autocuration,In vivo,2367.0,0,14323,BAO_0000218,13257
,,,,Muscle tissue,,,,U,,,22224,CHEMBL629193,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,Autocuration,In vivo,2385.0,0,14324,BAO_0000218,13257
,,,,Prostate gland,,,,U,,,22224,CHEMBL629194,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),Autocuration,In vivo,2367.0,0,14325,BAO_0000218,13257
,,,,,,,,U,,,22224,CHEMBL629195,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,Autocuration,In vivo,,0,14326,BAO_0000218,13257
,,,,Muscle tissue,,,,U,,,22224,CHEMBL629373,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,Autocuration,In vivo,2385.0,0,14327,BAO_0000218,13257
,,,,Spleen,,,,U,,,22224,CHEMBL629374,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,Autocuration,In vivo,2106.0,0,14328,BAO_0000218,13257
,,,,Prostate gland,,,,U,,,22224,CHEMBL629375,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,Autocuration,In vivo,2367.0,0,14329,BAO_0000218,13257
,,,,Urinary bladder,,,,U,,,22224,CHEMBL629376,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,Autocuration,In vivo,1255.0,0,14330,BAO_0000218,13257
,,,,Blood,,,,U,,,22224,CHEMBL629377,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,Autocuration,In vivo,178.0,0,14331,BAO_0000218,13257
,,,,Bone element,,,,U,,,22224,CHEMBL629378,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,Autocuration,In vivo,1474.0,0,14332,BAO_0000218,13257
,,,,,,,,U,,,22224,CHEMBL629379,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,Autocuration,In vivo,,0,14333,BAO_0000218,13257
,,,,Kidney,,,,U,,,22224,CHEMBL629151,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,Autocuration,In vivo,2113.0,0,14334,BAO_0000218,13257
,,,,Liver,,,,U,,,22224,CHEMBL629152,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,Autocuration,In vivo,2107.0,0,14335,BAO_0000218,13257
,,,,Lung,,,,U,,,22224,CHEMBL629153,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,Autocuration,In vivo,2048.0,0,14336,BAO_0000218,13257
,,,,Muscle tissue,,,,U,,,22224,CHEMBL629154,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,Autocuration,In vivo,2385.0,0,14337,BAO_0000218,13257
,,,,Prostate gland,,,,U,,,22224,CHEMBL629155,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),Autocuration,In vivo,2367.0,0,14338,BAO_0000218,13257
,,,,Prostate gland,,,,U,,,22224,CHEMBL629156,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,Autocuration,In vivo,2367.0,0,14339,BAO_0000218,13257
,,,,Muscle tissue,,,,U,,,22224,CHEMBL629157,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,Autocuration,In vivo,2385.0,0,14340,BAO_0000218,13257
,,,,Prostate gland,,,,U,,,22224,CHEMBL629158,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),Autocuration,In vivo,2367.0,0,14341,BAO_0000218,13257
,,,,,,,,U,,,22224,CHEMBL629159,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,Autocuration,In vivo,,0,14342,BAO_0000218,13257
,,,,Muscle tissue,,,,U,,,22224,CHEMBL629160,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,Autocuration,In vivo,2385.0,0,14343,BAO_0000218,13257
,,,,Spleen,,,,U,,,22224,CHEMBL629161,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,Autocuration,In vivo,2106.0,0,14344,BAO_0000218,13257
,,,,Urinary bladder,,,,U,,,22224,CHEMBL629162,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,Autocuration,In vivo,1255.0,0,14345,BAO_0000218,13257
,,,,Blood,,,,U,,,22224,CHEMBL629163,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,Autocuration,In vivo,178.0,0,14346,BAO_0000218,13257
,,,,Bone element,,,,U,,,22224,CHEMBL629164,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,Autocuration,In vivo,1474.0,0,14347,BAO_0000218,13257
,,,,,,,,U,,,22224,CHEMBL629165,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,Autocuration,In vivo,,0,14348,BAO_0000218,13257
,,,,Liver,,,,U,,,22224,CHEMBL629166,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,Autocuration,In vivo,2107.0,0,14349,BAO_0000218,13257
,,,,Lung,,,,U,,,22224,CHEMBL629167,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,Autocuration,In vivo,2048.0,0,14350,BAO_0000218,13257
,,,,Muscle tissue,,,,U,,,22224,CHEMBL629168,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,Autocuration,In vivo,2385.0,0,14351,BAO_0000218,13257
,,,,,,,,U,,,22224,CHEMBL629169,1,A,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,Autocuration,,,0,14352,BAO_0000019,2193
,,,,,,,,U,,,22224,CHEMBL629170,1,A,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,Autocuration,,,0,14353,BAO_0000019,2193
,,,,,,,,U,,,22224,CHEMBL631153,1,A,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,Autocuration,,,0,14354,BAO_0000019,2193
,,,,,,,,U,,,22224,CHEMBL875121,1,A,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,Autocuration,,,0,14355,BAO_0000019,2193
,,,,,,,,U,,,22224,CHEMBL631154,1,A,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,Autocuration,,,0,14356,BAO_0000019,2193
,,,,,,,,U,,,22224,CHEMBL631155,1,A,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,Autocuration,,,0,14357,BAO_0000019,2193
,,,,,,,,U,,,22224,CHEMBL631156,1,A,Hydrolysis rate constant was determined,Autocuration,,,0,14358,BAO_0000019,568
,,,,,,,,U,,,22224,CHEMBL631157,1,A,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",Autocuration,,,0,14359,BAO_0000019,9680
,,,,,,,,U,,,22224,CHEMBL631158,1,A,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",Autocuration,,,0,14360,BAO_0000019,9680
,,,,,,,,U,,,22224,CHEMBL631159,1,A,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",Autocuration,,,0,14361,BAO_0000019,9680
,,,,,,,,U,,,22224,CHEMBL631160,1,A,Observed second order rate constant,Autocuration,,,0,14362,BAO_0000019,10026
,,,,,,,,U,,,22224,CHEMBL631161,1,A,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,Autocuration,,,0,14363,BAO_0000019,10281
,,,,,,,,U,,,22224,CHEMBL631162,1,A,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,Autocuration,,,0,14364,BAO_0000019,10014
,,,,,,,,U,,,22224,CHEMBL630313,1,A,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,Autocuration,,,0,14365,BAO_0000019,10014
,,,,,,,,U,,,22224,CHEMBL630314,1,A,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",Autocuration,,,0,14366,BAO_0000019,9680
,,,,,,,,U,,,22224,CHEMBL630315,1,A,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",Autocuration,,,0,14367,BAO_0000019,9680
,,,,,,,,U,,,22224,CHEMBL630316,1,A,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14368,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL630986,1,A,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14369,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL630987,1,A,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14370,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL630988,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14371,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL630989,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14372,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL630990,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14373,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL630991,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14374,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL630992,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14375,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL630993,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14376,BAO_0000019,13028
,,,,,,,,U,,,22224,CHEMBL630994,1,A,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,Autocuration,,,0,14377,BAO_0000019,13028
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630995,1,A,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,Intermediate,,,1,14378,BAO_0000218,10014
,,,,,,,,U,,,22224,CHEMBL629252,1,A,Association constant for compound at 31 degree C was determined,Autocuration,,,0,14379,BAO_0000019,9962
,,,,,,,,U,,,22224,CHEMBL629253,1,A,Calculated antagonist equilibrium dissociation constant of the compound,Autocuration,,,0,14380,BAO_0000019,12029
,,,,,,,,U,,,22224,CHEMBL629944,1,A,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,Autocuration,,,0,14381,BAO_0000019,12029
,10141.0,,Cavia porcellus,Trachea,,,,N,,,50512,CHEMBL629945,1,A,Dissociation constants vs LTE4 on guinea pig trachea,Intermediate,,3126.0,1,14382,BAO_0000218,10583
,,,,,,,,U,,,22224,CHEMBL629946,1,A,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",Autocuration,,,0,14383,BAO_0000019,568
,,,,,,,,U,,,22224,CHEMBL629947,1,A,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",Autocuration,,,0,14384,BAO_0000019,568
,,,,,,,,U,,,22224,CHEMBL629948,1,A,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",Autocuration,,,0,14385,BAO_0000019,568
,,,,,,,,U,,,22224,CHEMBL856024,1,A,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",Autocuration,,,0,14386,BAO_0000019,568
,,,,,,,,U,,,22224,CHEMBL629949,1,A,Affinity constant KD value was derived from TMP,Autocuration,,,0,14387,BAO_0000019,7493
,,,,,,,,U,,,22224,CHEMBL629950,1,A,Apparent dissociation (binding) rate constant was evaluated,Autocuration,,,0,14388,BAO_0000019,8371
,,,,,,,,U,,,22224,CHEMBL630127,1,P,Dissociation constant (KD) of the compound,Autocuration,,,0,14389,BAO_0000100,13114
,,,,,,,,U,,,22224,CHEMBL630128,1,P,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,Autocuration,,,0,14390,BAO_0000100,15515
,,,,,,,,U,,,22224,CHEMBL630129,1,P,Dissociation constant from ESR titration experiments,Autocuration,,,0,14391,BAO_0000100,522
,,,,,,,,U,,,22224,CHEMBL630130,1,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),Autocuration,,,0,14392,BAO_0000019,13888
,,,,,,,,U,,,22224,CHEMBL875234,1,P,Dissociation constant was evaluated.,Autocuration,,,0,14393,BAO_0000100,2616
,,,,,,,,U,,,22224,CHEMBL630131,1,P,Dissociation constant was reported,Autocuration,,,0,14394,BAO_0000100,3798
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630132,1,A,Dissociation constant was determined in rat pituitary cells.,Intermediate,,,1,14395,BAO_0000218,8731
,,,,,,,,U,,,22224,CHEMBL630133,1,A,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,Autocuration,,,0,14396,BAO_0000019,11892
,,,,,,,,U,,,22224,CHEMBL630134,1,A,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,Autocuration,,,0,14397,BAO_0000019,11892
,,,,,,,,U,,,22224,CHEMBL630135,1,A,Equilibrium dissociation constant of the compound,Autocuration,,,0,14398,BAO_0000019,2582
,,,,,,,,U,,,22224,CHEMBL630136,1,A,Equilibrium dissociation constant was determined,Autocuration,,,0,14399,BAO_0000019,11892
,,,,,,,,U,,,22224,CHEMBL630137,1,A,Kinetic constant KD was evaluated,Autocuration,,,0,14400,BAO_0000019,13396
,,,,,,,,U,,,22224,CHEMBL630138,1,A,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,Autocuration,,,0,14401,BAO_0000019,603
,,,,,,,,U,,,22224,CHEMBL630139,1,A,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,Autocuration,,,0,14402,BAO_0000019,15673
,,,,,,,,U,,,22224,CHEMBL630140,1,A,Rate constant for hydrolysis in aqueous acetone.,Autocuration,,,0,14403,BAO_0000019,10368
,,,,,,,,U,,,22224,CHEMBL875235,1,A,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,Autocuration,,,0,14404,BAO_0000019,14228
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876439,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,Intermediate,,,1,14405,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630605,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,Intermediate,,,1,14406,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630606,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,Intermediate,,,1,14407,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630607,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,Intermediate,,,1,14408,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630608,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,Intermediate,,,1,14409,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630609,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,Intermediate,,,1,14410,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630610,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,Intermediate,,,1,14411,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630611,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,Intermediate,,,1,14412,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629552,1,A,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,Intermediate,,,1,14413,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629733,1,A,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Intermediate,,,1,14414,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629734,1,A,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Intermediate,,,1,14415,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629735,1,A,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Intermediate,,,1,14416,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629736,1,A,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Intermediate,,,1,14417,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629737,1,A,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Intermediate,,,1,14418,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629738,1,A,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Intermediate,,,1,14419,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629739,1,A,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Intermediate,,,1,14420,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629740,1,A,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Intermediate,,,1,14421,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629741,1,A,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Intermediate,,,1,14422,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629742,1,A,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Intermediate,,,1,14423,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629743,1,A,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Intermediate,,,1,14424,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629744,1,A,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Intermediate,,,1,14425,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629745,1,A,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Intermediate,,,1,14426,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629746,1,A,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Intermediate,,,1,14427,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629747,1,A,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Intermediate,,,1,14428,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629748,1,A,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Intermediate,,,1,14429,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629749,1,A,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Intermediate,,,1,14430,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629750,1,A,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Intermediate,,,1,14431,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629751,1,A,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Intermediate,,,1,14432,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629752,1,A,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Intermediate,,,1,14433,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629753,1,A,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Intermediate,,,1,14434,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629754,1,A,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Intermediate,,,1,14435,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629755,1,A,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Intermediate,,,1,14436,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629756,1,A,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Intermediate,,,1,14437,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629757,1,A,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Intermediate,,,1,14438,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629758,1,A,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Intermediate,,,1,14439,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629759,1,A,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Intermediate,,,1,14440,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL629760,1,A,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Intermediate,,,1,14441,BAO_0000218,11510
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876443,1,A,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Intermediate,,,1,14442,BAO_0000218,11510
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL629761,1,A,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,Intermediate,,,1,14443,BAO_0000218,8310
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL629762,1,A,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,Intermediate,,,1,14444,BAO_0000218,8310
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629763,1,A,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Intermediate,,,1,14445,BAO_0000218,8310
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629764,1,A,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Intermediate,,,1,14446,BAO_0000218,8310
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629765,1,A,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Intermediate,,,1,14447,BAO_0000218,8310
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629766,1,A,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,Intermediate,,,1,14448,BAO_0000218,8310
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629767,1,A,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Intermediate,,,1,14449,BAO_0000218,8310
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL629768,1,A,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,Intermediate,,,1,14450,BAO_0000218,8310
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629769,1,A,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,Intermediate,,,1,14451,BAO_0000218,8310
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL629770,1,A,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,Intermediate,,,1,14452,BAO_0000218,8310
,9615.0,,Canis lupus familiaris,,,,,N,,,50588,CHEMBL629771,1,A,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,Intermediate,,,1,14453,BAO_0000218,8310
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629772,1,A,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Intermediate,,,1,14454,BAO_0000218,8310
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL629773,1,A,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Intermediate,,,1,14455,BAO_0000218,8310
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625455,1,A,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Intermediate,,,1,14456,BAO_0000218,8310
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625456,1,A,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,Intermediate,,,1,14457,BAO_0000218,8310
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL625457,1,A,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,Intermediate,,,1,14458,BAO_0000218,8310
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL625458,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Intermediate,,1088.0,1,14459,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL625459,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,Intermediate,,1088.0,1,14460,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL875483,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Intermediate,,1088.0,1,14461,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL634779,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,Intermediate,,1088.0,1,14462,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL625460,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,Intermediate,,1088.0,1,14463,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626117,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Intermediate,,1088.0,1,14464,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626118,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,Intermediate,,1088.0,1,14465,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628342,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,Intermediate,,1088.0,1,14466,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628343,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Intermediate,,1088.0,1,14467,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628344,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,Intermediate,,1088.0,1,14468,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628345,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Intermediate,,1088.0,1,14469,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628346,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,Intermediate,,1088.0,1,14470,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628347,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,Intermediate,,1088.0,1,14471,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628348,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Intermediate,,1088.0,1,14472,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628349,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Intermediate,,1088.0,1,14473,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL875611,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,Intermediate,,1088.0,1,14474,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628350,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,Intermediate,,1088.0,1,14475,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628351,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Intermediate,,1088.0,1,14476,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628352,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,Intermediate,,1088.0,1,14477,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628353,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Intermediate,,1088.0,1,14478,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628354,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,Intermediate,,1088.0,1,14479,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626667,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Intermediate,,1088.0,1,14480,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626668,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Intermediate,,1088.0,1,14481,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626669,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Intermediate,,1088.0,1,14482,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626670,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,Intermediate,,1088.0,1,14483,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626671,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,Intermediate,,1088.0,1,14484,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626672,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Intermediate,,1088.0,1,14485,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626673,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,Intermediate,,1088.0,1,14486,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626674,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Intermediate,,1088.0,1,14487,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626675,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Intermediate,,1088.0,1,14488,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626676,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,Intermediate,,1088.0,1,14489,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626677,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,Intermediate,,1088.0,1,14490,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626678,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Intermediate,,1088.0,1,14491,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626679,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Intermediate,,1088.0,1,14492,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL875612,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Intermediate,,1088.0,1,14493,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626680,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Intermediate,,1088.0,1,14494,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626681,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Intermediate,,1088.0,1,14495,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626682,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Intermediate,,1088.0,1,14496,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626683,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Intermediate,,1088.0,1,14497,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626684,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Intermediate,,1088.0,1,14498,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626685,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Intermediate,,1088.0,1,14499,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626686,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Intermediate,,1088.0,1,14500,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626687,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Intermediate,,1088.0,1,14501,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL624978,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Intermediate,,1088.0,1,14502,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL624979,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Intermediate,,1088.0,1,14503,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL624980,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Intermediate,,1088.0,1,14504,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL624981,1,A,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Intermediate,,1088.0,1,14505,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL624982,1,A,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Intermediate,,1088.0,1,14506,BAO_0000218,12582
,,,,Prostate gland,,,,U,,,22224,CHEMBL627564,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),Autocuration,In vivo,2367.0,0,14507,BAO_0000218,13257
,,,,Prostate gland,,,,U,,,22224,CHEMBL627565,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),Autocuration,In vivo,2367.0,0,14508,BAO_0000218,13257
,,,,,,,,U,,,22224,CHEMBL627566,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,Autocuration,In vivo,,0,14509,BAO_0000218,13257
,,,,Muscle tissue,,,,U,,,22224,CHEMBL627567,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,Autocuration,In vivo,2385.0,0,14510,BAO_0000218,13257
,,,,Spleen,,,,U,,,22224,CHEMBL627568,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,Autocuration,In vivo,2106.0,0,14511,BAO_0000218,13257
,,,,Kidney,,,,U,,,22224,CHEMBL627569,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,Autocuration,In vivo,2113.0,0,14512,BAO_0000218,13257
,,,,Urinary bladder,,,,U,,,22224,CHEMBL627570,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,Autocuration,In vivo,1255.0,0,14513,BAO_0000218,13257
,,,,Blood,,,,U,,,22224,CHEMBL627571,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,Autocuration,In vivo,178.0,0,14514,BAO_0000218,13257
,,,,Bone element,,,,U,,,22224,CHEMBL627572,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,Autocuration,In vivo,1474.0,0,14515,BAO_0000218,13257
,,,,,,,,U,,,22224,CHEMBL627573,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,Autocuration,In vivo,,0,14516,BAO_0000218,13257
,,,,Kidney,,,,U,,,22224,CHEMBL627574,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,Autocuration,In vivo,2113.0,0,14517,BAO_0000218,13257
,,,,Liver,,,,U,,,22224,CHEMBL627575,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,Autocuration,In vivo,2107.0,0,14518,BAO_0000218,13257
,,,,Lung,,,,U,,,22224,CHEMBL627576,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,Autocuration,In vivo,2048.0,0,14519,BAO_0000218,13257
,,,,Muscle tissue,,,,U,,,22224,CHEMBL627577,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,Autocuration,In vivo,2385.0,0,14520,BAO_0000218,13257
,,,,Prostate gland,,,,U,,,22224,CHEMBL627578,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),Autocuration,In vivo,2367.0,0,14521,BAO_0000218,13257
,,,,Prostate gland,,,,U,,,22224,CHEMBL627579,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,Autocuration,In vivo,2367.0,0,14522,BAO_0000218,13257
,,,,Muscle tissue,,,,U,,,22224,CHEMBL627580,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,Autocuration,In vivo,2385.0,0,14523,BAO_0000218,13257
,,,,Prostate gland,,,,U,,,22224,CHEMBL627581,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),Autocuration,In vivo,2367.0,0,14524,BAO_0000218,13257
,,,,,,,,U,,,22224,CHEMBL627582,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,Autocuration,In vivo,,0,14525,BAO_0000218,13257
,,,,Muscle tissue,,,,U,,,22224,CHEMBL627583,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,Autocuration,In vivo,2385.0,0,14526,BAO_0000218,13257
,,,,Spleen,,,,U,,,22224,CHEMBL627584,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,Autocuration,In vivo,2106.0,0,14527,BAO_0000218,13257
,,,,Prostate gland,,,,U,,,22224,CHEMBL627585,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,Autocuration,In vivo,2367.0,0,14528,BAO_0000218,13257
,,,,Muscle tissue,,,,U,,,22224,CHEMBL627586,1,A,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,Autocuration,In vivo,2385.0,0,14529,BAO_0000218,13257
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627587,1,A,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,Intermediate,In vivo,,1,14530,BAO_0000218,15413
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL627588,1,A,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,In vivo,,1,14531,BAO_0000218,15413
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628250,1,A,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,Intermediate,In vivo,,1,14532,BAO_0000218,15413
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628251,1,A,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,In vivo,,1,14533,BAO_0000218,15413
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL628252,1,A,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,Intermediate,In vivo,10000000.0,1,14534,BAO_0000218,15413
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL628253,1,A,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,In vivo,10000000.0,1,14535,BAO_0000218,15413
,10116.0,,Rattus norvegicus,Hypothalamus,,,,N,,,50597,CHEMBL628254,1,A,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,Intermediate,In vivo,1898.0,1,14536,BAO_0000218,15413
,10116.0,,Rattus norvegicus,Hypothalamus,,,,N,,,50597,CHEMBL877493,1,A,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,In vivo,1898.0,1,14537,BAO_0000218,15413
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628255,1,A,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,In vivo,,1,14538,BAO_0000218,15413
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628256,1,A,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,In vivo,,1,14539,BAO_0000218,15413
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL628257,1,A,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,In vivo,10000000.0,1,14540,BAO_0000218,15413
,10116.0,,Rattus norvegicus,Hypothalamus,,,,N,,,50597,CHEMBL628258,1,A,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,In vivo,1898.0,1,14541,BAO_0000218,15413
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628259,1,A,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,In vivo,,1,14542,BAO_0000218,15413
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628429,1,A,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,In vivo,,1,14543,BAO_0000218,15413
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL626862,1,A,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Intermediate,In vivo,10000000.0,1,14544,BAO_0000218,15413
,10116.0,,Rattus norvegicus,Hypothalamus,,,,N,,,50597,CHEMBL626863,1,A,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,Intermediate,In vivo,1898.0,1,14545,BAO_0000218,15413
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL625886,1,A,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,Intermediate,In vivo,2037.0,1,14546,BAO_0000218,15413
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL625887,1,A,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,Intermediate,In vivo,2037.0,1,14547,BAO_0000218,15413
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625888,1,A,Biodistribution of the [11C]-radiolabeled compound in rat cortex,Intermediate,In vivo,,1,14548,BAO_0000218,15413
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625889,1,A,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,Intermediate,In vivo,,1,14549,BAO_0000218,15413
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL625890,1,A,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,Intermediate,In vivo,10000000.0,1,14550,BAO_0000218,15413
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL625891,1,A,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,Intermediate,In vivo,10000000.0,1,14551,BAO_0000218,15413
,10116.0,,Rattus norvegicus,Hypothalamus,,,,N,,,50597,CHEMBL625892,1,A,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,Intermediate,In vivo,1898.0,1,14552,BAO_0000218,15413
,10116.0,,Rattus norvegicus,Hypothalamus,,,,N,,,50597,CHEMBL625893,1,A,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,Intermediate,In vivo,1898.0,1,14553,BAO_0000218,15413
,10116.0,,Rattus norvegicus,Cerebellum,,,,N,,,50597,CHEMBL625894,1,A,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,Intermediate,In vivo,2037.0,1,14554,BAO_0000218,15413
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625895,1,A,Biodistribution of the [18F]-radiolabeled compound in rat cortex,Intermediate,In vivo,,1,14555,BAO_0000218,15413
,,,,,,,,U,,,22224,CHEMBL625896,1,A,Reaction rate parameter value for phosphate with transfer with respect to ATP,Autocuration,,,0,14556,BAO_0000019,12404
,,,,,,,,U,,,22224,CHEMBL625897,1,A,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",Autocuration,,,0,14557,BAO_0000019,568
,,,,,,,,U,,,22224,CHEMBL625898,1,A,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",Autocuration,,,0,14558,BAO_0000019,568
,,,,,,,,U,,,22224,CHEMBL625899,1,A,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",Autocuration,,,0,14559,BAO_0000019,568
,,,,,,,,U,,,22224,CHEMBL626124,1,A,Reaction rate parameter value for phosphate with transfer with respect to ATP,Autocuration,,,0,14560,BAO_0000019,12404
,562.0,,Escherichia coli,,,,,N,,,50212,CHEMBL628500,1,A,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,Intermediate,,,1,14561,BAO_0000218,7624
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL857856,1,A,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",Intermediate,,,1,14562,BAO_0000218,7624
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628501,1,A,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",Intermediate,,,1,14563,BAO_0000218,7624
,,,,,,,,U,,,22224,CHEMBL628502,1,A,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",Autocuration,,,0,14564,BAO_0000019,4643
,,,,,,,,U,,,22224,CHEMBL628503,1,A,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,Autocuration,,,0,14565,BAO_0000019,11532
,,,,,,,,U,,,22224,CHEMBL628504,1,A,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,Autocuration,,,0,14566,BAO_0000019,11018
,,,,,,,,U,,,22224,CHEMBL628505,1,A,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",Autocuration,,,0,14567,BAO_0000019,2276
,,,,,,,,U,,,22224,CHEMBL874452,1,A,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",Autocuration,,,0,14568,BAO_0000019,2276
,,,,,,,,U,,,22224,CHEMBL628506,1,A,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",Autocuration,,,0,14569,BAO_0000019,2276
,,,,,,,,U,,,22224,CHEMBL628507,1,A,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",Autocuration,,,0,14570,BAO_0000019,2276
,,,,,,,,U,,,22224,CHEMBL628508,1,A,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",Autocuration,,,0,14571,BAO_0000019,2276
,,,,,,,,U,,,22224,CHEMBL628509,1,A,Michaelis constant (KM) was evaluated,Autocuration,,,0,14572,BAO_0000019,8949
,,,,,,,,U,,,22224,CHEMBL628510,1,A,Reaction rate parameter value for phosphate with transfer with respect to ATP,Autocuration,,,0,14573,BAO_0000019,12404
,,,,,,,,U,,,22224,CHEMBL628511,1,B,Substrate concentration for half maximal velocity was reported for rat hexokinase I,Autocuration,,,0,14574,BAO_0000019,7625
,,,,,,,,U,,,22224,CHEMBL628512,1,B,Substrate concentration for half maximal velocity was reported for rat hexokinase II,Autocuration,,,0,14575,BAO_0000019,7625
,,,,,,,,U,,,22224,CHEMBL628513,1,B,Substrate concentration for half maximal velocity was reported for rat hexokinase III,Autocuration,,,0,14576,BAO_0000019,7625
,,,,,,,,U,,,22224,CHEMBL628514,1,B,Substrate concentration for half maximal velocity was reported for yeast hexokinase,Autocuration,,,0,14577,BAO_0000019,7625
,,,,,,,,U,,,22224,CHEMBL628515,1,A,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,Autocuration,,,0,14578,BAO_0000019,12908
,,,,,,,,U,,,22224,CHEMBL628516,1,A,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,Autocuration,,,0,14579,BAO_0000019,10368
,,,,,,,,U,,,22224,CHEMBL628517,1,A,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),Autocuration,,,0,14580,BAO_0000019,13108
,,,,,,,,U,,,22224,CHEMBL628518,1,A,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),Autocuration,,,0,14581,BAO_0000019,13108
,,,,,,,,U,,,22224,CHEMBL628519,1,A,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,Autocuration,,,0,14582,BAO_0000019,15217
,,,,,,,,U,,,22224,CHEMBL628520,1,A,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,Autocuration,,,0,14583,BAO_0000019,15217
,,,,,,,,U,,,22224,CHEMBL628521,1,A,Binding constant was determined,Autocuration,,,0,14584,BAO_0000019,10933
,,,,,,,,U,,,22224,CHEMBL630443,1,A,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,Autocuration,,,0,14585,BAO_0000019,2363
,,,,,,,,U,,,22224,CHEMBL630444,1,A,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,Autocuration,,,0,14586,BAO_0000019,2363
,,,,,,,,U,,,22224,CHEMBL857732,1,A,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,Autocuration,,,0,14587,BAO_0000019,2276
,,,,,,,,U,,,22224,CHEMBL630445,1,P,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,Autocuration,,,0,14588,BAO_0000100,14915
,,,,,,,,U,,,22224,CHEMBL630446,1,A,Catalytic rate constant of the compound,Autocuration,,,0,14589,BAO_0000019,8847
,,,,,,,,U,,,22224,CHEMBL630447,1,B,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,Autocuration,,,0,14590,BAO_0000019,15357
,,,,,,,,U,,,22224,CHEMBL630448,1,A,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),Autocuration,,,0,14591,BAO_0000019,2869
,,,,,,,,U,,,22224,CHEMBL630449,1,A,Catalytic rate constant against phospholipase A2 was determined,Autocuration,,,0,14592,BAO_0000019,3484
,,,,,,,,U,,,22224,CHEMBL630450,1,A,"Compound was evaluated for catalytic constant, Kcat",Autocuration,,,0,14593,BAO_0000019,1373
,,,,,,,,U,,,22224,CHEMBL630451,1,A,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,Autocuration,,,0,14594,BAO_0000019,8142
,,,,,,,,U,,,22224,CHEMBL630452,1,A,Kcat calculated from 0.693/T1/2,Autocuration,,,0,14595,BAO_0000019,14131
,,,,,,,,U,,,22224,CHEMBL630453,1,A,Kcat was determined,Autocuration,,,0,14596,BAO_0000019,17269
,,,,,,,,U,,,22224,CHEMBL630454,1,A,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,Autocuration,,,0,14597,BAO_0000019,3485
,,,,,,,,U,,,22224,CHEMBL630455,1,A,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,Autocuration,,,0,14598,BAO_0000019,3485
,,,,,,,,U,,,22224,CHEMBL631487,1,A,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,Autocuration,,,0,14599,BAO_0000019,3485
,,,,,,,,U,,,22224,CHEMBL631488,1,A,Kcat value was determined,Autocuration,,,0,14600,BAO_0000019,5962
,,,,,,,,U,,,22224,CHEMBL876440,1,A,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,Autocuration,,,0,14601,BAO_0000019,3133
,,,,,,,,U,,,22224,CHEMBL631489,1,A,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,Autocuration,,,0,14602,BAO_0000019,3133
,,,,,,,,U,,,22224,CHEMBL857742,1,A,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",Autocuration,,,0,14603,BAO_0000019,2276
,,,,,,,,U,,,22224,CHEMBL631490,1,A,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",Autocuration,,,0,14604,BAO_0000019,2276
,,,,,,,,U,,,22224,CHEMBL631491,1,A,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",Autocuration,,,0,14605,BAO_0000019,2276
,,,,,,,,U,,,22224,CHEMBL631492,1,A,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",Autocuration,,,0,14606,BAO_0000019,2276
,,,,,,,,U,,,22224,CHEMBL631493,1,A,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",Autocuration,,,0,14607,BAO_0000019,2276
,,,,,,,,U,,,22224,CHEMBL631494,1,A,Kinetic parameter for rate of conversion to PABA was determined,Autocuration,,,0,14608,BAO_0000019,4892
,,,,,,,,U,,,22224,CHEMBL631495,1,A,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,Autocuration,,,0,14609,BAO_0000019,3133
,10116.0,,Rattus norvegicus,Feces,,,,N,,,50597,CHEMBL631496,1,A,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Intermediate,,1988.0,1,14610,BAO_0000218,11488
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631497,1,A,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Intermediate,,1088.0,1,14611,BAO_0000218,11488
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631498,1,A,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Intermediate,,1088.0,1,14612,BAO_0000218,11488
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL629776,1,A,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Intermediate,,1088.0,1,14613,BAO_0000218,11488
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL629777,1,A,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Intermediate,,1088.0,1,14614,BAO_0000218,11488
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL629778,1,A,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Intermediate,,1088.0,1,14615,BAO_0000218,11488
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630456,1,A,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,Intermediate,,,1,14616,BAO_0000218,11488
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630457,1,A,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,Intermediate,,,1,14617,BAO_0000218,11488
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630458,1,A,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,Intermediate,,,1,14618,BAO_0000218,11488
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630459,1,A,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,Intermediate,,,1,14619,BAO_0000218,11488
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630460,1,A,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,Intermediate,,,1,14620,BAO_0000218,11488
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL876550,1,A,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,Intermediate,,,1,14621,BAO_0000218,11488
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630461,1,A,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,Intermediate,,,1,14622,BAO_0000218,11488
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630462,1,A,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,Intermediate,,,1,14623,BAO_0000218,11488
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630463,1,A,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,Intermediate,,,1,14624,BAO_0000218,11488
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630464,1,A,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,Intermediate,,,1,14625,BAO_0000218,11488
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630465,1,A,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,Intermediate,,,1,14626,BAO_0000218,11488
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630466,1,A,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,Intermediate,,,1,14627,BAO_0000218,11488
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630467,1,A,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,Intermediate,,,1,14628,BAO_0000218,11488
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630633,1,A,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,Intermediate,,,1,14629,BAO_0000218,11488
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630634,1,A,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,Intermediate,,,1,14630,BAO_0000218,11488
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630635,1,A,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,Intermediate,,,1,14631,BAO_0000218,11488
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630636,1,A,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,Intermediate,,,1,14632,BAO_0000218,11488
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630637,1,A,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,Intermediate,,,1,14633,BAO_0000218,11488
,9986.0,,Oryctolagus cuniculus,Feces,,,,N,,,50592,CHEMBL630638,1,A,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Intermediate,,1988.0,1,14634,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Feces,,,,N,,,50592,CHEMBL630639,1,A,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Intermediate,,1988.0,1,14635,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Feces,,,,N,,,50592,CHEMBL630640,1,A,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Intermediate,,1988.0,1,14636,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Feces,,,,N,,,50592,CHEMBL876551,1,A,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Intermediate,,1988.0,1,14637,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL630641,1,A,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",Intermediate,,1088.0,1,14638,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL630642,1,A,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Intermediate,,1088.0,1,14639,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL630643,1,A,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Intermediate,,1088.0,1,14640,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL630644,1,A,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Intermediate,,1088.0,1,14641,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL630645,1,A,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Intermediate,,1088.0,1,14642,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Feces,,,,N,,,50592,CHEMBL625599,1,A,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Intermediate,,1988.0,1,14643,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Feces,,,,N,,,50592,CHEMBL625600,1,A,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Intermediate,,1988.0,1,14644,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Feces,,,,N,,,50592,CHEMBL625601,1,A,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Intermediate,,1988.0,1,14645,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Feces,,,,N,,,50592,CHEMBL625602,1,A,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Intermediate,,1988.0,1,14646,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL627470,1,A,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",Intermediate,,1088.0,1,14647,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL627471,1,A,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Intermediate,,1088.0,1,14648,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL627472,1,A,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Intermediate,,1088.0,1,14649,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL627473,1,A,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Intermediate,,1088.0,1,14650,BAO_0000218,7132
,9986.0,,Oryctolagus cuniculus,Urine,,,,N,,,50592,CHEMBL627474,1,A,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Intermediate,,1088.0,1,14651,BAO_0000218,7132
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627475,1,A,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,In vivo,178.0,1,14652,BAO_0000218,13925
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL627476,1,A,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,In vivo,178.0,1,14653,BAO_0000218,13925
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627477,1,A,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Intermediate,,1088.0,1,14654,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627478,1,A,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Intermediate,,1088.0,1,14655,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627479,1,A,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Intermediate,,1088.0,1,14656,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627480,1,A,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Intermediate,,1088.0,1,14657,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627481,1,A,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Intermediate,,1088.0,1,14658,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627482,1,A,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Intermediate,,1088.0,1,14659,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL627483,1,A,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Intermediate,,1088.0,1,14660,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL875636,1,A,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Intermediate,,1088.0,1,14661,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL625764,1,A,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Intermediate,,1088.0,1,14662,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL625765,1,A,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Intermediate,,1088.0,1,14663,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL625766,1,A,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,Intermediate,,1088.0,1,14664,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL625767,1,A,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Intermediate,,1088.0,1,14665,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL625768,1,A,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Intermediate,,1088.0,1,14666,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL625769,1,A,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Intermediate,,1088.0,1,14667,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL625770,1,A,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Intermediate,,1088.0,1,14668,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL625771,1,A,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Intermediate,,1088.0,1,14669,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL625772,1,A,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,Intermediate,,1088.0,1,14670,BAO_0000218,12582
,9615.0,,Canis lupus familiaris,Urine,,,,N,,,50588,CHEMBL625773,1,A,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Intermediate,,1088.0,1,14671,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL625774,1,A,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Intermediate,,1088.0,1,14672,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL625775,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,Intermediate,,1088.0,1,14673,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL625776,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Intermediate,,1088.0,1,14674,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL625777,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Intermediate,,1088.0,1,14675,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL625778,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Intermediate,,1088.0,1,14676,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL625779,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,Intermediate,,1088.0,1,14677,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL625780,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,Intermediate,,1088.0,1,14678,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL625781,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Intermediate,,1088.0,1,14679,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL875637,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,Intermediate,,1088.0,1,14680,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626473,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Intermediate,,1088.0,1,14681,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626474,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,Intermediate,,1088.0,1,14682,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626475,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Intermediate,,1088.0,1,14683,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626476,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,Intermediate,,1088.0,1,14684,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL634397,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Intermediate,,1088.0,1,14685,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL626477,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,Intermediate,,1088.0,1,14686,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631069,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Intermediate,,1088.0,1,14687,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631070,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,Intermediate,,1088.0,1,14688,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631071,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Intermediate,,1088.0,1,14689,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631072,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,Intermediate,,1088.0,1,14690,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631073,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Intermediate,,1088.0,1,14691,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631074,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,Intermediate,,1088.0,1,14692,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631075,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,Intermediate,,1088.0,1,14693,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631725,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Intermediate,,1088.0,1,14694,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631726,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,Intermediate,,1088.0,1,14695,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631727,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,Intermediate,,1088.0,1,14696,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631728,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Intermediate,,1088.0,1,14697,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631729,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Intermediate,,1088.0,1,14698,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631730,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,Intermediate,,1088.0,1,14699,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631731,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,Intermediate,,1088.0,1,14700,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631910,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Intermediate,,1088.0,1,14701,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Hippocampus,,,,N,,,50597,CHEMBL631911,1,A,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,Intermediate,In vivo,10000000.0,1,14702,BAO_0000218,15413
,10116.0,,Rattus norvegicus,Hypothalamus,,,,N,,,50597,CHEMBL631912,1,A,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,Intermediate,In vivo,1898.0,1,14703,BAO_0000218,15413
,10116.0,,Rattus norvegicus,Hypothalamus,,,,N,,,50597,CHEMBL631913,1,A,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,Intermediate,In vivo,1898.0,1,14704,BAO_0000218,15413
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631914,1,A,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,178.0,1,14705,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631915,1,A,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,178.0,1,14706,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL875778,1,A,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,178.0,1,14707,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631916,1,A,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,178.0,1,14708,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631917,1,A,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,178.0,1,14709,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631918,1,A,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,178.0,1,14710,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631919,1,A,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,178.0,1,14711,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631920,1,A,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,178.0,1,14712,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631921,1,A,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,178.0,1,14713,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631922,1,A,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,178.0,1,14714,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL631923,1,A,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,178.0,1,14715,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631924,1,A,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,,1,14716,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630234,1,A,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,,1,14717,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630235,1,A,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,,1,14718,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630236,1,A,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,,1,14719,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630237,1,A,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,,1,14720,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630238,1,A,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,,1,14721,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630239,1,A,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,,1,14722,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630303,1,A,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,,1,14723,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630304,1,A,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,,1,14724,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630305,1,A,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,,1,14725,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL630306,1,A,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2113.0,1,14726,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL630307,1,A,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2113.0,1,14727,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL630308,1,A,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,2113.0,1,14728,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL630309,1,A,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2113.0,1,14729,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL629309,1,A,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2113.0,1,14730,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL629993,1,A,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2113.0,1,14731,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL629994,1,A,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2113.0,1,14732,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL629995,1,A,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,2113.0,1,14733,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL631993,1,A,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2113.0,1,14734,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL631994,1,A,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2113.0,1,14735,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL631995,1,A,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2113.0,1,14736,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL631996,1,A,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,2107.0,1,14737,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL631997,1,A,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2107.0,1,14738,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL631998,1,A,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2107.0,1,14739,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL631999,1,A,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2107.0,1,14740,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL632000,1,A,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,2107.0,1,14741,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL632001,1,A,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2107.0,1,14742,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL874424,1,A,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2107.0,1,14743,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL632002,1,A,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2107.0,1,14744,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL632003,1,A,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2107.0,1,14745,BAO_0000218,12017
,,,,,,,,U,,,22224,CHEMBL632004,1,A,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,Autocuration,,,0,14746,BAO_0000019,3133
,,,,,,,,U,,,22224,CHEMBL632005,1,A,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,Autocuration,,,0,14747,BAO_0000019,2742
,,,,,,,,U,,,22224,CHEMBL632006,1,A,Compound was tested for amidase rate in the presence of N62C screen enzyme,Autocuration,,,0,14748,BAO_0000019,2742
,,,,,,,,U,,,22224,CHEMBL632007,1,A,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,Autocuration,,,0,14749,BAO_0000019,2742
,,,,,,,,U,,,22224,CHEMBL632008,1,A,Compound was tested for amidase rate in the presence of S166C screen enzyme,Autocuration,,,0,14750,BAO_0000019,2742
,,,,,,,,U,,,22224,CHEMBL632009,1,A,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,Autocuration,,,0,14751,BAO_0000019,2742
,,,,,,,,U,,,22224,CHEMBL632010,1,A,Compound was tested for esterase rate in the presence of N62C screen enzyme,Autocuration,,,0,14752,BAO_0000019,2742
,,,,,,,,U,,,22224,CHEMBL857750,1,A,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,Autocuration,,,0,14753,BAO_0000019,2742
,,,,,,,,U,,,22224,CHEMBL632011,1,A,Compound was tested for esterase rate in the presence of S166C screen enzyme,Autocuration,,,0,14754,BAO_0000019,2742
,,,,,,,,U,,,22224,CHEMBL632012,1,A,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",Autocuration,,,0,14755,BAO_0000019,2276
,,,,,,,,U,,,22224,CHEMBL632013,1,A,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",Autocuration,,,0,14756,BAO_0000019,2276
,,,,,,,,U,,,22224,CHEMBL632014,1,A,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",Autocuration,,,0,14757,BAO_0000019,2276
,,,,,,,,U,,,22224,CHEMBL629622,1,A,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",Autocuration,,,0,14758,BAO_0000019,2276
,,,,,,,,U,,,22224,CHEMBL629623,1,A,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",Autocuration,,,0,14759,BAO_0000019,2276
,,,,,,,,U,,,22224,CHEMBL629624,1,A,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",Autocuration,,,0,14760,BAO_0000019,2276
,,,,,,,,U,,,22224,CHEMBL629625,1,A,Ratio of Kcat to that of Km was determined,Autocuration,,,0,14761,BAO_0000019,17269
,,,,,,,,U,,,22224,CHEMBL629626,1,A,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",Autocuration,,,0,14762,BAO_0000019,2276
,,,,,,,,U,,,22224,CHEMBL629627,1,A,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",Autocuration,,,0,14763,BAO_0000019,2276
,,,,,,,,U,,,22224,CHEMBL629628,1,A,"Compound was evaluated for constant, Kd",Autocuration,,,0,14764,BAO_0000019,15917
,,,,,,,,U,,,22224,CHEMBL629629,1,A,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,Autocuration,,,0,14765,BAO_0000019,10933
,,,,,,,,U,,,22224,CHEMBL629630,1,A,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,Autocuration,,,0,14766,BAO_0000019,10933
,,,,,,,,U,,,22224,CHEMBL856030,1,A,Dissociation Constant of compound determined,Autocuration,,,0,14767,BAO_0000019,14293
,,,,,,,,U,,,22224,CHEMBL629631,1,B,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,Autocuration,,,0,14768,BAO_0000019,6698
,,,,,,,,U,,,22224,CHEMBL629632,1,B,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,Autocuration,,,0,14769,BAO_0000019,6698
,,,,,,,,U,,,22224,CHEMBL629633,1,P,Dissociation constant of compound with Fructose was determined,Autocuration,,,0,14770,BAO_0000100,4318
,,,,,,,,U,,,22224,CHEMBL629634,1,P,Dissociation constant of compound with Fructose was determined; Not determined,Autocuration,,,0,14771,BAO_0000100,4318
,,,,,,,,U,,,22224,CHEMBL629635,1,P,Dissociation constant of compound with Lactulose was determined,Autocuration,,,0,14772,BAO_0000100,4318
,,,,,,,,U,,,22224,CHEMBL629636,1,P,Dissociation constant of compound with Lactulose was determined; Not determined,Autocuration,,,0,14773,BAO_0000100,4318
,,,,,,,,U,,,22224,CHEMBL629637,1,P,Dissociation constant of the Compound,Autocuration,,,0,14774,BAO_0000100,14959
,,,,,,,,U,,,22224,CHEMBL629638,1,P,Dissociation constant by non-linear regression analysis,Autocuration,,,0,14775,BAO_0000100,5913
,,,,,,,,U,,,22224,CHEMBL629639,1,P,Dissociation constant was determined,Autocuration,,,0,14776,BAO_0000100,14218
,,,,,,,,U,,,22224,CHEMBL629640,1,P,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,Autocuration,,,0,14777,BAO_0000100,10689
,,,,,,,,U,,,22224,CHEMBL629641,1,P,Dissociation constant was determined,Autocuration,,,0,14778,BAO_0000100,13925
,,,,,,,,U,,,22224,CHEMBL631344,1,P,Dissociation constant was determined,Autocuration,,,0,14779,BAO_0000100,16359
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL631345,1,A,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,Intermediate,,2385.0,1,14780,BAO_0000218,10944
,,,,,,,,U,,,22224,CHEMBL631346,1,A,The dissociation constant determined by fluorescence displacement assay,Autocuration,,,0,14781,BAO_0000019,11080
,,,,,,,,U,,,22224,CHEMBL631524,1,A,kd value surface plasmon resonance (SPR) method,Autocuration,,,0,14782,BAO_0000019,17805
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL631525,1,A,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,Intermediate,,2385.0,1,14783,BAO_0000218,10944
,,,,,,,,U,,,22224,CHEMBL631526,1,F,First dissociation constant of the binding of compound to V30M TTR,Autocuration,,,0,14784,BAO_0000019,16645
,,,,,,,,U,,,22224,CHEMBL631527,1,F,Second dissociation constant of the binding of compound to V30M TTR,Autocuration,,,0,14785,BAO_0000019,16645
,,,,,,,,U,,,22224,CHEMBL631528,1,A,"Compound was evaluated for equilibrium constant, Ke",Autocuration,,,0,14786,BAO_0000019,7793
,,,,Hypothalamus,,,,U,,,22224,CHEMBL631529,1,A,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,Autocuration,,1898.0,0,14787,BAO_0000019,12199
,,,,Hypothalamus,,,,U,,,22224,CHEMBL631530,1,A,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,Autocuration,,1898.0,0,14788,BAO_0000019,12199
,,,,,,,,U,,,22224,CHEMBL631531,1,A,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,Autocuration,,,0,14789,BAO_0000019,9680
,,,,,,,,U,,,22224,CHEMBL631532,1,A,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,Autocuration,,,0,14790,BAO_0000019,9680
,,,,,,,,U,,,22224,CHEMBL631533,1,A,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,Autocuration,,,0,14791,BAO_0000019,9680
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL876552,1,A,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Intermediate,,,1,14792,BAO_0000218,13758
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL631534,1,A,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,Intermediate,,,1,14793,BAO_0000218,13758
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL631535,1,A,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Intermediate,,,1,14794,BAO_0000218,13758
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL631536,1,A,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Intermediate,,,1,14795,BAO_0000218,13758
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL631537,1,A,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,Intermediate,,,1,14796,BAO_0000218,13758
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL631538,1,A,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,Intermediate,,,1,14797,BAO_0000218,13758
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL631539,1,A,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,Intermediate,,,1,14798,BAO_0000218,13758
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL631540,1,A,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Intermediate,,,1,14799,BAO_0000218,13758
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625637,1,A,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,,,1,14800,BAO_0000218,14393
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625638,1,A,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Intermediate,,,1,14801,BAO_0000218,14393
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL625639,1,A,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",Intermediate,,,1,14802,BAO_0000218,15078
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL625640,1,A,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,In vivo,955.0,1,14803,BAO_0000218,13925
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL625641,1,A,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,In vivo,955.0,1,14804,BAO_0000218,13925
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL625642,1,A,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,In vivo,948.0,1,14805,BAO_0000218,13925
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL625643,1,A,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,In vivo,948.0,1,14806,BAO_0000218,13925
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL625644,1,A,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,In vivo,2113.0,1,14807,BAO_0000218,13925
,10116.0,,Rattus norvegicus,Kidney,,,,N,,,50597,CHEMBL625645,1,A,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,In vivo,2113.0,1,14808,BAO_0000218,13925
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625646,1,A,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,In vivo,2107.0,1,14809,BAO_0000218,13925
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625647,1,A,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,In vivo,2107.0,1,14810,BAO_0000218,13925
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL625648,1,A,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,In vivo,2048.0,1,14811,BAO_0000218,13925
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL625649,1,A,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,Intermediate,In vivo,2048.0,1,14812,BAO_0000218,13925
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL625650,1,A,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,In vivo,2385.0,1,14813,BAO_0000218,13925
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL625651,1,A,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,In vivo,2385.0,1,14814,BAO_0000218,13925
,10116.0,,Rattus norvegicus,Zone of skin,,,,N,,,50597,CHEMBL625652,1,A,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,In vivo,14.0,1,14815,BAO_0000218,13925
,10116.0,,Rattus norvegicus,Zone of skin,,,,N,,,50597,CHEMBL625653,1,A,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,In vivo,14.0,1,14816,BAO_0000218,13925
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL625654,1,A,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,In vivo,2106.0,1,14817,BAO_0000218,13925
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL625655,1,A,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Intermediate,In vivo,2106.0,1,14818,BAO_0000218,13925
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625656,1,A,Biodistribution of Compound in rat blood after 15 minutes of administration,Intermediate,In vivo,178.0,1,14819,BAO_0000218,9712
,10116.0,,Rattus norvegicus,Blood,,,,N,,,50597,CHEMBL625657,1,A,Biodistribution of Compound in rat blood after 2 minutes of administration,Intermediate,In vivo,178.0,1,14820,BAO_0000218,9712
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL625658,1,A,Biodistribution of Compound in rat brain after 15 minutes of administration,Intermediate,In vivo,955.0,1,14821,BAO_0000218,9712
,10116.0,,Rattus norvegicus,Brain,,,,N,,,50597,CHEMBL625659,1,A,Biodistribution of Compound in rat brain after 2 minutes of administration,Intermediate,In vivo,955.0,1,14822,BAO_0000218,9712
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL625660,1,A,Biodistribution of Compound in rat heart after 15 minutes of administration,Intermediate,In vivo,948.0,1,14823,BAO_0000218,9712
,10116.0,,Rattus norvegicus,Heart,,,,N,,,50597,CHEMBL625661,1,A,Biodistribution of Compound in rat heart after 2 minutes of administration,Intermediate,In vivo,948.0,1,14824,BAO_0000218,9712
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625662,1,A,Biodistribution of Compound in rat liver after 15 minutes of administration,Intermediate,In vivo,2107.0,1,14825,BAO_0000218,9712
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL625663,1,A,Biodistribution of Compound in rat liver after 2 minutes of administration,Intermediate,In vivo,2107.0,1,14826,BAO_0000218,9712
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL875621,1,A,Biodistribution of Compound in rat lung after 15 minutes of administration,Intermediate,In vivo,2048.0,1,14827,BAO_0000218,9712
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL628382,1,A,Biodistribution of Compound in rat lung after 2 minutes of administration,Intermediate,In vivo,2048.0,1,14828,BAO_0000218,9712
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL628383,1,A,Biodistribution of Compound in rat muscle after 15 minutes of administration,Intermediate,In vivo,2385.0,1,14829,BAO_0000218,9712
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL628384,1,A,Biodistribution of Compound in rat muscle after 2 minutes of administration,Intermediate,In vivo,2385.0,1,14830,BAO_0000218,9712
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628385,1,A,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,Intermediate,,,1,14831,BAO_0000218,13925
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875753,1,A,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,Intermediate,,,1,14832,BAO_0000218,13925
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628386,1,A,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,Intermediate,,,1,14833,BAO_0000218,13925
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628387,1,A,Organ distribution in rat blood 2 minutes after intravenous injection,Intermediate,,,1,14834,BAO_0000218,6941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628388,1,A,Organ distribution in rat blood 2 hr after intravenous injection,Intermediate,,,1,14835,BAO_0000218,6941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628389,1,A,Organ distribution in rat blood 30 minutes after intravenous injection,Intermediate,,,1,14836,BAO_0000218,6941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL632756,1,A,Organ distribution in rat blood 30 min after intravenous injection,Intermediate,,,1,14837,BAO_0000218,6941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628390,1,A,Organ distribution in rat brain 2 minutes after intravenous injection,Intermediate,,,1,14838,BAO_0000218,6941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631811,1,A,Organ distribution in rat brain 2 hr after intravenous injection,Intermediate,,,1,14839,BAO_0000218,6941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631812,1,A,Organ distribution in rat brain 30 minutes after intravenous injection,Intermediate,,,1,14840,BAO_0000218,6941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631813,1,A,Organ distribution in rat heart 2 minutes after intravenous injection,Intermediate,,,1,14841,BAO_0000218,6941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631814,1,A,Organ distribution in rat heart 2 hr after intravenous injection,Intermediate,,,1,14842,BAO_0000218,6941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631815,1,A,Organ distribution in rat heart 30 minutes after intravenous injection,Intermediate,,,1,14843,BAO_0000218,6941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631816,1,A,Organ distribution in rat kidney 2 minutes after intravenous injection,Intermediate,,,1,14844,BAO_0000218,6941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL875758,1,A,Organ distribution in rat kidney 2 hr after intravenous injection,Intermediate,,,1,14845,BAO_0000218,6941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631817,1,A,Organ distribution in rat kidney 30 minutes after intravenous injection,Intermediate,,,1,14846,BAO_0000218,6941
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL631818,1,A,Organ distribution in rat liver 2 minutes after intravenous injection,Intermediate,,2107.0,1,14847,BAO_0000218,6941
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL631819,1,A,Organ distribution in rat liver 2 hr after intravenous injection,Intermediate,,2107.0,1,14848,BAO_0000218,6941
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL631820,1,A,Organ distribution in rat liver 30 minutes after intravenous injection,Intermediate,,2107.0,1,14849,BAO_0000218,6941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631821,1,A,Organ distribution in rat lung 2 minutes after intravenous injection,Intermediate,,,1,14850,BAO_0000218,6941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631822,1,A,Organ distribution in rat lung 2 hr after intravenous injection,Intermediate,,,1,14851,BAO_0000218,6941
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL631823,1,A,Organ distribution in rat lung 30 minutes after intravenous injection,Intermediate,,,1,14852,BAO_0000218,6941
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL631824,1,A,Organ distribution in rat muscle 2 minutes after intravenous injection,Intermediate,,2385.0,1,14853,BAO_0000218,6941
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL631825,1,A,Organ distribution in rat muscle 2 hr after intravenous injection,Intermediate,,2385.0,1,14854,BAO_0000218,6941
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL631826,1,A,Organ distribution in rat muscle 30 minutes after intravenous injection,Intermediate,,2385.0,1,14855,BAO_0000218,6941
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL631827,1,A,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),Intermediate,In vivo,,1,14856,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL631828,1,A,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),Intermediate,In vivo,,1,14857,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL631829,1,A,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),Intermediate,In vivo,,1,14858,BAO_0000218,14439
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL875759,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Intermediate,,1088.0,1,14859,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631830,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,Intermediate,,1088.0,1,14860,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631831,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,Intermediate,,1088.0,1,14861,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631832,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Intermediate,,1088.0,1,14862,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631833,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,Intermediate,,1088.0,1,14863,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631834,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Intermediate,,1088.0,1,14864,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631835,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,Intermediate,,1088.0,1,14865,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631836,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Intermediate,,1088.0,1,14866,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631837,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Intermediate,,1088.0,1,14867,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631838,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Intermediate,,1088.0,1,14868,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631839,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,Intermediate,,1088.0,1,14869,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631840,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,Intermediate,,1088.0,1,14870,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631841,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Intermediate,,1088.0,1,14871,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631842,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Intermediate,,1088.0,1,14872,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631843,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Intermediate,,1088.0,1,14873,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631844,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Intermediate,,1088.0,1,14874,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631845,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Intermediate,,1088.0,1,14875,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631846,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Intermediate,,1088.0,1,14876,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL875760,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Intermediate,,1088.0,1,14877,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL632199,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Intermediate,,1088.0,1,14878,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631847,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Intermediate,,1088.0,1,14879,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL631848,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Intermediate,,1088.0,1,14880,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628707,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Intermediate,,1088.0,1,14881,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628708,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Intermediate,,1088.0,1,14882,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628709,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Intermediate,,1088.0,1,14883,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628710,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Intermediate,,1088.0,1,14884,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628711,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Intermediate,,1088.0,1,14885,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628712,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Intermediate,,1088.0,1,14886,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628713,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Intermediate,,1088.0,1,14887,BAO_0000218,12582
,10116.0,,Rattus norvegicus,Urine,,,,N,,,50597,CHEMBL628714,1,A,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Intermediate,,1088.0,1,14888,BAO_0000218,12582
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL628715,1,A,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",Intermediate,,,1,14889,BAO_0000218,7415
,,,,,,,,U,,,22224,CHEMBL629179,1,A,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,Autocuration,,,0,14890,BAO_0000019,7313
,,,,,,,,U,,,22224,CHEMBL629180,1,A,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,Autocuration,,,0,14891,BAO_0000019,7313
,,,,,,,,U,,,22224,CHEMBL875108,1,A,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,Autocuration,,,0,14892,BAO_0000019,7313
,,,,Adrenal cortex,,,,U,,,22224,CHEMBL629181,1,A,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,Autocuration,,1235.0,0,14893,BAO_0000019,7570
,,,,Adrenal cortex,,,,U,,,22224,CHEMBL629182,1,A,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,Autocuration,,1235.0,0,14894,BAO_0000019,7570
,,,,,,,,U,,,22224,CHEMBL629183,1,A,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,Autocuration,,,0,14895,BAO_0000019,7570
,,,,,,,,U,,,22224,CHEMBL629184,1,A,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,Autocuration,,,0,14896,BAO_0000019,7570
,,,,Adrenal cortex,,,,U,,,22224,CHEMBL629185,1,A,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,Autocuration,,1235.0,0,14897,BAO_0000019,7570
,,,,Adrenal cortex,,,,U,,,22224,CHEMBL629186,1,A,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,Autocuration,,1235.0,0,14898,BAO_0000019,7570
,,,,,,,,U,,,22224,CHEMBL629187,1,A,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,Autocuration,,,0,14899,BAO_0000019,7570
,,,,,,,,U,,,22224,CHEMBL629887,1,A,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,Autocuration,,,0,14900,BAO_0000019,7570
,,,,,,,,U,,,22224,CHEMBL629888,1,A,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,Autocuration,,,0,14901,BAO_0000019,7570
,,,,,,,,U,,,22224,CHEMBL629889,1,A,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,Autocuration,,,0,14902,BAO_0000019,7570
,,,,Adrenal cortex,,,,U,,,22224,CHEMBL629890,1,A,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,Autocuration,,1235.0,0,14903,BAO_0000019,7570
,,,,,,,,U,,,22224,CHEMBL629891,1,A,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,Autocuration,,,0,14904,BAO_0000019,7570
,,,,,,,,U,,,22224,CHEMBL629892,1,A,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,Autocuration,,,0,14905,BAO_0000019,7570
,,,,Adrenal cortex,,,,U,,,22224,CHEMBL629893,1,A,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,Autocuration,,1235.0,0,14906,BAO_0000019,7570
,,,,,,,,U,,,22224,CHEMBL629894,1,A,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,Autocuration,,,0,14907,BAO_0000019,7570
,,,,,,,,U,,,22224,CHEMBL629895,1,A,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,Autocuration,,,0,14908,BAO_0000019,7570
,9615.0,,Canis lupus familiaris,,,,,U,,,22224,CHEMBL875109,1,A,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",Autocuration,In vivo,,0,14909,BAO_0000218,14122
,9541.0,,Macaca fascicularis,,,,,U,,,22224,CHEMBL629896,1,A,Absolute bioavailability in male cynomolgus monkeys,Autocuration,In vivo,,0,14910,BAO_0000218,16449
,10116.0,,Rattus norvegicus,,,,,U,,,22224,CHEMBL629897,1,A,Absolute bioavailability in maleSprague-Dawley rats,Autocuration,In vivo,,0,14911,BAO_0000218,16449
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL629898,1,A,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,2107.0,1,14912,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL630057,1,A,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2107.0,1,14913,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Liver,,,,N,,,50597,CHEMBL630058,1,A,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2107.0,1,14914,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL630059,1,A,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2048.0,1,14915,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL630060,1,A,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2048.0,1,14916,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL630061,1,A,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,2048.0,1,14917,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL630062,1,A,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2048.0,1,14918,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL630063,1,A,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2048.0,1,14919,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL630064,1,A,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2048.0,1,14920,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL630065,1,A,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2048.0,1,14921,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL630066,1,A,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,2048.0,1,14922,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL630067,1,A,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2048.0,1,14923,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Lung,,,,N,,,50597,CHEMBL630068,1,A,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2048.0,1,14924,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL631113,1,A,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2385.0,1,14925,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL631114,1,A,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2385.0,1,14926,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL631115,1,A,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,2385.0,1,14927,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL631116,1,A,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2385.0,1,14928,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL630528,1,A,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2385.0,1,14929,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL630529,1,A,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2385.0,1,14930,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL630530,1,A,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2385.0,1,14931,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL630531,1,A,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,2385.0,1,14932,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL630532,1,A,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2385.0,1,14933,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Muscle tissue,,,,N,,,50597,CHEMBL630533,1,A,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2385.0,1,14934,BAO_0000218,12017
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL630534,1,A,Biodistribution in normal mice blood after 120 hr,Intermediate,In vivo,178.0,1,14935,BAO_0000218,15045
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL630535,1,A,Biodistribution in normal mice blood after 24 hr,Intermediate,In vivo,178.0,1,14936,BAO_0000218,15045
,10090.0,,Mus musculus,Blood,,,,N,,,50594,CHEMBL630536,1,A,Biodistribution in normal mice blood after 4 hr,Intermediate,In vivo,178.0,1,14937,BAO_0000218,15045
,10090.0,,Mus musculus,Bone,,,,N,,,50594,CHEMBL630537,1,A,Biodistribution in normal mice bone after 120 hr,Intermediate,In vivo,10000001.0,1,14938,BAO_0000218,15045
,10090.0,,Mus musculus,Bone,,,,N,,,50594,CHEMBL630538,1,A,Biodistribution in normal mice bone after 24 hr,Intermediate,In vivo,10000001.0,1,14939,BAO_0000218,15045
,10090.0,,Mus musculus,Bone,,,,N,,,50594,CHEMBL630539,1,A,Biodistribution in normal mice bone after 4 hr,Intermediate,In vivo,10000001.0,1,14940,BAO_0000218,15045
,10090.0,,Mus musculus,Heart,,,,N,,,50594,CHEMBL630540,1,A,Biodistribution in normal mice heart after 120 hr,Intermediate,In vivo,948.0,1,14941,BAO_0000218,15045
,10090.0,,Mus musculus,Heart,,,,N,,,50594,CHEMBL630541,1,A,Biodistribution in normal mice heart after 24 hr,Intermediate,In vivo,948.0,1,14942,BAO_0000218,15045
,10090.0,,Mus musculus,Heart,,,,N,,,50594,CHEMBL630542,1,A,Biodistribution in normal mice heart after 4 hr,Intermediate,In vivo,948.0,1,14943,BAO_0000218,15045
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL630543,1,A,Biodistribution in normal mice kidney after 120 hr,Intermediate,In vivo,2113.0,1,14944,BAO_0000218,15045
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL630544,1,A,Biodistribution in normal mice kidney after 24 hr,Intermediate,In vivo,2113.0,1,14945,BAO_0000218,15045
,10090.0,,Mus musculus,Kidney,,,,N,,,50594,CHEMBL630545,1,A,Biodistribution in normal mice kidney after 4 hr,Intermediate,In vivo,2113.0,1,14946,BAO_0000218,15045
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL630546,1,A,Biodistribution in normal mice liver after 120 hr,Intermediate,In vivo,2107.0,1,14947,BAO_0000218,15045
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL630547,1,A,Biodistribution in normal mice liver after 24 hr,Intermediate,In vivo,2107.0,1,14948,BAO_0000218,15045
,10090.0,,Mus musculus,Liver,,,,N,,,50594,CHEMBL630548,1,A,Biodistribution in normal mice liver after 4 hr,Intermediate,In vivo,2107.0,1,14949,BAO_0000218,15045
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL630549,1,A,Biodistribution in normal mice spleen after 120 hr,Intermediate,In vivo,2106.0,1,14950,BAO_0000218,15045
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL630550,1,A,Biodistribution in normal mice spleen after 24 hr,Intermediate,In vivo,2106.0,1,14951,BAO_0000218,15045
,10090.0,,Mus musculus,Spleen,,,,N,,,50594,CHEMBL876426,1,A,Biodistribution in normal mice spleen after 4 hr,Intermediate,In vivo,2106.0,1,14952,BAO_0000218,15045
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL630551,1,A,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2106.0,1,14953,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL630552,1,A,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2106.0,1,14954,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL630553,1,A,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,2106.0,1,14955,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL630554,1,A,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2106.0,1,14956,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL630555,1,A,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2106.0,1,14957,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL630556,1,A,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2106.0,1,14958,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL630557,1,A,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2106.0,1,14959,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL630558,1,A,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Intermediate,In vivo,2106.0,1,14960,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL630559,1,A,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2106.0,1,14961,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Spleen,,,,N,,,50597,CHEMBL630560,1,A,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2106.0,1,14962,BAO_0000218,12017
,10116.0,,Rattus norvegicus,Thyroid gland,,,,N,,,50597,CHEMBL876427,1,A,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Intermediate,In vivo,2046.0,1,14963,BAO_0000218,12017
,10116.0,,Rattus norvegicus,,,,,N,,,50597,CHEMBL630561,1,A,The Kel values in female wistar rats.,Intermediate,,,1,14964,BAO_0000218,14941
,,,,,,,,U,,,22224,CHEMBL630562,1,A,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,Autocuration,,,0,14965,BAO_0000019,4646
,,,,,,,,U,,,22224,CHEMBL630563,1,A,Hydrolysis rate constant of the compound,Autocuration,,,0,14966,BAO_0000019,8847
,,,,,,,,U,,,22229,CHEMBL629673,1,P,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,Autocuration,,,0,14967,BAO_0000100,11778
,,,,,,,,U,,,22224,CHEMBL629674,1,A,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",Autocuration,,,0,14968,BAO_0000019,2363
,,,,,,,,U,,,22224,CHEMBL629675,1,A,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",Autocuration,,,0,14969,BAO_0000019,2363
,,,,,,,,U,,,22224,CHEMBL629676,1,A,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",Autocuration,,,0,14970,BAO_0000019,2363
,,,,,,,,U,,,22224,CHEMBL629677,1,A,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",Autocuration,,,0,14971,BAO_0000019,2363
,,,,,,,,U,,,22224,CHEMBL629678,1,A,Apparent inactivation rate constant was evaluated,Autocuration,,,0,14972,BAO_0000019,8371
,,,,,,,,U,,,22224,CHEMBL629679,1,A,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,Autocuration,,,0,14973,BAO_0000019,14883
,,,,,,,,U,,,22224,CHEMBL629680,1,A,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,Autocuration,,,0,14974,BAO_0000019,14883
,,,,,,,,U,,,22224,CHEMBL629681,1,A,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,Autocuration,,,0,14975,BAO_0000019,4643
,,,,,,,,U,,,22224,CHEMBL629682,1,A,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,Autocuration,,,0,14976,BAO_0000019,3519
,,,,,,,,U,,,22224,CHEMBL629683,1,A,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,Autocuration,,,0,14977,BAO_0000019,10600
,,,,,,,,U,,,22224,CHEMBL629684,1,F,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,Autocuration,,,0,14978,BAO_0000019,8501
,,,,,,,,U,,,22224,CHEMBL629685,1,P,Dissociation constant was determined,Autocuration,,,0,14979,BAO_0000100,8505
,,,,,,,,U,,,22224,CHEMBL629686,1,P,Dissociation constant was determined,Autocuration,,,0,14980,BAO_0000100,9778
,,,,,,,,U,,,22224,CHEMBL872932,1,P,Dissociation constant at pH 7.4,Autocuration,,,0,14981,BAO_0000100,9778
,,,,,,,,U,,,22224,CHEMBL629687,1,P,Dissociation constant in presence of 1 mM dithiothreitol,Autocuration,,,0,14982,BAO_0000100,9778
,,,,,,,,U,,,22224,CHEMBL872931,1,A,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,Autocuration,,,0,14983,BAO_0000019,13007
,,,,,,,,U,,,22224,CHEMBL628151,1,A,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,Autocuration,,,0,14984,BAO_0000019,13007
,,,,,,,,U,,,22224,CHEMBL628152,1,A,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,Autocuration,,,0,14985,BAO_0000019,13007
,,,,,,,,U,,,22224,CHEMBL628153,1,A,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,Autocuration,,,0,14986,BAO_0000019,13007
,,,,,,,,U,,,22224,CHEMBL628154,1,A,Kinetic constant for aromatization of androstenedione,Autocuration,,,0,14987,BAO_0000019,11482
,,,,,,,,U,,,22224,CHEMBL628155,1,A,Kinetic constant for aromatization of testosterone,Autocuration,,,0,14988,BAO_0000019,11482
,,,,,,,,U,,,22224,CHEMBL628156,1,A,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,Autocuration,,,0,14989,BAO_0000019,2303
,,,,,,,,U,,,22224,CHEMBL628157,1,A,Local inhibition constant was determined,Autocuration,,,0,14990,BAO_0000019,11964
,4932.0,,Saccharomyces cerevisiae,,,,,N,,,50347,CHEMBL857533,1,A,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,Intermediate,,,1,14991,BAO_0000218,3140
,,,,,,,,U,,,22224,CHEMBL628158,1,P,Dissociation constant value of the compound,Autocuration,,,0,14992,BAO_0000100,10650
,,,,Cornea,,,,U,,,22224,CHEMBL628159,1,A,In vitro permeability through cornea without epithelium,Autocuration,,964.0,0,14993,BAO_0000019,4667
,,,,Cornea,,,,U,,,22224,CHEMBL875616,1,A,In vitro permeability through intact cornea,Autocuration,,964.0,0,14994,BAO_0000019,4667
,9986.0,,Oryctolagus cuniculus,Cornea,,,,N,,,50592,CHEMBL628160,1,A,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,Intermediate,,964.0,1,14995,BAO_0000218,9199
,,,,,,,,U,,,22224,CHEMBL628161,1,A,Rate of enzyme inactivation for the compound was determined,Autocuration,,,0,14996,BAO_0000019,11966
,,,,Cornea,,,,U,,,22224,CHEMBL628162,1,A,In vitro permeability through cornea without epithelium,Autocuration,,964.0,0,14997,BAO_0000019,4667
,,,,Cornea,,,,U,,,22224,CHEMBL628163,1,A,In vitro permeability through intact cornea,Autocuration,,964.0,0,14998,BAO_0000019,4667
,,,,,,,,U,,,22224,CHEMBL628164,1,A,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,14999,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL628165,1,A,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,15000,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL628166,1,A,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,15001,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL628167,1,A,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,15002,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL628168,1,A,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,15003,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL628169,1,A,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,15004,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL628170,1,A,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,15005,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL628171,1,A,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,15006,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL627434,1,A,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,15007,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL627435,1,A,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,15008,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL628110,1,A,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,15009,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL628111,1,A,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,15010,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL628112,1,A,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,15011,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL628260,1,A,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,15012,BAO_0000019,8354
,,,,,,,,U,,,22224,CHEMBL628261,1,A,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",Autocuration,,,0,15013,BAO_0000019,8354
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL628262,1,A,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),Intermediate,In vivo,,1,15014,BAO_0000218,14439
,9606.0,,Homo sapiens,,,,,N,,,50587,CHEMBL628263,1,A,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,Intermediate,In vivo,,1,15015,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL628264,1,A,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),Intermediate,In vivo,,1,15016,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL628265,1,A,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),Intermediate,In vivo,,1,15017,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL628266,1,A,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),Intermediate,In vivo,,1,15018,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL628267,1,A,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),Intermediate,In vivo,,1,15019,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL628268,1,A,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,Intermediate,In vivo,,1,15020,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL628269,1,A,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),Intermediate,In vivo,,1,15021,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL628270,1,A,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),Intermediate,In vivo,,1,15022,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL628271,1,A,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),Intermediate,In vivo,,1,15023,BAO_0000218,14439
,10090.0,,Mus musculus,,,,,N,,,50594,CHEMBL628272,1,A,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),Intermediate,In vivo,,1,15024,BAO_0000218,14439
